| ID | CAS | Name | Synonyms | Description |
|---|---|---|---|---|
| 1 | 101477-55-8 | Lomerizine | KB 2796 TERRANAS LOMERIZINE Lomerizine Lomerizine2HCl LOMERIZINE HCL LOMERIZINE DIHCL KB-2796 dihydrochloride Lomerizine hydrochloride Flometizine hydrochloride LOMERIZINE DIHYDROCHLORIDE N,N'-dibutylpropanediamide 1-[bis(4-fluorophenyl)methyl]-4-[2,3,4-trimethoxyphenylmethyl] 1-[bis(4-fluorophenyl)methyl]-4-(2,3,4-trimethoxybenzyl)piperazine 1-[bis(4-fluorophenyl)methyl]-4-[(2,3,4-trimethoxyphenyl)methyl]piperazine 1-(4,4'-Difluorobenzhydryl)-4-(2,3,4-trimethoxybenzyl)piperazine·dihydrochloride 1-[bis(4-fluorophenyl)methyl]-4-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride 1-(Bis(4-fluorophenyl)methyl)-4-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride | APIs;Organi;Aromatics;Inhibitors;Piperazine;Heterocycles;Raw materials;Neurochemicals;Pharmaceuticals;Organic raw materials |
| 2 | 1022150-57-7 | 6-((6-(1-methyl-1h-pyrazol-4-yl)-1,2,4-triazolo(4,3-b)pyridazin-3-yl)thio)quinoline | SGX523 SGX-523 SGX 523 SGX 523(SGX-523) 6-((6-(1-methyl-1h-pyrazol-4-yl)-1,2,4-triazolo(4,3-b)pyridazin-3-yl)thio)quinoline 6-[[6-(1-Methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]thio]quinoline 6-[[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl]quinoline Quinoline,6-[[6-(1-Methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]thio]- 6-[[6-(1-Methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]thio]quinoline SGX 523 | API;Quinoline;Inhibitors;Pharmaceutical intermediates |
| 3 | 1028486-01-2 | 4-{[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoic acid | MLN-823 MLN 8237 MLN8237 MLN-8237 ALISERTIB (MLN8237) Fluorocyclopentenylcytosine alisertib (auroura A kinase inhibitor) 4-((9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido-[4,5-e]azepin-2-yl)amino)-2-meth 4-{[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoic acid Benzoic acid, 4-[[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxy- MLN-8237 4-[[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid | API;Inhibitor;Inhibitors;Intermediates;Pharmaceuticals;Pharmaceutical intermediates;Intermediates & Fine Chemicals |
| 4 | 103639-04-9 | Ondansetron hydrochloride dihydrate | Zudan sn307 EMeset Zofran Osetron Zophren Zofran ODT Ondansetron HCl Paroxetine EP IMpurity A carbazol-4-one dihydrate ONDANSETRON HYDROCHLORIDE ondansetron hcl dihydrate ondansetron hydrochloride hydrate odansetron hydrochloride dihydrate Ondansetron hydrochloride dihydrate 9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one monohydrochloride 1,2,3,9-Tetrahydro-9-Methyl-3-[(2-Methyl-1H-iMidazol-1-yl)Methyl]-4H-carbazol-4-one Hydochloride 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1h-carbazol-4-one dihydrate hydrochloride 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-, monohydrochloride (+-)-2,3-dihydro-9-methyl-3-((2-methylimidazol-1-yl)methyl)carbazol-4(1h)-one monohydrochloride dihydrate 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one hydrochloride dihydrate 1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one hydrochloride dihydrate 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride dihydrate 4h-carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-, monohydrochloride, (+-)-, dihydrate | Amines;Inhibitors;Heterocycles;Inorganic salt;Pharmaceuticals;Serotonin receptor;Intermediates & Fine Chemicals;Inorganic Chemical Engineering;Active Pharmaceutical Ingredients |
| 5 | 105826-92-4 | tropisetron hydrochloride | Novaban SDZ-ICS 930 105826-92-4 Tropisetron HCl Tropisetron hydrochloride Tropiserton Hydrochloride tropisetron hydrochloride 3-TROPANYLINDOLE-3-CARBOXYLATE HYDROCHLORIDE 1H-Indole-3-carboxylic acid (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester hydrochloride (3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-INDOLE-3-CARBOXYLIC ACID ESTER MONOHYDROCHLORIDE | Ant;NAVOBAN;Serotonin;Heterocycles;Inorganic salt;Pharmaceuticals;Serotonin receptor;Intermediates & Fine Chemicals;Inorganic Chemical Engineering |
| 6 | 108605-62-5 | A77 1726 | SU 20 CS-862 A771726 A77 1726 A 771726 HMR 1726 Flucyamide Teriflunomide UNII-1C058IKG3B Malononitrilamide Teriflunomide [INN] Active metabolite of leflunomide Teriflunomide(Random Configuration) 2-Cyano-3-hydroxy-N-(4-trifluoromethylphenyl)cro N-(4-Trifluoromethylphenyl)-2-cyano-2-hydroxycrotonamide 2-Cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-butenamide 2-Cyano-3-hydroxy-N-(4'-trifluoromethylphenyl)-crotone amide 2-Butenamide, 2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)- (Z)-2-Cyano-alpha'alpha'alpha-trifluoro-3-hydroxy-p-crotonotoluidide (2Z)-2-[hydroxy-[4-(trifluoromethyl)anilino]methylidene]-3-oxobutanenitrile (2Z)-2-(hydroxy{[4-(trifluoromethyl)phenyl]amino}methylidene)-3-oxobutanenitrile (2Z)-2-[hydroxy-[[4-(trifluoromethyl)phenyl]amino]methylidene]-3-oxo-butanenitrile N-(4-Trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide, 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-beuteamide, LEF-M | Organic intermediates;Metabolites & Impurities;Tyrosine Kinase Inhibitors;Impurity reference substance;Various Metabolites and Impurities |
| 7 | 110221-44-8 | Temocapril hydrochloride | CS-622 Acecol TemocarpileHCL Temocapril Hcl Temocarpilhydrochloride Temocapril hydrochloride TEMOCAPRIL HYDROCHLORIDE Temocapril HCl and intermediates [(2S,6R)-6-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-5-oxo-2-(thiophen-2-yl)-1,4-thiazepan-4-yl]acetic acid (2S,6R)-6-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]tetrahydro-5-oxo-2-(2-thienyl)-1,4-thiazepine-4(5H)-acetic Acid Hydrochloride 1,4-Thiazepine-4(5H)-acetic acid, 6-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]tetrahydro-5-oxo-2-(2-thienyl)-, monohydrochloride, [2S-[2a,6b(R*)]]- 1,4-Thiazepine-4(5H)-acetic acid, 6-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]tetrahydro-5-oxo-2-(2-thienyl)-, monohydrochloride, (2S,6R)- (9CI) | Inhibitors;Inorganic salt;Pharmaceuticals;Intermediates & Fine Chemicals;Inorganic Chemical Engineering |
| 8 | 115007-34-6 | Mycophenolate mofetil | MMF Aids059828 Aids-059828 Mycophenolate Matimaikaofenzhi mmf cellcept(tm) Mycophenolate Ether Macophenolate Mofetil Mycophenolate mofetil Mycophenolate Mofetil COS Mycophenolate Mofetil(MMF) MycophenolicAcid-2-(4-Morpholinyl)ethylEster 2-Morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoate 6-[(7-hydroxy-5-methoxy-4-methyl-1-oxo-3h-isobenzofuran-6-yl)]-4-methyl-hex-4-enoic acid 2-morpholinoethyl ester 2-(morpholin-4-yl)ethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate 4-HEXENOIC ACID,6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-,2-(4-MORPHOLINYL)ETHYL ESTER 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (E)- | API;Compounds;Raw materials;Anti-cancer & immunity;Pharmaceutical raw drugs;Small molecule inhibitors;Analytical reagents-refere;Pharmaceutical raw materials;Pharmaceutical immunosuppressants |
| 9 | 1152311-62-0 | VX-661 | VX661 VX 661 VX-661 TEZACAFTOR 1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)indol-5-yl]cyclopropane-1-carboxamide 1-(2,2-Difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethylethyl)-1H-indol-5-yl]-cyclopropanecarboxamide 1-(2,2-Difluoro-1,3-benzodioxol-5-yl)-N-{1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(1-hydroxy-2-methyl-2-propanyl)-1H-indol-5-yl}cyclopropanecarboxamide Cyclopropanecarboxamide, 1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethylethyl)-1H-indol-5-yl]- (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-Methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxaMide 1-(2,2-Difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethylethyl)-1H-indol-5-yl]-cyclopropanecarboxamide VX661 | API;Inhibitors;Fine chemical products;Small molecule inhibitors;Pharmaceutical bulk drugs;Pharmaceutical raw materials;Membrane transport/ion channels;Small molecule inhibitors, natural products |
| 10 | 1170905-43-7 | 3-[2-(Boc-amino)ethyl]azetidine Hydrochloride | 3-[2-(BOC-AMINO)ETHYL]AZETIDINE HCL 3-Boc-aminoethylazetidine hydrochlordie 3-Boc-AMinoethylazetidine hydrochloride 3-[2-(Boc-aMino)ethyl]azetidine Hydrochloride 3-[2-(Boc-amino)ethyl]azetidine Hydrochloride tert-butyl 2-(azetidin-3-yl)ethylcarbamate HCl tert-Butyl 2-(3-azetidinyl)ethylcarbamate hydrochloride N-[2-(3-Azetidinyl)ethyl]-carbamic acid tert-butyl ester tert-butyl N-[2-(azetidin-3-yl)ethyl]carbamate hydrochloride | Intermediates;Pharmaceutical intermediates |
| 11 | 122647-32-9 | Ibutilide fumarate | D00648 Corvert (tn) Ibutibide Fumarate Ibulitide fumarate Ibutilide fumarate IBUTILIDE FUMRTATE Ibutilide fumarate (usan) N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide N-[4-[4-(ethyl-heptyl-amino)-1-hydroxy-butyl]phenyl]methanesulfonamide fumarate (±)-N-[4-[4-(Ethylheptylamino)-1-hydroxybutyl]phenyl]methanesulfonamide hemifumarate | ;Aromatics;Ion channels;Antiarrhythmic;Pharmaceuticals;Membrane transport;Cardiovascular APIs;Medicine intermediate;Pharmaceutical bulk drugs;Sulfur & Selenium Compounds |
| 12 | 1268524-70-4 | (6s)-6-(2-Tert-butoxy-2-oxoethyl)-4-(4-chlorophenyl)-2,3,9-trimethyl-6,7-dihydrothieno[3,2-F][1,2,4]triazolo[4,3-A][1,4]diazepin-10-ium | CS-799 (+)-JQ-1 BroModoMain Inhibitor, (+)-JQ1 (S)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-triMethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate (+)-JQ1,(S)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-triMethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate (S)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-triMethyl-6H-thienol[3,2-f][1,2,4]troazolo[4,3-a][1,4]diazepin-6-yl)acetate[(+)-6] (6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid 1,1-dimethylethyl ester (6s)-6-(2-Tert-butoxy-2-oxoethyl)-4-(4-chlorophenyl)-2,3,9-trimethyl-6,7-dihydrothieno[3,2-F][1,2,4]triazolo[4,3-A][1,4]diazepin-10-ium | Apis;Inhibitors;Epigenetics;Organic materials;Organic acid esters |
| 13 | 132810-10-7 | Blonanserin | AD-5423 Lonasen AD 5423 Bunanserin Blonanserin Blonansarin – Blonanserin-d8 HCl Blonanserin, AD-5423, Lonasen 6-broMo-4,8-dichloro-5-Methoxyquinoline 2-(4-Ethyl-1-piperazinyl)-4-(p-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine 2-(4-Ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine 2-(4-ethylpiperazin-1-yl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(1-fluorophenyl)-5,6,7,8,9,10-hexahydro- Cycloocta[B]Pyridine, 2-(4-Ethyl-1-Piperazinyl)-4-(4-Fluorophenyl)-5,6,7,8,9,10-Hexahydro- Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro- CYCLOOCTA[B]PYRIDINE, 2-(4-ETHYL-1-PIPERAZINYL)-4-(4-FLUOROPHENYL)-5,6,7,8,9,10-HEXAHYDRO- | APIs;Aromatics;Raw drugs;Heterocycles;Schizophrenia;Neural signals;Pharmaceuticals;Pharmaceutical bulk drugs;Small molecule inhibitors;Other biochemical reagents |
| 14 | 1374640-70-6 | CO-1686 | CO1686 CNX-419 CO-1686 AVL-301 ROCILETINIB Clovis CO-1686 N-[3-[[2-[[4-(4-Acetyl-1-piperazinyl)-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-2-propenamide | API;Inhibitors |
| 15 | 143664-11-3 | ELACRIDAR | GG 918 GW-918 GW 0918 GF120918 Elacridar elacridar ELACRIDAR GF-120918 GF 120918 n-[4-[2-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)ethyl]phenyl]-5-methoxy-9-oxo-10h-acridine-4-carboxamide N-{4-[2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl]phenyl}-5-methoxy-9-oxo-9,10-dihydroacridine-4-carboxamide N-[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamide 4-acridinecarboxamide, N-[4-[2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo- | ;Inhibitors;Miscellaneous;All Inhibitors;Pharmaceuticals;Cell biology reagents;Chemical raw materials;Small molecule inhibitors;Raw drugs and intermediates;Intermediates & Fine Chemicals |
| 16 | 144143-96-4 | Eprosartan mesylate | Eprosartan Myslate EPROSARTAN MESYLATE Eprosartan mesylate Eprosartan Methanesulfonate (E)-4-((2-butyl-5-(2-carboxy-3-(thiophen-2-yl)prop-1-enyl)-1H-imidazol-1-yl)methyl)benzoic acid 4-[[2-butyl-5-(2-carboxy-3-thiophen-2-yl-prop-1-enyl)-imidazol-1-yl]methyl]benzoic acid mesylate 4-({2-butyl-5-[(1E)-2-carboxy-2-(thiophen-2-ylMethyl)eth-1-en-1-yl]-1H-iMidazol-1-yl}Methyl)benzoic acid (E)-α-[[2-Butyl-1-[(4-carboxyphenyl)Methyl]-1H-iMidazol-5-yl]Methylene]-2-thiophenepropanoic Acid Methanesulfonate 4-({2-butyl-5-[(1E)-2-carboxy-3-thiophen-2-ylprop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid methanesulfonate (αE)-α-[[2-Butyl-1-[(4-carboxyphenyl)Methyl]-1H-iMidazol-5-yl]Methylene]-2-thiophenepropanoic Acid MonoMethanesulfonate | API;Inhibitors;Eprosartan;Organic raw materials;Carboxylic acid compounds |
| 17 | 144675-97-8 | Benz(g)isoquinoline-5,10-dione, 6,9-bis((2-aminoethyl)amino)-, (2Z)-2- butenedioate (1:2) | CS-1295 Pixolti Pixuvri BBR 2778 Bbr 2778 UNII-P0R64C4CR9 Pixantrone maleate BBR 2778 dimaleate Pixatrone dimaleate Pixantrone-dimaleate, BBR2778 dimaleate 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione di[(2E)-but-2-enedioate] | API;Inhibitors;Small molecule inhibitors;Pharmaceutical bulk drugs;Pharmaceutical intermediates;Small molecule inhibitors, natural products |
| 18 | 150683-30-0 | N-[4-(9-chloro-6-hydroxy-2-azabicyclo[5.4.0]undeca-8,10,12-triene-2-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide | SaMsca OPC 41061 Tolvaptan OPC-41061 Tolvaptan Tablets N-[4-[(5R)-7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl]-3-methylphenyl]-2-methylbenzamide N-{4-[(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl}-2-methylbenzamide N-[4-(9-chloro-6-hydroxy-2-azabicyclo[5.4.0]undeca-8,10,12-triene-2-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide N-(4-{[(5R)-7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl}-3-Methylphenyl)-2-MethylbenzaMide N-(4-{[(5R)-7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl}-3-methylphenyl)-2-methylbenzamide | Sa;APIs;Samsca;Tovaptan;Aromatics;Inhibitors;Intermediat;Heterocycles;Intermediates;Medical raw materials |
| 19 | 157212-55-0 | Bosentan monohydrate | CS-170 Bosetan Bosentan hydrate bosentan hydrate Bosentan (200 mg) Bosentan monohydrate Bosentan Hydrate See B675900 4-(tert-Butyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfona 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-Methoxyphenoxy)-2-(pyriMidin-2-yl)pyriMidin-4-yl]benzene-1-sulfonaMide 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)(2,2'-bipyrimidin)-4-yl)benzenesulfonamide monohydrate | API;Spot;Inhibitors;Medical raw material;Medical raw materials;Heterocyclic Compounds;Other scientific research bulk drugs;G protein coupled receptor & G protein;Small molecule inhibitors, natural pro |
| 20 | 162635-04-3 | Temsirolimus | C15182 CS-442 CCI-779 CCL-779 NSC 683864 Temsirolimus TeMsiroliMus (Torisel) temsirolimus 162635-04-3 TeMsiroliMus (CCI-779, Torisel) 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]rapamycin Rapamycin 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate rapaMycin 42-ester with 3-hydroxy-2-(hydroxyMethyl)-2-Methylpropionic acid 4-{2-[(7E,15Z,17E,19E)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate (1R,2R,5S)-5-{(2S)-2-[(3S,6R,7E,9R,10R,12R,14S,15Z,17E,19E,21S,26R,27R,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate | M;Akt;mTOR;PI3K;Inhibitors;Fermentation;PI3K/Akt/mTOR;mTOR inhibitor;Anticancer drugs;CCI-779, NSC 683864 |
| 21 | 168273-06-1 | Rimonabant | A 281 xibuqum ACOMPLIA Rimonabant RIMONABANT RIMONABANT(ACOMPLIA,SR141716) 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidinopyrazole-3-carboxamide 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide 1H-Pyrazole-3-carboxamide, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide | API;SR141716;Weight Loss;Anti-fat drugs;Weight loss raw materials;Health care raw materials;Small molecule inhibitors;Pharmaceutical raw materials;G protein coupled receptor &;Raw material intermedia |
| 22 | 172732-68-2 | Varespladib | LY315920 LY-333013 Varepladib Varespladib VARESPLADIB UNII-2Q3P98DATH LY315920(Varespladib) Varespladib (LY315920) ((3-(Aminooxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yl)oxy)acetic acid ({3-[amino(oxo)acetyl]-1-benzyl-2-ethyl-1H-indol-4-yl}oxy)acetic acid sodium ({3-[amino(oxo)acetyl]-1-benzyl-2-ethyl-1H-indol-4-yl}oxy)acetate 2-(3-(2-amino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yloxy)acetic acid [[3-(Aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]acetic acid Acetic acid, ((3-(aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl)oxy)-, 2-[[3-(2-Amino-2-oxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]Acetic Acid | Inhibitor;Inhibitors;Metabolism;Small molecule inhibitors;Scientific research reagents;Small molecule inhibitors, natural products |
| 23 | 177036-94-1 | Ambrisentan | LU 208075 Lu 208075 Bsf 208075 BSF 208075 Ambrisentan AMBRISENTAN 2-(4,6-Dimethylpyrimidin-2-Yl)Oxy-3-Methoxy-3,3-Di(Phenyl)Propanoic Acid 2-(4,6-Dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-di(phenyl)propanoic acid (S)-2-(4,6-dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid (2S)-2-[(4,6-Dimethylpyrimidin-2-Yl)Oxy]-3-Methoxy-3,3-Diphenylpropanoic Acid (aS)-a-[(4,6-Dimethyl-2-pyrimidinyl)oxy]--methoxy--phenylbenzenepropanoic Acid (As)-A-[(4,6-Dimethyl-2-Pyrimidinyl)Oxy]--Methoxy--Phenylbenzenepropanoic Acid BSF 208075,(+)-(2S)-2-[(4,6-DIMETHYLPYRIMIDIN-2-YL)OXY]-3-METHOXY-3,3-DIPHENYLPROPANOIC ACID Bsf 208075,(+)-(2S)-2-[(4,6-Dimethylpyrimidin-2-Yl)Oxy]-3-Methoxy-3,3-Diphenylpropanoic Acid (+-)-(2S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid,bsf-208075 | APIs;Hete;Aromatics;Other APIs;Heterocycles;Raw materials;Pharmaceuticals;Medical raw materials;Heterocyclic compounds;Pharmaceutical bulk drugs |
| 24 | 182349-12-8 | Rupatadine fumarate | Rupax FuMarate Rupafin FuMarate Pafinur FuMarate Rinialer FuMarate Rupatadine Fumarate RUPATADINE FUMARATE Rupatadine fumarate Alergoliber FuMarate 8-Chloro-6,11-dihydro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidylidene]-5H-benzo[5,6]cyclohepta[1,2-b]pyridine fumarate 8-chloro-6,11-dihydro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidylidene]-5h-benzo[5,6]cyclohepta[1,2-b]pyridine fumarate | H;Inhibitors;Heterocycles;Raw materials;Pharmaceuticals;Chemical reagents;Biochemical industry;Medical raw materials;Pharmaceutical raw materials;Impurity reference substance |
| 25 | 19171-19-8 | Pomalidomide | CC-4047 ActiMid Pomalidomide Pomalidomide(CC-4047) Pomalidomide(CC-4047,Actimid) 3-Amino-N-(2,6-dioxo-3-piperidyl)phthalimide 4-Amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione 4-AMino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione 4-amino-2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione 1H-Isoindole-1,3(2H)-dione,4-aMino-2-(2,6-dioxo-3-piperidinyl)- | CC-4047;Inhibitor;Inhibitors;Intermediates;Pharmaceutical intermediates |
| 26 | 193275-84-2 | LONAFARNIB | Sarasar SARASAR SCH66336 SCH-66336 SCH 66336 LONAFARNIB Lonafarnib [usan] Lonafarnib (SCH66336) 4-(2-(4-((R)-3,10-dibroMo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)cyclohexyl)-2-oxoethyl)piperidine-1-carboxaMide ( )4-(2-(4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo(5,6)cyclohepta (1,2-b)pyridin-11-yl)-1-piperidinyl)-2-oxoethyl)-1-piperidinecarboxami de 4-(2-(4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo-(5,6)-cyclohepta(1,2-B)-pyridin-11(R)-yl)-1-piperidinyl)-2-oxo-ethyl)-1-piperidinecarboxamide 1-Piperidinecarboxamide, 4-(2-(4-((11R)-3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-B)pyridin-11-yl)-1-piperidinyl)-2-oxoethyl)- | APIs;Inhibitor;Aromatics;Standards;Inhibitors;Metabolism;Heterocycles;Pharmaceuticals;Cell biology reagents;Intermediates & Fine Chemicals |
| 27 | 207679-81-0 | 2-[(1R)-3-(dipropan-2-ylamino)-1-phenylpropyl]-4-(hydroxymethyl)phenol | PNU-200577 PNU 200577 Desfesoterodine (R)-5-HydroxyMethyl Tolterodine (R)-5-Hydroxymethyl tolterodine 5-hydroxyMethyl tolterodine (PNU 200577) R-(+)-2(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenol R-(+)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenol 2-[(1R)-3-(dipropan-2-ylamino)-1-phenylpropyl]-4-(hydroxymethyl)phenol (R)-2-(3-(diisopropylaMino)-1-phenylpropyl)-4-(hydroxyMethyl)phenol (5-HMT) 3-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxybenzenemethanol 3-[(1R)-3-[Bis(1-Methylethyl)Amino]-1-Phenylpropyl]-4-Hydroxy-Benzenemethanol | Spot;Inhibitors;Benzene rings;Neural signals;Chiral Reagents;Pharmaceuticals;Metabolites & Impurities;Intermediates & Fine Chemicals;Small molecule inhibitors, natural products |
| 28 | 212631-79-3 | 2-(2-Chloro-4-iodophenylamino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide | CI1040 CS-333 Ci-1040 PD184352 PD-184352 CI 1040 (PD184352) 2-[(2-CHLORO-4-IODOPHENYL) AMINO]-N-(CYCLOPROPYLME 2-(2-CHLORO-4-IODOANILINO)-N-(CYCLOPROPYLMETHOXY)-3,4-DIFLUOROBENZAMIDE 2-(2-Chloro-4-iodophenylamino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide 2-[(2-Chloro-4-iodophenyl)amino]-N-(cyclopropylmethoxy)-3,4-difluorobenzamide Benzamide, 2-[(2-chloro-4-iodophenyl)amino]-N-(cyclopropylmethoxy)-3,4-difluoro- | MAPK;Amines;Aromatics;Inhibitors;Intermediates;All Inhibitors;Pharmaceuticals;Pfizer compounds;Anti-cancer&immunity;Pharmaceutical intermediates |
| 29 | 219580-11-7 | 1-tert-butyl-3-[2-{[4-(diethylamino)butyl]amino}-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]urea | CS-458 PD173074 PD-173074 PD 173074 1-tert-butyl-3-[2-{[4-(diethylamino)butyl]amino}-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]urea 1-(tert-butyl)-3-(2-((4-(diethylaMino)butyl)aMino)-6-(3,5-diMethoxyphenyl)pyrido[2,3-d]pyriMidin-7-yl)urea N-[2-[[4-(diethylaMino)butyl]aMino]-6-(3,5-diMethoxyphenyl)pyrido[2,3-d ]pyriMidin-7-yl]-N'-(1,1-diMethylethyl)- n-[2-[[4-(diethylamino)butyl]amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-n'-(1,1-dimethylethyl)urea Urea, N-[2-[[4-(diethylamino)butyl]amino]-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)- | API;Aromatics;Inhibitors;Nucleotides;Heterocycles;Intermediates;Antineoplastic;Pharmaceuticals;Bases & Related Reagents;Pharmaceutical intermediates |
| 30 | 22978-25-2 | 2-chloro-5-nitro-N-phenylbenzamide | GW9662 CS-762 GW 9662 GW 9662 TIMTEC-BB SBB006523 2-CHLORO-5-NITROBENZANILIDE 2-chloro-5-nitro-N-phenylbenzamide 2-CHLORO-5-NITRO-N-PHENYLBENZAMIDE | Amides;Inhibitor;Inhibitors;DNA damage;Carbonyl Compounds;Carbonyl Compounds;Intracellular receptor;Organic Building Blocks;Organic Building Blocks;Small molecule inhibitors |
| 31 | 257933-82-7 | Pelitinib | EKB-569 EKB569 EKB 569 PELITINIB Pelitinib WAY-EKB 569 WAY-EKB 569) WAY-EKB 569 PELITINIB (EKB-569 (E)-N-(4-(3-chloro-4-fluorophenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide (2E)-N-{4-[(3-chloro-4-fluorophenyl)aMino]-3-cyano-7-ethoxyquinolin-6-yl}-4-(diMethylaMino)but-2-enaMide (2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxyquinolin-6-yl}-4-(dimethylamino)but-2-enamide 2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-, (2E)- | API;Isot;pyridine;Pyridine;Aromatics;Raw drugs;Inhibitors;Heterocycles;All Inhibitors;Pharmaceuticals |
| 32 | 26095-59-0 | Otilonium bromide | SP-63 Spasen Menoctyl Pasminox Spasmome Otilonium 247-457-4 Spasmoctyl Otilonium bromide N,N-Diethyl-N-methy-2-[[4-[[2-(octyloxy)benzoyl]amino]benzoyl]oxy]ethanaminium Bromide N,N-Diethyl-N-methyl-2-[(4-{[2-(octyloxy)benzoyl]amino}benzoyl)oxy]ethanaminium bromide N,N-diethyl-2-[(4-{[2-(heptyloxy)benzoyl]amino}benzoyl)oxy]-N-methylethanaminium bromide | Raw drugs;Inhibitor;Inhibitors;Intermediates;Neural signals;Pharmaceuticals;Digestive system;Small molecule inhibitors;Pharmaceutical raw materials;Intermediates & Fine Chemicals |
| 33 | 269055-15-4 | Etravirine | TMC125 TMC 125 TMC-125 R 165335 Intelence Etravirine R165335-TMC125 UNII-0C50HW4FO1 Unii-0C50hw4fo1 Etravirine [INN] IntelenceBenzonitrile 4-[[6-AMino-5-broMo-2-[(4-cyanophenyl)aMino]-4-pyriMidinyl]oxy]-3,5-diMethyl - 6-amino-5-bromo-4-(4-cyano-2,6-dimethylphenoxy)-2-(4-cyanophenylamino)pyrimidine 4-(6-Amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile 4-[6-amino-5-bromo-2-[(4-cyanophenyl)amino]pyrimidin-4-yl]oxy-3,5-dimethyl-benzonitrile 4-({6-amino-5-bromo-2-[(4-cyanophényl)amino]pyrimidin-4-yl}oxy)-3,5-diméthylbenzonitrile 4-[[6-Amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethylbenzonitrile 4-({6-amino-5-bromo-2-[(4-cyanophenyl)amino]pyrimidin-4-yl}oxy)-3,5-dimethylbenzonitrile 4-[[6-Amino-5-Bromo-2-[(4-Cyanophenyl)Amino]-4-Pyrimidinyl]Oxy]-3,5–Dimethylbenzonitrile 4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)-4-pyrimidinyl)oxy)-3,5-dimethyl-benzonitrile 4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3, 5 –dimethylbenzonitrile 4-({6-Amino-5-brom-2-[(4-cyanphenyl)amino]pyrimidin-4-yl}oxy)-3,5-dimethylbenzolcarbonitril 4-(6-amino-5-bromo-2-(4-cyanobenzyl)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile, Etravirine benzonitrile, 4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl- Benzonitrile, 4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)-4-pyrimidinyl)oxy)-3,5-dimethyl- | Inhibitors;Other APIs;Bulk drugs;Heterocyclic;All Inhibitors;Pharmaceuticals;New anti-HIV drugs;Microbial Microbiology;Small molecule inhibitors;Intermediate of bulk drugs |
| 34 | 345627-80-7 | N-[5-[(5-tert-Butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide | CS-202 SNS 032 SNS032 SNS-032 SNS-032 SNS 032 BMS387032 BMS-387032 BMS387032 BMS 387032 BMS-387032 BMS 387032 N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-peridinecarboxamide N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamid 4-Piperidinecarboxamide, N-(5-(((5-(1,1-dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)- N-[5-[(5-tert-Butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)piperidine-4-carboxamide BMS-3870032 N-[5-[(5-tert-Butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide N-[5-[(5-tert-Butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide SNS-032 (BMS-387032) | Aromatics;Inhibitors;Heterocycles;Pharmaceutica;Organic raw materials;Organic sulfur compounds;Intermediates & Fine Chemicals. Sulfur & Selenium Compounds;Specific and potent inhibitor of cyclin-depen |
| 35 | 391210-10-9 | N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide | PD325901 PD 0325901 PD-0235901 N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)aMino]be N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide (R)-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)benzamide N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide N-[(2R)-2,3-DIHYDROXYPROPOXY]-3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]-BENZAMIDE N-[(R)-2,3 -Dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-phenylaMino)-benzaMide N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide PD0325901 | API;MAPK;Inhibitor;Aromatics;Inhibitors;Intermediates;Chiral Reagents;Pharmaceuticals;Pharmaceutical intermediates;Intermediates & Fine Chemicals |
| 36 | 417716-92-8 | Lenvatinib | XL147 XL-147 SAR245408 Lenvatinib PI3K inhibitorX XL-147(SAR245408) N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide, 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide N-[3-(Benzo[c][1,2,5]thiadiazol-5-ylaMino)quinoxalin-2-yl]-4-MethylbenzenesulfonaMide N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide XL 147 | Akt;Sul;mTOR;PI3K;Amines;Aromatics;Inhibitors;Heterocycles;Pharmaceuticals;Cell biology reagents |
| 37 | 425386-60-3 | Semagacestat | LY450139 semagacestat Semagacestat Unii-3yn0602W4w LY450139(Semagacestat) (2S)-2-HYDROXY-3-METHYL-N-[(2S)-1-{[(1S)-3-METHYL-2-OXO-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPIN-1-YL]AMINO}-1-OXOPROPAN-2-YL]BUTANAMIDE (2S)-2-Hydroxy-3-methyl-N-[(1S)-1-methyl-2-oxo-2-[[(1S)-2,3,4,5-tetrahydro-3-methyl-2-oxo-1H-3-benzazepin-1-yl]amino]ethyl]butanamide (2S)-2-hydroxy-3-methyl-N-[(1S)-1-methyl-2-{[(1S)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-3-benzazepin-1-yl]amino}-2-oxoethyl]butanamide Butanamide, 2-hydroxy-3-methyl-N-[(1S)-1-methyl-2-oxo-2-[[(1S)-2,3,4,5- tetrahydro-3-methyl-2-oxo-1H-3-benzazepin-1-yl]amino]ethyl]-, (2S)- | Protease;Inhibitor;Inhibitors;Scientific research reagents;Small molecule inhibitors, natural products |
| 38 | 459868-92-9 | 8-Fluoro-2-[4-(methylaminomethyl)phenyl]-3,4,5,6-tetrahydro-1H-azepino[5,4,3-cd]indol-6-one phosphate | CS-47 AG-14699 AG014699 AG-014699 PF-01367338 RUCAPARIB PHOSPHATE PF01367338 phosphate Rucaparib phosphate salt AG-014447 (as free base) Rucaparib (AG-014699) phosphate Rucaparib phosphate (AG-14699, PF-01367338) Rucaparib (AG-014699,PF-01367338) phosphate Rucaparib (phosphate)(AG-014699,PF-01367338) 8-Fluoro-2-[4-(methylaminomethyl)phenyl]-3,4,5,6-tetrahydro-1H-azepino[5,4,3-cd]indol-6-one phosphate 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one phosphate | Aro;Amines;Aromatics;Inhibitor;Inhibitors;DNA damage;Anti-tumor;Heterocycles;Raw materials;Pharmaceuticals |
| 39 | 477575-56-7 | (3Z)-5-[(2,6-dichlorobenzyl)sulfonyl]-3-[(3,5-dimethyl-4-{[(2R)-2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl]carbonyl}-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one | CS-40 PHA665752 PHA 665752 TCMDC-125885 (R,Z)-5-((2,6-Dichlorobenzyl)sulfonyl)-3-((3,5-dimethyl-4-(2-(pyrrolidin-1-ylmethyl)pyrrolidin (R,Z)-5-(2,6-dichlorobenzylsulfonyl)-3-((3,5-dimethyl-4-(2-(pyrrolidin-1-ylmethyl)pyrrolidine-1-carbonyl)-1H-pyrrol-2-yl)methylene)indolin-2-one (3Z)-5-[(2,6-Dichlorobenzyl)sulfonyl]-3-[(3,5-dimethyl-4-{[(2R)-2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl]carbonyl}-1H-pyrrol-2-yl)methylene]-1,3-dihydro-2H-indol-2-one (3Z)-5-[(2,6-dichlorobenzyl)sulfonyl]-3-[(3,5-dimethyl-4-{[(2R)-2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl]carbonyl}-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one (2R)-1-[[5-[(Z)-[5-[[(2,6-DICHLOROPHENYL)METHYL]SULFONYL]-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE]METHYL]-2,4-DIMETHYL-1H-PYRROL-3-YL]CARBONYL]-2-(1-PYRROLIDINYLMETHYL)PYRROLIDINE (2R)-1-[[5-[(z)-[5-[[(2,6-dichlorophenyl)methyl]sulfonyl]-1,2-dihydro-2-oxo-3h-indol-3-ylidene]methyl]-2,4-dimethyl-1h-pyrrol-3-yl]carbonyl]-2-(1-pyrrolidinylmethyl)pyrrolidine 2H-Indol-2-one, 5-[[(2,6-dichlorophenyl)methyl]sulfonyl]-3-[[3,5-dimethyl-4-[[(2R)-2-(1-pyrrolidinylmethyl)-1-pyrrolidinyl]carbonyl]-1H-pyrrol-2-yl]methylene]-1,3-dihydro-, (3Z)- (2R)-1-[[5-[(Z)-[5-[[(2,6-DICHLOROPHENYL)METHYL]SULFONYL]-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE]METHYL]-2,4-DIMETHYL-1H-PYRROL-3-YL]CARBONYL]-2-(1-PYRROLIDINYLMETHYL)PYRROLIDINE PHA 665752 PHA 665752 (2R)-1-[[5-[(Z)-[5-[[(2,6-Dichlorophenyl)methyl]sulfonyl]-1,2-dihydro-2-oxo-3H-indol-3-ylidene]methyl]-2,4-dimethyl-1H-pyrrol-3-yl]carbonyl]-2-(1-pyrrolidinylmethyl)pyrrolidine | Inhibitor;Inhibitors;Standard substance;Cell biology reagent;Protein tyrosine kinase;Small molecule inhibitor, natural product;Signal transduction pathway kinase inhibitor |
| 40 | 519055-62-0 | Tasisulam | TS81557 Ly573636 Tasisulam Ly-573636 Tasisulam(Ly-573636 LY573636 (TasisulaM) N-(2,4-Dichlorobenzoyl)-5-bromothiophene-2-sulfonamide Benzamide, N-((5-bromo-2-thienyl)sulfonyl)-2,4-dichloro- Tasisulam N-(2,4-Dichlorobenzoyl)-5-bromothiophene-2-sulfonamide N-(2,4-Dichlorobenzoyl)-5-bromothiophene-2-sulfonamide LY573636 Tasisulam | Inhibitors;Small molecule inhibitors, natural products |
| 41 | 552325-73-2 | (2S)-1-{[5-(3-Methyl-2H-indazol-5-yl)-3-pyridinyl]oxy}-3-phenyl-2-propanamine | A-674563 A 674563 A674563 (S)-1-(5-(3-Methyl-1H-indazol-5-yl)pyridin-3-yloxy)-3-phenylpropan-2-amine (2S)-1-(5-(3-methyl-1H-indazol-5-yl)pyridin-3-yloxy)-3-phenylpropan-2-amine (2S)-1-{[5-(3-Methyl-2H-indazol-5-yl)-3-pyridinyl]oxy}-3-phenyl-2-propanamine (alphaS)-alpha-[[[5-(3-Methyl-1H-indazol-5-yl)-3-pyridinyl]oxy]methyl]benzeneethanamine (S)-1-((5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl)oxy)-3-phenylpropan-2-amine hydrochloride (alphaS)-alpha-[[[5-(3-Methyl-1H-indazol-5-yl)-3-pyridinyl]oxy]methyl]benzeneethanamine A-674563 | Akt;mTOR;PI3K;Inhibitors;Amino compounds;Organic raw materials |
| 42 | 555-55-5 | Hispidine | Hispidin HISPIDIN Hispidine 6-(3,4-Dihydroxystyryl)-4-hydroxy-2-pyrone 6-(3,4-Dihydroxystyryl)-4-hydroxy-2H-pyran-2-one 4-hydroxy-6-(3,4-dihydroxystyryl)-2-pyrone (hispidine) 6-[(E)-2-(3,4-Dihydroxyphenyl)vinyl]-4-hydroxy-2H-pyran-2-one (E)-6-[2-(3,4-Dihydroxyphenyl)ethenyl]-4-hydroxy-2H-pyran-2-one 2-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-6-hydroxy-4H-pyran-4-one 6-[(1E)-2-(3,4-Dihydroxyphenyl)ethenyl]-4-hydroxy-2H-pyran-2-one | Standard |
| 43 | 566-48-3 | 4-androsten-4-ol-3,17-dione | Formestane B, Aromatase inhibitor 4-androsten-4-ol-3,17-dione 4-hydroxyandrost-4-ene-3,17-dione (8xi,9xi,14xi)-4-methylandrost-4-ene-3,17-dione | ;Steroids;Miscellaneous Biochemicals;Pharmaceutical Raw Materials |
| 44 | 586966-54-3 | Pitavastatin tert-Butyl Ester | Tert-butyl Pitavastatin Tert-buthyl Pitavastatin Pitavastatin t-Butyl Ester Pitavastatin tert-Butyl Ester pitavastatin-defluorination impurity (3R,5S,6E)7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydrosy-6-heptaneacid,ethylester 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid tert-butyl ester tert-butyl (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate (3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid tert-butyl ester (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydrosy-6-heptenoic acid,1,1-dimethylethyl ester | Other APIs;Intermediates;Pharmaceutica;Organic chemistry;Standard substance;Organic raw materials;Pharmaceutical intermediates;Impurity reference substance;Reference substance-impurity reference subst |
| 45 | 658084-23-2 | (3Z)-N-(3-chlorophenyl)-3-({3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl}methylidene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide | SU-11274 SU 11274 PKI-SU11274 (3Z)-N-(3-chlorophenyl)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-N-methyl-2-oxo-1H-indole-5-sulfonamide N-(3-Chlorophenyl)-N-methyl-3-[[3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl]methylene]-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide (3Z)-N-(3-Chlorophenyl)-3-[[3,5-dimethyl-4-[(4-methyl-1-piperazinyl)carbonyl]-1H-pyrrol-2-yl]methylene]-2,3-dihydro-N-methyl-2-oxo-1H-indole-5-sulfonamide (3Z)-N-(3-chlorophenyl)-3-({3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl}methylidene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide N-(3-Chlorophenyl)-N-methyl-3-[[3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl]methylene]-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide SU11274 | API;Inhibitors;Antimalarial drugs;Small molecule inhibitors, natural products |
| 46 | 670220-88-9 | Crenolanib | ARO 002 CP 868596 cp-868596 Crenolanib CVC, TAK-652, TBR-652 Crenolanib (CP-868596) Crenolanib (CP-868569) [1-[2-[5-(3-Methyloxetan-3-ylMethoxy)benziMidazol-1-yl]quinolin-8-yl]piperidin-4-yl]aMine [1-[2-[5-(3-Methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine 1-[2-[5-[(3-Methyl-3-oxetanyl)Methoxy]-1H-benziMidazol-1-yl]-8-quinolinyl]-4-piperidinaMine | Aromatics;Inhibitors;Heterocycles;Pharmaceuticals;Organic materials;Hydrocarbon compounds;Tyrosine Kinase Inhibitors;Intermediates & Fine Chemicals |
| 47 | 69308-37-8 | (R)-baclofen | STX 209 l-Baclofen D-Baclofen (R)-baclofen (R)-Baclofen (-)-Baclofen R-(-)-Baclofen UNII-NYU6UTW25B (R)-(-)-Baclofen 4-azanyl-3-(4-chlorophenyl)butanoic acid (R)-4-Amino-3-(4-chlorophenyl)butyric acid (R)-4-Amino-3-(4-chlorophenyl)butanoic acid (3R)-4-amino-3-(4-chlorophenyl)butanoic acid (βR)-β-(AMinoMethyl)-4-chlorobenzenepropanoic Acid Benzenepropanoic acid, b-(aMinoMethyl)-4-chloro-, (bR)- Benzenepropanoic acid, β-(aminomethyl)-4-chloro-, (βR)- Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-, (R)- Benzeneporopanoic acid, (beta-(aminomethyl)-4-chloro-, (betaR)- | Amines;Aromatics;Inhibitors;Organic acids;Chiral Reagents;Pharmaceuticals;GABA/Glycine receptor;Intermediates & Fine Chemicals;Small molecule inhibitors, natural products |
| 48 | 702674-56-4 | BX-912 | BX 912 BX-912 N-(3-((4-((2-(1H-Imidazol-4-yl)ethyl)amino)-5-bromopyrimidin-2-yl)amino)phenyl)pyrrolidine-1-c N-(3-(4-(2-(1H-imidazol-5-yl)ethylamino)-5-bromopyrimidin-2-ylamino)phenyl)pyrrolidine-1-carboxamide N-[3-[[5-Bromo-4-[[2-(1H-imidazol-5-yl)ethyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide 1-PYRROLIDINECARBOXAMIDE, N-[3-[[5-BROMO-4-[[2-(1H-IMIDAZOL-4-YL)ETHYL]AMINO]-2-PYRIMIDINYL]AMINO]PHENYL]- PYRROLIDINE-1-CARBOXYLIC ACID (3-(5-BROMO-4-[2-(1H-IMIDAZOL-4-YL)-ETHYLAMINO]-PYRIMIDIN-2-YLAMINO)-PHENYL)-AMIDE | Akt;mTOR;PI3K;Inhibitors;Cell biology reagent;Small molecule inhibitor;Small molecule inhibitor, natural product;Signal transduction pathway kinase inhibitor;Inhibitor of 3-Phosphoinositide-dependent |
| 49 | 763113-22-0 | Olaparib | AZD2281 KU 59436 Olaparib Olaparid AZD2281 AZD2281(olaparib) 4-(3-(4-(Cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one 4-(3-(1-(cyclopropanecarbonyl)piperazine-4-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one 4-[3-(4-Cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one 1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)Methyl]-2-fluorobenzoyl]piperazin 4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]Methyl]-1(2H)-phthalazinone | API;APIs;Inhibitor;Organic materials;Hydrocarbon compounds |
| 50 | 78712-43-3 | Ozagrel hydrochloride | Vega Domenan Ozagrel HCL OKY-046 HCl Ozagrel hydrochloride Ozagrel hydrochloride (JAN) Ozagrel hydrate hydrochloride (2E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]acrylic acid hydrochloride (2E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]prop-2-enoic acid hydrochloride (E)-3-[4-(Imidazol-1-ylmethyl)phenyl]propenoic acid hydrochloride hydrate OKY-046, (E)-3-[4-(Imidazol-1-ylmethyl)phenyl]propenoic acid hydrate hydrochloride Ozagrel hydrochloride hydrate,(E)-3-[4-(Imidazol-1-ylmethyl)phenyl]propenoic acid hydrochloride hydrate, OKY-046 | Inhibitors;Cardiovascular;Inorganic salt;Inorganic Chemical Engineering;Piperidones ,Piperidines ,Homopiperidines |
| 51 | 863031-21-4 | Azilsartan medoxomil | CS-306 TAK 491 Azilsaran medoxomil Azilsartan Medoxomil Azilsartan medoxomil 1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzim (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-4H-1,2,4-+oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate 1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester 1H-BenziMidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl]-2-ethoxy-, (5-Methyl-2-oxo-1,3-dioxol-4-yl)Methyl ester 1H-Benzimidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester | Inhibitors;Organic materials;Organic acid esters;Azilsartan Medoxomil |
| 52 | 868540-17-4 | Carfilzomib | PR 171 PX-171-007 Carfilzomib CarfilzoMib salt PR-171 (CarfilzoMib) Carfilzomib API and intermediates (alphaS)-alpha-[(4-Morpholinylacetyl)amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]-L-phenylalaninamide N-{(2S)-2-[(Morpholin-4-ylacetyl)aMino]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-Methyl-1-[(2R)-2-Methyloxiran-2-yl]-1-oxopentan-2-yl}-L-phenylalaninaMide N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}-L-phenylalaninamide (S)-2-((S)-2-(2-(2H-1,4-oxazin-4(3H)-yl) acetamido)-4-phenylbutanamide)-4-methyl-N-((S)-1-((S)-4-methyl-1-((R)-2-methyl oxiran-2-yl)-1-oxopentan-2-ylamino)-1-oxo-3-phenylpropan-2-yl)pentanamide | API;peptides;Inhibitor;Inhibitors;Raw materials;Pharmaceutical;Peptide inhibitors;High purity reagents;Small molecule inhibitors;Small molecule inhibitors, |
| 53 | 871224-64-5 | (2R)-[6,7-Dimethoxy-1(S)-[2-[4-(trifluoromethyl)phenyl]ethyl]-1,2,3,4-tetrahydroisoquinolin-2-yl]-N-methyl-2-phenylacetamide | CS-942 ACT078573 ACT-078573 Almorexant ACT 078573 Almorexant HCI ACT078573 HYDROCHLORIDE ACT078573 hydrochloride ACT-078573 HYDROCHLORIDE ACT 078573 HYDROCHLORIDE AlMorexant (hydrochloride) Almorexant HCl (Act-078573) (R)-2-((R)-6,7-diMethoxy-1-(4-(trifluoroMethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-Methyl-2-phenylacetaMide (R)-2-((R)-6,7-Dimethoxy-1-(4-(Trifluoromethyl)Phenethyl)-3,4-Dihydroisoquinolin-2(1H)-Yl)-N-Methyl-2-Phenylacetamide (2R)-[6,7-Dimethoxy-1(S)-[2-[4-(trifluoromethyl)phenyl]ethyl]-1,2,3,4-tetrahydroisoquinolin-2-yl]-N-methyl-2-phenylacetamide (R)-2-((S)-1-(4-(trifluoromethyl)phenethyl)-6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide hydrochloride (alphaR,1S)-3,4-Dihydro-6,7-dimethoxy-N-methyl-alpha-phenyl-1-[2-[4-(trifluoromethyl)phenyl]ethyl]-2(1H)-isoquinolineacetamide monohydrochloride | Inhibitors;Small molecule inhibitors, natural products |
| 54 | 873697-71-3 | 1-Piperazinecarboxylic acid,4-[[2-fluoro-3-[[[(6-methyl-3-pyridinyl)amino]carbonyl]amino]phenyl]methyl]-, methyl ester | CK1827452 CK-1827452 CK 1827452O mecamtiv mecarbil Omecamtiv mecarbil OMecaMtiv Mecarbil CK-1827452 (OMecaMtiv Mecarbil) OMecaMtiv Mecarbil (CK-1827452) 1-Piperazinecarboxylic acid,4-[[2-fluoro-3-[[[(6-methyl-3-pyridinyl)amino]carbonyl]amino]phenyl]methyl]-, methyl ester | Inhibitors;Organic fluoride;Organic raw materials |
| 55 | 89778-27-8 | TOREMIFENE CITRATE |
nk622 nk622 fc1157a fareston fc1157a fareston Toremifene citrate TOREMIFENE CITRATE TROPISETRON CITRATE 2-[4-[(1Z)-4-CHLORO-1,2-DIPHENYL-1-BUTENYL]PHENOXY]-N,N-DIMETHYLETHANAMINE (z)-4-chloro-1,2-diphenyl-1-(4-(2-(n,n-dimethylamino)ethoxy)phenyl)-1-butene (z)-4-chloro-1,2-diphenyl-1-(4-(2-(n,n-dimethylamino)ethoxy)phenyl)-1-butene 2-(4-(4-chloro-1,2-diphenyl-1-butenyl)phenoxy)-n,n-dimethyl-ethanamin(z)-ethanamin 2-(4-(4-chloro-1,2-diphenyl-1-butenyl)phenoxy)-n,n-dimethyl-ethanamin(z)-ethanamin (z)-2-[4-(4-chloro-1,2-diphenyl-1-butenyl)phenoxy]-n,n-dimethyl-ethanamine 2-hydroxy-1,2,3-propanetricarboxylate (z)-2-[4-(4-chloro-1,2-diphenyl-1-butenyl)phenoxy]-n,n-dimethyl-ethanamine 2-hydroxy-1,2,3-propanetricarboxylate | XYREM;Amines;Aromatics;Inhibitors;Analgesics;Anti-tumor;Antibiotics;Cell biology;Raw materials;Intermediates |
| 56 | 939791-38-5 | PF-562271 benzenesulfonate salt | PF-562271 PF-562271 (besylate) PF-562271 PhSO3H salt PF-00562271 (PF-562271) PF-562271 benzenesulfonate PF-562271 benzenesulfonate salt N-methyl-N-(3-((2-(2-oxoindolin-5-ylamino)-5-(trifluoromethyl)pyrimidin-4-ylamino)methyl)pyridin-2-yl)methanesulfonamide benzenesulfonate N-[3-[[[2-[(2,3-Dihydro-2-oxo-1H-indol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]-2-pyridinyl]-N-methyl-methanesulfonamide benzenesulfonate | Inhibitors;Organic raw materials;Carboxylic acid compounds |
| 57 | 943540-75-8 | 6-[difluoro-[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[3,4-f]pyridazin-3-yl]methyl]quinoline | JNJ-38877605 JNJ-33877605 6-[difluoro-[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[3,4-f]pyridazin-3-yl]methyl]quinoline 6-[Difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline 6-(Difluoro(6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]-triazolo[4,3-b]pyridazin-3-yl)methyl)quinolin Quinoline,6-[difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]- Quinoline, 6-[difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]- JNJ 38877605 6-[Difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline 6-[Difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline JNJ 38877605 | Quinoline;Inhibitors;Pharmaceutical intermediates |
| 58 | 944396-07-0 | 5-[2,6-Di(4-morpholinyl)-4-pyrimidinyl]-4-(trifluoromethyl)-2-pyridinamine | BKM120 BKM-120 BKM120BASE Buparlisib NVP-BKM-120 BKM120 (NVP-BKM120) NVP-BKM120, Buparlisib BKM120 (NVP-BKM120, Buparlisib) 5-(2,6-diMorpholinopyriMidin-4-yl)-4-(trifluoroMethyl)pyridin-2-aMine 5-[2,6-Di(4-morpholinyl)-4-pyrimidinyl]-4-(trifluoromethyl)-2-pyridinamine | API;Akt;mTOR;PI3K;Inhibitor;Inhibitors;Organic fluoride;Organic raw materials |
| 59 | 95734-82-0 | Nedaplatin |
254-s Aqupla 254-s Nedaplait NEDAPLATIN Nedaplatin Nedaplait cis-diammine(glycolato)platinum(ii) (glycolato-o,o')diammineplatinum(ii) cis-diammine(glycolato)platinum(ii) (glycolato-o,o')diammineplatinum(ii) cis-diamine-glycolate-O,O'-platinum(II) diamino[(hydroxy-kappaO)acetato(2-)-kappaO]platinum diammine(glycolato)platinum(ii) nedaplatin nsc 375101d o(sup2))-diammine(hydroxyacetato(2-)-o(sup1(sp-4-3)-platinu o(sup2))-diammine(hydroxyacetato(2-)-o(sup1(sp-4-3)-platinu o(sup 2))- diammine(hydroxyacetato(2-)-o(sup 1 (sp-4-3)-platinu (glycolato-o,o')diammineplatinum(ii) 254-s cis- | API;Inhibitors;Anticancer;Pharmaceutica;Standard substance;Anticancer Platinum Agent;Small molecule inhibitors;G protein coupled receptor & G protein;Small molecule inhibitors, natural products;Tradit |
| 60 | 865759-25-7 | Trelagliptin | Trelagliptin Trelagliptin(syr472) Trelagliptin free base Trelagliptin Isomer Impurity (S)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile Benzonitrile, 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H) -pyrimidinyl]methyl]-4-fluoro- Trelagliptin (R)-2-[[6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]methyl]-4-fluorobenzonitrile | API;Inhibitors;Metabolism;Trelagliptin;Impurity reference subs;Pharmaceutical intermediates;Antihypertensive and hypoglycemic;Small molecule inhibitors, natural products;Reference substance-impurity r |
| 61 | 507475-17-4 | TPCA-1 | TPCA-1 GW683965 TPCA-1(TPCA 1) TPCA-1 IKK-2 Inhibitor IV 5-(4-Fluorophenyl)-2-ureidothiophene-3-carboxamide 2-[(Aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide 3-ThiophenecarboxaMide, 2-[(aMinocarbonyl)aMino]-5-(4-fluorophenyl)- 5-(4-Fluorophenyl)-2-ureidothiophene-3-carboxamide TPCA-1 | NF-kB;Pharmaceutical bulk drug |
| 62 | 677297-51-7 | TG100-115 | CS-427 TG100115 TG100-115 TG100 115 TG100 115 3,3,-(2,4-diaminopteridine-6,7-diyl)diphenol 6,7-Bis(3-hydroxyphenyl)pteridine-2,4-diamine 3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol 3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol TG100-115 | Akt;mTOR;PI3K;APIs;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 63 | 869363-13-3 | MLN8054 | CS-410 MLN8054 MLN 8054 ETHYL 8-METHOXY-2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO[B]AZEPINE-4-CARBOXYLATE 4-[[9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid Benzoic acid, 4-[[9-chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]- | Inhibitor;Standards;Inhibitors;Cell cycle;Pharmaceuticals;Cell biology reagents;Intermediates & Fine Chemicals;Small molecule inhibitors, natural products |
| 64 | 867160-71-2 | Linsitinib | OSI-906 OSI 906AA Linsitinib OSI-906 Linsitinib cis-3-[8-Amino-1-(2-phenyl-7-quinolinyl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutanol Cyclobutanol, 3-[8-aMino-1-(2-phenyl-7-quinolinyl)iMidazo[1,5-a]pyrazin-3-yl]-1-Methyl-, cis- (1s,3r)-3-[4-aMino-3-(2-phenylquinolin-7-yl)iMidazo[1,5-a]pyrazin-1-yl]-1-Methylcyclobutan-1-ol (1S,3r)-3-((S)-8-aMino-1-(2-phenylquinolin-7-yl)-2,3-dihydroiMidazo[1,5-a]pyrazin-3-yl)-1-Methylcyclobutanol | Amines;Heterocy;Aromatics;Inhibitors;Heterocycles;Pharmaceuticals;Cell biology reagents;Protein tyrosine kinase;Tyrosine Kinase Inhibitors;Intermediates & Fine Chemicals |
| 65 | 950769-58-1 | N-(5-tert-Butylisoxazol-3-yl)-N-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea | CS-53 AC220 AC-220 QUIZARTINIB quizartinib (FLT3 inhibitor) 1-(5-(tert-Butyl)isoxazol-3-yl)-3-(4-(7-(2-morpholinoethoxy)-benzo[d]imidazo[2,1-b]thiazol-2-y N-(5-tert-Butylisoxazol-3-yl)-N-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea N-[5-(1,1-Dimethylethyl)-3-isoxazolyl]-N'-[4-[7-[2-(4-morpholinyl)ethoxy]imidazo[2,1-b]benzothiazol-2-yl]phenyl]urea N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea AC-220 | Inhibitor;Raw drugs;Inhibitors;Anti-cancer;Angiogenesis;Antineoplastic;Anti-tumor drugs;Cell biology reagent;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 66 | 154447-36-6 | 2-(4-MORPHOLINO)-8-PHENYL-4H-1-BENZOPYRAN-4-ON | CS-1859 LY 294002 LY294002 (HCl Salt) LY 294002 HYDROCHLORIDE 2-(4-MORPHOLINO)-8-PHENYL-4H-1-BENZOPYRAN-4-ON 2-(4-MORPHOLINO)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE 2-[4-MORPHOLINYL]-8-PHENYL-1[4H]-BENZOPYRAN-4-ONE 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE HYDROCHLORIDE | Akt;apis;mTOR;PI3K;Smal;Inhibitor;Signalling;Inhibitors;Heterocyclic;PI3K/Akt/mTOR |
| 67 | 606143-89-9 | Binimetinib | Binimetinib MEK162 (ARRY-438162) MEK162 (ARRY-162, ARRY-438162) BiniMetinib (MEK162, ARRY-162, ARRY-438162) 5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide 1H-Benzimidazole-6-carboxamide, 5-[(4-bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl- ARRY-438162 5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide 5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide Binimetinib (MEK162, ARRY-162, ARRY-438162) | API;MAPK;Organic;Inhibitors;Raw materials;Cell biology reagents;Chemical raw materials;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 68 | 936623-90-4 | Sacubitril|Valsartan | LCZ696 LZC696 Entresto LCZ696 Entresto LCZ696 ENTRESTO TM Sacubitril mixture with Valsartan Cocrystal of Sacubitril and Valsartan [(C24H29N5O3).(C24H29NO5).2.5(H2O).3Na] 4-[[(2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoate | API;Small mo;Inhibitor;Inhibitors;Anti-tumor;Cardiovascular Series;Cell biology reagents;Chemical intermediates;Pharmaceutical raw materials;Pharmaceutical anti-heart failure drugs |
| 69 | 59338-87-3 | Alizapride hydrochloride | AlizaprideHCl Alizapride HCl alizapridehydrochloride alizapride hydrochloride Alizapride hydrochloride 6-methoxy-n-[(1-prop-2-enylpyrrolidin-2-yl)methyl]-2h-benzotriazole-5-carboxamidehydrochloride 6-methoxy-n-[(1-prop-2-enylpyrrolidin-2-yl)methyl]-2h-benzotriazole-5-carboxamide hydrochloride N-((1-Allylpyrrolidin-2-yl)methyl)-6-methoxy-1H-benzo[d][1,2,3]triazole-5-carboxamidehydrochlori N-((1-Allylpyrrolidin-2-yl)methyl)-6-methoxy-1H-benzo[d][1,2,3]triazole-5-carboxamide hydrochlori 6-Methoxy-N-{[(2S)-1-(prop-2-en-1-yl)pyrrolidin-2-yl]Methyl}-2H-1,2,3-benzotriazole-5-carboxaMide N-((1-Allylpyrrolidin-2-yl)Methyl)-6-Methoxy-1H-benzo[d][1,2,3]triazole-5-carboxaMidehydrochloride N-((1-Allylpyrrolidin-2-yl)Methyl)-6-Methoxy-1H-benzo[d][1,2,3]triazole-5-carboxaMide hydrochloride 6-methoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-1H-1,2,3-benzotriazole-5-carboxamidehydrochloride 6-methoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-1H-1,2,3-benzotriazole-5-carboxamide hydrochloride | Fine;Aromatics;Inhibitors;Heterocycles;Neurochemicals;Pharmaceuticals;Aripiride hydrochloride;Small molecule inhibitors;Pharmaceutical bulk drugs;Pharmaceutical raw materials |
| 70 | 317318-84-6 | GW0742 | GW0742 GW0742X GW610742 GW 0742X GW 610742 GWdelta0742 GWdelta 0742 2-(4-(((2-(3-Fluoro-4-(trifluoromethyl)phenyl)-4-methylthiazol-5-yl)methyl)thio)-2-methylpheno 2-(4-(((2-(3-Fluoro-4-(trifluoromethyl)phenyl)-4-methylthiazol-5-yl)methyl)thio)-2-methylphenoxy) 4-[2-(3-FLUORO-4-TRIFLUOROMETHYL-PHENYL)-4-METHYL-THIAZOL-5-YLMETHYLSULFANYL]-2-METHYL-PHENOXY-ACETIC ACID [4-[[[2-[3-FLUORO-4-(TRIFLUOROMETHYL)PHENYL]-4-METHYL-5-THIAZOLYL]METHYL]THIO]-2-METHYLPHENOXY]ACETIC ACID | Inhibitor;Inhibitors;Metabolism;SARM series;Shaanxi Linna;All Inhibitors;Pharmaceuticals;Export raw materials;Cell biology reagents;Intracellular receptor |
| 71 | 1229194-11-9 | Edoxaban (tosylate Monohydrate) | Edoxaban tosilate edoxaban tosylate hydrate Edoxaban Tosylate Hydrate 1 Edoxaban (tosylate Monohydrate) Edoxaban p-toluenesulfonate monohydrate N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide 4-methylbenzenesulfonate hydrate N-(5-Chloropyridin-2-yl)-N'-((1S,2R,4S)-4-[(dimethyl amino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl)ethanediamide p-toluenesulfonate monohydrate Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-, 4-methylbenzenesulfonate, hydrate | API;Bulk drug;Inhibitors;Methanesulfonic acid;Cell biology reagents;Medical raw materials;Cardio-cerebrovascular;Small molecule Inhibitors;Small molecule Inhibitors, natural products |
| 72 | 1228690-36-5 | AM095 | AM095 AM-095 AM 095 CS-1624 AM-095 FREE ACID AM 095 FREE ACID AM095 (free acid) AM-095 (free base) AM 095 (parent compound) [4'-[3-Methyl-4-[[[((R)-1-phenylethyl)oxy]carbonyl]amino]isoxazol-5-yl]biphenyl-4-yl]acetic acid 2-[4-[4-[3-methyl-4-[[(1r)-1-phenylethoxy]carbonylamino]-1,2-oxazol-5-yl]phenyl]phenyl]acetic Acid [1,1'-Biphenyl]-4-acetic acid, 4'-[3-methyl-4-[[[(1R)-1-phenylethoxy]carbonyl]amino]-5-isoxazolyl]- | LPA inhibitor molecules |
| 73 | 19542-67-7 | BAY 11-7082 | 100824 CS-608 BAY 11-7821 BAY 11-7082 Bay 11-7821(BAY 11-7082) (E)-3-(P-TOLUENESULFONYL)ACRYLONITRILE (e)-3-(4-methylphenyl)sulfonylprop-2-enenitrile (E)-3-(4-METHYLPHENYLSULFONYL)-2-PROPENENITRILE | NF-kB;Inhibitors;Cytokine signaling;Small molecule inhibitors;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 74 | 177834-92-3 | Eletriptan hydrobromide | Relert Eletriptan HCl Unii-m41W832ta3 Eletriptan hydrobromide eletriptan hydrobromide (R)-3-((1-Methylpyrrolidin-2-yl)Methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobroMide (R)-5-[2-(Benzenesulfonyl)ethyl]-3-[(N-Methylpyrrolidin-2-yl)Methyl]-1H-indole hydrobroMide 1H-Indole,3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-,hydrobromide | Aromatics;Heterocycles;Chiral Reagents;Pharmaceuticals;Pfizer compounds;Intermediates & Fine Chemicals |
| 75 | 14176-50-2 | TILETAMINE HYDROCHLORIDE | CL-399 CI-634 CS-708 Nsc167740 CN-54521-2 TILETAMINE HYDROCHLORIDE TILETAMINE HYDROCHLORIDE) TILETAMINE HYDROCHLORIDE (200 MG) Cyclohexanone, 2-(ethylamino)-2-(2-thienyl)-, hydrochloride | Amines;Heterocycles;Pharmaceuticals;Sulfur & Selenium Compounds;Intermediates & Fine Chemicals |
| 76 | 66104-23-2 | Pergolide mesylate salt | Nopar Permax Celance Pergolidemetylsulfonate Pergolide mesylate salt Pergolide mesylate EPIV (8b)-8-[(Methylthio)methyl]-6-propylergoline Mesylate 8BETA-[(METHYLTHIO)METHYL]-6-PROPYLERGOLINE MESYLATE SALT 8-BETA-[(METHYLTHIO)METHYL]-6-PROPYLERGOLINE MONOMETHANE SULFONATE | API;LOCOID;Neurochemicals;Pharmaceuticals;Intermediates & Fine Chemicals |
| 77 | 61350-00-3 | 2-PyridinecarboxaMide, N-(3-chlorophenyl)- | SKL856 VU0364770 VU 0364770 VU-0364770 N-(3-Chlorophenyl)picolinamide N-(3-chlorophenyl)pyridine-2-carboxamide 2-PyridinecarboxaMide, N-(3-chlorophenyl)- | Inhibitors;Aromatics, Heterocycles |
| 78 | 90417-38-2 | 8-HYDROXY-2-METHYL-4(3H)-QUINAZOLINONE | NU1025 8-HYDROXY-2-METHYLQUINAZOLINE-4-ONE 8-HYDROXY-2-METHYLQUINAZOLIN-4[3H]-ONE 8-hydroxy-2-methyl-1H-quinazolin-4-one 8-HYDROXY-2-METHYL-4(3H)-QUINAZOLINONE | Aromatics;Inhibitors;All Inhibitors |
| 79 | 2089251-47-6 | Heptadecan-9-yl 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy) hexyl) amino) octanoate | SM102 SM-102 SM 102 SM-102 heptadecan-9-yl 8-[2-hydroxyethyl-(6-oxo-6-undecoxyhexyl)amino]octanoate Heptadecan-9-yl 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy) hexyl) amino) octanoate (heptadecan-9-yl 8-((2-hydroxyethyl)(6-oxO-6-(undecyloxy) hexyl) amino) octanoate), Octanoic acid, 8-[(2-hydroxyethyl)[6-oxo-6-(undecyloxy)hexyl]amino]-, 1-octylnonyl ester | Intermediates |
| 80 | 1369764-02-2 | Lemborexant | Lemborexant E-2006 Lemborexant (1R,2S)-2-[[(2,4-Dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropanecarboxamide 2-((1S,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)cyclopropyl)-N-(5-fluoropyridin-2-yl)acetamide | ;Inhibitors;API and intermediates |
| 81 | 3258-02-4 | N(4)-hydroxycytidine | EIDD-1931 N-Hydroxycytidine N(4)-hydroxycytidine MolnupiravirImpurity1 β-D-N4-Hydroxycytidine Beta-d-N4-hydroxycytidine Beta-d-N4-hydroxycytidine (NHC) 3,4-Dihydro-1-β-D-ribofuranosyl-4-(hydroxyimino)pyrimidin-2(1H)-one 1-[(2R)-3α,4α-Dihydroxy-5β-(hydroxymethyl)oxolane-2β-yl]-4-(hydroxyamino)pyrimidine-2(1H)-one | Compound products;Pharmaceutical raw materials |
| 82 | 155148-31-5 | Plerixafor hcl | JM3100 SID791 AMD3100 BISCYCLAM Plerixafor hcl AMD3100 OCTAHYDROCHLORIDE Plerixafor 8HCl (AMD3100 8HCl) amd3100 octahydrochloride hydrate AMD3100 OCTAHYDROCHLORIDE HYDRATE ANHYDROUS | Inhibitors |
| 83 | 1642288-47-8 | MYK-461 | MYK461 MYK-461 SAR-439152 Mavacamten (MYK-461 2,4(1H,3H)-Pyrimidinedione, 3-(1-methylethyl)-6-[[(1S)-1-phenylethyl]amino]- | Pharmaceutical API-API |
| 84 | 1454846-35-5 | Lorlatinib | Loratinib EOS-60936 PF0643922 Lorlatinib PF-06463922 Lorlatinib,PF-06463922 PF-06463922, Lorlatinib Lorlatinib (PF-06463922) (R)-26-amino-55-fluoro-11,4,7-trimethyl-6-oxo-11H-3-oxa-7-aza-2(3,5)-pyridina-1(4,3)-pyrazola-5(1,2)-benzenacyclooctaphane-15-carbonitrile (10R)-7-Amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-2H-4,8-methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile | 1;API;Inhibitors;Series of s;Standard products;Chemical reagents;Small molecule inhibitors;PF0643922, scientific research raw materials;Small molecule targeted bulk drug [for scientific research only] |
| 85 | 857890-39-2 | Lenvatinib mesylate | E7080 Mesylate Lenvatinib mesylate lenvatinib Methanesulfonate 4-[3chloro-4-(N'-cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamide methanesulfonate 4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide monomethanesulfonate | Intermediates-Pharmaceutical Intermediates |
| 86 | 1029712-80-8 | Capmatinib | NVP-INC280 INCB028060 Capmatinib NC280 BenzaMide,2-fluoro-N-Methyl-4-[7-(6-quinolinylMethyl)iMidazo[1,2-b][1,2,4]triazin-2-yl]- 2-Fluoro-N-methyl-4-[7-[(quinolin-6-yl)methyl]imidazo[1,2-b]-[1,2,4]triazin-2-yl]benzamide Capmatinib (INCB28060) | Intermediates-Pharmaceutical Intermediates |
| 87 | 1257044-40-8 | ABT-199 | ABT-199 GDC-0199 Venclexta ABT-199 (GDC-0199) ABT-199, Venetoclax ABT-199 (GDC-0199)Venetoclax 2-(1H-Pyrrolo[2,3-b]pyridin-5-yloxy)-4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl)met 4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]ami | Intermediates-Pharmaceutical Intermediates |
| 88 | 1197958-12-5 | Brigatinib-analog | AP26113 AP26113-ANALOG Brigatinib-analog (2-((5-Chloro-2-((4-(4-(dimethylamino)piperidin-1-yl)-2-methoxyphenyl)amino)pyrimidin-4-yl)ami 5-chloro-2-N-[4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl]-4-N-(2-dimethylphosphorylphenyl)pyrimidine-2,4-diamine | API;Inhibitors |
| 89 | 1092364-38-9 | Poziotinib | Poziotinib UNII-OEI6OOU6IK Poziotinib (HM781-36B) 1-[4-[[4-[(3,4-Dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-2-propen-1-one | Inhibitors |
| 90 | 1421373-65-0 | AZD9291 | AZD9291 AZD-9291 Mereletinib Osimertinib Intermediate 4 Mereletinib mesylate(AZD9291) Pharmaceutical Chemical Anticancer Drug Azd-9291 for for Lung Cancer 1421373-65-0 N-(2-{2-dimethylaminoethyl-methylamino}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide | API;AZD9291;Inhibitors;Anticancer |
| 91 | 1256580-46-7 | Alectinib | AF-802 Alectinib RO 5424802 | ;Anti-cancer&immunity |
| 92 | 1402836-58-1 | NLG919 | NLG919 CS-820 NLG-919 GDC 0919 IDO INHIBITOR 5-(2-Cyclohexyl-2-hydroxyethyl)-5H-imidazo[5,1-a]isoindole | Inhibitor;Inhibitors |
| 93 | 1346574-57-9 | 1-[(2S)-butan-2-yl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-methyl-6-(6-piperazin-1-ylpyridin-3-yl)indole-4-carboxamide | GSK126 GSK 126 1-[(2S)-butan-2-yl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-methyl-6-(6-piperazin-1-ylpyridin-3-yl)indole-4-carboxamide S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide N-[(4,6-Dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-((1S)-1-methylpropyl)-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide | API;Inhibitors |
| 94 | 700874-72-2 | LY 2157299 | LY 2157299 LY-2157299 GALUNISERTIB 4-[5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxamide 6-QuinolinecarboxaMide, 4-[5,6-dihydro-2-(6-Methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]- 4-[2-(6-Methyl-2-pyridinyl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxaMideor | Smad;TGF-beta;Inhibitors |
| 95 | 1009298-09-2 | AZD-8055 | CS-1935 AZD8055 AZD8055 AZD-8055 AZD 8055. [5-[2,4-Bis((3S)-3-MethylMorpholin-4-yl)pyrido[ (5-{2,4-dichloropyrido[2,3-d]pyriMidin-7-yl}-2-Methoxyphenyl)Methyl 2,2-diMethylpropanoate {5-[2,4-Bis-(3-methyl-morpholin-4-yl)-pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy-phenyl}-methanol AZD 8055 [5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol Propanoic acid, 2,2-dimethyl-, [5-(2,4-dichloropyrido[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl]methyl ester AZD 8055 [5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol | Akt;mTOR;PI3K;Aromatics;Inhibitors;Intermediat;Heterocycles;PI3K/Akt/mTOR;Pharmaceuticals;Cell biology reagents |
| 96 | 85650-56-2 | Asenapine Maleate | Org 5222 Org5222 Maleate Unii-cu9463U2E2 Org 5222 Maleate Einecs 288-064-8 Asenapine maleate Asenapine Maleate | API;Saphris;Inhibitors;Scientific rese;Proteins and derivatives;Pharmaceutical bulk drugs;Small molecule inhibitors;Pharmaceutical intermediates;Pharmaceutical raw materials;Small molecule inhibitors, |
| 97 | 953769-46-5 | 4-((2-(((1R,2R)-2-hydroxycyclohexyl)aMino)benzo[d]thiazol-6-yl)oxy)-N-MethylpicolinaMide | 106245 BLZ945 BLZ-945 CS-1735 BLZ 945 4-((2-(((1R,2R)-2-hydroxycyclohexyl)aMino)benzo[d]thiazol-6-yl)oxy)-N-MethylpicolinaMide 4-((2-(((1R,2R)-2-hydroxycyclohexyl)aMino)benzo[d]thiazol-6-yl)oxy)-N-MethylpicolinaMide BLZ945 4-[[2-[[(1R,2R)-2-Hydroxycyclohexyl]amino]-6-benzothiazolyl]oxy]-N-methyl-2-pyridinecarboxamide 4-[[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]-1,3-benzothiazol-6-yl]oxy]-N-methylpyridine-2-carboxamide | API;Inhibitors |
| 98 | 1228591-30-7 | N-[7-cyano-6-[4-fluoro-3-[[2-[3-(trifluoromethyl)phenyl]acetyl]amino]phenoxy]-1,3-benzothiazol-2-yl]cyclopropanecarboxamide | CS-854 TAK632 TAK 632 TAK-632 TAK-0632 N-(7-CYANO-6-(4-FLUORO-3-(2-(3-(TRIFLUOROMETHYL)PHENYL)ACETAMIDO)PHENOXY)BENZO[D]THIAZOL-2-YL)CYCLOPROPANECARBOXAMIDE N-[7-Cyano-6-[4-fluoro-3-[[[3-(trifluoromethyl)phenyl]acetyl]amino]phenoxy]-1,3-benzothiazol-2-yl]cyclopropanecarboxamide N-[7-cyano-6-[4-fluoro-3-[[2-[3-(trifluoromethyl)phenyl]acetyl]amino]phenoxy]-1,3-benzothiazol-2-yl]cyclopropanecarboxamide N-[7-Cyano-6-[4-fluoro-3-[[[3-(trifluoromethyl)phenyl]acetyl]amino]phenoxy]-1,3-benzothiazol-2-yl]cyclopropanecarboxamide TAK632 TAK 632 N-[7-Cyano-6-[4-fluoro-3-[[[3-(trifluoromethyl)phenyl]acetyl]amino]phenoxy]-1,3-benzothiazol-2-yl]cyclopropanecarboxamide | Inhibitors |
| 99 | 697761-98-1 | elvitegravir | CS-789 CS-456 GS9137 JTK 303 GS-9137 GS 9137 Elvitegravir elvitegravir Elvitegravir,EVG,JTK-303 Elvitegravir,EVG,GS-9137,JTK-303 (S)-6-(3-CHLORO-2-FLUOROBENZYL)-1-(1-HYDROXY-3-METHYLBUTAN-2-YL)-7-METHOXY-4-OXO (S)-6-(3-CHLORO-2-FLUOROBENZYL)-1-(1-HYDROXY-3-METHYLBUTAN-2-YL)-7-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID 6-[(3-chloro-2-fluorophenyl)Methyl]-1-[(2S)-1-hydroxy-2,3-diMethylbutan-2-yl]-7-Methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | API;Aromatics;Inhibitor;Inhibitors;Heterocycles;Pharmaceuticals;Intermediates & Fine Chemicals |
| 100 | 872511-34-7 | NVP-BGJ398 | BGJ 398 NVP-BGJ398 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1-methylurea | Inhibitor;Inhibitors |
| 101 | 1229705-06-9 | RG 7388 | RG7388 RG 7388 RG7388 RG-7388 RG-7388 Idasanutlin RG-7388, Idasanutlin Idasanutlin (RG-7388) 4-[[[(2R,3S,4R,5S)-3-(3-Chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)-2-pyrrolidinyl]carbonyl]amino]-3-methoxybenzoic acid | Inhibitors |
| 102 | 6101-15-1 | Succinylcholine chloride dihydrate | CHOLINE CHLORIDE SUCCINATE Succinylcholine chloride dihydrate SUCCINYLCHOLINE CHLORIDE DIHYDRATE SUCCINYLDICHOLINE DICHLORIDE DIHYDRATE bis(trimethylammonioethyl) succinate chloride 2-DIMETHYLAMINOETHYL SUCCINATE DIMETHOCHLORIDE DIHYDRATE | Inhibitors |
| 103 | 109581-93-3 | TACROLIMUS | FK-506 TACROLIMUS Tacrolimus monohydrate | Signalling |
| 104 | 284028-89-3 | xav-939 | CS-300 xav-939 XAV 939 2-[4-(trifluoromethyl)phenyl]-1,5,7,8-tetrahydrothiopyrano[4,3-d]pyrimidin-4-one 3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one | Aromatics;Inhibitors;Heterocycles;Pharmaceuticals;Intermediates & Fine Chemicals |
| 105 | 1032568-63-0 | BAY 80-6946 (Copanlisib) | Copanlisib BAY 80-6946 BAY 80-6946 (Copanlisib) 7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-amine 2-Amino-N-[2,3-dihydro-7-methoxy-8-[3-(4-morpholinyl)propoxy]imidazo[1,2-c]quinazolin-5-yl]-5-pyrimidinecarboxamide 5-Pyrimidinecarboxamide, 2-amino-N-[2,3-dihydro-7-methoxy-8-[3-(4-morpholinyl)propoxy]imidazo[1,2-c]quinazolin-5-yl]- | Akt;mTOR;PI3K;Inhibitors;PI3K/Akt/mTOR |
| 106 | 414864-00-9 | Belinostat (PXD101) | PXD101 Beliomsta Belinostat (PXD101) BELINOSTAT (PXD101) N-HYDROXY-3-(3-PHENYLSULFAMOYLPHENYL)ACRYLAMIDE N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PROPENAMIDE | API;Inhibitor;Inhibitors |
| 107 | 1035270-39-3 | AZD-4547 | AZD-4547 N-(5-(3,5-Dimethoxyphenethyl)-1H-pyrazol-3-yl)-4-((3R,5S)-rel-3,5-dimethylpiperazin-1-yl)benzamide rel-N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethyl-1-piperazinyl]benzamide | Inhibitors;Anti-cancer&immunity |
| 108 | 1037624-75-1 | 1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-[(7S)-6,7,8,9-tetrahydro-7-(1-pyrrolidinyl)-5H-benzocyclohepten-2-yl]-1H-1,2,4-triazole-3,5-diamine | R428 BGB-324 EOS-62006 R428 (BGB324) BGB-324, CPDB1725 (S)-1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8 (S)-1-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine 1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-[(7S)-6,7,8,9-tetrahydro-7-(1-pyrrolidinyl)-5H-benzocyclohepten-2-yl]-1H-1,2,4-triazole-3,5-diamine | API;APIs;Inhibitors |
| 109 | 193611-67-5 | N-[3-[3-(Dimethylamino)ethoxy]-4-methoxyphenyl]-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-carboxamide hydrochloride PFI-3 | SB 216641A SB 216641 hydrochloride N-[3-[3-(Dimethylamino)ethoxy]-4-methoxyphenyl]-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-carboxamide hydrochloride PFI-3 | Intermediates-Pharmaceutical Intermediates |
| 110 | 1420290-99-8 | 2-(2-Aminoethoxy)-5-chloro-N-(2-chloro-4-nitrophenyl)benzamide hydrochloride | HJC0152 2-(2-Aminoethoxy)-5-chloro-N-(2-chloro-4-nitrophenyl)benzamide HCl 2-(2-Aminoethoxy)-5-chloro-N-(2-chloro-4-nitrophenyl)benzamide hydrochloride | Intermediates-Pharmaceutical Intermediates |
| 111 | 1338540-63-8 | 9-[4-[(1R)-2-Amino-1-methylethyl]phenyl]-8-hydroxy-6-methylthieno[2,3-c]quinolin-4(5H)-one | OTS515 OTS514 9-[4-[(1R)-2-Amino-1-methylethyl]phenyl]-8-hydroxy-6-methylthieno[2,3-c]quinolin-4(5H)-one Thieno[2,3-c]quinolin-4(5H)-one, 9-[4-[(1R)-2-amino-1-methylethyl]phenyl]-8-hydroxy-6-methyl- | Intermediates-Pharmaceutical Intermediates |
| 112 | 1691249-45-2 | Zanubrutinib | BGB3111 BGB-3111 BGB 3111 anubrutinib Zanubrutinib ZANUBRUTINIB The BTK inhibitor BGB-3111(Zanubrutinib) Zanubrutinib (BGB-3111) (S)-7-(1-Acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 4,5,6,7-tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-, (7S)- | API;Intermediates-Pharmaceutical Intermediates |
| 113 | 1818314-88-3 | PD-1|PD-L1-IN1 | BMS-1166 D-Proline, 1-[[5-chloro-2-[(3-cyanophenyl)methoxy]-4-[[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylphenyl]methoxy]phenyl]methyl]-4-hydroxy-, (4R)- (2R,4R)-1-(5-chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-4-hydroxypyrrolidine-2-carboxylic acid | Inhibitor |
| 114 | 2621928-55-8 | 2-Naphthalenol, 4-[4-(3,8-diazabicyclo[3.2.1]oct-3-yl)-8-fluoro-2-[[(2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy]pyrido[4,3-d]pyrimidin-7-yl]-5-ethynyl-6-fluoro- | MRTX1133 2-NAPHTHALENOL, 4-[4-(3,8-DIAZABICYCLO[3.2.1]OCT-3-YL)-8-FLUORO-2-[[(2R,7AS)-2-FLUOROTETRAHYDRO-1H- 4-(4-(3,8-Diazabicyclo[3.2.1]octan-3-yl)-8-fluoro-2-(((2R,7aS)-2-fluorohexahydro-1H-pyrrolizin-7a-yl)methoxy)pyrido[4,3-d]pyrimidin-7-yl)-5-ethynyl-6-fluoronaphthalen-2-ol 2-Naphthalenol, 4-[4-(3,8-diazabicyclo[3.2.1]oct-3-yl)-8-fluoro-2-[[(2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy]pyrido[4,3-d]pyrimidin-7-yl]-5-ethynyl-6-fluoro- 4-[4-[(1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl]-8-fluoro-2-[[(2S,7aS)-2-fluorohexahydro-1H-pyrrolizin-7a-yl]methoxy]pyrido[4,3-d]pyrimidin-7-yl]-5-ethynyl-6-fluoronaphthalen-2-ol | Intermediates-Pharmaceutical Intermediates |
| 115 | 2630904-45-7 | MRTX-1719 | MRTX-1719 Benzonitrile, 2-[4-[4-(aminomethyl)-1,2-dihydro-1-oxo-6-phthalazinyl]-1-methyl-1H-pyrazol-5-yl]-4-chloro-6-(cyclopropyloxy)-3-fluoro-, (2R)- | Intermediates-Pharmaceutical Intermediates |
| 116 | 1072833-77-2 | (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid | CS-1976 MLN2238 IXAZOMIB IxazoMib MLN 2238 MLN-2238 ixazomib(MLN2238) 1-(2-(2,5-dichlorobenzamido)acetamido)- 3-methylbutylboronic acid (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid B-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid | Im;apis;Protease;Inhibitor;Inhibitors;New raw materials;Cell biology reagents;Heterocyclic compounds;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 117 | 1044870-39-4 | 2-(4-(2-Hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one | RVX-208 RVX-000222 Apabetalone Apabetalone-RVX-208 RVX-208(RVX 000222) 2-(4-(2-Hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one 4(3H)-Quinazolinone, 2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy- 2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy-4(3H)-quinazolinone RVX-208 | Inhibitors |
| 118 | 3690-10-6 | ZEBULARINE | NSC309132 ZEBULARINE NSC 309132 4-DEOXYURIDINE 4-Deoxyuridine Pyrimidin-2-one -D-Ribofuranoside pyrimidin-2-one beta-ribofuranoside 1--D-Ribofuranosyl-2(1H)-pyrimidinone 1-(β-d-ribofuranosyl)-1,2-dihydropyrimidin-2-one | Interme;Synthesis;Standards;Inhibitors;Nucleosides;Pharmaceuticals;Small molecules;Small molecule inhibitors;Carbohydrates & Derivatives;Pharmaceutical intermediates |
| 119 | 6129-66-4 | 4-hydroxyphenyl-β-D-Glucopyranoside-2,3,4,6-tetraacetate | Acylated arbutin 4-hydroxyphenyl-β-D-Glucopyranoside-2,3,4,6-tetraacetate | Pharmaceutical intermediate |
| 120 | 3690-10-6 | 4-Deoyuridine | NSC309132 ZEBULARINE NSC 309132 4-Deoyuridine 4-Deoxyuridine Pyrimidin-2-one -D-Ribofuranoside pyrimidin-2-one beta-ribofuranoside 1--D-Ribofuranosyl-2(1H)-pyrimidinone 1-(β-d-ribofuranosyl)-1,2-dihydropyrimidin-2-one | Inhibitors;Carbohydrates & Derivatives |
| 121 | 1700637-55-3 | CD38 inhibitor 78c | cd38-1 CD38 inhibitor CD38 inhibitor 1 CD38 inhibitor 78c CD38 inhibitor 1 (compound 78c) 4-[[trans-4-(2-methoxyethoxy)cyclohexyl]amino]-1-methyl-6-(5-thiazolyl)-2(1H)-Quinolinone 4-((trans-4-(2-Methoxyethoxy)cyclohexyl)amino)-1-methyl-6-(thiazol-5-yl)quinolin-2(1H)-one 2(1H)-Quinolinone, 4-[[trans-4-(2-methoxyethoxy)cyclohexyl]amino]-1-methyl-6-(5-thiazolyl)- | Small molecule inhibitor |
| 122 | 16611-84-0 | Ginkgolic acid C15:0 | NSC 623096 NSC 333857 Anacardic Acid Anachardic acid PENTADECYLSALICYLICACID 6-pentadecylsalicylic acid 6-pentadecylsalicylic Acid Hodrogenated anacardic acid 6-Pentadecyl-2-hydroxybenzoic acid | Inhibitors;General biochemical reagents-organic acids |
| 123 | 184025-18-1 | Ciproxifan | CS-757 FUB 359 Ciproxifan Ciproxifan (FUB-359) Cyclopropyl[4-[3-(1H-imidazol-5-yl)propoxy]phenyl]methanone Methanone, cyclopropyl[4-[3-(1H-imidazol-5-yl)propoxy]phenyl]- Methanone, cyclopropyl[4-[3-(1H-iMidazol-4-yl)propoxy]phenyl]- | Inhibitors;Neural signals;Small molecule inhibitors, natural products |
| 124 | 714272-27-2 | Plinabulin (NPI-2358) | NPI-2358 Plinabulin Plinabulin(NPI-2358) NPI-2358 (Plinabulin) Plinabulin (NPI-2358) Plinabulin (NPI-2358) (3Z,6Z)-3-benzylidene-6-((5-tert-butyl-1H-imidazol-4-yl)methylene)piperazine-2,5-dione (3Z,6Z)-3-[(5-tert-Butyl-1H-imidazol-4-yl)methylene]-6-(phenylmethylene)-2,5-piperazinedione Plinabulin (3Z,6Z)-3-[(5-tert-Butyl-1H-imidazol-4-yl)methylene]-6-(phenylmethylene)-2,5-piperazinedione (3Z,6Z)-3-[(5-tert-Butyl-1H-imidazol-4-yl)methylene]-6-(phenylmethylene)-2,5-piperazinedione Plinabulin (NPI-2358) | APIs;Inhibitors;Angiogenesis;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 125 | 1357576-48-7 | AZD4320 | AZD4320 Benzamide, 4-[4-[(R)-(4'-chloro[1,1'-biphenyl]-2-yl)hydroxymethyl]-1-piperidinyl]-N-[[4-[[(1R)-3-[(2-hydroxyethyl)methylamino]-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]- | |
| 126 | 2089288-03-7 | AZD-1390 | CS-2816 AZD 1390 AZD-1390 7-fluoro-1-isopropyl-3-methyl-8-(6-(3-(piperidin-1-yl)propoxy)pyridin-3-yl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one 7-Fluoro-1,3-dihydro-3-methyl-1-(1-methylethyl)-8-[6-[3-(1-piperidinyl)propoxy]-3-pyridinyl]-2H-imidazo[4,5-c]quinolin-2-one 2H-Imidazo[4,5-c]quinolin-2-one, 7-fluoro-1,3-dihydro-3-methyl-1-(1-methylethyl)-8-[6-[3-(1-piperidinyl)propoxy]-3-pyridinyl]- | Standard |
| 127 | 1034895-42-5 | 9-ING-41 | 9-ING-41 3-(5-Fluoro-3-benzofuranyl)-4-(5-methyl-5H-1,3-dioxolo[4,5-f]indol-7-yl)-1H-pyrrole-2,5-dione 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)-1H-pyrrole-2,5-dione 9-ING-41 3-?(5-?Fluorobenzofuran-?3-?yl)?-?4-?(5-?methyl-?5H- ?[1,?3]?dioxolo[4,?5-?f]?indol-?7-?yl)?pyrrole-?2,?5-?dione | Preparation-inhibitor |
| 128 | 2169916-18-9 | VTP50469 | VTP50469 Benzamide, 5-fluoro-N,N-bis(1-methylethyl)-2-[[4-[7-[[trans-4-[(methylsulfonyl)amino]cyclohexyl]methyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]- | Inhibitor;Small molecule inhibitor |
| 129 | 21102-95-4 | 8-(2-(4-(2-Methoxyphenyl)piperazin-1-yl)ethyl)-8-azaspiro[4.5]decane-7,9-dione dihydrochloride | BMY 7378 BMY7378 HCl BMY 7378 2hydrochloride BMY 7378 DIHYDROCHLORIDE 8-(2-(4-(2-Methoxyphenyl) -8-azaspiro[4.5]decane-7,9-dione dihydrochloride 1-cyclopentanediacetimide,n-(2-(4-(o-methoxyphenyl)-1-piperazinyl)ethyl)-d n-(2-(4-(o-methoxyphenyl)-1-piperazinyl)ethyl)-1,1-cyclopentanediacetimided 8-(2-(4-(2-Methoxyphenyl)piperazin-1-yl)ethyl)-8-azaspiro[4.5]decane-7,9-dione dihydrochloride | Inhibitors;Neural signals;Serotonin receptor;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 130 | 487021-52-3 | AR-A014418 | CS-1021 AR 014418 AR 014418 AR 0133418 AR-A014418 AR-AO 14418 AR-A 014418 AR 0133418 AR-A014418-D3 GSK 3Β INHIBITOR GSK 3Β INHIBITOR VIII AR-A014418(GSK3β Inhibitor VIII) N-(4-Methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea AR 0133418 | Akt;mTOR;PI3K;Inhibito;Aromatics;Inhibitors;Heterocycles;Pharmaceuticals;Small molecule inhibitors;Sulfur & Selenium Compounds |
| 131 | 126643-37-6 | KT5823 | KT5823 PROTEIN KINASE INHIBITOR KT 5823 | P to;antibiotic;Antibiotics;Protein kinase;Enzyme Inhibitor;Biochemical reagents;Cyclic Nucleotide related;Other biochemical reagents;Kinase/Phosphatase Biology;Pharmaceutical raw materials |
| 132 | 209481-20-9 | SB271046 | SB271046 SB 737050 SB 271046 SB 271046 hydrochloride 5-Chloro-N-[4-methoxy-3-(1-piperazinyl)phenyl]-3-methylbenzo[b]thiophene-2-sulfonamide 5-Chloro-3-Methyl-Benzo[b]Thiophene-2-Carboxylic Acid (4-Methoxy-3-Piperazin-1-yl-Phenyl)-AMide H 5-Chloro-N-[4-methoxy-3-(1-piperazinyl)phenyl]-3-methyl-benzo[b]thiophen-2-sulfonamide hydrochloride 1. 5-Chloro-3-Methyl-Benzo[b]Thiophene-2-Carboxylic Acid (4-Methoxy-3-Piperazin-1-yl-Phenyl)-AMide H 5-chloro-N-(4-methoxy-3-(piperazin-1-yl)phenyl)-3-methylbenzo[b]thiophene-2-sulfonamide hydrochloride | Inhibitors;Neural signals;Small molecule inhibitors, natural products |
| 133 | 1396841-57-8 | RGFP966 | RGFP966 CS-1872 (E,E)-RGFP966 RGFP966 Racemate (E)-N-(2-amino-4-fluorophenyl)-3-(1-cinnamyl-1H-pyrazol-4-yl)acrylamide (E,E)-N-(2-Amino-4-fluorophenyl)-3-(1-cinnamyl-1H-pyrazol-4-yl)acrylamide 2-Propenamide (N-(2-amino-4-fluorophenyl)-3-[1-[(2E)-3-phenyl-2-propen-1-yl]-1H-pyrazol-4-yl] 2-Propenamide, N-(2-amino-4-fluorophenyl)-3-[1-[(2E)-3-phenyl-2-propen-1-yl]-1H-pyrazol-4-yl]-, (2E)- RGFP966 (E)-N-(2-Amino-4-fluorophenyl)-3-[1-[(E)-3-phenylprop-2-enyl]pyrazol-4-yl]prop-2-enamide | Inhibitors;Epigenetics;Small molecule inhibitors, natural products |
| 134 | 1448867-41-1 | NVP-HDM201 | HDM201 HDM-201 CS-2787 CS-2613 HDM-201 HDM 201 NVP-HDM201 Siremadlin NVP-HDM201 NVP-HDM 201 NVP-HDM-201 (S)-5-(5-chloro-1-methyl-2-oxo-1,2-dihydropyridin-3-yl)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-isopropyl-5,6-dihydropyrrolo[3,4-d]imidazol-4(1H)-one (6S)-5-(5-chloro-1,2-dihydro-1-methyl-2-oxo-3-pyridinyl)-6-(4-chlorophenyl)-2-(2,4-dimethoxy-5-pyrimidinyl)-5,6-dihydro-1-(1-methylethyl)-Pyrrolo[3,4-d]imidazol-4(1H)-one | |
| 135 | 1050500-29-2 | AST-1306 TsOH | AST-6 AST-1306 AST-1306 TsOH AST-1306 (TsOH) AST1306 tosilate AST 1306 tosylate AST1306 (p-Toluenesulfonic acid) AST 1306 (p-Toluenesulfonic acid) AST-1306 (p-Toluenesulfonic acid) N-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-propenamide 4-methylbenzenesulfonate | Inhibito;Standards;Inhibitors;Anti-cancer&immunity;Cell biology reagents;Protein tyrosine kinase;Anti-tumor and immunosuppressive agents;Small molecule inhibitors, natural products;Signal transduction |
| 136 | 1173900-33-8 | AZD6482 | KIN-193 AZD6482 JNJ-5279 AZD 6482 AZD6482(r) AZD6482(PI3-kinase β inhibitor) 2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid (R)AZD64822-[[(1R)-1-[7-Methyl-2-(4-Morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyriMidin-9-yl]ethyl]aMino]benzoic acid 2-[[(1R)-1-[7-Methyl-2-(4-morpholinyl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid AZD 6482 | Akt;mTOR;PI3K;Inhibitors;PI3K/Akt/mTOR;Cell biology reagents;Small molecule inhibitors, natural products |
| 137 | 1191252-49-9 | IOWH032 | CS-950 IOWH032 IOWH032 IOWH-032 IOWH 032 iOWH-032 IOWH 032 3-(3,5-DibroMo-4-hydroxyphenyl)-N-(4-phenoxybenzyl)-1,2,4-oxadiazole-5-carboxaMide 3-(3,5-Dibromo-4-hydroxyphenyl)-N-[(4-phenoxyphenyl)methyl]-1,2,4-oxadiazole-5-carboxamide 1,2,4-Oxadiazole-5-carboxamide, 3-(3,5-dibromo-4-hydroxyphenyl)-N-[(4-phenoxyphenyl)methyl]- 3-(3,5-DIBROMO-4-OXOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-[(4-PHENOXYPHENYL)METHYL]-1,2,4-OXADIAZOLE-5-CARBOXAMIDE | Inhibitors;Ion channels;Membrane transport;Small molecule inhibitors;Membrane transport/ion channels;Small molecule inhibitors, natural products |
| 138 | 1191951-57-1 | PHT-427 | CS-303 PHT 427 CS-0223 PHT-427 4-Dodecyl-N-1,3,4-thiadiazol-2-ylbenzenesulfonamide PHT-427 4-Dodecyl-N-1,3,4-thiadiazol-2-ylbenzenesulfonamide 4-Dodecyl-N-1,3,4-thiadiazol-2-ylbenzenesulfonamide PHT 427 | Akt;mTOR;PI3K;Inhibitors;PI3K/Akt/mTOR;Cell biology reagent;Small molecule inhibitor;Small molecule inhibitor, natural product;Signal transduction pathway kinase inhibitor |
| 139 | 1196109-52-0 | PF-3845 | PF 3845 PF-3845 PF 3845 hydrate 4-(3-(5-(trifluoromethyl)pyridin-2-yloxy)benzyl)-N-(pyridin-3-yl)piperidine-1-carboxamide N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxami N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide hydrate N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide PF 3845 | Inhibitor;Inhibitors;Metabolism;Pharmaceutical intermediate;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 140 | 1202757-89-8 | AVL-292 | AVL292 CC-292 AVL-292 LMK-435 CC-292,LMK-435 CC-292 (AVL-292) N-[3-[[5-Fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-2-propenamide 2-Propenamide, N-[3-[[5-fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]- N-[3-[[5-Fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-2-propenamide AVL292 | Inhibitors;Standard substance;Cell biology reagent;Protein tyrosine kinase;Small molecule inhibitor;Active small molecule library;Small molecule inhibitor, natural product |
| 141 | 1219168-18-9 | Dorsomorphin 2HCl | BML-275 Dorsomorphin 2HCl BML-275,Compound C BML-275 dihydrochloride Dorsomorphin-2HCl BML-275 dorsoMorphin (Hydrochloride) Dorsomorphin(BML-275)dihydrochloride | Akt;mTOR;PI3K;Inhibitors;PI3K/Akt/mTOR;High purity reagent;Small molecule inhibitor, natural product |
| 142 | 1222781-70-5 | ML133 HCl | ML133 HCl ML 133 Hydrochloride CID 781301 hydrochloride (4-Methoxybenzyl)(1-naphthylMethyl)aMine Hydrochloride N-(4-methoxybenzyl)-1-(naphthalen-1-yl)methanamine hydrochloride 1-(4-methoxyphenyl)-N-(naphthalen-1-ylmethyl)methanamine hydrochloride | Amines;Aromatics;Inhibitors;Ion channels;Pharmaceuticals;Membrane transport;Intermediates & Fine Chemicals;Membrane transport/ion channels;Small molecule inhibitors, natural products |
| 143 | 1223001-51-1 | Torin 2 | Torin 2 9-(6-AMino-pyridin-3-yl)-... 9-(6-AMino-pyridin-3-yl)-1-(3-trifluoroMethyl-phenyl)-1H-benzo[h][1,6]naphthyridin-2-one 9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one Benzo[h]-1,6-naphthyridin-2(1H)-one, 9-(6-amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]- 9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one Torin 2 Torin 2 9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one | Akt;mTOR;PI3K;Standards;Inhibitors;PI3K/Akt/mTOR;High purity reagents;Cell biology reagents;Small molecule inhibitors, natural products |
| 144 | 1254473-64-7 | LY2874455 | CS-650 LY2874455 LY 2874455 LY-2874455 CYC202, R-ROSCOVITINE (R,E)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethanol 4-[(1E)-2-[5-[(1R)-1-(3,5-Dichloro-4-pyridinyl)ethoxy]-1H-indazol-3-yl]ethenyl]-1H-pyrazole-1-ethanol (R,E)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethan-1-ol 4-[(1E)-2-[5-[(1R)-1-(3,5-Dichloro-4-pyridinyl)ethoxy]-1H-indazol-3-yl]ethenyl]-1H-pyrazole-1-ethanol LY2874455 | Inhibitors;Cell biology reagents;Protein tyrosine kinase;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 145 | 1258861-20-9 | LY2940680 | LY2940680 Taladegib Taladegib (LY2940680) LY2940680 (Taladegib) Taladegib hydrochloride 4-Fluoro-N-methyl-N-(1-(4-(1-methyl-1H-pyrazol-5-yl)phthalazin-1-yl)piperidin-4-yl)-2-(trifluo 4-Fluoro-N-methyl-N-[1-[4-(1-methyl-1H-pyrazol-5-yl)-1-phthalazinyl]-4-piperidinyl]-2-(trifluoromethyl)benzamide 4-Fluoro-N-methyl-N-[1-[4-(1-methyl-1H-pyrazol-5-yl)-1-phthalazinyl]-4-piperidinyl]-2-(trifluoromethyl)benzamide LY 2940680 | Inhibitors;Active molecules;Small molecule inhibitors;Stem cells and Wnt signals;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 146 | 1262036-50-9 | LY2886721 | LY2886721 LY2886721HCL LY2886721 HCL SALT N-(3-((4aS,7aS)-2-aMino-4a,5,7,7a-tetrahydro-4H-furo[3,4-d][1,3]thiazin-7a-yl)-4-fluorophenyl)-5-fluoropicolinaMide N-[3-[(4aS,7aS)-2-Amino-4a,5-dihydro-4H-furo[3,4-d][1,3]thiazin-7a(7H)-yl]-4-fluorophenyl]-5-fluoro-2-pyridinecarboxamide N-[3-[(4aS,7aS)-2-Amino-4a,5-dihydro-4H-furo[3,4-d][1,3]thiazin-7a(7H)-yl]-4-fluorophenyl]-5-fluoro-2-pyridinecarboxamide LY2886721 | Inhibitors;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 147 | 130964-39-5 | H 89 2HCl | H 89 2HCl H-89 DIHYDROCHLORIDE HYDRATE H-89 hydrate dihydrochloride Protein kinase inhibitor H-89 dihydrochloride (E)-N-(2-(4-bromocinnamylamino)ethyl)isoquinoline-5-sulfonamide dihydrochloride N-[2-[[3-(4-BroMophenyl)-2-propen-1-yl]aMino]ethyl]-5-isoquinolinesulfonaMide Hydrochloride 5-IsoquinolinesulfonaMide, N-[2-[[3-(4-broMophenyl)-2-propenyl]aMino]ethyl]-, dihydrochloride H-89 dihydrochloride hydrate,N-[2-(p-Bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide dihydrochloride | Akt;mTOR;PI3K;Inhibitors;PI3K/Akt/mTOR;Protein Kinase Inhibitors and Activators;Small molecule inhibitors, natural products |
| 148 | 1333151-73-7 | KPT-185 | CS-844 KPT185 KPT-185 (Z)-Isopropyl 3-(3-(3-methoxy-5-(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylate (2Z)-3-[3-[3-Methoxy-5-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-2-propenoic acid 1-methylethyl ester 2-Propenoic acid, 3-[3-[3-methoxy-5-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-, 1-methylethyl ester, (2Z)- (2Z)-3-[3-[3-Methoxy-5-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-2-propenoic acid 1-methylethyl ester KPT185 | Inhibitors;Ion channels;Membrane transport;Small molecule inhibitors;Membrane transport/ion channels;Small molecule inhibitors, natural products |
| 149 | 154447-35-5 | NU7026 | CS-595 NU7026 NU 7026 NU-7026 LY293646 LY 293646 2-MORPHOLINO-4H-BENZO[H]CHROMEN-4-ONE 2-(4-Morpholinyl)-4H-naphthol[1,2-b]pyran-4-one | Standards;Inhibitors;DNA damage;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 150 | 156897-06-2 | Licofelone | ML 3000 Licofelone Licofelone, ML-3000 6-(4-Chlorophenyl)-2,3-dihydro-2,2-dimethyl-7-phenyl- 1H-pyrrolizine-5-acetic Acid 2-[2-(4-chlorophenyl)-6,6-dimethyl-1-phenyl-5,7-dihydropyrrolizin-3-yl]acetic acid 1H-Pyrrolizine-5-aceticacid, 6-(4-chlorophenyl)-2,3-dihydro-2,2-diMethyl-7-phenyl- [2,2-Dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]acetic acid 2-[6-(4-Chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]acetic acid | Inhibitors;Neural signal;Pharmaceuticals;Scientific research reagents;Pharmaceutical intermediates;Intermediates & Fine Chemicals;Small molecule inhibitors, natural products |
| 151 | 157716-52-4 | Perifosine (KRX-0401) | Perifosine Perifosine,D 21266 Perifosine (KRX-0401) (1,1-Dimethylpiperidin-1-ium-4-yl) octadecyl phosphate D-21266 octadecyl-(N,N-diMethyl-piperidino-4-yl)-phosphate Perifosine【(1,1-dimethylpiperidin-1-ium-4-yl) octadecyl phosphate】 4-((Hydroxy(octadecyloxy)phosphinyl)oxy)-1,1-dimethylpiperidinium inner salt 4-[[Hydroxy(octadecycloxy)phosphinyl]oxy]-1,1-diMethylpiperidiniuM inner salt | Akt;mTOR;PI3K;PI3K/;Inhibitors;PI3K/Akt/mTOR;Antineoplastic;Pharmaceuticals;Cell biology reagents;Small molecule inhibitors |
| 152 | 196868-63-0 | PQ 401 | PQ401 PQ 401 IGF-1R Inhibitor II N-(5-chloro-2-methoxyphenyl)-N'-(2-methyl-4-quinolinyl)- 1-(5-Chloro-2-Methoxyphenyl)-3-(2-Methylquinolin-4-yl)urea N-(5-Chloro-2-methoxyphenyl)-N'-(2-methyl-4-quinolinyl)urea N-(5-Chloro-2-methoxyphenyl)-N′-(2-methylquinolin-4-yl)urea Urea, N-(5-chloro-2-Methoxyphenyl)-N'-(2-Methyl-4-quinolinyl)- IGF-1R Inhibitor II, N-(5-Chloro-2-methoxyphenyl)-Nμ-(2-methylquinolin-4-yl)urea | Inhibitors;Cell biology reagents;Protein tyrosine kinase;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 153 | 208260-29-1 | ZM 336372 | ZM 336372 Zinc00581684 N-[5-(3-DIMETHYLAMINOBENZAMIDO)-2-METHYLPHENYL]-4-HYDROXYBENZAMIDE 3-(diMethylaMino)-N-(3-(4-hydroxybenzaMido)-4-Methylphenyl)benzaMide 3-(DIMETHYLAMINO)-N-[3-[(4-HYDROXYBENZOYL)-AMINO]-4-METHYLPHENYL]BENZAMIDE Benzamide, 3-(dimethylamino)-N-[3-[(4-hydroxybenzoyl)amino]-4-methylphenyl]- ZM 336372 3-(Dimethylamino)-N-[3-[(4-hydroxybenzoyl)amino]-4-methylphenyl]benzamide | MAPK;Amines;Aromatics;Inhibitors;Intermediat;Pharmaceuticals;Cell biology reagents;Small molecule inhibitors;Intermediates & Fine Chemicals;Small molecule inhibitors, natural products |
| 154 | 211555-04-3 | WHI-P154 | CS-1516 WHI-P154 JAK3 Inhibitor 2-Bromo-4-((6,7-dimethoxyquinazolin-4-yl)amino)phenol 2-Bromo-4-[(6,7-dimethoxy-4-quinazolinyl)amino]phenol Phenol, 2-bromo-4-[(6,7-dimethoxy-4-quinazolinyl)amino]- 4-(3'-Bromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline WHI-P 154 | JAK;STAT;JAK/STAT;Inhibitor;Standards;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 155 | 213261-59-7 | RITA (NSC 652287) | RITA (NSC 652287) p53 Activator III 5,5'-(2,5-FURANDIYL)BIS-2-THIOPHENEMETHANOL 2-Thiophenemethanol, 5,5'-(2,5-furandiyl)bis- (5,5'-(furan-2,5-diyl)bis(thiophene-5,2-diyl))diMethanol 5,5'-(2,5-Furandiyl)bis-2-thiophenemethanol NSC 652287 5,5'-(2,5-Furandiyl)bis-2-thiophenemethanol RITA (NSC 652287) NSC 652287 5,5'-(2,5-Furandiyl)bis-2-thiophenemethanol | Inhibitor;Apoptosis;Inhibitors;High purity reagent;Small molecule inhibitor;Small molecule inhibitor, natural product |
| 156 | 261901-57-9 | SB269970 HCl | SB-269970A SB269970 HCl SB269970 HClSB269970 HCl (r)-3-[2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidine-1-sulfonyl]phenol hydrochloride (R)-3-((2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidin-1-yl)sulfonyl)phenol hydrochloride (2R)-1-[(3-Hydroxyphenyl)sulfonyl]-2-[2-(4-methyl-1-piperidinyl)ethyl]pyrrolidine monohydrochloride SB 269970A, (R)-3-[2-[2-(4-Methylpiperidin-1-yl)ethyl]pyrrolidine-1-sulfonyl]phenol hydrochloride | Inhibitors;Neural signals;Small molecule inhibitors, natural products |
| 157 | 2854-32-2 | BML-190 | IMMA BML-190 INDOMETHACIN MORPHOLINYLAMIDE 4-((2-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl)acetyl)-morpholin 1h-indole,1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1-(2-(4-morpholinyl)-2-oxoe BML-190, N-[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetyl]morpholine 1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOLE-3-ACETIC ACID, MORPHOLINEAMIDE 1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1-[2-(4-MORPHOLINYL)-2-OXOETHYL]-1H-INDOLE | Inhibitors;Cannabinoid receptor;G protein coupled receptor & G protein;Small molecule inhibitors, natural products |
| 158 | 289905-88-0 | TRAM-34 | TRAM34 TRAM 34 CS-1574 TRAM-34 Triarylmethane-34 TRIARYLMETHANE-34 Clotrimazole Impurity 8 2',3',4'-TRIHYDROXY FLAVONE Clotrimazole TRAM-34 Impurity 1-[(2-Chlorophenyl)diphenylmethyl]- 1-[(2-chlorophenyl)-diphenylmethyl]pyrazole | Inhibitors;Heterocycles;Ion channels;Membrane transport;Heterocyclic Compounds;Chemical raw materials;Small molecule inhibitors, natural products |
| 159 | 304448-55-3 | Dynasore | DYNASORE Dynasore Dynasore monohydrate Dynasore monohydrate (E)-N'-(3,4-DIHYDROXYBENZYLIDENE)-3-HYDROXY-2-NAPHTHOHYDRAZIDE 3-Hydroxynaphthalene-2-carboxylicacid(3,4-dihydroxybenzylidene)hydrazide 3-Hydroxy-2-naphthalenecarboxylic acid [(3,4-dihydroxyphenyl)Methylene]hydrazide 2-Naphthalenecarboxylic acid, 3-hydroxy-, 2-[(3,4-dihydroxyphenyl)methylene]hydrazide 3-Hydroxy-naphthalene-2-carboxylic acid (3,4-dihydroxy-benzylidene)-hydrazide monohydrate 3-Hydroxy-naphthalene-2-carboxylic acid (3,4-dihydroxy-benzylidene)-hydrazide monohydrate 3-Hydroxy-2-naphthalenecarboxylic acid [(3,4-dihydroxyphenyl)methylene]hydrazide Dynasore 3-hydroxy-N'-[(E)-(3-hydroxy-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]naphthalene-2-carbohydrazide | Inhibitors;Signalling;Cell Cycle Regulation;Small molecule inhibitors |
| 160 | 380315-80-0 | Tenovin-1 | CS-571 Tenovin-1 TENOVIN-1 N-[(4-acetaMidophenyl)carbaMothioyl]-4-tert-butylbenzaMide N-[[[4-(Acetylamino)phenyl]amino]thioxomethyl]-4-(1,1-dimethylethyl)benzamide Benzamide, N-[[[4-(acetylamino)phenyl]amino]thioxomethyl]-4-(1,1-dimethylethyl)- N-[[[4-(Acetylamino)phenyl]amino]thioxomethyl]-4-(1,1-dimethylethyl)benzamide Tenovin 1 Tenovin 1 N-[[[4-(Acetylamino)phenyl]amino]thioxomethyl]-4-(1,1-dimethylethyl)benzamide | Inhibitor;Apoptosis;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 161 | 403811-55-2 | (Z,E)-5-(4-ETHYLBENZYLIDINE)-2-THIOXOTHIAZOLIDIN-4-ONE | CS-1512 10058-F4 ZINC01085340 c-Myc Inhibitor (Z,E)-5-(4-ETHYLBENZYLIDINE)-2-THIOXOTHIAZOLIDIN-4-ONE 5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone (5E)-5-(4-ethylbenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one (5E)-5-[(4-ethylphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | Inhibitors;Cell cycle;Cell biology reagents;Small molecule inhibitors, natural products |
| 162 | 438190-29-5 | SMI-4a | SMI-4a (Z)-SMI-4a TCS PIM-1 4a (Z)-5-(3-(trifluoroMethyl)benzylidene)thiazolidine-2,4-dione (5Z)-5-[[3-(TRIFLUOROMETHYL)PHENYL]METHYLENE]-2,4-THIAZOLIDINEDIONE (5Z)-5-[[3-(Trifluoromethyl)phenyl]methylene]-2,4-thiazolidinedione 2,4-Thiazolidinedione, 5-[[3-(trifluoromethyl)phenyl]methylene]-, (5Z)- (5E)-5-{[3-(trifluoromethyl)phenyl]methylidene}-1,3-thiazolidine-2,4-dione | JAK;STAT;Inhibitor;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 163 | 501925-31-1 | N-(5-CHLORO-2,4-DIMETHOXYPHENYL)-N'-(5-METHYL-3-ISOXAZOLYL)-UREA | CS-224 PNU120596 PNU 120596 PNU-120596 Nsc 216666 NSC 216666 1-(5-Chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)urea N-(5-Chloro-2,4-dimethoxphenyl)-N'-(5-methyl-3-isoxazolyl)-urea N-(5-CHLORO-2,4-DIMETHOXYPHENYL)-N'-(5-METHYL-3-ISOXAZOLYL)-UREA Urea, N-(5-chloro-2,4-dimethoxyphenyl)-N'-(5-methyl-3-isoxazolyl)- | Inhibitors;Neural signals;Small molecule inhibitors, natural products |
| 164 | 537705-08-1 | CP-724714 | CP-724714 -Ethyl (3-(4-((3-methyl-4-((6-methylpyridin-3-yl) (E)-Ethyl (3-(4-((3-methyl-4-((6-methylpyridin-3-yl)-oxy)phenyl)amino)quinazolin-6-yl)allyl)ca (E)-Ethyl (3-(4-((3-methyl-4-((6-methylpyridin-3-yl)-oxy)phenyl)amino)quinazolin-6-yl)allyl)carba (E)-Ethyl (3-(4-((3-Methyl-4-((6-Methylpyridin-3-yl)oxy)phenyl)aMino)quinazolin-6-yl)allyl)carbaMate (E)-2-Methoxy-N-(3-(4-(3-Methyl-4-(6-Methylpyridin-3-yloxy)phenylaMino)quinazolin-6-yl)allyl)acetaMide 2-Methoxy-N-[3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide acetaMide, 2-Methoxy-N-[3-[4-[[3-Methyl-4-[(6-Methyl-3-pyridinyl)oxy]phenyl]aMino]-6-quinazolinyl]-2-propen-1-yl]- | Inhibitors;Cell biology reagents;Protein tyrosine kinase;Small molecule inhibitors, natural products |
| 165 | 57477-39-1 | BRL-54443 | BRL54443 BRL 54443 BRL-54443 BRL 54443 HCl 3-(1-Methyl-4-piperidinyl)-1H-indol-5-ol 3-(1-methylpiperidin-4-yl)-1H-indol-5-ol 1H-Indol-5-ol, 3-(1-Methyl-4-piperidinyl)- 5-HYDROXY-3-(1-METHYLPIPERIDIN-4-YL)-1H-INDOLE 3-(1-Methyl-4-piperidinyl)-1H-indol-5-ol BRL 54443 | Inhibitors;Neural signals;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 166 | 648449-76-7 | AS-604850 | AS 604850 AS-604850 PI 3-Kγ Inhibitor II PI 3-Kinase Inhibitor (AS604850) B-0302 5-[(2,2-Difluoro-1,3-benzodioxol-5-yl)methylene]thiazolidine-2,4-dione 5-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethylene)-thiazolidine-2,4-dione (Z)-5-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)methylene)thiazolidine-2,4-dione PI3Kγ inhibitor, 5-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethylene)-thiazolidine-2,4-dione | Akt;mTOR;PI3K;Inhibitors;Small molecule inhibitors, natural products |
| 167 | 6960-45-8 | 7-Nitroindole-2-carboxylic acid | 7-NO2-ICA TIMTEC-BB SBB003487 2-Carboxy-7-nitro-1H-indole 7-Nitroindole-2-carboxylic acid 7-NITROINDOLE-2-CARBOXYLIC ACID 7-nitro-1h-indole-2-carboxylicaci 7-NITRO-1H-INDOLE-2-CARBOXYLIC ACID | Inhibitors;Standard products;Indoles and derivatives;Other heterocyclic rings;Organic chemical raw materials;Small molecule inhibitors, natural products |
| 168 | 702675-74-9 | BX-795 盐酸盐 | BX 795 BX-795 hydrochloride N-[3-[[5-Iodo-4-[[3-[(2-thienylcarbonyl)aMino]propyl]aMino]-2-pyriMidinyl]aMino]phenyl]-1-pyrrolidin N-(3-(5-IODO-4-(3-(THIOPHENE-2-CARBOXAMIDO)PROPYLAMINO)PYRIMIDIN-2-YLAMINO)PHENYL)PYRROLIDINE-1-CARBOXAMIDE N-[3-[[5-Iodo-4-[[3-[(2-thienylcarbonyl)amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide N-[3-[[5-iodo-4-[[3-[(2-thienylcarbonyl)amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-Pyrrolidinecarboxamide hydrochloride N-[3-[[5-Iodo-4-[[3-[(2-thienylcarbonyl)amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide BX-795 | Akt;mTOR;PI3K;Inhibitors;PDK1 inhibitor;Cell biology reagent;Small molecule inhibitor;Small molecule inhibitor, natural product;Signal transduction pathway kinase inhibitor |
| 169 | 717906-29-1 | PF-431396 | PF431396 PF-431396 PF-431396 hydrate N-methyl-N-(2-((2-(2-oxoindolin-5-ylamino)-5-(trifluoromethyl)pyrimidin-4-ylamino)methyl)phenyl)methanesulfonamide N-Methyl-N-[2-[[[2-[(2-oxo-2,3-dihydro-1H-indol-5-yl)amino]-5-trifluoromethylpyrimidin-4-yl]amino]methyl]phenyl]methanesulfonamide N-[2-[[[2-[(2,3-Dihydro-2-oxo-1H-indol-5-yl)aMino]-5-(trifluoroMethyl)-4-pyriMidinyl]aMino]Methyl]phenyl]-N-MethylMethanesulfonaMide N-[2-[[[2-[(2,3-dihydro-2-oxo-1H-indol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]phenyl]-N-methyl-Methanesulfonamide hydrate N-Methyl-N-[2-[[[2-[(2-oxo-2,3-dihydro-1H-indol-5-yl)amino]-5-trifluoromethylpyrimidin-4-yl]amino]methyl]phenyl]methanesulfonamide PF-431396 | Ar;Spot;Amines;Inhibitors;Pharmaceuticals;Pfizer compounds;Dual focus adhesion ki;Protein tyrosine kinase;Small molecule inhibitors;Intermediates & Fine Chemicals |
| 170 | 726169-73-9 | Mocetinostat (MGCD0103) | MG0103 MGCD0103 Mocetinostat MGCD0103(Mocetinostat) Mocetinostat (MGCD0103) Mocetinostat (MGCD0103,MG0103) BKT140, TF 14016, 4-FLUOROBENZOYL, 4F-BENZOYL-TN14003, T140 N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide Mocetinostat (MGCD0103) | API;Inhibitor;Standards;Inhibitors;Epigenetics;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 171 | 780757-88-2 | (6S,9aS)-6-(4-Hydroxybenzyl)-8-[(naphthalen-1-yl)methyl]-4,7-dioxohexahydropyrazino[1,2-a]pyrimidine-1-carboxylic acid N-benzylamide | ICG-001 (S,S)-ICG 001 (6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylMethyl)- (6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylmethyl)-4,7-dioxooctahydro-1H-pyrazino[1,2-a]pyrimidine-1-carboxamide (6S,9AS)-6-(4-HYDROXYBENZYL)-8-NAPHTHALEN-1-YLMETHYL-4,7-DIOXO-HEXAHYDRO-PYRAZINO[1,2-A]PYRIMIDINE-1-CARBOXYLIC ACID BENZYLAMIDE (6S,9aS)-6-(4-hydroxybenzyl)-N-benzyl-8-(naphthalen-1-ylmethyl)-4,7-dioxo-hexahydro-2H-pyrazino[1,2-a]pyrimidine-1(6H)-carboxamide (6S,9aS)-6-(4-Hydroxybenzyl)-8-[(naphthalen-1-yl)methyl]-4,7-dioxohexahydropyrazino[1,2-a]pyrimidine-1-carboxylic acid N-benzylamide (6S,9aS)-rel-Hexahydro-6-[(4-hydroxyphenyl)Methyl]-8-(1-naphthalenylMethyl)-4,7-dioxo-N-(phenylMethyl)-2H-pyrazino[1,2-a]pyriMidine-1(6H)-carboxaMide 2H-PYRAZINO[1,2-A]PYRIMIDINE-1(6H)-CARBOXAMIDE,HEXAHYDRO-6-[(4-HYDROXYPHENYL)METHYL]-8-(1-NAPHTHALENYLMETHYL)-4,7-DIOXO-N-(PHENYLMETHYL)-,(6R,9AR)-REL- | Colorectal cancer cell inhibitor |
| 172 | 79183-19-0 | Apoptosis Activator 2 | CS-572 APOPTOSIS ACTIVATOR 2 Apoptosis Activator 2 APOPTOSIS ACTIVATOR II 1-(3,4-DICHLOROBENZYL)-1H-INDOLE-2,3-DIONE 1-[(3,4-DICHLOROPHENYL)METHYL]-1H-INDOLE-2,3-DIONE 1H-Indole-2,3-dione, 1-[(3,4-dichlorophenyl)methyl]- | Apoptosis;Inhibitors;Caspases/Apoptosis;Cell biology reagents;Small molecule inhibitors;Cell signaling pathway inhibitors;Small molecule inhibitors, natural products |
| 173 | 84680-54-6 | Enalaprilat Dihydrate | MK-422 ENALAPRILATE ENALAPRILAT USP Enalaprilate USP25 Enalaprilat (300 mg) ENALAPRILAT DIHYDRATE Enalaprilat Dihydrate Enalaprilic Acid Dihydrate (S)-1-[N-[1-(CARBOXY)-3-PHENYLPROPYL]-L-ALANYL]-L-PROLINE, DIHYDRATE | Inhibitors;Raw materials;Pharmaceuticals;Standard products;Pharmaceutical raw m;Endocrine and hormones;Metabolites & Impurities;Pharmaceutical bulk drugs;Intermediates & Fine Chemicals;Small molecule |
| 174 | 905973-89-9 | CGK 733 | CGK733 CS-713 CGK-733 CGK 733 CGK 733 2,2-DIPHENYL-N-(2,2,2-TRICHLORO-1-[3-(4-FLUORO-3-NITROPHENYL)THIOUREIDO]ETHYL)ACETAMIDE A-PHENYL-N-[2,2,2-TRICHLORO-1-[[[(4-FLUORO-3-NITROPHENYL)AMINO]THIOXOMETHYL]AMINO]ETHYL]BENZENEACETAMIDE α-Phenyl-N-[2,2,2-trichloro-1-[[[(4-fluoro-3-nitrophenyl)amino]thioxomethyl]amino]ethyl]benzeneacetamide alpha-Phenyl-N-[2,2,2-trichloro-1-[[[(4-fluoro-3-nitrophenyl)amino]thioxomethyl]amino]ethyl]-benzeneacetamide | Inhibitors;DNA damage;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 175 | 1619994-69-2 | Bromosporine | CS-921 C17H20N6O4S BroMosporine Bromosporine N-[6-(3-Methanesulfonamido-4-methylphenyl)-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-yl]carbamate ethyl 3-Methyl-6-(4-Methyl-3-(MethylsulfonaMido)phenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-ylcarbaMate Carbamic acid, N-[3-methyl-6-[4-methyl-3-[(methylsulfonyl)amino]phenyl]-1,2,4-triazolo[4,3-b]pyridazin-8-yl]-, ethyl ester | API;Inhibitors;Biological chemicals;Small molecule inhibitors, natural products |
| 176 | 690206-97-4 | ZM 306416 | CB676475 CB-676475 CB 676475 ZM 306416 ZM 306416 HYDROCHLORIDE 4-QuinazolinaMine,N-(4-chloro-2-fluorophenyl)-6,7-diMethoxy- 4-[(4'-CHLORO-2'-FLUORO)PHENYLAMINO]-6,7-DIMETHOXYQUINAZOLINE HYDROCHLORIDE ZM 213689 DisodiuM Salt (MeropeneM iMpurity) (Mixture of double bond isoMers) | ;Medicine;Inhibitors;Gefitinib impurity;Standard substance;Protein tyrosine kinase;Small molecule inhibitor;Angiogenesis and Metastasis;Small molecule inhibitor, natural product;Pharmaceutical impurit |
| 177 | 908112-43-6 | SNX-2112 (PF-04928473) | SNX-2112 PF 04928473 SNX-2112 (PF-04928473) 4-(6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hyd 4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide 4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide 2-[(trans-4-Hydroxycyclohexyl)amino]-4-[4,5,6,7-tetrahydro-6,6-dimethyl-4-oxo-3-(trifluoromethyl)-1H-indazol-1-yl]benzamide 4-(6,6-DIMETHYL-4-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-INDAZOL-1-YL)-2-((1R,4R)-4-HYDROXYCYCLOHEXYLAMINO)BENZAMIDE SNX-2112 4-(6,6-DIMETHYL-4-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-INDAZOL-1-YL)-2-((1R,4R)-4-HYDROXYCYCLOHEXYLAMINO)BENZAMIDE | Inhibitor;Inhibitors;Cytoskeleton signal;Cell biology reagents;Small molecule inhibitors, natural products |
| 178 | 1001264-89-6 | GDC-0068 | RG7440 RG 7440 RG-7440 GDC0068 GDC-0068 GDC 0068 Ipatasertib GDC-0068(RG7440) Ipatasertib (GDC-0068) (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one (2S)-2-(4-Chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-1-propanone | Akt;mTOR;PI3K;Inhibitor;Inhibitors;PI3K/Akt/mTOR;Cell biology reagents;Fine chemical products;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 179 | 1001350-96-4 | BMS-754807 | BMS-754807 (S)-1-(1-(4-((5-cyclopropyl-1H-pyrazol-3-yl)amino)pyrrolo[2,1-f][1,2,4]triazin-2-yl)-2-me (S)-1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrrolo[1,2-f][1,2,4]triazin-2-yl)-N-(6-fluoropyridin-3-yl)-2-methylpyrrolidine-2-carboxamide (S)-1-(4-((5-cyclopropyl-1H-pyrazol-3-yl)aMino)pyrrolo[2,1-f][1,2,4]triazin-2-yl)-N-(6-fluoropyridin-3-yl)-2-Methylpyrrolidine-2-carboxaMide (2S)-1-[4-[(5-Cyclopropyl-1H-pyrazol-3-yl)aMino]pyrrolo[2,1-f][1,2,4]triazin-2-yl]-N-(6-fluoropyridin-3-yl)-2-Methylpyrrolidine-2-carboxaMide (2S)-1-[4-[(5-Cyclopropyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1-f][1,2,4]triazin-2-yl]-N-(6-fluoro-3-pyridinyl)-2-methyl-2-pyrrolidinecarboxamide BMS 754807 (2S)-1-[4-[(5-Cyclopropyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1-f][1,2,4]triazin-2-yl]-N-(6-fluoro-3-pyridinyl)-2-methyl-2-pyrrolidinecarboxamide (2S)-1-[4-[(5-Cyclopropyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1-f][1,2,4]triazin-2-yl]-N-(6-fluoro-3-pyridinyl)-2-methyl-2-pyrrolidinecarboxamide BMS 754807 | Inhibitors;Cell biology reagent;Protein tyrosine kinase;Small molecule inhibitor;Active small molecule library;Small molecule inhibitor, natural product |
| 180 | 1002304-34-8 | 7-methoxy-4-((6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy)quinoline | CS-191 AMG208 AMG 208 AMG-208 AMG 208 7-Methoxy-4-[(6-phenyl-1,2,4-triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline 7-methoxy-4-((6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy)quinoline Quinoline, 7-Methoxy-4-[(6-phenyl-1,2,4-triazolo[4,3-b]pyridazin-3-yl)Methoxy]- 7-Methoxy-4-[(6-phenyl-1,2,4-triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline AMG 208 | Inhibitors;Cell biology reagents;Protein tyrosine kinase;Active small molecule library;Small molecule inhibitor, natural product;Signal transduction pathway kinase inhibitor |
| 181 | 1009817-63-3 | (3E,5E)-1-Acryloyl-3,5-bis(4-nitrobenzylidene)piperidin-4-one | b-AP15 LM-3077 b-AP15 (NSC687852) b-AP15 ( NSC 687852) NSC 687852 (b-AP15) (3E,5E)-1-Acryloyl-3,5-bis(4-nitrobenzylidene)piperidin-4-one 3,5-Bis[(4-nitrophenyl)methylene]-1-(1-oxo-2-propene-1-yl)-4-piperidone (3E,5E)-3,5-bis[(4-nitrophenyl)methylidene]-1-prop-2-enoylpiperidin-4-one (3E,5E)-3,5-Bis[(4-nitrophenyl)methylene]-1-(1-oxo-2-propen-1-yl)-4-piperidinone 4-Piperidinone, 3,5-bis[(4-nitrophenyl)methylene]-1-(1-oxo-2-propen-1-yl)-, (3E,5E)- | Inhibitors;Small molecule inhibitors;Small active molecule library;Small molecule inhibitors, natural products;Traditional Chinese medicine reference substance |
| 182 | 1010085-13-8 | MK-5108 (VX-689) | CS-545 VX689 VX-689 MK-5108 MK 5108 VX-689 VX 689 MK-5198 MK5108 MK-5108(VX-689) MK-5108 (VX-689) trans-4-(3-Chloro-2-fluorophenoxy)-1-[[6-(2-thiazolylamino)-2-pyridinyl]methyl]cyclohexanecarboxylic acid (1r,4r)-4-(3-chloro-2-fluorophenoxy)-1-((6-(thiazol-2-ylaMino)pyridin-2-yl)Methyl)cyclohexanecarboxylic acid | Inhibitor;Inhibitors;Cell cycle;Cell biology reagents;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 183 | 1012054-59-9 | CUDC-101 | CS-330 CUDC101 CUDC-101 CUDC 101 CUDC 101 CUDC-101. 7-[[4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yl]oxy]-N-hydroxyheptanamide 7-[[4-[(3-Ethynylphenyl)aMino]-7-Methoxy-6-quinazolinyl]oxy]-N-hydroxyheptanaMide HeptanaMide, 7-[[4-[(3-ethynylphenyl)aMino]-7-Methoxy-6-quinazolinyl]oxy]-N-hydroxy- | Inhibitor;Inhibitors;Epigenetics;Antineoplastic;Cell biology reagents;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 184 | 1020172-07-9 | DCC-2036 (Rebastinib) | DCC2036 CS-1867 DCC 2036 Rebastinib Rebastinib(DCC-2036) DCC-2036 (Rebastinib) N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(MethylcarbaMoyl)pyridin-4-yl) 1-(3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl)-3-(2-fluoro-4-(2-(methylcarbamoyl)pyridin-4-yloxy)phenyl)urea N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea DCC-2036 (Rebastinib) | Standards;Inhibitors;Angiogenesis;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 185 | 1025065-69-3 | SGI-1776 free base | SGI1776 SGI-1776 RG7422, GNE 390 SGI-1776 FREE BASE SGI-1776 free base N-((1-methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo[1,2-b]pyridazin-6-amine N-[(1-Methyl-4-piperidinyl)methyl]-3-[3-(trifluoromethoxy)phenyl]-imidazo[1,2-b]pyridazin-6-amine SGI-1776 free base N-[(1-Methyl-4-piperidinyl)methyl]-3-[3-(trifluoromethoxy)phenyl]-imidazo[1,2-b]pyridazin-6-amine N-[(1-Methyl-4-piperidinyl)methyl]-3-[3-(trifluoromethoxy)phenyl]-imidazo[1,2-b]pyridazin-6-amine SGI-1776 | JAK;STAT;JAK/STAT;Inhibitor;Standards;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 186 | 1026785-59-0 | VX-222 (VCH-222, Lomibuvir) | VX-222 VCH222 VCH-222 VCH 222 VX-222, VCH222 VX-222 (VCH-222, LoMibuvir) VX-222 (VCH-222, Lomibuvir) 5-(3,3-Dimethyl-1-butyn-1-yl)-3-[(cis-4-hydroxycyclohexyl)[(trans-4-methylcyclohexyl)carbonyl]amino]-2-thiophenecarboxylic acid 2-Thiophenecarboxylic acid, 5-(3,3-dimethyl-1-butyn-1-yl)-3-[(cis-4-hydroxycyclohexyl)[(trans-4-methylcyclohexyl)carbonyl]amino]- | Protease;Inhibitor;Inhibitors;Small molecule inhibitors, natural products |
| 187 | 1030612-90-8 | MK-8245 | MK8245 CS-1662 MK 8245 MK-8245 ]-5-isoxazoL ]-2H-tetrazoL 5-[3-[4-(2-Bromo-5-fL 5-[3-[4-(2-Bromo-5-fluorophenoxy)-1-piperidinyl]-5-isoxazolyl]-2H-tetrazole-2-acetic acid 2-(5-(3-(4-(2-broMo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid | Inhibitor;Inhibitors;Metabolism;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 188 | 1037184-44-3 | YK-4-279 | CS-1785 YK 4-279 YK-4-279 4,7-dichloro-3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1H-indol-2-one 4,7-Dichloro-1,3-dihydro-3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-2H-indol-2-one 2H-Indol-2-one, 4,7-dichloro-1,3-dihydro-3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]- 4,7-Dichloro-1,3-dihydro-3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-2H-indol-2-one YK-4-279 | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 189 | 1048371-03-4 | UPF 1069 | CS-874 UPF1069 UPF 1069 UPF-1069 5-(2-Oxo-2-phenylethoxy)-1(2H)-isoquinolinone 1(2H)-Isoquinolinone, 5-(2-oxo-2-phenylethoxy)- 5-(2-Oxo-2-phenylethoxy)-3,4-dihydroisoquinolin-1(2H)-one | Inhibitor;Inhibitors;DNA damage;Cell biology reagents;Small molecule inhibitors, natural products |
| 190 | 1051375-10-0 | Cabotegravir | GSK744 GSK1265744 Cabotegravir SK744, GSK1265744 Cyclic pyranopterin Cabotegravir Free Acid Cabotegravir (GSK744, GSK1265744) (3S,11aR)-N-[(2,4-Difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide | Inhibitors;Raw materials;Raw materials and interm;Pharmaceutical raw materials;Shaanxi Linnaeus's main products;Pharmaceutical and chemical industries;Small molecule inhibitors, natural products |
| 191 | 1056901-62-2 | AT13148 | CS-1252 AT13148 AT-13148 AT13148 AT 13148 AT 13148 AT13148 HCl AT13148 HCL AT13148 hydrochloride AT13148 HYDROCHLORIDE (+)-(S)-2-Amino-1-(4-chlorophenyl)-1-[4-(1H-pyrazol-4-yl)phenyl]ethanol (alphaS)-alpha-(Aminomethyl)-alpha-(4-chlorophenyl)-4-(1H-pyrazol-4-yl)benzenemethanol | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 192 | 1059734-66-5 | BMS-833923 | XL139 XL 139 XL-139 BMS-833923 BMS 833923 BMS-833923 (XL-139) N-[2-Methyl-5-[(methylamino)methyl]phenyl]-4-[(4-phenylquinazolin-2-yl)amino]benzamide Benzamide, N-[2-methyl-5-[(methylamino)methyl]phenyl]-4-[(4-phenyl-2-quinazolinyl)amino]- BMS 833923 N-[2-Methyl-5-[(methylamino)methyl]phenyl]-4-[(4-phenylquinazolin-2-yl)amino]benzamide | Inhibitors;Cell biology reagents;Small molecule inhibitor;G protein coupled receptor & G protein;Small molecule inhibitor, natural product |
| 193 | 1061353-68-1 | PND-1186 | SR2516 SR 2516 SR-2516 PND1186 VS-4718 PND 1186 PND-1186 PND-1186 (VS-4718) | API;Inhibitors;Cell biology reagents;Protein tyrosine kinase;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 194 | 1062169-56-5 | WYE-354 | CS-441 WYE-354 WYE354 WYE 354 WYE-354 (Degrasyn) Methyl 4-(6-(4-(methoxycarbonylamino)phenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pip methyl 4-[6-[4-(methoxycarbonylamino)phenyl]-4-morpholin-4-ylpyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate 4-[6-[4-[(Methoxycarbonyl)amino]phenyl]-4-(4-morpholinyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinecarboxylic acid methyl ester 1-Piperidinecarboxylic acid, 4-[6-[4-[(methoxycarbonyl)amino]phenyl]-4-(4-morpholinyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-, methyl ester | ;Akt;mTOR;PI3K;Amines;Aromatics;Inhibitors;Heterocycles;PI3K/Akt/mTOR;Pharmaceuticals |
| 195 | 1062368-24-4 | LDN-193189 | CS-205 DM 3189 DM-3189 LDN193189 LDN-193189 LDN 193189 LDN193189(DM3189) LDN193189 free base LDN193189 LDN193189 HCl 4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | Smad;TGF-beta;Inhibitors;Pyrimidines;TGF-beta/Smad;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 196 | 1062368-49-3 | LDN 193719 | (ML347) LDN 193719 ML-347(LDN-193719) 5-[6-(4-Methoxyphenyl)pyrazolo[1,5-a] 5-[6-(4-Methoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline Quinoline, 5-[6-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]- 5-[6-(4-Methoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline ML-347(LDN-193719) LDN 193719 5-[6-(4-Methoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 197 | 1062368-62-0 | LDN193189 (Hydrochloride) | LDN-193189 HCl LDN-193189 HCL LDN 193189 HCL LDN 193189 HYDROCHLORIDE LDN-193189 HYDROCHLORIDE LDN193189 (Hydrochloride) 4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyriMidin-3-yl)quinoline HCl 4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline hydrochloride | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 198 | 1082949-68-5 | LY-2584702 (tosylate salt) | LYS6K2 CS-2145 LY-2584702 LY 2584702 LY2584702 Tosylate LY-2584702 (tosylate salt) LYS6K2(LY2584702) tosylate salt 4-{4-[4-(4-fluoro-3-trifluoromethyl-phenyl)-1-methyl-1H-imidazol-2-yl]-piperidin-1-yl}-1H-pyrazolo[3,4-d]pyrimidine p-toluenesulfonate | Medicine;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 199 | 108409-83-2 | FH535 | FH535 FH 535 CS-1433 FH 535(FH-535) 2,5-Dichloro-N-(2-Methyl-4-nitrophenyl)benzenesulfonaMide N-(2-Methyl-4-nitrophenyl)-2,5-dichlorobenzenesulfonaMide 2,5-Dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide FH535 | API;Aromatics;Inhibitors;Pharmaceuticals;Cell biology reagents;Small molecule inhibitors;Intermediates & Fine Chemicals;Small molecule inhibitors, natural products |
| 200 | 1092499-93-8 | NVP-BSK805 | BSK805 BSK-805 BSK 805 NVP-BSK805 NVP-BSK805 2HCl NVP-BSK805 dihydrochloride 8-(3,5-difluoro-4-(morpholinomethyl)phenyl)-2-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)quinoxaline 8-[3,5-Difluoro-4-(4-morpholinylmethyl)phenyl]-2-[1-(4-piperidinyl)-1H-pyrazol-4-yl]quinoxaline | JAK;STAT;Inhibitor;Standards;Inhibitors;Cell biology reagents;Protein tyrosine kinase;Small molecule inhibitors, natural products |
| 201 | 1093403-33-8 | SRT 2104 | CS-2293 SRT-2104 SRT 2104 GSK2245840 sirtuin Modulator SRT2104 (GSK2245840) (E)-3-(3-HYDROXY-4-METHOXYPHENYL)PROP-2-ENOIC ACID 4-Methyl-N-[2-[3-(morpholinomethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-(pyridin-3-yl)thiazole-5-carboxamide 5-ThiazolecarboxaMide, 4-Methyl-N-[2-[3-(4-MorpholinylMethyl)iMidazo[2,1-b]thiazol-6-yl]phenyl]-2-(3-pyridinyl)- | Inhibitors;Small molecule inhibitors, natural products |
| 202 | 1095382-05-0 | CCT137690 | CS-56 CCT137690 CCT137690 CCT-137690 CCT 137690 3-((4-(6-Bromo-2-(4-(4-methylpiperazin-1-yl)phenyl)-3H-imidazo[4,5-b]pyridin-7-yl)piperazin-1- 6-bromo-7-(4-((5-methylisoxazol-3-yl)methyl)piperazin-1-yl)-2-(4-(4-methylpiperazin-1-yl)phenyl)-3H-imidazo[4,5-b]pyridine 6-Bromo-7-[4-[(5-methyl-3-isoxazolyl)methyl]-1-piperazinyl]-2-[4-(4-methyl-1-piperazinyl)phenyl]-3H-imidazo[4,5-b]pyridine 3-[[4-[6-Bromo-2-[4-(4-methylpiperazin-1-yl)phenyl]-3H-imidazo[4,5-b]pyridin-7-yl]piperazin-1-yl]methyl]-5-methylisoxazole CCT-137690 | Inhibitor;Inhibitors;Cell cycle;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 203 | 1097917-15-1 | ASP3026 | CS-286 ASP3026 ASP 3026 ASP-3026 ASP-3026 N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfon N2-(2-(isopropylsulfonyl)phenyl)-N4-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)-1,3,5-triazine-2,4-diamine N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 1,3,5-Triazine-2,4-diamine, N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]- | Inhibitors;Cell biology reagent;Protein tyrosine kinase;Small molecule inhibitor;Small molecule inhibitor, natural product;Signal transduction pathway kinase inhibitor |
| 204 | 1100598-32-0 | EMD 1214063 | CS-977 EMD1214063 EMD-1214063 EMD 1214063 epotinib(EMD 1214063) 3-(1-(3-(5-((1-METHYLPIPERIDIN-4-YL)METHOXY)PYRIMIDIN-2-YL)BENZYL)-1,6-DIHYDRO-6-OXOPYRIDAZIN-3-YL)B 3-[1-[[3-[5-[(1-methylpiperidin-4-yl)methoxy]pyrimidin-2-yl]phenyl]methyl]-6-oxopyridazin-3-yl]benzonitrile 3-(1-(3-(5-((1-Methylpiperidin-4-yl)Methoxy)pyriMidin-2-yl)benzyl)-6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile Benzonitrile, 3-[1,6-Dihydro-1-[[3-[5-[(1-Methyl-4-Piperidinyl)Methoxy]-2-PyriMidinyl]Phenyl]Methyl]-6-Oxo-3-Pyridazinyl] | API;Standards;Inhibitors;Raw materials;Cell biology reagents;Protein tyrosine kinase;Active small molecule library;Small molecule inhibitors, natural products |
| 205 | 1124329-14-1 | 9-cyclopentyl-2-(2-methoxy-4-(1-methylpiperidin-4-yloxy)phenylamino)-7-methyl-7H-purin-8(9H)-one | CS-511 AZ3146 AZ 3146 AZ-3146 9-Cyclopentyl-2-((2-methoxy-4-((1-methylpiperidin-4-yl)oxy)phenyl)amino)-7-methyl-7H-purin-8(9 9-cyclopentyl-2-(2-Methoxy-4-(1-Methylpiperidin-4-yloxy)phenylaMino)-7-Methyl-7H-purin-8(9H)-one 9-cyclopentyl-2-(2-methoxy-4-(1-methylpiperidin-4-yloxy)phenylamino)-7-methyl-7H-purin-8(9H)-one 9-Cyclopentyl-7,9-dihydro-2-[[2-methoxy-4-[(1-methyl-4-piperidinyl)oxy]phenyl]amino]-7-methyl-8H-purin-8-one 9-Cyclopentyl-2-[[2-methoxy-4-[(1-methylpiperidin-4-yl)oxy]-phenyl]amino]-7-methyl-7,9-dihydro-8H-purin-8-one 9-Cyclopentyl-7,9-dihydro-2-[[2-methoxy-4-[(1-methyl-4-piperidinyl)oxy]phenyl]amino]-7-methyl-8H-purin-8-one AZ3146 | Stand;Inhibitors;Cytoskeleton signals;Cell biology reagents;Small molecule inhibitors;Small active molecule library;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhib |
| 206 | 1127442-82-3 | IWR-1-endo | IWR1 IWR 1 IWR-1 ENDO-IWR 1 IWR-1-ENDO IWR-1-endo endo-IWR 1 [(3aR*,4S*,7R*,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide rel-4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-Methano-2H-isoindol-2-yl]-N-8-quinolinylbenzaMide Benzamide, 4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinyl-, rel- rel-4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide IWR-1-endo | I;Inhibitors;Heterocycles;Chiral Reagents;Pharmaceuticals;Cell biology reagents;Small molecule inhibitors;Stem cells and Wnt signals;Intermediates & Fine Chemicals;Small molecule inhibitors, natural p |
| 207 | 1129669-05-1 | IM-12 | IM-12 CS-1819 CS-2144 The GSK3β Inhibitor XIX 3-(4-fluorophenethylaMino)-1-Methyl-4-(2-Methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione 3-(4-Fluorophenylethylamino)-1-methyl-4-(2-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione 3-[[2-(4-fluorophenyl)ethyl]amino]-1-methyl-4-(2-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione 3-(4-Fluorophenylethylamino)-1-methyl-4-(2-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione IM-12 | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 208 | 1138549-36-6 | CX-5461 | CX-5461 CS-1938 2-(Hexahydro-4-Methyl-1H-1,4-diazepin-1-yl)-N-[(5-Methyl-2-pyrazinyl)Methyl]-5-oxo-5H-benzothiazolo[3,2-a][1,8]napht 2-(4-Methyl-1,4-diazepan-1-yl)-N-((5-Methylpyrazin-2-yl)Methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxaMide 2-(Hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-N-[(5-methyl-2-pyrazinyl)methyl]-5-oxo-5H-benzothiazolo[3,2-a][1,8]naphthyridine-6-carboxamide 5H-Benzothiazolo[3,2-a][1,8]naphthyridine-6-carboxamide, 2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-N-[(5-methyl-2-pyrazinyl)methyl]-5-oxo- | apis;Inhibi;Standards;Inhibitors;DNA damage;Cell biology reagents;Heterocyclic compounds;Small molecule inhibitors;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibi |
| 209 | 1144068-46-1 | WYE-125132 (WYE-132) | WYE 125132 WYE 125132(WYE-132) WYE-125132 (WYE-132) N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea Urea, N-[4-[1-(1,4-dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methyl- 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(1,4-dioxaspiro[4.5]decan-8-yl)-1H-pyrazolo[3,4-d]pyriMidin-6-yl)phenyl)-3-Methylurea WYE 125132 N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea WYE125132(WYE-132) | Akt;mTOR;PI3K;Inhibitors;PI3K/Akt/mTOR;Cell biology reagents;Small molecule inhibitors, natural products |
| 210 | 1158838-45-9 | Aurora A Inhibitor I | Aurora A-IN-10 Aurora A Inhibitor I TC-S 7010 (Aurora A Inhibitor I) N-(2-Chlorophenyl)-4-((2-((4-(2-(4-ethylpiperazin-1-yl)-2-oxoethyl)-phenyl)amino)-5-fluoropyri N-(2-Chlorophenyl)-4-((2-((4-(2-(4-ethylpiperazin-1-yl)-2-oxoethyl)-phenyl)amino)-5-fluoropyrimid N-(2-Chlorophenyl)-4-(2-(4-(2-(4-ethylpiperazin-1-yl)-2-oxoethyl)phenylamino)-5-fluoropyrimidin-4-ylamino)benzamide N-(2-Chlorophenyl)-4-[[2-[[4-[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]phenyl]amino]-5-fluoro-4-pyrimidinyl]amino]benzamide BenzaMide, N-(2-chlorophenyl)-4-[[2-[[4-[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]phenyl]aMino]-5-fluoro-4-pyriMidinyl]aMino]- | Inhibitors;Cell cycle;Cell biology reagents;Small molecule inhibitors, natural products |
| 211 | 1161205-04-4 | VU 0361737 | ML128 ML-128 VU 0361737 VU 0361737 VU-0361737 CID-44191096 1-(3,4-DICHLOROBENZYL)INDOLINE-2,3-DIONE N-(4-CHLORO-3-METHOXYPHENYL)PICOLINAMIDE N-(4-Chloro-3-methoxyphenyl)-2-pyridinecarboxamide 2-Pyridinecarboxamide, N-(4-chloro-3-methoxyphenyl)- | Inhibitors;Neural signals;Small molecule inhibitors, natural products |
| 212 | 1174043-16-3 | 2-Pyrazinecarboxamide, 3-amino-6-[4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-N-3-pyridinyl- | CS-739 AZD2461 4-[4-Fluoro-3-[(4-methoxypiperidin-1-yl)carbonyl]benzyl]phthalazin-1(2H)-one 4-[[4-fluoro-3-(4-methoxypiperidine-1-carbonyl)phenyl]methyl]-2H-phthalazin-1-one 4-[[4-Fluoro-3-[(4-methoxy-1-piperidinyl)carbonyl]phenyl]methyl]-1(2H)-phthalazinone 1(2H)-Phthalazinone, 4-[[4-fluoro-3-[(4-methoxy-1-piperidinyl)carbonyl]phenyl]methyl]- 2-Pyrazinecarboxamide, 3-amino-6-[4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-N-3-pyridinyl- | Inhibitor;Inhibitors;DNA damage;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 213 | 1174046-72-0 | BMS-794833 | MS-794833 BMS-794833 PDYXPCKITKHFOZ-UHFFFAOYSA-N N-[4-(2-AMINO-3-CHLOROPYRIDIN-4-YL)OXY-3-FLUOROPHENYL]-5-(4-FLUOROPHENYL)-4-OXO-1H-PYRIDINE-3-CARBOXAMIDE N-[4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl]-5-(4-fluorophenyl)-4-oxo-1,4-dihydropyridine-3-carboxamide N-[4-((2-Amino-3-chloropyridin-4-yl)oxy)-3-fluorophenyl]-5-(4-fluorophenyl)-4-oxo-1,4-dihydropyridine-3-carboxamide 3-PyridinecarboxaMide, N-[4-[(2-aMino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl]-5-(4-fluorophenyl)-1,4-dihydro-4-oxo- N-[4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl]-5-(4-fluorophenyl)-4-oxo-1,4-dihydropyridine-3-carboxamide MS-794833 | Inhibitor;Inhibitors;Cell biology reagent;Protein tyrosine kinase;Small molecule inhibitor;Small molecule inhibitor, natural product;Signal transduction pathway kinase inhibitor |
| 214 | 1177865-17-6 | NSC 23766 | NSC23766 NSC 23766 NSC-23766 NSC23766 NSC23766 trihydrochloride NSC 23766 (hydrochloride) NSC23766 TRIHYDROCHLORIDE NSC-23766 TRIHYDROCHLORIDE NSC-23766 trihydrochloride NSC 23766 (trihydrochloride) N6-[2-[[4-(Diethylamino)-1-methylbutyl]amino]-6-methyl-4-pyrimidinyl]-2-methyl-4,6-quinolinediamine trihydrochloride | Inhibitors;Cell cycle;Cell biology reagents;Amines, Aromatics, Inhibitors;Small molecule inhibitors, natural products |
| 215 | 1185763-69-2 | NVP-BVU972 | CS-529 NVP-BVU972 NVP-BVU 972 6-[[6-(1-Methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]methyl]quinoline Quinoline, 6-[[6-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]methyl]- 6-[[6-(1-Methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]methyl]quinoline NVP-BVU972 | Inhibitors;Cell biology reagents;Protein tyrosine kinase;Small molecule inhibitor;Small molecule inhibitor, natural product |
| 216 | 1186486-62-3 | Evacetrapib (LY2484595) | SW-86 SWF-86 LY2484595 LY-2484595 LY 2484595 Evacetrapib EVACETRAPIB (LY2484595) Evacetrapib (LY2484595) (1S,4r)-4-(((S)-5-((3,5-bis(trifluoroMethyl)benzyl)(2-Methyl-2H-tetrazol-5-yl)aMino)-7,9-diMethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)Methyl)cyclohexanecarboxylic acid trans-4-[[(5S)-5-[[[3,5-Bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]cyclohexanecarboxylic acid Cyclohexanecarboxylic acid, 4-[[(5S)-5-[[[3,5-bis(trifluoroMethyl)phenyl]Methyl](2-Methyl-2H-tetrazol-5-yl)aMino]-2,3,4,5-tetrahydro-7,9-diMethyl-1H-1-benzazepin-1-yl]Methyl]-, trans- | Inhibitor;Inhibitors;Metabolism;Active molecules;Pharmaceutical bulk drugs;Small molecule inhibitors, natural products |
| 217 | 1206101-20-3 | N-[5-[4-[(6-Cyano-3-pyridinyl)methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl] cyclopropanecarboxa | CS-1887 GLPG0634 GLPG634 analog GLPG0634 analog GLPG0634 analog, Filgotinib analog N-[5-[4-[(6-Cyano-3-pyridinyl)methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl] cyclopropanecarboxa N-[5-[4-[(6-cyano-3-pyridinyl)Methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]-cyclopropanecarboxaMide N-(5-(4-((6-cyanopyridin-3-yl)methoxy)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide N-[5-[4-[(6-Cyano-3-pyridinyl)Methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl] cyclopropanecarboxaMide (GLPG0634) N-[5-[4-[(6-Cyano-3-pyridinyl)methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]-cyclopropanecarboxamide GLPG0634 analogue GLPG0634 N-[5-[4-[(6-Cyano-3-pyridinyl)methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]-cyclopropanecarboxamide | API;Standards;Inhibitors;pan JAK inhibitor;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 218 | 1206711-16-1 | DMH 1 | DMH1 DMH 1 DMH-1 BMP Inhibitor II, DMH1 Bulk 4-[6-(4-Isopropoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline 4-[6-[4-(1-Methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline Quinoline, 4-[6-[4-(1-methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]- 4-[6-[4-(1-Methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline DMH 1 DMH 1 4-[6-[4-(1-Methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 219 | 1211441-98-3 | LEE011 | LEE011 Ribociclib LEE-011, Ribociclib 7-Cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide 7-cyclopentyl-N,N-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide 7H-Pyrrolo[2,3-d]pyrimidine-6-carboxamide, 7-cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]- 7-CYCLOPENTYL-2-(5-PIPERAZIN-1-YL-PYRIDIN-2-YLAMINO)-7H-PYRROLO[2,3-D]PYRIMIDINE-6-CARBOXYLIC ACID DIMETHYLAMIDE 7-Cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide LEE 011 LEE 011 7-Cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide | Inhibitors;Pharmaceutical raw materials;Impurity reference substance |
| 220 | 1218777-13-9 | CAY10505 | CAY10505 (E)-5-((5-(4-fluorophenyl)furan-2-yl)methylene)thiazolidine-2,4-dione (5E)-5-[[5-(4-Fluorophenyl)-2-furanyl]methylene]-2,4-thiazolidinedione 2,4-Thiazolidinedione, 5-[[5-(4-fluorophenyl)-2-furanyl]methylene]-, (5E)- CAY10505 ( 5E)-5-[[5-(4-Fluorophenyl)-2-furanyl]methylene]-2,4-thiazolidinedione | Akt;mTOR;PI3K;Inhibitors;PI3K/Akt/mTOR;Cell biology reagents;Small molecule inhibitors, natural products |
| 221 | 121917-57-5 | (-)-MK 801 Maleate | MK801 C13737 MK 801 (-)-MK 801 (-)-MK801MALEATE (-)-MK 801 Maleate (-)-MK-801 MALEATE 5H-Dibenzo[a,d]cyclohepten-5,10-imine,10,11-dihydro-5-methyl-,(5R,10S) (5S,10R)-(-)-5-METHYL-10,11-DIHYDRO-5H-DIBENZO[A,D]CYCLOHEPTEN-5,10-IMINE MALEATE (5R)-10,11-Dihydro-5-methyl-5H-dibenzo[a,d]cyclohepten-5,10-imine (Z)-2-butenedioate | Inhibitors;Neural signals;Small molecule inhibitors, natural products |
| 222 | 1222998-36-8 | 1-[4-[4-(1-Oxopropyl)-1-piperazinyl]-3-(trifluoromethyl)phenyl]-9-(3-quinolinyl)benzo[h]-1,6-naphthyridin-2(1H)-one | Torin 1 TORIN-1 CS-1958 TORIN 1 mTOR Inhibitor XI,Torin1-Calbiochem mTOR Inhibitor XI, Torin1 - Calbiochem 1-[4-(4-PROPANOYLPIPERAZIN-1-YL)-3-(TRIFLUOROMETHYL)PHENYL]-9-QUINOLIN-3-YLBENZO[H][1,6]NAPHTHYRIDIN-2-ONE 1-[4-[4-(1-Oxopropyl)-1-piperazinyl]-3-(trifluoromethyl)phenyl]-9-(3-quinolinyl)benzo[h]-1,6-naphthyridin-2(1H)-one Benzo[h]-1,6-naphthyridin-2(1H)-one, 1-[4-[4-(1-oxopropyl)-1-piperazinyl]-3-(trifluoromethyl)phenyl]-9-(3-quinolinyl)- 1-[4-[4-(1-Oxopropyl)-1-piperazinyl]-3-(trifluoromethyl)phenyl]-9-(3-quinolinyl)benzo[h]-1,6-naphthyridin-2(1H)-one Torin 1 | Akt;mTOR;PI3K;Amines;Aromatics;Inhibitors;Heterocycles;PI3K/Akt/mTOR;Pharmaceuticals;Pfizer Compounds |
| 223 | 1227911-45-6 | GSK2334470 | GSK2334470 GSK 2334470 1S,4R)-3-(6-(3-aMino-1H-indazol-6-yl)-2-(MethylaMino)pyriMidin-4-yl)-N-cyclohexyl-4-MethylcyclohexanecarboxaMide (3S,6R)-1-[6-(3-Amino-1H-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-N-cyclohexyl-6-methyl-3-piperidinecarboxamide 3-Piperidinecarboxamide, 1-[6-(3-amino-1H-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-N-cyclohexyl-6-methyl-, (3S,6R)- | Small molecule inhibitor |
| 224 | 1231930-82-7 | 2-Pyrimidinamine, N-[5-[(4-ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimida | LY2835219 Bemaciclib(salt) LY2835219 mesylate LY2835219 Ms salt, Abemaciclib Ms salt 2-Pyrimidinamine, N-[5-[(4-ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimida N-[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine,methanesulfonic acid N-[5-[(4-Ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-2-pyrimidinamine Methanesulfonate | Cell biology reagents |
| 225 | 1240299-33-5 | AZD3514 | CS-795 AZD3514 AZD 3514 AZD-3514 AZD-3514 1-(4-(2-(4-(1-(3-(Trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin- 1-(4-(2-(4-(1-(3-(trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)piperazin-1-yl)ethanone 1-[4-[2-[4-[1-[7,8-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-b]pyridazin-6-yl]-4-piperidinyl]phenoxy]ethyl]-1-piperazinyl]-ethanone Ethanone, 1-[4-[2-[4-[1-[7,8-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-b]pyridazin-6-yl]-4-piperidinyl]phenoxy]ethyl]-1-piperazinyl]- | Inhibitors;Small molecule inhibitors, natural products |
| 226 | 1243244-14-5 | LGK974 | LGK974 LGK-974 CS-1102 LGK-974 MK-0991, L-743872 LGK974(NVP-LGK974) 2',3-Dimethyl-N-[5-(2-pyrazinyl)-2-pyridinyl]-[2,4'-bipyridine]-5-acetamide 2-(2',3-Dimethyl-2,4'-bipyridin-5-yl)-N-[5-(2-pyrazinyl)-2-pyridi nyl]acetamide 2-(2',3-diMethyl-[2,4'-bipyridin]-5-yl)-N-(5-(pyrazin-2-yl)pyridin-2-yl)acetaMide 2-[5-Methyl-6-(2-methyl-4-pyridyl)-3-pyridyl]-N-(5-pyrazin-2-yl-2-pyridyl)acetamide | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 227 | 124431-80-7 | CGS 21680 HCL | 100688 CGS 21680A CGS21680HCL CGS 21680 HCL [3H]-CGS 21680A CGS 21680 HCl NEW CGS 21680 (HCl salt) 4-[2-[[6-Amino-9-(N-ethyl-beta-D-ribofuranuronamidosyl)-9H-purin-2-yl]amino]ethyl]benzenepropanoic acid monohydrochloride | Inhibitors;Chiral Reagents;Pharmaceuticals;Carbohydrates & Derivatives;Intermediates & Fine Chemicals;Small molecule inhibitors, natural products |
| 228 | 1245537-68-1 | 8-(6-methoxypyridin-3-yl)-3-methyl-1-(4-(piperazin-1-yl)-3-(trifluoromethyl)phenyl)-1H-imidazo[4,5-c]quinolin-2(3H)-one Maleic a | BGT226 NVP-BGT226 BGT-226 maleate BGT226 (NVP-BGT226) 8-(6-Methoxypyridin-3-yl)-3-methyl-1-(4-(piperazin-1-yl)-3-(trifluoromethyl)phenyl)-1H-imidazo 8-(6-methoxypyridin-3-yl)-3-methyl-1-(4-(piperazin-1-yl)-3-(trifluoromethyl)phenyl)-1H-imidazo[4,5-c]quinolin-2(3H)-one Maleic a 8-(6-methoxypyridin-3-yl)-3-methyl-1-(4-(piperazin-1-yl)-3-(trifluoromethyl)phenyl)-1H-imidazo[4,5-c]quinolin-2(3H)-one Maleic acid 1-(3-(Trifluoromethyl)-4-(piperazin-1-yl)phenyl)-8-(6-methoxypyridin-3-yl)-3-methyl-1H-imidazo[4,5-c]quinolin-2(3H)-one maleic acid salt | Akt;mTOR;PI3K;Raw drugs;Inhibitors;PI3K/Akt/mTOR;Anti-tumor drugs;Cell biology reagents;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 229 | 1246560-33-7 | VS-5584 (SB2343) | SB2343 VS-5584 SB 2343 SB-2343 VS-5584 (SB2343) 2-Pyrimidinamine, 5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6-yl]- 5-[8-Methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6-yl]-2-pyrimidinamine VS-5584 | Akt;mTOR;PI3K;Inhibitors;PI3K/Akt/mTOR;Cell biology reagents;Small molecule inhibitors, natural products |
| 230 | 1247819-59-5 | P22077 | P22077 CS-1115 P 22077 1-(5-(2,4-difluorophenylthio)-4-nitrothiophen-2-yl)ethanone 1-[5-[(2,4-Difluorophenyl)thio]-4-n-itro-2-thienyl]-ethanone Ethanone, 1-[5-[(2,4-difluorophenyl)thio]-4-nitro-2-thienyl]- 1-[5-(2,4-Difluoro-phenylsulfanyl)-4-nitro-thiophen-2-yl]-ethanone 1-[5-[(2,4-Difluorophenyl)thio]-4-nitro-2-thienyl]ethanone P 22077 P 22077 1-[5-[(2,4-Difluorophenyl)thio]-4-nitro-2-thienyl]ethanone | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products;Traditional Chinese medicine reference substance |
| 231 | 1251156-08-7 | XL388 | XL388 XL 388 XL-388 (7-(6-Aminopyridin-3-yl)-2,3-dihydrobenzo[f][1,4]oxazepin-4(5H)-yl)(3-fluoro-2-methyl-4-(methy [7-(6-Amino-3-pyridinyl)-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl][3-fluoro-2-methyl-4-(methylsulfonyl)phenyl]-methanone Methanone, [7-(6-amino-3-pyridinyl)-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl][3-fluoro-2-methyl-4-(methylsulfonyl)phenyl]- [7-(6-Amino-3-pyridinyl)-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl][3-fluoro-2-methyl-4-(methylsulfonyl)phenyl]-methanone XL388 | Akt;mTOR;PI3K;Inhibitors;PI3K/Akt/mTOR;Cell biology reagents;Pharmaceutical intermediates;Small molecule inhibitors, natural products |
| 232 | 1252003-15-8 | Tubastatin-A | Tubastatin-A TUBASTATIN A Tubastatin A BASE Tubastatin A(free base) N-hydroxy-4-(2-methyl-1,2,3,4-tetrahydro-pyrido[4,3-b]indol-5-ylmethyl)benzamide N-hydroxy-4-((2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)methyl)benzamide N-Hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide N-Hydroxy-4-[(2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5 -yl)methyl]benzamide N-hydroxy-4-((2-methyl-2,3,4,5-tetrahydro-1H-indeno[1,2-c]pyridin-5-yl)methyl)benzamide N-Hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide Tubastatin A | Standards;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 233 | 1255517-76-0 | PF-4708671 | PF 4708671 PF-4708671 PF-04708671 2-[[4-(5-ethyl-4-pyriMidinyl)-1-piperazinyl]Methyl]-6-(trifluoroMethyl)-1H-benziMidazole 2-[[4-(5-ethylpyrimidin-4-yl)piperazin-1-yl]methyl]-6-(trifluoromethyl)-1H-benzimidazole 1H-Benzimidazole, 2-[[4-(5-ethyl-4-pyrimidinyl)-1-piperazinyl]methyl]-6-(trifluoromethyl)- 2-[[4-(5-Ethylpyrimidin-4-yl)piperazin-1-yl]methyl]-5-(trifluoromethyl)-1H-benzo[d]imidazole 2-[[4-(5-Ethyl-4-pyrimidinyl)-1-piperazinyl]methyl]-6-(trifluoromethyl)-1H-benzimidazole PF-4708671 | P;API;Akt;mTOR;PI3K;Amines;Aromatics;Inhibitors;Heterocycles;PI3K/Akt/mTOR |
| 234 | 1260251-31-7 | Birinapant | TL 32711 Birinapant Birinapant (TL32711) (2S,2'S)-N,N'-[(6,6'-Difluoro[2,2'-bi-1H-indole]-3,3'-diyl)bis[methylene[(2R,4S)-4-hydroxy-2,1-pyrrolidinediyl][(1S)-1-ethyl-2-oxo-2,1-ethanediyl]]]bis[2-(methylamino)-propanamide Propanamide, N,N'-[(6,6'-difluoro[2,2'-bi-1H-indole]-3,3'-diyl)bis[methylene[(2R,4S)-4-hydroxy-2,1-pyrrolidinediyl][(1S)-1-ethyl-2-oxo-2,1-ethanediyl]]]bis[2-(methylamino)-, (2S,2'S)- Birinapant (2S,2'S)-N,N'-[(6,6'-Difluoro[2,2'-bi-1H-indole]-3,3'-diyl)bis[methylene[(2R,4S)-4-hydroxy-2,1-pyrrolidinediyl][(1S)-1-ethyl-2-oxo-2,1-ethanediyl]]]bis[2-(methylamino)-propanamide (2S,2'S)-N,N'-[(6,6'-Difluoro[2,2'-bi-1H-indole]-3,3'-diyl)bis[methylene[(2R,4S)-4-hydroxy-2,1-pyrrolidinediyl][(1S)-1-ethyl-2-oxo-2,1-ethanediyl]]]bis[2-(methylamino)-propanamide Birinapant TL 32711 | Inhibitor;Apoptosis;Inhibitors;Small active molecule library;Small molecule inhibitors, natural products |
| 235 | 1260907-17-2 | GSK 525762A | I-BET-762 GSK525762 GSK 525762A IBET762(GSK525762A) GSK525762 (I-BET-762) GSK 525762A (I-BET-762) 4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine-4-acetamide, 6-(4-chlorophenyl)-N-ethyl-8-methoxy-1-methyl-, (4S)- (4S)-6-(4-Chlorophenyl)-N-ethyl-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4-acetamide GSK 525762A I-BET-762 GSK 525762A (4S)-6-(4-Chlorophenyl)-N-ethyl-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4-acetamide | Apis;Inhibitors;Bioactive molecules;Cell biology reagents;Small molecule libraries;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 236 | 1286739-19-2 | FRAX597 | FRAX597 CS-1774 FRAX 597 FRAX-597 6-(2-chloro-4-(thiazol-5-yl)phenyl)-8-ethyl-2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrido[2,3-d]pyrimidin-7(8H)-one 6-[2-Chloro-4-(5-thiazolyl)phenyl]-8-ethyl-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one 6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylaMino]-8H-pyrido[2,3-d]pyriMidin-7-one Pyrido[2,3-d]pyriMidin-7(8H)-one, 6-[2-chloro-4-(5-thiazolyl)phenyl]-8-ethyl-2-[[4-(4-Methyl-1-piperazinyl)phenyl]aMino]- | API;Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 237 | 1300031-49-5 | I-BET151 | I-BET151 I-BET 151 GSK 1210151A GSK1210151A (I-BET151) I-BET151 (GSK1210151A) 7-(3,5-Dimethylisoxazol-4-yl)-8-methoxy-1-((R)-1-(pyridin-2-yl)ethyl)-1H-imidazo[4,5-c]quinolin-2 7-(3,5-diMethylisoxazol-4-yl)-8-Methoxy-1-((R)-1-(pyridin-2-yl)ethyl)-1H-iMidazo[4,5-c]quinolin-2(3H)-one 7-(3,5-Dimethyl-4-isoxazolyl)-1,3-dihydro-8-methoxy-1-[(1R)-1-(2-pyridinyl)ethyl]-2H-imidazo[4,5-c]quinolin-2-one 7-(3,5-Dimethyl-4-isoxazolyl)-1,3-dihydro-8-methoxy-1-[(1R)-1-(2-pyridinyl)ethyl]-2H-imidazo[4,5-c]quinolin-2-one I-BET151(GSK1210151A) | Inhibitors;Small molecule inhibitor;Active small molecule library;Small molecule inhibitor, natural product;Signal transduction pathway kinase inhibitor |
| 238 | 1303607-60-4 | SAR405838 | MI 77301 SAR405838 SAR 405838 SAR-405838 MI-773 (SAR405838) SAR405838 (MI-773) SAR405838, MI-77301 MI-77301 (SAR405838) (2'S,3R,4'S,5'R)-6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-1,2-dihydro-N-(trans-4-hydroxycyclohexyl)-2-oxo-spiro[3H-indole-3,3'-pyrrolidine]-5'-carboxamide | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 239 | 1314890-29-3 | TMP269 | TMP269 N-((4-(4-Phenylthiazol-2-yl)tetrahydro-2H-pyran-4-yl)methyl)-3-(5-(trifluoromethyl)-1,2,4-oxad N-((4-(4-phenylthiazol-2-yl)tetrahydro-2H-pyran-4-yl)Methyl)-3-(5-(trifluoroMethyl)-1,2,4-oxadiazol-3-yl)benzaMide N-[[Tetrahydro-4-(4-phenyl-2-thiazolyl)-2H-pyran-4-yl]methyl]-3-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide BenzaMide, N-[[tetrahydro-4-(4-phenyl-2-thiazolyl)-2H-pyran-4-yl]Methyl]-3-[5-(trifluoroMethyl)-1,2,4-oxadiazol-3-yl]- N-[[Tetrahydro-4-(4-phenyl-2-thiazolyl)-2H-pyran-4-yl]methyl]-3-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide TMP269 TMP269 N-[[Tetrahydro-4-(4-phenyl-2-thiazolyl)-2H-pyran-4-yl]methyl]-3-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide | Standards;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 240 | 1316215-12-9 | Citarinostat | HDAC-IN-2 Citarinostat ACY-241(CITARINOSTAT) Citarinostat (ACY-241) Citarinostat(ACY-241,HDAC-IN-2) 2-[(2-Chlorophenyl)phenylamino]-N-[7-(hydroxyamino)-7-oxoheptyl]-5-pyrimidinecarboxamide 5-Pyrimidinecarboxamide, 2-[(2-chlorophenyl)phenylamino]-N-[7-(hydroxyamino)-7-oxoheptyl]- 2-((2-Chlorophenyl)(phenyl)aMino)-N-(7-(hydroxyaMino)-7-oxoheptyl)pyriMidine-5-carboxaMide | Standard;Cell biology reagent |
| 241 | 1345675-02-6 | ETP-46464 | ETP46464 ETP 46464 ETP46464 ETP-46464 2-Methyl-2-(4-(2-oxo-9-(quinolin-3-yl)-2,4-dihydro-1H-[1,3]oxazino[5,4-c]quinolin-1-yl)phenyl) 2-methyl-2-[4-(2-oxo-9-quinolin-3-yl-4H-[1,3]oxazino[5,4-c]quinolin-1-yl)phenyl]propanenitrile Benzeneacetonitrile, α,α-dimethyl-4-[2-oxo-9-(3-quinolinyl)-2H-[1,3]oxazino[5,4-c]quinolin-1(4H)-yl]- alpha,alpha-Dimethyl-4-[2-oxo-9-(3-quinolinyl)-2H-[1,3]oxazino[5,4-c]quinolin-1(4H)-yl]-benzeneacetonitrile alpha,alpha-Dimethyl-4-[2-oxo-9-(3-quinolinyl)-2H-[1,3]oxazino[5,4-c]quinolin-1(4H)-yl]-benzeneacetonitrile ETP46464 | Akt;mTOR;PI3K;Inhibitors;PI3K/Akt/mTOR;Standard products;Cell biology reagents;Small molecule inhibitors;Organic chemical raw materials;Small molecule inhibitors, natural products |
| 242 | 1355326-35-0 | AGI-5198 | IDH C35 IDH-C35 AGI5198 AGI-5198 GTX-007, S-4 AGI-5198 (IDH-C35) N-CYCLOHEXYL-2-(N-(3-FLUOROPHENYL)-2-(2-METHYL-1H-IMIDAZOL-1-YL)ACETAMIDO)-2-(O-TOLYL)ACETAMIDE N-cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-Methyl-1H-iMidazol-1-yl)acetaMido)-2-(o-tolyl)acetaMide N-[2-(Cyclohexylamino)-1-(2-methylphenyl)-2-oxoethyl]-N-(3-fluorophenyl)-2-methyl-1H-imidazole-1-acetamide | apis;Inhibitors;Metabolism;Cell biology reagent;Small molecule inhibitor;Small molecule inhibitor, natural product;Signal transduction pathway kinase inhibitor |
| 243 | 1364488-67-4 | YH239-EE | YH239-EE YH 239 EE YH 239-EE Ethyl 3-[2-(tert-Butylamino)-1-[N-(4-chlorobenzyl)formamido]-2-oxoet Ethyl 3-(2-(tert-butylamino)-1-(N-(4-chlorobenzyl)formamido)-2-oxoethyl)-6-chloro-1H-indole-2- Ethyl 3-(2-(tert-butylamino)-1-(N-(4-chlorobenzyl)formamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate ethyl 3-[2-(tert-butylamino)-1-[(4-chlorophenyl)methyl-formylamino]-2-oxoethyl]-6-chloro-1H-indole-2-carboxylate YH239-EE ethyl 3-[2-(tert-butylamino)-1-[(4-chlorophenyl)methyl-formylamino]-2-oxoethyl]-6-chloro-1H-indole-2-carboxylate YH239-EE 6-Chloro-3-[1-[[(4-chlorophenyl)methyl]formylamino]-2-[(1,1-dimethylethyl)amino]-2-oxoethyl]-1H-indole-2-carboxylic acid Ethyl Ester | Inhibitors;Small molecule inhibitors, natural products |
| 244 | 1373423-53-0 | GSK-J4 | GSK-J4 GSK J4 GSK J4 HCl ethyl 3-[[2-pyridin-2-yl-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)pyrimidin-4-yl]amino]propanoate Ethyl 3-((6-(4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoate N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-beta-alanine ethyl ester | API;Inhibitor;Inhibitors;Active molecules;Cell biology reagents;Small molecule inhibitors, natural products |
| 245 | 1373615-35-0 | PF-5274857 | CS-601 PF5274857 PF-5274857 PF 5274857 pf-5274857 PF-5274857 hydrochloride 1-[4-(5'-Chloro-3,5-dimethyl[2,4'-bipyridin]-2'-yl)-1-piperazinyl]-3-(methylsulfonyl)-1-propanone 1-(4-(5-chloro-4-(3,5-diMethylpyridin-2-yl)pyridin-2-yl)piperazin-1-yl)-3-(Methylsulfonyl)propan-1-one 1-[4-(5′-Chloro-3,5-dimethyl-2,4′-bipyridin-2′-yl)piperazin-1-yl] -3- (methylsulfonyl)propan-1-one hydrochloride | Inhibitors;Stem cells and Wnt signaling;Small molecule inhibitors, natural products |
| 246 | 1375465-09-0 | N-[3-[[2-[[4-[[1-(2-Fluoroethyl)-3-azetidinyl]amino]-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-py | CNX2006 CS-1000 CNX-2006 CNX 2006 N-[3-[[2-[[4-[[1-(2-Fluoroethyl)-3-azetidinyl]amino]-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-py N-(3-((2-((4-((1-(2-Fluoroethyl)azetidin-3-yl)amino)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)acrylamide N-[3-({2-[(4-{[1-(2-Fluoroethyl)-3-azetidinyl]amino}-2-methoxyphe nyl)amino]-5-(trifluoromethyl)-4-pyrimidinyl}amino)phenyl]acrylam ide N-[3-[[2-[[4-[[1-(2-Fluoroethyl)-3-azetidinyl]aMino]-2-Methoxyphenyl]aMino]-5-(trifluoroMethyl)-4-pyriMidinyl]aMino]phenyl]-2-propenaMide 2-Propenamide, N-[3-[[2-[[4-[[1-(2-fluoroethyl)-3-azetidinyl]amino]-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]- CNX 2006 N-[3-[[2-[[4-[[1-(2-Fluoroethyl)-3-azetidinyl]amino]-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-2-propenamide | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products;Aromatics, Agonist, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals |
| 247 | 1380288-87-8 | EPZ-5676 | EPZ-5676 EPZ 5676 EPZ-5676,Pinometostat 9-[5-Deoxy-5-[[cis-3-[2-[6-(1,1-diMethylethyl)-1H-benziMidazol-2-yl]ethyl]cyclobutyl](1-Methylethyl)aMino]-β-D-ribofuranosyl]-9H-purin-6-aMine 9H-Purin-6-amine, 9-[5-deoxy-5-[[cis-3-[2-[6-(1,1-dimethylethyl)-1H-benzimidazol-2-yl]ethyl]cyclobutyl](1-methylethyl)amino]-β-D-ribofuranosyl]- 9-[5-Deoxy-5-[[cis-3-[2-[6-(1,1-dimethylethyl)-1H-benzimidazol-2-yl]ethyl]cyclobutyl](1-methylethyl)amino]-beta-D-ribofuranosyl]-9H-purin-6-amine 9-[5-Deoxy-5-[[cis-3-[2-[6-(1,1-diMethylethyl)-1H-benziMidazol-2-yl]ethyl]cyclobutyl](1-Methylethyl)aMino]-β-D-ribofuranosyl]-9H-purin-6-aMine EPZ-5676 (2R,3R,4S,5R)-2-(6-aMino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H-benzo[d]iMidazol-2-yl)ethyl)cyclobutyl)(isopropyl)aMino)Methyl)tetrahydrofuran-3,4-diol | Inhibitors;Cell cycle;Pharmaceutical intermediates;Small molecule inhibitors, natural products |
| 248 | 138489-18-6 | Ro 31-8220 Mesylate | RO-31-8220 MK-7123, PS-291822 Ro 31-8220 Mesylat Ro 31-8220 Mesylate BisindolylMaleiMide IX Mesylate BISINDOLYLMALEIMIDE IX, METHANESULFONATE BISINDOLYLMALEIMIDE IX METHANESULPHONATE SALT BisindolylMaleiMide IX . Methansulfonate [Ro 31-8220] 3-[1-[3-(AMIDINOTHIO)PROPYL-1H-INDOL-3-YL]-3-(1-METHYL-1H-INDOL-3-YL)MALEIMIDE | Smad;TGF-beta;inhibitor;Inhibitors;TGF-beta/Smad;Small molecule inhibitors, natural products |
| 249 | 1397219-81-6 | BS-181 (hydrochloride) | BS181 CS-979 BS 181 BS-181 HCl BS-181 (hydrochloride) N5-(6-aminohexyl)-N7-benzyl-3-isopropylpyrazolo[1,5-a]pyrimidine-5,7-diamine hydrochloride | Inhibitors;Bioactive molecules;Small molecule inhibitors, natural products |
| 250 | 1401223-22-0 | N-isopropyl-2-(4-propylphenoxy)-N-((3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide | PI1840 PI-1840 CS-2559 PI 1840 N-isopropyl-2-(4-propylphenoxy)-N-((3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide N-(1-methylethyl)-2-(4-propylphenoxy)-N-[[3-(3-pyridinyl)-1,2,4-oxadiazol-5-yl]methyl]-acetamide | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 251 | 1403783-31-2 | Nexturastat A | Nexturastat A 4-((1-BUTYL-3-PHENYLUREIDO)METHYL)-N-HYDROXYBENZAMIDE 4-[[butyl(phenylcarbamoyl)amino]methyl]-N-hydroxybenzamide 4-[[Butyl[(phenylamino)carbonyl]amino]methyl]-N-hydroxybenzamide Benzamide, 4-[[butyl[(phenylamino)carbonyl]amino]methyl]-N-hydroxy- Nexturastat A Benzamide, 4-[[butyl[(phenylamino)carbonyl]amino]methyl]-N-hydroxy- Nexturastat A 4-((1-BUTYL-3-PHENYLUREIDO)METHYL)-N-HYDROXYBENZAMIDE | Standards;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 252 | 1410880-22-6 | JNK-IN-8 | CS-1339 JNK-IN-8 JNK inhibitor 8 JNK Inhibitor XVI (E)-3-(4-(diMethylaMino)but-2-enaMido)-N-(3-Methyl-4-(4-(pyridin-3-yl)pyriMidin-2-ylaMino)phenyl)benzaMide 3-[[4-(Dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[3-methyl-4-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide Benzamide, 3-[[4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[3-methyl-4-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]- 3-[[4-(Dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[3-methyl-4-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide JNK-IN-8 | MAPK;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 253 | 1415800-43-9 | UNC 1215 | CS-714 UNC1215 UNC 1215 UNC1215 UNC-1215 N-Phenyl-2,5-bis({[4-(pyrrolidin-1-yl)piperidin-1-yl]carbonyl})aniline (2-(phenylaMino)-1,4-phenylene)bis((4-(pyrrolidin-1-yl)piperidin-1-yl)Methanone) 1,1'-[2-(Phenylamino)-1,4-phenylene]bis[1-[4-(1-pyrrolidinyl)-1-piperidinyl]methanone] | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 254 | 1418033-25-6 | LMK 235 | LMK235 CS-1820 LMK 235 LMK-235 LMK 235 LMK-235 (Fandachem) N-[[6-(Hydroxyamino)-6-oxohexyl]oxy]-3,5-dimethyl-benzamide Benzamide, N-[[6-(hydroxyamino)-6-oxohexyl]oxy]-3,5-dimethyl- N-[[6-(Hydroxyamino)-6-oxohexyl]oxy]-3,5-dimethylbenzamide LMK-235 | Standards;Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 255 | 1421227-52-2 | N-(6-(4-(3-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)ureido)phenoxy)pyrimidin-4-yl)cyclopropanecarboxamide | WS3 WS-3 WS 3 CS-1800 WS3, 1421227-52-2 N-(6-(4-(3-(4-((4-METHYLPIPERAZIN-1-YL)METHYL)-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)PYRIMIDIN-4-YL)CYCLOPROPANECARBOXAMIDE N-(6-(4-(3-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)ureido)phenoxy)pyrimidin-4-yl)cyclopropanecarboxamide N-[6-[4-[[[[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-4-pyrimidinyl]-cyclopropanecarboxamide N-[6-[4-[[[[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-4-pyrimidinyl]-cyclopropanecarboxamide WS3 WS3 N-(6-(4-(3-(4-((4-METHYLPIPERAZIN-1-YL)METHYL)-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)PYRIMIDIN-4-YL)CYCLOPROPANECARBOXAMIDE | api;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 256 | 1421227-53-3 | WS6 | WS6 WS6, 1421227-53-3 4-[[6-[(cyclopropylcarbonyl)amino]-4-pyrimidinyl]oxy]-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-benzeneacetamide N-(6-(4-(2-(4-((4-METHYLPIPERAZIN-1-YL)METHYL)-3-(TRIFLUOROMETHYL)PHENYLAMINO)-2-OXOETHYL)PHENOXY)PYRIMIDIN-4-YL)CYCLOPROPANECARBOXAMIDE N-(6-{4-[2-({4-[(4-Methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl}amino)-2-oxoethyl]phenoxy}-4-pyrimidinyl)cyclopropanecarboxamide N-[6-[4-[2-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)anilino]-2-oxoethyl]phenoxy]pyrimidin-4-yl]cyclopropanecarboxamide WS6 WS6 N-(6-(4-(2-(4-((4-METHYLPIPERAZIN-1-YL)METHYL)-3-(TRIFLUOROMETHYL)PHENYLAMINO)-2-OXOETHYL)PHENOXY)PYRIMIDIN-4-YL)CYCLOPROPANECARBOXAMIDE | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 257 | 1427782-89-5 | 2-((4-Oxo-3-phenyl-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)-N-(5-phenylpyridin-2-yl)aceta | IWP L6 IWP-L6 CS-1445 Porcn Inhibitor III IWP L6 (Porcn Inhibitor III) 2-((4-Oxo-3-phenyl-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)-N-(5-phenylpyridin-2-yl)aceta 2-((4-Oxo-3-phenyl-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)-N-(5-phenylpyridin-2-yl)acetamide N-(5-Phenyl-2-pyridinyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]acetamide 2-[(4-Oxo-3-phenyl-3,4,6,7-tetrahydrothieno[3,2-d]pyriMidin-2-yl) sulfanyl]-N-(5-phenyl-2-pyridinyl)acetaMide N-(5-Phenyl-2-pyridinyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]acetamide IWP-L6 | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 258 | 1429651-50-2 | HPOB | HPOB CS-1829 N-hydroxy-4-(2-((2-hydroxyethyl)(phenyl)amino)-2-oxoethyl)benzamide 4-[(Hydroxyamino)carbonyl]-N-(2-hydroxyethyl)-N-phenyl-benzeneacetamide Benzeneacetamide, 4-[(hydroxyamino)carbonyl]-N-(2-hydroxyethyl)-N-phenyl- 4-[(hydroxyamino)carbonyl]-N-(2-hydroxyethyl)-N-phenyl- benzeneacetamide HPOB | Standards;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 259 | 1431985-92-0 | K02288 | K02288 K-02288 CS-1877 K 02288 LM-3151 K02288 K 02288(K 02288a) 3-[(6-Amino-5-(3,4,5-trimethoxyphenyl)-3-pyridinyl]phenol K02288 3-[(6-Amino-5-(3,4,5-trimethoxyphenyl)-3-pyridinyl]phenol K 02288 Phenol, 3-[6-amino-5-(3,4,5-trimethoxyphenyl)-3-pyridinyl]- | Others;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 260 | 1432597-26-6 | 5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline | CS-1202 LDN212854 LDN 212854 LDN-212854 (LDN212854) BMP Inhibitor III BMP INHIBITOR III 5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyriMidin-3-yl]quinoline 5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline Quinoline, 5-[6-[4-(1-piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]- 5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline LDN 212854 LDN 212854 5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 261 | 1432660-47-3 | AGI-6780 | CS-1019 AGI6780 AGI-6780 N-cyclopropyl-4-(thiophen-3-yl)-3-(3-(3-(trifluoroMethyl)phenyl)ureido)benzenesulfonaMide N-Cyclopropyl-4-(3-thienyl)-3-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-benzenesulfonamide Benzenesulfonamide, N-cyclopropyl-4-(3-thienyl)-3-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]- N-Cyclopropyl-4-(3-thienyl)-3-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-benzenesulfonamide AGI-6780 AGI-6780 N-Cyclopropyl-4-(3-thienyl)-3-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-benzenesulfonamide | API;Inhibitors;Metabolism;Cell biology reagents;Small molecule inhibitors;Pharmaceutical intermediates;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 262 | 1433953-83-3 | SAR131675 | CS-994 SAR131675 SAR 131675 (R)-2-amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methylbut-1-ynyl)-N-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide 1,8-Naphthyridine-3-carboxamide, 2-amino-1-ethyl-1,4-dihydro-7-[(3R)-3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl]-N-methyl-4-oxo- | API;Inhibitors;Active molecules;Protein tyrosine kinase;Small molecule inhibitors, natural products |
| 263 | 143851-98-3 | Elacridar hydrochloride | Elacridar HC1 Elacridar HCl Elacridar hydrochloride Elacridar (hydrochloride) N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-5-methoxy-9-oxo-9,10-dihydroacridine-4-carboxamidehydrochloride N-[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamide monohydrochloride GW 0918 N-[4-[2-(3,4-Dihydro-6,7-diMethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-Methoxy-9-oxo-4-acridinecarboxaMide, (HCl salt) 1-{2-carbaMoyl-5-[2-(6,7-diMethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]phenyl}-5-Methoxy-9-oxo-9,10-dihydroacridine-4-carboxylic acid hydrochloride | Scientific research raw materials |
| 264 | 1456632-40-8 | SH-4-54 | SH-4-54 CS-1773 4-[[(4-cyclohexylphenyl)methyl][2-[methyl[(2,3,4,5,6-pentafluorophenyl)sulfonyl]amino]acetyl]amino]-benzoic acid Benzoic acid, 4-[[(4-cyclohexylphenyl)methyl][2-[methyl[(2,3,4,5,6-pentafluorophenyl)sulfonyl]amino]acetyl]amino]- 4-[[(4-cyclohexylphenyl)methyl][2-[methyl[(2,3,4,5,6-pentafluorophenyl)sulfonyl]amino]acetyl]amino]-Benzoic Acid SH-4-54 | API;Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 265 | 1457983-28-6 | G-749 | G-49 G-749 G-749 (Free base) 8-bromo-2-((1-methylpiperidin-4-yl)amino)-4-((4-phenoxyphenyl)amino)pyrido[4,3-d]pyrimidin-5(6H)-one 8-Bromo-2-[(1-methyl-4-piperidinyl)amino]-4-[(4-phenoxyphenyl)amino]pyrido[4,3-d]pyrimidin-5(6H)-one Pyrido[4,3-d]pyrimidin-5(6H)-one, 8-bromo-2-[(1-methyl-4-piperidinyl)amino]-4-[(4-phenoxyphenyl)amino]- 8-Bromo-2-[(1-methyl-4-piperidinyl)amino]-4-[(4-phenoxyphenyl)amino]pyrido[4,3-d]pyrimidin-5(6H)-one G749 | API;Standards;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 266 | 1493694-70-4 | (1r,4r)-4-((2-(Butylamino)-5-(5-(morpholinomethyl)pyridin-2-yl)pyrimidin-4-yl)amino)cyclohexanol | UNC2250 CS-1346 UNC2250(UNC 2250) 4-[[2-(butylamino)-5-[5-(morpholin-4-ylmethyl)pyridin-2-yl]pyrimidin-4-yl]amino]cyclohexan-1-ol (1r,4r)-4-((2-(Butylamino)-5-(5-(morpholinomethyl)pyridin-2-yl)pyrimidin-4-yl)amino)cyclohexanol (1r,4r)-4-((2-(butylamino)-5-(5-(morpholinomethyl)pyridin-2-yl)pyrimidin-4-yl)amino)cyclohexanol trans-4-[[2-(Butylamino)-5-[5-(4-morpholinylmethyl)-2-pyridinyl]-4-pyrimidinyl]amino]cyclohexanol Cyclohexanol, 4-[[2-(butylamino)-5-[5-(4-morpholinylmethyl)-2-pyridinyl]-4-pyrimidinyl]amino]-, trans- trans-4-[[2-(Butylamino)-5-[5-(4-morpholinylmethyl)-2-pyridinyl]-4-pyrimidinyl]amino]cyclohexanol UNC2250 | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 267 | 1493764-08-1 | UNC2881 | 110849 UNC2881 CS-1177 UNC 2881 UNC-2881 N-(4-(1H-Imidazol-1-yl)benzyl)-2-(butylamino)-4-(((1r,4r)-4-hydroxycyclohexyl)amino)pyrimidine N-(4-(1H-iMidazol-1-yl)benzyl)-2-(butylaMino)-4-(((1r,4r)-4-hydroxycyclohexyl)aMino)pyriMidine-5-carboxaMide 2-(Butylamino)-4-[(trans-4-hydroxycyclohexyl)amino]-N-[[4-(1H-imidazol-1-yl)phenyl]methyl]-5-pyrimidinecarboxamide N-(4-(1H-imidazol-1-yl)benzyl)-2-(butylamino)-4-((1r,4r)-4-hydroxycyclohexylamino)pyrimidine-5-carboxamide UNC2881 | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 268 | 153436-53-4 | 4-(3-Chloroanilino)-6,7-Dimethoxyquinazoline Hydrochloride | AG1478 AG-1478 NSC 693255 AG 1478 HYDROCHLORIDE AG-1478 (Tyrphostin AG-1478) 4-(3-CHLOROANILINO)-6,7-DIMETHOXYQUINAZOLINE HCL (3-Chlorophenyl)(6,7-dimethoxyquinazolin-4-yl)amine 4-(3-CHLOROANILINO)-6,7-DIMETHOXYQUINAZOLINE HYDROCHLORIDE 4-(3-Chloroanilino)-6,7-Dimethoxyquinazoline Hydrochloride N-(3-CHLOROPHENYL)-6,7-DIMETHOXY-4-QUINAZOLINANINE HYDROCHLORIDE | API;Inhibitor;Inhibitors;Protein tyrosine kinase;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 269 | 154039-60-8 | Marimastat | TA 2516 GI 5712 BB 2516 KB-R 8898 Marimastat (2R,3S)-N1-((S)-3,3-diMethyl-1-(MethylaMino)-1-oxobutan-2-yl)-N4 (2R,3S)-N1-((S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl)-N4,3-dihydroxy-2-isobutylsuccinamide (2S,3R)-N4-[(1S)-2,2-Dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)butanediamide | API;Inhibitor;Cell biology reagent |
| 270 | 1561178-17-3 | SGC-0946 | CS-1937 CS-1475 SGC0946 SGC-0946 SGC 0946 1-(3-((((2R,3S,4R,5R)-5-(4-Amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahy 5-Bromo-7-[5-deoxy-5-[[3-[[[[4-(1,1-dimethylethyl)phenyl]amino]carbonyl]amino]propyl](1-methylethyl)amino]-beta-D-7H-Pyrrolo[2,3- 5-Bromo-7-[5-deoxy-5-[[3-[[[[4-(1,1-dimethylethyl)phenyl]amino]carbonyl]amino]propyl](1-methylethyl)amino]-beta-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine 1-(3-((((2R,3S,4R,5R)-5-(4-Amino-5-bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea 1-[3-[[[(2R,3S,4R,5R)-5-(4-Amino-5--bromo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydro-xytetrahydrofuran-2-yl]methyl](isopropyl)amino]pro-pyl]-3-[4-(2,2-dimethylethyl)phenyl]urea | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 271 | 1572414-83-5 | ML-323 | ML323 ML-323 N-(4-(1H-1,2,3-Triazol-1-yl)benzyl)-2-(2-isopropylphenyl)-5-methylpyrimidin-4-amine 5-Methyl-2-(2-propan-2-ylphenyl)-N-[[4-(triazol-1-yl)phenyl]methyl]pyrimidin-4-amine 5-Methyl-2-[2-(1-methylethyl)phenyl]-N-[[4-(1H-1,2,3-triazol-1-yl)phenyl]methyl]-4-pyrimidinamine 4-Pyrimidinamine, 5-methyl-2-[2-(1-methylethyl)phenyl]-N-[[4-(1H-1,2,3-triazol-1-yl)phenyl]methyl]- 5-Methyl-2-[2-(1-methylethyl)phenyl]-N-[[4-(1H-1,2,3-triazol-1-yl)phenyl]methyl]-4-pyrimidinamine ML323 | Medicine;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products;Traditional Chinese medicine reference substance |
| 272 | 1594094-64-0 | CW 069 | CW069 CW 069 CS-1425 CW 069 (S)-2-(2-(BENZYLAMINO)-3-PHENYLPROPANAMIDO)-5-IODOBENZOIC ACID 2-[(2S)-2-(Benzylamino)-3-phenylpropanamido]-5-iodobenzoic acid 5-Iodo-2-[[(2S)-1-oxo-3-phenyl-2-[(phenylmethyl)amino]propyl]amino]benzoic acid Benzoic acid, 5-iodo-2-[[(2S)-1-oxo-3-phenyl-2-[(phenylmethyl)amino]propyl]amino]- | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 273 | 172889-26-8 | PP1 | PP1 PP 1 CS-716 PP-1. EI 275 PP1 Base PP1, Free Base 1-(1,1-Dimethylethyl)-3-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 1-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE | Standards;Inhibitors;Nucleotides;Heterocycles;Angiogenesis;Protein Kinase;Cell biology reagents;Heterocyclic Compounds;Bases & Related Reagent;Protein Kinase Inhibitor |
| 274 | 179461-52-0 | PD 151746 | CS-1888 PD151746 PD 151746 PD-151746 3-(5-FLUORO-3-INDOLYL)-2-MERCAPTO-(Z)-2-PROPENOIC ACID 3-(5-fluoro-1H-indol-3-yl)-2-mercapto-2-propenoic acid PD151746 3-(5-fluoro-1H-indol-3-yl)-2-mercapto-2-Propenoic acid | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 275 | 180977-34-8 | FTI-277 (hydrochloride) | FTI 277 CS-1757 FTI 277 HCl FTI 277 HCL FTI 277 HYDROCHLORIDE FTI-277 (hydrochloride) FTI-277 TRIFLUOROACETATE SALT 4-[2(R)-amino-3-mercaptopropyl]amino-2-phenylbenzoyl-(S)-methionine methyl ester hydrochloride (S)-methyl 2-(5-(((R)-2-amino-3-mercaptopropyl)amino)-[1,1'-biphenyl]-2-ylcarboxamido)-4-(methylthio)butanoate FTI 277 HCl | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 276 | 182498-32-4 | SB 225002 | SB225002 SB-225002 SB 225002 1-(2-bromophenyl)-3-(2-hydroxy-4-nitrophenyl)urea N-(2-HYDROXY-4-NITROPHENYL)-N'-(2-BROMOPHENYL)UREA N-(2-BROMOPHENYL)-N'-(2-HYDROXY-4-NITROPHENYL)UREA Urea, N-(2-bromophenyl)-N'-(2-hydroxy-4-nitrophenyl)- | Standards;Inhibitors;Antineoplastic;Small molecule inhibitors;Small molecule inhibitors, natural products;A potent, selective, and competitive antagonist of the G-protein coupled receptor CXCR2. |
| 277 | 183322-45-4 | PD153035 HCl | SU5271 CS-473 SU 5271 AG-1517 AG 1517 PD 153035 PD-153035 PD153035 HCl PD153035 Hydrochloride (ZM 252868 SU-5271 (AG1517) HCl ,ZM 252868 HCl 6,7-Dimethoxy-4-[N-(3-bromophenyl)amino]quinazoline hydrochloride 4-Quinazolinamine, N-(3-bromophenyl)-6,7-dimethoxy-, monohydrochloride 6,7-Dimethoxy-4-[N-(3-bromophenyl)amino]quinazoline hydrochloride PD153035 | Medicine;Inhibitors;Protein tyrosine kinase;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 278 | 188011-69-0 | 4-[(5-bromopyridin-2-yl)amino]-4-oxobutanoic acid | Abrasin Bikinin CS-1658 Bikinin(Abrasin) CID-44246499, NCGC00186528 N-(5-Bromopyridin-2-yl)succinamic acid 4-((5-Bromo-2-pyridinyl)amino)-4-oxobutanoic acid 4-[(5-bromopyridin-2-yl)amino]-4-oxobutanoic acid 4-[(5-Bromo-2-pyridinyl)amino]-4-oxo-butanoic acid Butanoic acid, 4-[(5-bromo-2-pyridinyl)amino]-4-oxo- | Pyridine;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 279 | 192927-92-7 | LY310762 | CS-195 LY310762 LY-310762 LY 310762 HCl 1-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-3,3-dimethylindol-2-one,hydrochloride 1-(2-(4-(4-fluorobenzoyl)piperidin-1-yl)ethyl)-3,3-diMethylindolin-2-one Hydrochloride 1-[2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl]-1,3-dihydro-3,3-dimethyl-2H-indol-2-onehydrochloride 3,3-Dimethyl-1-{2-[4-(4-fluorobenzoyl)-1-piperidinyl]-1-ethyl}-1,3-dihydro-2H-indol-2-one hydrochloride 2H-Indol-2-one, 1-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-1,3-dihydro-3,3-diMethyl-, Monohydrochloride | Inhibitors;Neural signals;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 280 | 194423-06-8 | CL-387785 | 785 CL-387 CS-1630 EKI785 EKI-785 EKI 785 CL-387785 CL387785 CL 387785 WAY-EKI785 WAY-EKI 785 CL-387785 (EKI-785) N-(4-(3-bromophenylamino)quinazolin-6-yl)but-2-ynamide 2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]- N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]-2-ButynaMide CL-387785 | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 281 | 196309-76-9 | BAY 11-7085 | CS-1876 BAY117085 BAY11-7085 BAY 11-7085 BAY-11-7085 BAY 11-7083 (E)-3-(T-BUTYLPHENYLSULFONYL)-2-PROPENENITRILE (E)3-[(4-T-BUTYLPHENYL)SULFONYL]-2-PROPENENITRILE (2E)-3-[[4-(1,1-DIMETHYLETHYL)PHENYL]SULFONYL]-2-PROPENENITRILE BAY 117083 (2E)-3-[[4-(1,1-Dimethylethyl)phenyl]sulfonyl]-2-propenenitrile | Inhibitors;Cytokine signaling;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 282 | 209410-46-8 | VX-745 | VX-745 CS-1918 5-(2,6-Dichlorophenyl)-2-(2,4-difluorophenylthio)-6H-pyrimido[1,6-b]pyridazin-6-one 5-(2,6-Dichlorophenyl)-2-((2,4-difluorophenyl)thio)-6H-pyrimido[1,6-b]pyridazin-6-on 5-(2,6-Dichlorophenyl)-2-(2,4-difluorophenyl)sulfanylpyridazino[6,1-f]pyrimidin-6-one 5-(2,6-Dichlorophenyl)-2-((2,4-difluorophenyl)thio)-6H-pyrimido[1,6-B]pyridazine-6-one 5-(2,6-Dichlorophenyl)-2-(2,4-difluorophenylsulfanyl)-6H-pyriMido[3,4-b]pyridazin-6-one 6H-PYRIMIDO[1,6-B]PYRIDAZIN-6-ONE, 5-(2,6-DICHLOROPHENYL)-2-[(2,4-DIFLUOROPHENYL)THIO]- 6H-PYRIMIDO[1,6-B]PYRIDAZIN-6-ONE, 5-(2,6-DICHLOROPHENYL)-2-[(2,4-DIFLUOROPHENYL)THIO]- (9CI) | MAPK;Aromatics;Inhibitors;Heterocycles;Pharmaceuticals;Sulfur & Selenium Compounds;Intermediates & Fine Chemicals;Small molecule inhibitors, natural products |
| 283 | 209984-56-5 | YO-01027 | YO01027 YO-01027 DIBENZAZEPINE γ-Secretase Inhibitor XX Dibenzazepine (Deshydroxy LY 411575) (S)-2-(2-(3,5-Difluorophenyl)acetamido)-N-((S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7 (2S)-2-[2-(3,5-Difluorophenyl)acetaMide]-N-[(7S)-5-Methyl-6-oxo-6,7-dihydro-5H-dibenzo[B,D]azepin-7- N-[(1S)-2-[[(7S)-6,7-Dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluorobenzeneacetamide | Protease;Inhibitor;Inhibitors;All Inhibitors;Pharmaceuticals;Cell biology reagents;A dipeptidic (c)-secretase;Intermediates & Fine Chemicals;Small molecule inhibitors, natural products;A dipeptidic (c |
| 284 | 209984-57-6 | LY-411575 | LY411575 LY-411575 LSN-411575 (S)-2-(2-(3,5-difluorophenyl)acetaMido)-N-((S)-5-Methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)propanaMide N2-[(2S)-2-(3,5-Difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide (aS)-N-[(1S)-2-[[(7S)-6,7-Dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluoro-alpha-hydroxybenzeneacetamide Benzeneacetamide, N-[(1S)-2-[[(7S)-6,7-dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluoro-α-hydroxy-, (αS)- (aS)-N-[(1S)-2-[[(7S)-6,7-Dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluoro-alpha-hydroxybenzeneacetamide LY 411575 LY 411575 (aS)-N-[(1S)-2-[[(7S)-6,7-Dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluoro-alpha-hydroxybenzeneacetamide | Inhibitor;Inhibitors;Neural signal;Small molecule inhibitor, natural product;Signal transduction pathway kinase inhibitor |
| 285 | 219793-45-0 | BTB06584 | CS-1880 BTB06584 BTB-06584 BTB 06584 AHAS inhibitor -Chlorobenzoic acid 2-nitro-5-(phenylsulfonyl)phenyl ester 4-Chlorobenzoic acid 2-nitro-5-(phenylsulfonyl)phenyl ester 4-Chlorobenzoic acid 2-nitro-5-(phenylsulfonyl)phenyl ester AHAS inhibitor BTB06584 AHAS inhibitor 4-Chlorobenzoic acid 2-nitro-5-(phenylsulfonyl)phenyl ester | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 286 | 220904-83-6 | GW5074 | GW5074 RAF1 KINASE INHIBITOR I 5-IODO-3-[(3,5-DIBROMO-4-HYDROXYPHENYL)METHYLENE]-2-INDOLINONE 3-(3,5-dibromo-4-hydroxybenzyliden)-5-iodo-1,3-dihydroindol-2-one 3-(3,5-DIBROMO-4-HYDROXYBENZYLIDINE)-5-IODO-1,3-DIHYDRO-INDOL-2-ONE 3-(3,5-DIBROMO-4-HYDROXY-BENZYLIDENE)-5-IODO-1,3-DIHYDRO-INDOL-2-ONE (3Z)-3-[(3,5-DIBROMO-4-HYDROXYPHENYL)METHYLIDENE]-5-IODO-1H-INDOL-2-ONE 2H-Indol-2-one, 3-[(3,5-dibromo-4-hydroxyphenyl)methylene]-1,3-dihydro-5-iodo- | MAPK;Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 287 | 228559-41-9 | Ki8751 | Ki8751 KI8751 KI 8751 KI-8751 Ki8751 hydrate VEGFR2 Kinase Inhibitor VI, Ki8751 1-(2,4-difluorophenyl)-3-(4-(6,7-diMethoxyquinolin-4-yloxy)-2-fluorophenyl)urea N-(2,4-Difluorophenyl)-N'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]-2-fluorophenyl]urea 1-(2,4-Difluoro-phenyl)-3-[4-(6,7-dimethoxy-quinolin-4-yloxy)-2-fluoro-phenyl]-urea hydrate | Inhibitors;Cell biology reagent;Protein tyrosine kinase;Small molecule inhibitor;Small molecule inhibitor, natural product |
| 288 | 252916-29-3 | TSU-68 (SU6668, Orantinib) | TSU-68 orantinib SU 6668(TSU-68) TSU-68 (SU6668) Orantinib (SU6668) TSU-68 (SU6668, Orantinib) (E)-3-(2,4-diMethyl-5-((2-oxoindolin-3-ylidene)Methyl)-1H-pyrrol-3-yl)propanoic acid (Z)-3-(2,4-dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid 3-[2,4-dimethyl-5-[(E)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid 5-[1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid 1H-Pyrrole-3-propanoic acid, 5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)Methyl]-2,4-diMethyl- | API;Spot;Inhibitors;Cell biology reagents;Protein tyrosine kinase;Angiogenesis and Metastasis;Small molecule inhibitors, natural products |
| 289 | 252935-94-7 | CHIR-98014 | CT98014 CHIR-98014 CHIR 98014 BIIB057, PRT-2607 CHIR98014(CT98014) 2,6-PYRIDINEDIAMINE, N6-[2-[[4-(2,4-DICHLOROPHENYL)-5-(1H-IMIDAZOL-1-YL)-2-PYRIMIDINYL]AMINO]ETHYL]- N6-[ 2-[4-(2,4-DICHLORO-PHENYL)-5-IMIDAZOL-1-YL-PYRIMIDIN-2-YLAMINO]-ETHYL]-3-NITRO-PYRIDINE-2,6-DIAMINE N6-[2-[[4-(2,4-Dichlorophenyl)-5-(1H-imidazol-1-yl)-2-pyrimidinyl]amino]ethyl]-3-nitro-2,6-pyridinediamine N2-(2-((4-(2,4-dichlorophenyl)-5-(1H-iMidazol-1-yl)pyriMidin-2-yl)aMino)ethyl)-5-nitropyridine-2,6-diaMine 2,6-PYRIDINEDIAMINE, N6-[2-[[4-(2,4-DICHLOROPHENYL)-5-(1H-IMIDAZOL-1-YL)-2-PYRIMIDINYL]AMINO]ETHYL]-3-NITRO- N6-[2-[[4-(2,4-dichlorophenyl)-5-(1H-imidazol-1-yl)-2-pyrimidinyl]amino]ethyl]-3-nitro-2,6-Pyridinediamine CHIR98014 | Akt;mTOR;PI3K;Standards;Inhibitors;PI3K/Akt/mTOR;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 290 | 254964-60-8 | Tasquinimod | ABR-215050 tasquinimod Tasquinimod 4-Hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-(4-(trifluoromethyl)-phenyl)-1,2-dihydroquinoline-3-c 1,2-dihydro-4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-[4-trifluoromethyl)phenyl]-3-quinolinecarboxamide 3-QuinolinecarboxaMide, 1,2-dihydro-4-hydroxy-5-Methoxy-N,1-diMethyl-2-oxo-N-[4-(trifluoroMethyl)phenyl]- N-Methyl-N-(4-trifluoromethylphenyl)-1,2-dihydro-4-hydroxy-5-methoxy-1-methyl-2-oxoquinoline-3-carboxamide 4-Hydroxy-5-methoxy-N-methyl-1-methyl-2-oxo-N-(4-trifluoromethylphenyl)-1,2-dihydroquinoline-3-carboxamide 4-Hydroxy-5-Methoxy-1-Methyl-2-oxo-1,2- dihydro-quinoline-3-carboxylic acid Methyl- (4-trifluoroMethyl-phenyl)-aMide | Standards;Inhibitors;Cell cycle;Angiogenesis inhibitor;S100 calcium binding protein A9 modulator;Small molecule inhibitors, natural products |
| 291 | 292605-14-2 | SB 3CT | SB 3CT CS-860 SB-3CT [[(4-Phenoxyphenyl)sulfonyl]methyl]thiirane 2-[[(4-phenoxyphenyl)sulfonyl]methyl]-thiirane SB-3CT (This product is only available in Japan.) | Inhibitors;Cell biology reagents;Chemical raw materials;Synthetic intermediates;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 292 | 301305-73-7 | TCS 359 | TCS359 TCS 359 Flt-3 inhibitor 2-(3,4-DIMETHOXY-BENZOYLAMINO)-4,5,6,7-T 2-[(3,4-Dimethoxybenzoyl)amino]-4,5,6,7-benzo[b]thiophene-3-carboxamide 2-(3,4-diMethoxybenzaMido)- 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxaMide 2-[(3,4-Dimethoxybenzoyl)amino]-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxamide Benzo[b]thiophene-3-carboxaMide,2-[(3,4-diMethoxybenzoyl)aMino]-4,5,6,7-tetrahydro- 2-(3,4-Dimethoxy-benzoylamino)-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid amide | API;Standards;Inhibitors;Angiogenesis;Cell biology reagents;Small molecule inhibitors, natural products |
| 293 | 313516-66-4 | T0070907 | CS-2314 T0070907 T 0070907 T0070907 (T-0070907 2-CHLORO-5-NITRO-N-4-PYRIDINYLBENZAMIDE 2-CHLORO-5-NITRO-N-(4-PYRIDYL)BENZAMIDE N1-(4-PYRIDYL)-2-CHLORO-5-NITROBENZAMIDE BenzaMide, 2-chloro-5-nitro-N-4-pyridinyl- | Inhibitor;Inhibitors;DNA damage;PPARγ antagonist;Kit-Cell Analysis Kit;Intracellular receptor;Small molecule inhibitors, natural products |
| 294 | 313553-47-8 | N-[4-(2,4-Dimethylphenyl)-2-thiazolyl]benzamide | INH1 IBT 13131 INH1 (IBT13131) N-[4-(2,4-Dimethylphenyl)-2-thiazolyl]benzamide N-[4-(2,4-Dimethylphenyl)-2-thiazolyl]-benzamide N-[4-(2,4-Dimethylphenyl)-2-thiazolyl]benzamidehydrochloride N-(4-(2,4-diMethylphenyl)thiazol-2-yl)benzaMide hydrochloride N-[4-(2,4-dimethylphenyl)-1,3-thiazol-2-yl]benzamide,hydrochloride N-[4-(2,4-Dimethylphenyl)-2-thiazolyl]-benzamide INH1 | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 295 | 313967-18-9 | FLI-06 | FLI-06 CS-1434 Cyclohexyl 1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-3-quinolinecarboxylate 1,4,5,6,7,8-Hexahydro-2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-3-quinolinecarboxylic acid cyclohexyl ester 3-QUINOLINECARBOXYLIC ACID, 1,4,5,6,7,8-HEXAHYDRO-2,7,7-TRIMETHYL-4-(4-NITROPHENYL)-5-OXO-, CYCLOHEXYL ESTER 1,4,5,6,7,8-Hexahydro-2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-3-quinolinecarboxylic acid cyclohexyl ester FLI-06 | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 296 | 314245-33-5 | IU1 | IU1 IU-1 IU 1 CS-1901 IU-1 (USP14 inhibitor IU1) 1-[1-(4-Fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(1-pyrrolidinyl)ethanone 1-[1-(4-FLUOROPHENYL)-2,5-DIMETHYL-1H-PYRROL-3-YL]-2-(1-PYRROLIDINYL)ETHANONE 1-(1-(4-fluorophenyl)-2,5-diMethyl-1H-pyrrol-3-yl)-2-(pyrrolidin-1-yl)ethanone Ethanone, 1-[1-(4-fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(1-pyrrolidinyl)- | Inhibitor;Inhibitors;Small molecule inhibitors, natural products;Traditional Chinese medicine reference substance |
| 297 | 315183-21-2 | PAC-1 | PAC1 PAC-1 PAC-1,PAC1 (E)-N'-(3-allyl-2-hydroxybenzylidene)-2-(4-benzylpiperazin-1-yl)acetohydrazide 4-(Phenylmethyl)-1-piperazineaceticacid[[2-hydroxy-3-(2-propenyl)phenyl]methylene]hydrazide PAC1,4-(PhenylMethyl)-1-piperazineaceticacid[[2-hydroxy-3-(2-propenyl)phenyl]Methylene]hydrazide 4-(Phenylmethyl)-1-piperazineacetic acid 2-[[2-hydroxy-3-(2-propen-1-yl)phenyl]methylene]hydrazide 4-(Phenylmethyl)-1-piperazineacetic acid 2-[[2-hydroxy-3-(2-propen-1-yl)phenyl]methylene]hydrazide PAC-1 | Inhibitor;Apoptosis;Inhibitors;Small molecule inhibitors;Cell signaling pathway inhibitors;Molecular biological reagents-inhib;Small molecule inhibitors, natural products;Signal transduction pathway k |
| 298 | 321674-73-1 | BIBR 1532 | CS-1061 BIBR 1532 (E)-2-(3-phenylbut-2-enamido)benzoic acid (E)-2-(3-(naphthalen-2-yl)but-2-enamido)benzoic acid 2-[[(2E)-3-(2-Naphthalenyl)-1-oxo-2-butenyl]amino]benzoic acid 2-[[(2E)-3-(2-NAPHTHALENYL)-1-OXO-2-BUTEN-1-YL]AMINO]BENZOIC ACID 2-[[(2E)-3-(2-Naphthalenyl)-1-oxo-2-butenyl1-yl]amino]benzoicacid | API;Inhibitors;DNA damage;Bioactive molecules;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 299 | 327036-89-5 | TDZD-8 | TDZD8 TDZD 8 TDZD-8 NP 01139 GSK-3InhibitorI,TDZD-8 4-BENZYL-2-METHYL-1,2,4-THIADIAZOLIDINE-3,5-DIONE 2-Methyl-4-(phenylmethyl)-1,2,4-thiadiazolidine-3,5-dione 1,2,4-Thiadiazolidine-3,5-dione,2-Methyl-4-(phenylMethyl)- 4-Benzyl-2-methyl-[1,2,4]thiadiazolidine-3,5-dione TDZD-8 | Akt;mTOR;PI3K;Amines;Aromatics;Inhibitors;Sulfur & Selenium Compounds;Other Enzyme Inhibitors and Activators;Other Enzyme Inhibitors and Activators.;Small molecule inhibitors, natural products |
| 300 | 328968-36-1 | C646 | C646 C 646 104475 CS-1006 4-[(4Z)-4-[[5-(4,5-dimethyl-2-nitrophenyl)furan-2-yl]methylidene]-3-methyl-5-oxopyrazol-1-yl]benzoic acid 4-[4-[[5-(4,5-Dimethyl-2-nitrophenyl)-2-furanyl]methylene]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]-benzoic acid Benzoic acid, 4-[4-[[5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl]methylene]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]- (E)-4-(4-((5-(4,5-diMethyl-2-nitrophenyl)furan-2-yl)Methylene)-3-Methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid (Z)-4-(4-((5-(4,5-diMethyl-2-nitrophenyl)furan-2-yl)Methylene)-3-Methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 301 | 331244-89-4 | BAX Activator Molecule 7 | BAM7 CS-970 BAM-7 BAX activator molecule 7 BAX Activator Molecule 7 4-(2-(2-Ethoxyphenyl)hydrazono)-3-methyl-1-(4-phenylthiazol-2-yl)-1H-pyrazol-5(4H)-one 3-Methyl-1-(4-phenyl-2-thiazolyl)-1H-Pyrazole-4,5-dione 4-[2-(2-Ethoxyphenyl)hydrazone] 1H-Pyrazole-4,5-dione, 3-methyl-1-(4-phenyl-2-thiazolyl)-, 4-[2-(2-ethoxyphenyl)hydrazone] 3-Methyl-1-(4-phenyl-2-thiazolyl)-1H-Pyrazole-4,5-dione 4-[2-(2-Ethoxyphenyl)hydrazone] BAM7 | Apoptosis;Inhibitors;Small molecule inhibitors;Cell signaling pathway inhibitors;Small molecule inhibitors, natural products |
| 302 | 331771-20-1 | ZM 447439 | CS-77 ZM447439 ZM-447439 ZM 447439 N-(4-((6-Methoxy-7-(3-Morpholinopropoxy)quinazolin-4-yl)aMino)phenyl)benzaMide N-[4-[[6-METHOXY-7-[3-(4-MORPHOLINYL)PROPOXY]-4-QUINAZOLINYL]AMINO]PHENYL]BENZAMIDE BenzaMide, N-[4-[[6-Methoxy-7-[3-(4-Morpholinyl)propoxy]-4-quinazolinyl]aMino]phenyl]- | Inhibitor;Aromatics;Inhibitors;Cell cycle;Heterocycles;Pharmaceuticals;Intermediates & Fin;Cell biology reagents;Pharmaceutical bulk drugs;Scientific research reagents |
| 303 | 355025-24-0 | Ki16425 | CS-88 KI-6425 Ki16425 KI16425 KI-16425 KI 16425 3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl)-3-methylisoxazol-5-yl)benzylthio)propanoic acid 3-[[[4-[4-[[[1-(2-chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-isoxazoly]phenyl]methyl]thio]-propanoic acid 3-[[[4-[4-[[[1-(2-Chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-isoxazolyl]phenyl]methyl]thio]propanoic acid | API;Inhibitors;LPA inhibitor molecule;G protein coupled receptor & G protein;Small molecule inhibitor, natural product |
| 304 | 356559-20-1 | SB525334 | SB525334 SB522334 SB-525334 6-(2-tert-butyl-4-(6-methylpyridin-2-yl)-1H-imidazol-5-yl)quinoxaline 6-[2-tert-Butyl-5-(6-methyl-pyridin-2-yl)-1H-imidazol-4-yl]-quinoxaline 6-[2-(1,1-Dimethylethyl)-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline SB525334 6-[2-tert-Butyl-5-(6-methyl-pyridin-2-yl)-1H-imidazol-4-yl]-quinoxaline 6-[2-(1,1-Dimethylethyl)-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline SB 525334 SB 525334 6-[2-(1,1-Dimethylethyl)-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]quinoxaline | Smad;Amines;TGF-beta;Inhibitors;Heterocycles;Pharmaceuticals;Cell biology reagents;Small molecule inhibitors;Intermediates & Fine Chemicals;Small molecule inhibitors, natural products |
| 305 | 371242-69-2 | IC-87114 | IC-87114 IC-87114 (PIK-293) IC-87114 (IC87114) IC87114 (PI3-K delta inhibitor) 2-((6-AMINO-9H-PURIN-9-YL)METHYL)-5-METHYL-3-O-TOLYLQUINAZOLIN-4(3H)-ONE 2-[(6-Amino-9H-purin-9-yl)methyl]-5-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone 4(3H)-Quinazolinone, 2-[(6-aMino-9H-purin-9-yl)Methyl]-5-Methyl-3-(2-Methylphenyl)- 2-[(6-Amino-9H-purin-9-yl)methyl]-5-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone IC-87114 | Akt;mTOR;PI3K;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 306 | 371942-69-7 | YM201636 | CS-335 YM201636 YM 201636 | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 307 | 372196-77-5 | PIK-75 | PFK-15 PIK 75 PIK-75 PIK-75 HCl PIK-75 Hydrochloride (E)-N'-((6-Bromoimidazo[1,2-a]pyridin-3-yl)methylene)-N,2-dimethyl-5-nitrobenzenesulfonohydraz 2-Methyl-5-nitrobenzenesulfonic acid [(6-bromoimidazo[1,2-a]pyridin-3-yl)methylene]methylhydrazide hydrochloride (E)-N'-((6-bromoH-imidazo[1,2-a]pyridin-3-yl)methylene)-N,2-dimethyl-5-nitrobenzenesulfonohydrazide hydrochloride 2-Methyl-5-nitrobenzenesulfonic acid [(6-bromoimidazo[1,2-a]pyridin-3-yl)methylene]methylhydrazide hydrochloride PIK-75 | Akt;mTOR;PI3K;Inhibitors;Antineoplastic;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 308 | 404951-53-7 | 2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)- | LAQ-824 dacinostat Dacinostat LAQ824 (Dacinostat) Dacinostat(NVP-LAQ 824) (E)-3-(4-(((2-(1H-indol-3-yl)ethyl)(2-hydroxyethyl)amino)methyl)phenyl)-N-hydroxyacrylamide (E)-N-hydroxy-3-[4-[[2-hydroxyethyl-[2-(1H-indol-3-yl)ethyl]amino]meth yl]phenyl]prop-2-enamide 3-[4-[N-(2-Hydroxyethyl)-N-[2-(1H-indol-3-yl)ethyl]aminomethyl]phenyl]-2(E)-propenohydroxamic acid 2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)- | Strains;Inhibitor;Standards;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 309 | 42521-82-4 | IPA-3 | IPA3 IPA 3 IPA-3 1,1'-Dithiodi-2-naphthtol 2-Naphthalenol, 1,1'-dithiobis- 1,1′-Disulfanediyldinaphthalen-2-ol Bis(2-hydroxy-1-naphthyl) disulfide p21-Activated Kinase Inhibitor III, IPA-3 | Inhibitors;PAK Inhibitor III;Cytoskeleton signal;Cell biology reagent;PAK Inhibitor III, IPA-3;1,1'-disulfanediylbis(naphthalen-2-ol);1,1 '-disulfanediylbis(naphthalen-2-ol);Small molecule inhibitor, |
| 310 | 4311-88-0 | Necrostatin-1 | CS-959 NECROSTATIN1 NECROSTATIN-1 Necrostatin-1 NECROSTATIN 1 MTH-DL-TRYPTOPHAN IFLAB-BB F0911-6127 5-(INDOL-3-YLMETHYL)-3-METHYL-2-THIO-HYDANTOIN | Inhibitor;Inhibitors;Apoptosis Inhibitors;Miscellaneous Signaling;Small molecule inhibitor |
| 311 | 442632-72-6 | CK-636 | CK636 CK-636 CK 636 CK-0944636 N-[2-(2-Methyl-1H-indol-3-yl)ethyl]-2-thiophenecarboxamide N-(2-(2-METHYL-1H-INDOL-3-YL)ETHYL)THIOPHENE-2-CARBOXAMIDE N-[2-(2-Methyl-1H-indol-3-yl)ethyl]-2-thiophenecarboxamide CK636 CK-636 N-[2-(2-Methyl-1H-indol-3-yl)ethyl]-2-thiophenecarboxamide | Standards;Inhibitors;Chemical linkage;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 312 | 443797-96-4 | JNJ-7706621 | CS-409 JNJ7706621 JNJ-7706621 JNJ 7706621 4-[[5-Amino-1-(2,6-difluorobenzoyl)-1,2,4-triazol-3-yl]amino]benzenesulfonamide 4-[[5-Amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl]amino]benzenesulfonamide Benzenesulfonamide, 4-[[5-amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl]amino]- 4-[[5-Amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl]amino]benzenesulfonamide JNJ7706621 | Inhibitor;Inhibitors;Cell cycle;Research export;Small molecule inhibitors, natural products |
| 313 | 4727-31-5 | Kartogenin | KGN Kartogenin Kartogenin(KGN) 4'-Phenylphthalanilic Acid 4′-Phenyl-phthalanilic acid (8CI) 2-[(Biphenyl-4-yl)carbaMoyl]benzoic Acid 2-([1,1'-biphenyl]-4-ylcarbaMoyl)benzoic acid 2-[([1,1'-Biphenyl]-4-ylaMino)carbonyl]benzoic Acid | Cell Biology-Cell Line |
| 314 | 475110-96-4 | ZSTK474 | CS-438 ZSTK474 ZSTK474 BASE 2-(difluoromethyl)-1-(4,6-dimorpholino-1,3,5-triazin-2-yl)-1H-benzo[d]imidazole 2-(DifluoroMethyl)-1-[4,6-di(4-Morpholinyl)-1,3,5-triazin-2-yl]-1H-benziMidazole ZSTK 474 2-(2-Difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine 1H-BenziMidazole, 2-(difluoroMethyl)-1-(4,6-di-4-Morpholinyl-1,3,5-triazin-2-yl)- 2-(2-Difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine ZSTK-474 | Akt;mTOR;PI3K;Inhibitors;Heterocyclic;Cell biology reagents;Small molecule inhibitors, natural products |
| 315 | 475489-16-8 | NVP-AEW541 | CS-470 AEW541 AEW-541 NVP AEW541 AVP-AEW541 NVP-AEW541 NVP-AEW541(AEW541) NVP-AEW541,AEW541,AEW-541 [7-[cis-3-[(Azetidin-1-yl)methyl]cyclobutyl]-5-(3-benzyloxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amine | Standards;Inhibitors;Cell biology reagents;Protein tyrosine kinase;Pharmaceutical intermediates;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 316 | 486424-20-8 | AZD2858 | AZD2858 AZD-2858 AZD 2858 3-Amino-6-[4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-N-3-pyridinyl-pyrazinecarboxamide 2-Pyrazinecarboxamide, 3-amino-6-[4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-N-3-pyridinyl- 3-Amino-6-{4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl}-N-(3-pyridinyl)-2-pyrazinecarboxamide 3-Amino-6-(4-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-N-(pyridin-3-yl)pyrazine-2-carboxamide 3-Amino-6-[4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-N-3-pyridinyl-pyrazinecarboxamide AZD2858 | Akt;mTOR;PI3K;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 317 | 500579-04-4 | GANT61 | GNT61 GANT61 CS-867 GANT 61 NSC 136476 2,2'-[[Dihydro-2-(4-pyridinyl)-1,3(2H,4H)-pyrimidinediyl]bis(methylene)]bis[N,N-dimethylbenzenamine Benzenamine, 2,2'-[[dihydro-2-(4-pyridinyl)-1,3(2H,4H)-pyrimidinediyl]bis(methylene)]bis[N,N-dimethyl- 2,2'-[[Dihydro-2-(4-pyridinyl)-1,3(2H,4H)-pyrimidinediyl]bis(methylene)]bis[N,N-dimethylbenzenamine] GANT61 | Others;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 318 | 501437-28-1 | BI-D1870 | CS-606 BID1870 BI-D1870 BI-D 1870 TRETAZICAR, NSC 115829 2-(3,5-Difluoro-4-hydroxyphenylamino)-5,7-dimethyl-8-(3-methylbutyl)-7,8-dihydro-5H-pteridin-6-one 2-[(3,5-DIFLUORO-4-HYDROXYPHENYL)AMINO]-7,8-DIHYDRO-5,7-DIMETHYL-8-(3-METHYLBUTYL)-6(5H)-PTERIDINONE 6(5H)-Pteridinone, 2-[(3,5-difluoro-4-hydroxyphenyl)amino]-7,8-dihydro-5,7-dimethyl-8-(3-methylbutyl)- 2-[(3,5-difluoro-4-hydroxyphenyl)aMino]-5,7-diMethyl-8-(3-Methylbutyl)-5,6,7,8-tetrahydropteridin-6-one | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 319 | 518303-20-3 | UMI-77 | UMI77 UMI-77 UMI 77 CS-1799 2-((4-(4-Bromophenylsulfonamido)-1-hydroxynaphthalen-2-yl)thio)acetic acid 2-[[4-[[(4-bromophenyl)sulfonyl]amino]-1-hydroxy-2-naphthalenyl]thio]-acetic acid Acetic acid, 2-[[4-[[(4-bromophenyl)sulfonyl]amino]-1-hydroxy-2-naphthalenyl]thio]- 2-[4-[(4-Bromophenyl)sulfonylamino]-1-hydroxynaphthalen-2-yl]sulfanylacetic acid UMI-77 | API;Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 320 | 571203-78-6 | 2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone | CS-1430 Erastin ERASTIN 2-(1-(4-(2-(4-Chlorophenoxy)acetyl)piperazin-1-yl)ethyl)-3-(2-ethoxyphenyl)quinazolin-4(3H)-on 2-(1-(4-(2-(4-Chlorophenoxy)acetyl)piperazin-1-yl)ethyl)-3-(2-ethoxyphenyl)quinazolin-4(3H)-one 2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone 4(3H)-Quinazolinone, 2-[1-[4-[2-(4-chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)- 2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-quinazolinone Erastin 2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-quinazolinone Erastin | API;Inhibitors;Small molecule inhibitors |
| 321 | 582315-72-8 | BMS-265246 | CS-984 BMS265246 BMS-265246 BMS 265246 (4-Butoxy-1H-pyrazolo[3,4-b]pyridin-5-yl)(2,6-difluoro-4-methylphenyl)-methanone Methanone, (4-butoxy-1H-pyrazolo[3,4-b]pyridin-5-yl)(2,6-difluoro-4-methylphenyl)- (4-Butoxy-1H-pyrazolo[3,4-b]pyridin-5-yl)(2,6-difluoro-4-methylphenyl)-methanone BMS265246 | Inhibitors;Cell cycle;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 322 | 587871-26-9 | KU-55933 (ATM Kinase Inhibitor) | KV-55933 KU-55933 KU-55933 (ATM Kinase Inhibitor) 2-MORPHOLIN-4-YL-6-THIANTHREN-1-YL-PYRAN-4-ONE 2-morpholino-6-(thianthren-1-yl)-4H-pyran-4-one 2-(4-Morpholinyl)-6-(1-thianthrenyl)-4H-pyran-4-one 2-Morpholin-4-yl-6-thianthren-1-ylpyran-4-one KU-55933 (ATM Kinase Inhibitor) | Standards;Inhibitors;DNA damage;High purity reagent;Small molecule inhibitor;Small molecule inhibitor, natural product;Signal transduction pathway kinase inhibitor |
| 323 | 602306-29-6 | 4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(methylsulfonyl)phenyl)pyrimidin-2-amine | AZD AZD5438 AZD 5438 4-[2-Methyl-1-(1-Methylethyl)-1H-iMidazol-5-yl]-N-[4-(Methylsulfonyl)phenyl]- 4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(methylsulfonyl)phenyl)pyrimidin-2-amine 4-[2-Methyl-1-isopropyl-1H-imidazol-5-yl]-N-[4-(methylsulfonyl)phenyl]-2-pyrimidinamine 4-[2-Methyl-1-(1-methylethyl)-1H-imidazol-5-yl]-N-[4-(methylsulfonyl)phenyl]-2-pyrimidinamine 2-Pyrimidinamine,4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]-N-[4-(methylsulfonyl)phenyl]- 2-Pyrimidinamine,4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]-N-[4-(methylsulfonyl)phenyl]-(AZD 5438) 4-[2-Methyl-1-isopropyl-1H-imidazol-5-yl]-N-[4-(methylsulfonyl)phenyl]-2-pyrimidinamine AZD 5438 | Inhibitors;Cell cycle;Potent inhibitor;API intermediates;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors;Poten |
| 324 | 603288-22-8 | LY2090314 | CS-843 LY2090314 LY 2090314 LY-2090314 3-(9-fluoro-2-(piperidine-1-carbonyl)-1,2,3,4-tetrahydro-[1,4]diazepino[6,7,1-hi]indol-7-yl)-4-(imidazo[1,2-a]pyridin-3-yl)-1H-pyrrole-2,5-dione 7-(2,5-Dihydro-4-imidazo[1,2-a]pyridin-3-yl-2,5-dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4-tetrahydro-2-(1-piperidinylcarbonyl)pyrrolo[3,2,1-jk][1,4]benzodiazepine 7-(2,5-Dihydro-4-imidazo[1,2-a]pyridin-3-yl-2,5-dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4-tetrahydro-2-(1-piperidinylcarbonyl)pyrrolo[3,2,1-jk][1,4]benzodiazepine LY2090314 | Akt;mTOR;PI3K;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 325 | 627536-09-8 | SD-208 | SD208 SD-208 SD 208 CS-2295 SD-208 (SD 208 TGF-Β RI KINASE INHIBITOR V 2-(5-Chloro-2-fluorophenyl)-4-[(4-pyridyl)amino]pteridine 4-PteridinaMine, 2-(5-chloro-2-fluorophenyl)-N-4-pyridinyl- 2-[(5-CHLORO-2-FLUOROPHENYL)PTERIDIN-4-YL]PYRIDIN-4-YL-AMINE 2-(5-chloro-2-fluorophenyl)-N-(pyridin-4-yl)pteridin-4-amine | Smad;TGF-beta;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 326 | 648450-29-7 | (Z)-5-(quinoxalin-6-ylmethylene)thiazolidine-2,4-dione | AS605240 AS-605240 AS-605240(AS 605240) PI 3-Kinase Inhibitor (AS605240) B-0301 5-(6-Quinoxalinylmethylene)-2,4-thiazolidinedione 2,4-Thiazolidinedione, 5-(6-quinoxalinylMethylene)- (Z)-5-(quinoxalin-6-ylmethylene)thiazolidine-2,4-dione (E)-5-(quinoxalin-6-ylMethylene)thiazolidine-2,4-dione 5-(6-Quinoxalinylmethylene)-2,4-thiazolidine-2,4-dione | ;API;Akt;mTOR;PI3K;Inhibitors;Active molecules;Cell biology reagents;Small molecule inhibitors;Medical reference substance |
| 327 | 666260-75-9 | GW842166X | CS-631 GW 842166 GW842166X GW 842166X 2-(2,4-dichloroanilino)-N-(oxan-4-ylmethyl)-4-(trifluoromethyl)pyrimidine-5-carboxamide 2-(2,4-dichlorophenylamino)-N-((tetrahydro-2H-pyran-4-yl)methyl)-4-(trifluoromethyl)pyrimidine-5-carboxamide 2-(2,4-Dichlorophenylamino)-4-trifluoromethylpyrimidine-5-carboxylic acid [(tetrahydropyran-4-yl)methyl]amide | Inhibitors;G protein coupled receptor & G protein;Small molecule inhibitors, natural products |
| 328 | 668467-91-2 | LDN 57444 | LDN-57444 LDN 57444 UCH-L1 Inhibitor (Z)-3-(Acetoxyimino)-5-chloro-1-(2,5-dichlorobenzyl)indolin-2-one 5-Chloro-1-[(2,5-dichlorophenyl)methyl]-1H-indole-2,3-dione3-(O-acetyloxime) 3-(O-acetyloxime), 5-chloro-1-[(2,5-dichlorophenyl)methyl]-1H-Indole-2,3-dione 1H-Indole-2,3-dione, 5-chloro-1-[(2,5-dichlorophenyl)methyl]-, 3-(O-acetyloxime) 5-Chloro-1-[(2,5-dichlorophenyl)methyl]-1H-indole-2,3-dione 3-(O-acetyloxime) LDN 57444 | Synthesis;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 329 | 694433-59-5 | SB505124 | SB505124 SB-505124 SB-505124 hydrochloride hydrate SB-505124 hydrate hydrochloride 2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-iMidazol-4-yl)-6-Methylpyridine 2-[4-(1,3-Benzodioxol-5-yl)-2-(tert-butyl)-1H-imidazol-5-yl]-6-methylpyridine 2-(4-(benzo[d][1,3]dioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl)-6-methylpyridine 2-[4-(1,3-Benzodioxol-5-yl)-2-(1,1- diMethylethyl)-1H-iMidazol-5-yl]-6-Methyl-pyridine 2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrate hydrochloride | Smad;TGF-beta;Aromatics;Inhibitors;Heterocycles;Pharmaceuticals;Small molecule inhibitors;Tyrosine Kinase Inhibitors;Intermediates & Fine Chemicals;Small molecule inhibitors, natural products |
| 330 | 71441-28-6 | TTNPB | TTNPB RO 13-7410 (e)-openyl) TTNPB (Arotinoid Acid) 6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propen-1-(e)-4-(2-( 4-(2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthenyl)-1E-propen-1-yl)benzoic acid (E)-4-(2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-napthalenyl)-1-propenyl) benzoic acid (E)-4-(2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid (E)-4-(2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propen-1-yl)benzoic acid | Standards;Inhibitors;Cell biology reagents;Intracellular receptor;Small molecule inhibitors;pharmaceuticam intermediate;Small molecule inhibitors, natural products |
| 331 | 728033-96-3 | OSI-930 | OSI-930 CS-1804 OSI930 3-(Quinolin-4-ylmethylamino)-N-(4-(trifluoromethoxy)phenyl)thiophene-2-carboxamide 3-[(4-Quinolinylmethyl)amino]-N-[4-(trifluoromethoxy)phenyl]-2-thiophenecarboxamide 2-Thiophenecarboxamide, 3-[(4-quinolinylmethyl)amino]-N-[4-(trifluoromethoxy)phenyl]- 3-[(4-Quinolinylmethyl)amino]-N-[4-(trifluoromethoxy)phenyl]-2-thiophenecarboxamide OSI930 | Standards;Inhibitors;Cell biology reagents;Protein tyrosine kinase;Small molecule inhibitors;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 332 | 732302-99-7 | Givinostat (ITF2357) | ITF2357 ITF2357 (Givinostat) Givinostat (ITF2357) Givinostat(HCl hydrate) Givinostat Hydrochloride Hydrate Givinostat (ITF2357) HCl monohydrate Givinostat (hydrochloride monohydrate) (6-((diethylamino)methyl)naphthalen-2-yl)methyl 4-(hydroxycarbamoyl)phenylcarbamate hydrochloride hydrate N-[4-[(Hydroxyamino)carbonyl]phenyl]carbamic acid [6-[(diethylamino)methyl]-2-naphthalenyl]methyl ester hydrochloride hydrate | Inhibitor;Standards;Inhibitors;Cytoskeleton signal;Cell biology reagents;Small molecule inhibitors, natural products |
| 333 | 741713-40-6 | R547 | R547 Ro 4584820 R547(Ro 4584820) 3-difluoro-6-Methoxyphenyl)- [4-aMino-2-[[1-(Methylsulfonyl)-4-piperidinyl]aMino]-5-pyriMidinyl](2 5-[(2,3-difluoro-6-Methoxyphenyl)carbonyl]-2-N-(1-Methanesulfonylpiperidin-4-yl)pyriMidine-2,4-diaMine [4-Amino-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrimidin-5-yl](2,3-difluoro-6-methoxyphenyl)methanone [4-Amino-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrimidin-5-yl](2,3-difluoro-6-methoxyphenyl)methanone(R 547) | Inhibitors;Cell cycle;Cell biology reagents;Small molecule inhibitors, natural products |
| 334 | 749886-87-1 | 4-Methyl-N1-(3-phenylpropyl)benzene-1,2-diamine | JSH23 JSH 23 JSH-23 NF-κB Activation Inhibitor II NF-ΚB ACTIVATION INHIBITOR II 4-Methyl-N1-(3-phenylpropyl)-1,2-benzenediamine 4-METHYL-N1-(3-PHENYLPROPYL)BENZENE-1,2-DIAMINE 4-Methyl-N1-(3-phenylpropyl)benzene-1,2-diamine 4-Methyl-N1-(3-phenylpropyl)-1,2-phenylenediamine 4-Methyl-N1-(3-phenylpropyl)-1,2-benzenediamine JSH 23 JSH 23 4-Methyl-N1-(3-phenylpropyl)-1,2-benzenediamine | Amines;Aromatics;Synthesis;Inhibitors;Chemical Amines;Small molecule inhibitors;Shaanxi Linnaeus's main products;Small molecule inhibitors, natural products |
| 335 | 755038-02-9 | BI 2536 | BI 2536 BI-2536(R-) Boehringer PLK-1 inhibitor BI-2536, BoehringerPLK-1 inhibitor (R)-4-((8-cyclopentyl-7-ethyl-5-Methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)aMino)-3-Methoxy-N-(1-Methylpiperidin-4-yl)benzaMide 4-[[(7R)-8-Cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide Benzamide, 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)- | API;Inhibitor;Inhibitors;Cell cycle;Cell biology reagent;Small molecule inhibitor, natural product;Signal transduction pathway kinase inhibitor |
| 336 | 778277-15-9 | GNF-5 | GNF5 GNF-5 GNF 5 ert-butyl 2-oxopiperidine-1-carboxylate N-(2-Hydroxyethyl)-3-[6-[[4-(trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]benzamide N-(2-Hydroxyethyl)-3-[6-[[4-(trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]benzamide GNF-5 GNF 5 N-(2-Hydroxyethyl)-3-[6-[[4-(trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]benzamide | Standards;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 337 | 799264-47-4 | ML130 (Nodinitib-1) | ML 130 Nodinitib-1 Noditinib-1 CID-1088438 ML130 (Nodinitib-1) 1-[(4-Methylphenyl)sulfonyl]-1H-benziMidazol-2-aMine 1-[(4-Methylphenyl)sulfonyl]-1H-benzimidazol-2-ylamine 1H-BenziMidazol-2-aMine, 1-[(4-Methylphenyl)sulfonyl]- | API;NF-kB;Amines;Aromatics;Inhibitors;Heterocycles;Pharmaceuticals;Sulfur & Selenium Compounds;Intermediates & Fine Chemicals;Small molecule inhibitors, natural products |
| 338 | 801312-28-7 | GSK256066 | CS-27 GSK256066 GSK-256066 GSK2606416 GSK 256066 PDE4B inhibitor GS256066 6-(3-(dimethylcarbamoyl)phenylsulfonyl)-4-(3-methoxyphenylamino)-8-methylquinoline-3-carboxamide 6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide 6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide GSK-256066 | Inhibitor;Inhibitors;Metabolism;Small molecule inhibitors, natural products |
| 339 | 847499-27-8 | CEP-18770 (Delanzomib) | CT 47098 CEP-18770 CIP 18770 NPH 007098 Delanzomib CEP-18770 (Delanzomib) CEP-18770 (DelanzoMib) [(1R)-1-[[(2S,3R)-3-Hydroxy-2-[[(6-phenylpyridin-2-yl)carbonyl]amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid | Protease;Inhibitor;Inhibitors;High purity reagents;Cell biology reagents;Anti-tumor drugs and immunosuppressants;Small molecule inhibitors, natural products |
| 340 | 848695-25-0 | BIIB021 | BIIB021 CNF2024 BIIB-021 CNF-2024EC102 6-chloro-9-((4-Methoxy-3,5-diMethylpyridin-2-yl)Methyl)-9H-purin-2-aMine 6-Chloro-9-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-9H-purin-2-amine 9H-Purin-2-aMine, 6-chloro-9-[(4-Methoxy-3,5-diMethyl-2-pyridinyl)Methyl]- 9-[2-(2,2-diMethyl-propylaMino)ethyl]-8-(2-iodo-5-Methoxy-phenylsulfanyl)-9H-purin-6-ylaMine | In;Aromatics;Inhibitor;Inhibitors;Heterocycles;Antineoplastic;Pharmaceuticals;Cytoskeleton signals;Cytoskeleton reagents;Small molecule inhibitors |
| 341 | 850173-95-4 | ADL5859 HCl | CS-24 ADL5859 ADL 5859 ADL-5859 ADL 5859 ADL5859 HCl ADL5859 HCL ADL5859 hydrochloride N,N-Diethyl-4-(5-hydroxyspiro[2H-1-benzopyran-2,4'-piperidin]-4-yl)benzamide hydrochloride | API;Inhibitors;Neural signal;δ opioid receptor agonist;δ opioid receptor agonist.;Small molecule inhibitor, natural product;Signal transduction pathway kinase inhibitor |
| 342 | 852808-04-9 | ABT-737 | ABT-737 ABT 737 4-{4-[(4'-Chlorobiphenyl-2-yl)Methyl]piperazin-1-yl}-N-[(4-{[(2R)-4-(diMethylaMino)-1- (R)-4-(4-((4'-chlorobiphenyl-2-yl)Methyl)piperazin-1-yl)-N-(4-(4-(diMethylaMino)-1-(phenylthio)butan-2-ylaMino)-3-nitrophenylsulfonyl)benzaMide 4-{4-[(4'-Chlorobiphenyl-2-yl)Methyl]piperazin-1-yl}-N-[(4-{[(2R)-4-(diMethylaMino)-1-(phenylsulfanyl)butan-2-yl]aMino}-3-nitrophenyl)sulfonyl]benzaMide 4-[4-[(4'-Chloro[1,1'-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]benzamide BenzaMide, 4-[4-[(4'-chloro[1,1'-biphenyl]-2-yl)Methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(diMethylaMino)-1-[(phenylthio)Methyl]propyl]aMino]-3-nitrophenyl]sulfonyl]- 4-[4-[(4'-Chloro[1,1'-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]benzamide ABT-737 | APIs;Inhibitor;Apoptosis;Inhibitors;Small molecule;Chiral Reagents;Pharmaceuticals;Cell biology reagents;Heterocyclic compounds;Sulfur & Selenium Compounds |
| 343 | 85416-73-5 | S- (+)-Rolipram | (S)-ROLIPRAM (+)-ROLIPRAM S- (+)-Rolipram (S)-(+)-ROLIPRAM Rolipram (S)-(+)- (4S)-4-[3-(cyclopentoxy)-4-methoxy-phenyl]-2-pyrrolidone (4S)-(3-(Cyclopentyloxy)-4-methoxyphenyl)pyrrolidin-2-one (S)-4-[3-(Cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone (4S)-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]PYRROLIDIN-2-ONE (4S)-4-(3-(Cyclopentyloxy)-4-methoxyphenyl)pyrrolidine-2-one | Signalling;Inhibitors;Metabolism;Cyclic Nucleotide related;Other biochemical reagents;Small molecule inhibitors, natural products |
| 344 | 856243-80-6 | Degrasyn (WP1130) | WP1130 CS-701 WP-1130 WP 1130 Degrasyn WP-1130 WP 1130 DEGRASYN Degrasyn (WP1130) WP1130 ( Degrasyn ) (2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]-2-propenamide | Inhibitor;Standards;Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 345 | 860352-01-8 | AZD7762 | CS-314 AZD7762 AZD 7762 AZD-7762 White solid 1-(2-((S)-piperidin-3-ylcarbamoyl)-5-(3-fluorophenyl)thiophen-3-yl)urea 5-(3-Fluorophenyl)-3-ureidothiophene-N-[(S)-piperidin-3-yl]-2-carboxamide 3-[(Aminocarbonyl)amino]-5-(3-fluorophenyl)-N-(3S)-3-piperidinyl-2-Thiophenecarboxamide 5-(3-Fluorophenyl)-3-ureidothiophene-N-[(S)-piperidin-3-yl]-2-carboxamide AZD 7762 | api;Inhibitors;Small molecule inhibitor, natural product;Signal transduction pathway kinase inhibitor |
| 346 | 862507-23-1 | Ralimetinib dimesylate | LY2228820 LY 2228820 LY-2228820 LY2228820 2MsOH LY2228820(LY-2228820) Ralimetinib dimesylate 5-(2-tert-Butyl-5-(4-fluorophenyl)-1H-imidazol-4-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-am 5-(2-tert-butyl-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine dimethanesulfonate 5-(2-(tert-butyl)-5-(4-fluorophenyl)-1H-imidazol-4-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine dimethanesulfonate 5-[2-(1,1-DiMethylethyl)-5-(4-fluorophenyl)-1H-iMidazol-4-yl]-3-(2,2-diMethylpropyl)-3H-iMidazo[4,5-b]pyridin-2-aMine DiMethanesulfonate | MAPK;Aromatics;Inhibitors;Heterocycles;Pharmaceuticals;Cell biology reagents;Intermediates & Fine Chemicals;Protein Kinase Inhibitors and Activators;Small molecule inhibitors, natural products |
| 347 | 864814-88-0 | Resminostat | RAS2410 4SC-201 4SC-201 RAS2410 Resminostat RESMINOSTAT ResMinostat ResMinostat(4SC-201) ResMinostat (RAS2410) RESMINOSTAT 4SC-201 RAS2410 (E)-3-[1-[4-[(dimethylamino)methyl]phenyl]sulfonylpyrrol-3-yl]-N-hydroxyprop-2-enamide (E)-3-[1-[[4-[(Dimethylamino)methyl]benzene]sulfonyl]-1H-pyrrol-3-yl]-N-hydroxyacrylamide | Inhibitor;Inhibitors;Small active molecule library;Standard samples of bulk drugs;Small molecule inhibitors, natural products |
| 348 | 865854-05-3 | Tideglusib | NP-12 NP031112 NP 031112 NP-031112 TIDEGLUSIB Tideglusib Tideglusib(NP-031112) 4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione 1,2,4-Thiadiazolidine-3,5-dione, 2-(1-naphthalenyl)-4-(phenylmethyl)- | Akt;mTOR;PI3K;Inhibitors;Synthetic intermediates;Small molecule inhibitors;Pharmaceutical bulk drugs;Small molecule inhibitors, natural products |
| 349 | 868273-06-7 | Org 27569 | CS-412 Org 27569 Org 27569 N-(4-(piperidin-1-yl)phenethyl)-5-chloro-3-ethyl-1H-indole-2-carboxamide 5-Chloro-3-ethyl-N-(4-(piperidin-1-yl)phenethyl)-1H-indole-2-carboxamide 5-Chloro-3-ethyl-N-[2-[4-(1-piperidinyl)phenyl]ethyl-1H-indole-2-carboxamide 1H-Indole-2-carboxamide,5-chloro-3-ethyl-N-[2-[4-(1-piperidinyl)phenyl]ethyl]- Org27569 5-Chloro-3-ethyl-N-[2-[4-(1-piperidinyl)phenyl]ethyl-1H -indole-2-carboxamide 5-chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)-ethyl]-amide | Inhibitors;Small molecule inhibitors;G protein coupled receptor & G protein;Small molecule inhibitors, natural products |
| 350 | 869288-64-2 | PF-573228 | CS-253 PF 573228 PF-573228 6-[(4-((3-(Methanesulfonyl)benzyl)aMino)-5-trifluoroMethylpyriMidin-2-yl)aMino]-3,4-dihydro-1H-quinolin-2-one 6-((4-((3-(Methylsulfonyl)benzyl)aMino)-5-(trifluoroMethyl)pyriMidin-2-yl)aMino)-3,4-dihydroquinolin-2(1H)-one 3,4-Dihydro-6-[[4-[[[3-(methylsulfonyl)phenyl]methyl]amino]-5-(trifluoromethyl)-2-pyrimidinyl]amino]-2(1H)-quinolinone 2(1H)-Quinolinone, 3,4-dihydro-6-[[4-[[[3-(methylsulfonyl)phenyl]methyl]amino]-5-(trifluoromethyl)-2-pyrimidinyl]amino]- Methanesulfonyl)benzyl)amino)-5-trifluoromethylpyrimidin-2-yl)amino]-3,4-dihydro-1H-quinolin-2-one PF573228 | Int;Amines;Aromatics;Inhibitors;Heterocycles;Angiogenesis;Pharmaceuticals;Pfizer Compounds;Cell biology reagents;Small molecule inhibitors |
| 351 | 871026-44-7 | N-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide | CS-255 TAK285 TAK-285 TAK-285(TAK 285) N-(2-(4-(3-Chloro-4-(3-(trifluoromethyl)phenoxy)phenylamino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl)e N-[2-[4-[[3-Chloro-4-[3-(trifluoromethyl)phenoxy]phenyl]amino]-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-3-hydroxy-3-methylbutanamide N-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide Butanamide, N-[2-[4-[[3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl]amino]-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-3-hydroxy-3-methyl- | Inhibitor;Inhibitors;Cell biology reagent;Protein tyrosine kinase;Small molecule inhibitor, natural product |
| 352 | 873225-46-8 | IKK-16 (IKK Inhibitor VII) | IKK16 IKK-16 IKK 16 CS-1847 IKK Inhibitor IKK INHIBITOR VII IKK Inhibitor VII IKK-16 (IKK Inhibitor VII) 1-[4-[(4-Benzo[b]thien-2-yl-2-pyrimidinyl)amino]benzoyl]-4-(1-pyrrolidinyl)piperidine [4-[(4-Benzo[b]thien-2-yl-2-pyriMidinyl)aMino]phenyl][4-(1-pyrrolidinyl)-1-piperidinyl]-Methanone Methanone, [4-[(4-benzo[b]thien-2-yl-2-pyrimidinyl)amino]phenyl][4-(1-pyrrolidinyl)-1-piperidinyl]- 1-[4-[(4-Benzo[b]thien-2-yl-2-pyrimidinyl)amino]benzoyl]-4-(1-pyrrolidinyl)piperidine IKK-16 (IKK Inhibitor VII) | NF-kB;IκB/IKK;Inhibitors;Small molecule inhibitors, natural products;Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds |
| 353 | 873652-48-3 | GDC-0152 | GDC0152 CS-2247 GDC0152 GDC-0152 GDC 0152. GDC 0152. L-Prolinamide, N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl-N-(4-phenyl-1,2,3-thiadiazol-5-yl)- (S)-1-((S)-2-Cyclohexyl-2-((S)-2-(methylamino)propanamido)acetyl)-N-(4-phenyl-1,2,3-thiadiazol-5-yl)pyrrolidine-2-carboxamide | Inhibitor;Apoptosis;Inhibitors;Customized;Cell biology reagents;Small molecule inhibitors, natural products |
| 354 | 875320-29-9 | Quisinostat (JNJ-26481585) | Quisinostat JNJ-26481585 JNJ 26854165 Quisinostat (JNJ-26481585) N1-(2-(1H-indol-3-yl)ethyl)-N4-(pyridin-4-yl)benzene-1,4-diaMine N-Hydroxy-2-(4-((((1-methyl-1H-indol-3-yl)methyl)amino)-methyl)piperidin-1-yl)pyrimidine-5-car N-Hydroxy-2-(4-((((1-methyl-1H-indol-3-yl)methyl)amino)-methyl)piperidin-1-yl)pyrimidine-5-carbox N-Hydroxy-2-[4-[[[(1-methyl-1H-indol-3-yl)methyl]amino]methyl]-1-piperidinyl]-5-pyrimidinecarboxamide N-Hydroxy-2-(4-((((1-Methyl-1H-indol-3-yl)Methyl)aMino)Methyl)piperidin-1-yl)pyriMidine-5-carboxaMide | Inhibitor;Standards;Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 355 | 875337-44-3 | MGCD-265 | MGCD-265 MGCD-265 analog MGCD-265 (Synonyms MGCD265) N-(3-Fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbAmothioyl)- N-(3-fluoro-4-(2-(1-Methyl-1H-iMidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbaMothioyl)-2-phen N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide N-[[[3-fluoro-4-[[2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxy]phenyl]amino]thioxomethyl]-benzeneacetamide N-(3-Fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide MGCD-265 | Inhibitors;Cell biology reagent;Protein tyrosine kinase;Small molecule inhibitor, natural product;Signal transduction pathway kinase inhibitor |
| 356 | 877877-35-5 | TW-37 | TW-37 CS-299 N-[4-(2-tert-Butylphenylsulfonyl)phenyl]-2,3,4-trihydroxy-5-(2-isopropylbenzyl)benzamide 5-(2-isopropylbenzyl)-N-(4-(2-tert-butylphenylsulfonyl)phenyl)-2,3,4-trihydroxybenzamide N-[4-[(2-tert-Butylphenyl)sulfonyl]phenyl]-2,3,4-trihydroxy-5-[(2-isopropylphenyl)methyl]benzamide N-[4-[[2-(1,1-Dimethylethyl)phenyl]sulfonyl]phenyl]-2,3,4-trihydroxy-5-[[2-(1-methylethyl)phenyl]methyl]benzamide N-[4-[(2-tert-Butylphenyl)sulfonyl]phenyl]-2,3,4-trihydroxy-5-[(2-isopropylphenyl)methyl]benzamide TW-37 Bcl-2 Inhibitor N-[4-[(2-tert-Butylphenyl)sulfonyl]phenyl]-2,3,4-trihydroxy-5-[(2-isopropylphenyl)methyl]benzamide | Inhibitor;Apoptosis;Standards;Inhibitors;Polypeptides;Cell biology reagents;Inhibitors of cell signaling pathways;Small molecule inhibitors, natural products |
| 357 | 891494-63-6 | MK-8776 (SCH 900776) | MK-8776. SCH900776 SCH-900776 SCH 900776 SCH900776(R) MK-8776 (SCH 900776) SCH 900776 (MK-8776) 6-Bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(3R)-3-piperidinylpyrazolo[1,5-a]pyrimidin-7-amine 6-bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-((R)-piperidin-3-yl)pyrazolo[1,5-a]pyrimidin-7-amine (R)-6-Bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(piperidin-3-yl)pyrazolo[1,5-a]pyrimidin-7-amine | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 358 | 896705-16-1 | BMH-21 | BMH21 BMH-21 BMH 21 CS-1749 N-[2-(Dimethylamino)ethyl]-12-oxo-2H-benzo[g]pyrido[2,1-b]quinazoline-4-carboxamide N-[2-(dimethylamino)ethyl]-12-oxo-12H-benzo[g]pyrido[2,1-b]quinazoline-4-carboxamide 12H-Benzo[g]pyrido[2,1-b]quinazoline-4-carboxamide, N-[2-(dimethylamino)ethyl]-12-oxo- BMH-21 N-[2-(Dimethylamino)ethyl]-12-oxo-12H-benzo[g]pyrido[2,1-b]quinazoline-4-carboxamide | Medicine;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 359 | 897016-82-9 | KX2-391 | KX 01 KX2391 CS-234 KX2-391 KX2 391 TIRBANIBULIN Tirbanibulin KX2-391 (KX01) Tirbanibulin, KX2-391 N-benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetamide 5-[4-[2-(4-Morpholinyl)ethoxy]phenyl]-N-(phenylmethyl)-2-pyridineacetamide | Standards;Inhibitors;Angiogenesis;Small molecule inhibitors, natural products |
| 360 | 898044-15-0 | PF-3758309 | CS-1014 PF-3758309 PF-03758309 (S)-N-(2-(diMethylaMino)-1-phenylethyl)-6,6-diMethyl-3-((2-Methylthieno[3,2-d]pyriMidin-4-yl)aMino)-4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carboxaMide N-[(1S)-2-(Dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methylthieno[3,2-d]pyrimidin-4-yl)amino]-4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carboxamide Pyrrolo[3,4-c]pyrazole-5(1H)-carboxaMide, N-[(1S)-2-(diMethylaMino)-1-phenylethyl]-4,6-dihydro-6,6-diMethyl-3-[(2-Methylthieno[3,2-d]pyriMidin-4-yl)aMino]- N-[(1S)-2-(Dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methylthieno[3,2-d]pyrimidin-4-yl)amino]-4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carboxamide PF 3758309 | Inhibitors;Cell cycle;Cell biology reagents;Small molecule inhibitors, natural products |
| 361 | 923564-51-6 | Navitoclax | ABT263 CS-1871 ABT 263 ABT-263 CS-1967 NAVITOCLAX Navitoclax (R)-4-(4-((2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-enyl)methyl)piperazin-1-yl)-N-(4-(4-morpholino-1-(phenylthio)butan-2-ylamino)-3-(trifluoromethylsulfonyl)phenylsulfonyl)benzamide 4-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[[(2r)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide 4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]benzamide (R)-4-(4-((4'-chloro-4,4-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)-N-((4-((4-morpholino-1-(phenylthio)butan-2-yl)amino)-3-((trifluoromethyl)sulfonyl)phenyl)sulfonyl)benzamide | ;Apis;Inhibitor;Inhibitors;Chiral Reagents;Pharmaceuticals;Cell biology reagents;Heterocyclic compounds;Small molecule inhibitors;Sulfur & Selenium Compounds |
| 362 | 927880-90-8 | RAF265 (CHIR-265) | RAF265 CS-1852 RAF265(CHIR-265) RAF265 (CHIR-265) CHIR-265 or RAF265 1-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-1H-benzimidazol-2-amine 1-methyl-5-(2-(5-(trifluoromethyl)-1H-imidazol-2-yl)pyridin-4-yloxy)-N-(4-(trifluoromethyl)phenyl)-1H-benzo[d]imidazol-2-amine RAF 265 1-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-1H-benzimidazol-2-amine 1-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-1H-benzimidazol-2-amine RAF265 (CHIR-265) | MAPK;Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 363 | 929016-96-6 | Pracinostat (SB939) | SB939 Pracinostat Pracinostat (SB939) KaeMpferol 3-O-β-D-(6-E-p-CouMaroylglucoside) (2E)-3-[2-Butyl-1-[2-(diethylaMino)ethyl]-1H-benziMidazol-5-yl]-N-hydroxyacrylaMide (E)-3-[2-Butyl-1-(2-diethylaMinoethyl)-1H-benziMidazol-5-yl]-N-hydroxy-2-propenaMide (2E)-3-[2-Butyl-1-[2-(diethylaMino)ethyl]-1H-benziMidazol-5-yl]-N-hydroxy-2-propenaMide 2-Propenamide, 3-[2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl]-N-hydroxy-, (2E)- | ;Amines;Aromatics;Inhibitor;Standards;Inhibitors;Heterocycles;Pharmaceuticals;Cytoskeleton signals;Cell biology reagents |
| 364 | 931398-72-0 | IOX2 | IOX2 IOX 2 IOX-2 JICL38 (1-benzyl-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbonyl)glycine N-[[1,2-Dihydro-4-hydroxy-2-oxo-1-(phenylmethyl)-3-quinolinyl]carbonyl]-glycine Glycine, N-[[1,2-dihydro-4-hydroxy-2-oxo-1-(phenylmethyl)-3-quinolinyl]carbonyl]- N-[[4-Hydroxy-2-oxo-1-(phenylmethyl)-1,2-dihydro-3-quinolinyl]carbonyl]glycine IOX2 | Inhibitor;Inhibitors;Angiogenesis;Cell biology reagents;Small molecule inhibitors;Cell signaling pathway inhibitors;Small molecule inhibitors, natural products |
| 365 | 934343-74-5 | NVP-HSP990(HSP990) | CS-786 HSP-990 NVP-HSP990 NVP-HSP990(HSP990) HSP990 (NVP-HSP990) (7R)-2-Amino-7-[4-fluoro-2-(6-methoxypyridin-2-yl)phenyl]-4-methyl-7,8-dihydro-6H-pyrido[4,3-d (R)-2-Amino-7-[4-fluoro-2-(6-methoxypyridin-2-yl)phenyl]-4-methyl-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one (7R)-2-amino-7-[4-fluoro-2-(6-methoxy-2-pyridinyl)phenyl]-7,8-dihydro-4-methyl-pyrido[4,3-d]pyrimidin-5(6H)-one | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 366 | 934353-76-1 | ENMD-2076 | CS-406 ENMD-2076 (E)-N-(5-methyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-styrylpyrimidin-4-amine 6-(4-Methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(1E)-2-phenylethenyl]-4-pyrimidinamine 4-Pyrimidinamine, 6-(4-methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(1E)-2-phenylethenyl]- 6-(4-Methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(1E)-2-phenylethenyl]-4-pyrimidinamine ENMD-2076 | Inhibitor;Standards;Inhibitors;Angiogenesis;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 367 | 934660-93-2 | Cobimetinib | XL518 RG7420 GDC-0973 CobiMetinib Cobimetinib XL518 ,GDC-0973 GDC-0973(XL-518) (S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylaMino)phenyl)(3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl)Methanone [3,4-difluoro-2-[(2-fluoro-4-iodophenyl)aMino]phenyl][3-hydroxy-3-[(2S)-2-piperidinyl]-1-azetidinyl]Methanone | API;MAPK;Aromatics;Heterocycles;Pharmaceuticals;Active molecules;Cell biology reagents;Chemical raw materials;Protein Kinase Inhibitor;Intermediates & Fine Chemicals |
| 368 | 936091-14-4 | TG101209 | CS-94 TG101209 TG 101209 TG-101209 N-tert-Butyl-3-[[5-methyl-2-[4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]amino]benzenesul N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide Benzenesulfonamide, N-(1,1-dimethylethyl)-3-[[5-methyl-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]amino]- | JAK;API;STAT;Inhibitor;Standards;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 369 | 936890-98-1 | OSI-027 | OSI-027 ASP4786 4-(4-Amino-5-(7-methoxy-1H-indol-2-yl)imidazo[5,1-f] [1,2,4]Triazin-7-yl)cyclohexanecarboxylic Acid trans-4-[4-Amino-5-(7-methoxy-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexanecarboxylic acid (1r,4r)-4-(4-amino-5-(7-methoxy-1H-indol-2-yl)imidazo[1,5-f][1,2,4]triazin-7-yl)cyclohexanecarboxylic acid 4-(4-aMino-5-(7-Methoxy-1H-indol-2-yl)-1,2-dihydroiMidazo[5,1-f][1,2,4]triazin-7-yl)cyclohexanecarboxylic acid hydrochloride trans-4-[4-Amino-5-(7-methoxy-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexanecarboxylic acid OSI-027 OSI-027 trans-4-[4-Amino-5-(7-methoxy-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexanecarboxylic acid | Akt;mTOR;PI3K;Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitors |
| 370 | 937265-83-3 | ARRY-380 (analog ) | ARRY380 Arry-830 ARRY-380 ARRY 380 HER2-Inhibitor-1 ARRY-380 (analog ) 6-[5-[[[2-(Methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-N-[3-methyl-4-([1,2,4]triazolo[1,5-a] 6-[5-[[[2-(Methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4-quinazolinamine | Aromatics;Inhibitors;Heterocycles;Pharmaceuticals;Cell biology reagents;Protein tyrosine kinase;Small molecule inhibitors;Sulfur & Selenium Compounds;Intermediates & Fine Chemicals;Small molecule inhi |
| 371 | 937272-79-2 | Pacritinib | SB1518 Pacritinib PACRITINIB SB1518(Pacritinib) Pacritinib (SB1518) 14,19-Dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene, 11-[2-(1-pyrrolidinyl)ethoxy]-, (16E)- (16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene 16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene Pacritinib (SB1518) | Inhibitors;Benzoic acid;Standard products;Cell biology reagents;Pharmaceutical raw materials;Small molecule inhibitors, natural products |
| 372 | 938440-64-3 | KU-0063794 | CS-28 KU0063794 KU-0063794 KU0063794(KU63794) KU-0063794(KU 0063794) (5-(2-((2R,6S)-2,6-Dimethylmorpholino)-4-morpholinopyrido[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol 5-[2-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-4-(4-morpholinyl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol rel-5-[2-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-4-(4-morpholinyl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol BENZENEMETHANOL, 5-[2-[(2R,6S)-2,6-DIMETHYL-4-MORPHOLINYL]-4-(4-MORPHOLINYL)PYRIDO[2,3-D]PYRIMIDIN-7-YL]-2-METHOXY-, REL- | Akt;mTO;mTOR;PI3K;Pyridine;Inhibitors;Cell biology reagents;Small molecule inhibitors;Scientific research reagents;Small molecule inhibitors, natural products |
| 373 | 940310-85-0 | NVP-BHG712 | CS-475 CS-688 NVP-BHG712 NVP-BHG 712 NVP BHG 712 4-Methyl-3-(1-methyl-6-(pyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamino)-N-(3-(trifluorome 4-methyl-3-(1-methyl-6-(pyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamino)-N-(3-(trifluoromethyl)phenyl)benzamide 4-Methyl-3-[[1-methyl-6-(3-pyridinyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino]-N-[3-(trifluoromethyl)phenyl]benzamide NVP-BHG712 4-Methyl-3-[[1-methyl-6-(3-pyridinyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino]-N-[3-(trifluoromethyl)phenyl]benzamide | Inhibitors;Standard substance;Cell biology reagent;Protein tyrosine kinase;Small molecule inhibitor, natural product;Signal transduction pathway kinase inhibitor |
| 374 | 940929-33-9 | SB743921 | SB743921 SB 743921 SB-743921 HCl SB 743921 hydrochloride (R)-N-(3-aminopropyl)-N-(1-(3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methylpropyl)-4-methylbenzamide hydrochloride (R)-N-(3-AMINOPROPYL)-N-(1-(3-BENZYL-7-CHLORO-4-OXO-4H-CHROMEN-2-YL)-2-METHYLPROPYL)-4-METHYLBENZAMIDE HYDROCHLORIDE SB 743921 (R)-N-(3-AMINOPROPYL)-N-(1-(3-BENZYL-7-CHLORO-4-OXO-4H-CHROMEN-2-YL)-2-METHYLPROPYL)-4-METHYLBENZAMIDE HYDROCHLORIDE N-(3-Aminopropyl)-N-[(1R)-1-[7-chloro-4-oxo-3-(phenylmethyl)-4H-1-benzopyran-2-yl]-2-methylpropyl]-4-methylbenzamide hydrochloride SB 743921 N-(3-Aminopropyl)-N-[(1R)-1-[7-chloro-4-oxo-3-(phenylmethyl)-4H-1-benzopyran-2-yl]-2-methylpropyl]-4-methylbenzamide hydrochloride N-(3-Aminopropyl)-N-[(1R)-1-[7-chloro-4-oxo-3-(phenylmethyl)-4H-1-benzopyran-2-yl]-2-methylpropyl]-4-methylbenzamide hydrochloride SB 743921 | apis;Inhibitors;Cytoskeleton signal;Cell biology reagents;Heterocyclic compounds;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 375 | 942487-16-3 | PF-03814735 | CS-240 PF-03814735 Abecarnil Impurity 3 RYYNGWLOYLRZLK-RBUKOAKNSA-N N-[2-[(1S,4R)-6-[[4-(Cyclobutylamino)-5-(trifluoromethyl)-2-pyrimidinyl]amino]-1,2,3,4-tetrahydronaphthalen-1,4-imin-9-yl]-2-oxoethyl]acetamide Acetamide, N-[2-[(1S,4R)-6-[[4-(cyclobutylamino)-5-(trifluoromethyl)-2-pyrimidinyl]amino]-1,2,3,4-tetrahydronaphthalen-1,4-imin-9-yl]-2-oxoethyl]- | Inhibitor;Cell cycle |
| 376 | 944261-79-4 | 5-(4-chlorophenyl)-N-(3,5-dimethoxyphenyl)furan-2-carboxamide | A-803467 A 803467 5-(4-Chlorophenyl)-N-(3,5-dimethoxyphenyl)- 5-(4-Chlorophenyl)-furan-2-carboxylic acid 3,5 5-(4-Chlorophenyl)-N-(3,5-dimethoxyphenyl)-2-furancarboxamide 5-4(-Chlorophenyl)-N-(3,5-diMethoxyphenyl)furan-2-carboxaMide 5-(4-chlorophenyl)-N-(3,5-dimethoxyphenyl)furan-2-carboxamide 2-FurancarboxaMide,5-(4-chlorophenyl)-N-(3,5-diMethoxyphenyl)- 5-(4-Chlorophenyl)-furan-2-carboxylic acid 3,5-dimethoxyphenylamide | Amines;Aromatics;Inhibitors;Ion Channels;Heterocycles;Ion channels;Intermediates;Sodium channel;Pharmaceuticals;Membrane transport |
| 377 | 945755-56-6 | XL019 | XL019 XL-019 XL 019. Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide XL019 2-Pyrrolidinecarboxamide, N-[4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]phenyl]-, (2S)- 2S)-N-[4-[2-[[4-(4-Morpholinyl)phenyl]amino]-4-pyrimidinyl]phenyl]-2-pyrrolidinecarboxamide XL019 | JAK;STAT;Standards;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 378 | 950455-15-9 | Liproxstatin-1 | 152063 CS-1656 Liproxstatin-1 N-(3-Chlorobenzyl)-1'H-spiro[piperidine-4,2'-quinoxalin]-3'-amine N-[(3-chlorophenyl)methyl]spiro[4H-quinoxaline-3,4'-piperidine]-2-amine N-[(3-chlorophenyl)methyl]-1'H-spiro[piperidine-4,2'-quinoxaline]-3'-amine N-[(3-chlorophenyl)methyl]-spiro[piperidine-4,2'(1'H)-quinoxalin]-3'-amine | Small molecule inhibitor |
| 379 | 950762-95-5 | PCI-34051 | PCI-34051 PCI 34051 N-hydroxy-1-(4-Methoxybenzyl)-1H-indole-6-carboxaMide 1-(4-methoxybenzyl)-N-hydroxy-1H-indole-6-carboxamide N-hydroxy-1-[(4-methoxyphenyl)methyl]indole-6-carboxamide N-Hydroxy-1-[(4-methoxyphenyl)methyl]-1H-indole-6-carboxamide 1H-Indole-6-carboxamide, N-hydroxy-1-[(4-methoxyphenyl)methyl]- | Aromatic;Apoptosis;Aromatics;Inhibitor;Standards;Inhibitors;Epigenetics;Heterocycles;Pharmaceuticals;Cell biology reagents |
| 380 | 955977-50-1 | PI-3065 | 129556 PI-3065 6-((4-(cyclopropylmethyl)piperazin-1-yl)methyl)-2-(5-fluoro-1H-indol-4-yl)-4-morpholinothieno[3,2-d]pyrimidine 6-(4-CyclopropylMethyl-piperazin-1-ylMethyl)-2-(5-fluoro-1H-indol-4-yl)-4-Morpholin-4-yl-thieno[3,2-d]pyriMidine 4-(6-((4-(cyclopropylmethyl)piperazin-1-yl)methyl)-2-(5-fluoro-1H-indol-4-yl)thieno[3,2-d]pyrimidin-4-yl)morpholine 6-(4-CyclopropylMethyl-piperazin-1-ylMethyl)-2-(5-fluoro-1H-indol-4-yl)-4-Morpholin-4-yl-thieno[3,2-d]pyriMidine PI-3065 | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 381 | 957116-20-0 | MK-3207 (Hydrochloride) | CS-549 MK-3207 MK3207 HCl MK-3207 HCl salt MK3207 HYDROCHLORIDE MK 3207 hydrochloride MK 3207 HYDROCHLORIDE MK-3207 (Hydrochloride) 2-((R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl)-N-((R)-2'-oxo-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)acetamide hydrochloride 6,9-Diazaspiro[4.5]decane-9-acetamide, 8-(3,5-difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-, hydrochloride (8R)-8-(3,5-Difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-6,9-diazaspiro[4.5]decane-9-acetamide hydrochloride | Inhibitors;Small molecule inhibitors, natural products |
| 382 | 99873-43-5 | Droxinostat | CS-425 NS 41080 Droxinostat Droxinostat (NS41080) 4-(4-Chloro-2-methylphenoxy)-N-hydroxybutanamide 4-(4-Chloro-2-methyl-phenoxy)-N-hydroxy-butyramide ButanaMide, 4-(4-chloro-2-Methylphenoxy)-N-hydroxy- | Inhibitor;Standards;Inhibitors;Cytoskeleton signal;Cell biology reagents;Small molecule inhibitors, natural products |
| 383 | 1052532-15-6 | SBE13 (Hydrochloride) | CS-1632 SBE-13 HCl SBE13 HydrochL SBE 13 hydrochloride SBE13 (Hydrochloride) N-(4-((6-Chloro-3-pyridinyl)methoxy)-3-methoxybenzyl)-N-(2-(3,4-dimethoxyphenyl)ethyl)amine N-(4-((6-chloropyridin-3-yl)Methoxy)-3-Methoxybenzyl)-2-(3,4-diMethoxyphenyl)ethanaMine hydrochloride N-[[4-[(6-Chloro-3-pyridinyl)methoxy]-3-methoxyphenyl]methyl]-3,4-dimethoxy-benzeneethanamine hydrochloride | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 384 | 1073485-20-7 | LDC000067 | LDC067 LDC 067 LDC-067 CS-1535 LDC000067 LDC-000067 LDC 000067 (3-(6-(2-Methoxyphenyl)pyrimidin-4-ylamino)phenyl)methanesulfonamide 3-[[6-(2-methoxyphenyl)-4-pyrimidinyl]amino]-benzenemethanesulfonamide | API;Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 385 | 1078166-57-0 | PF-04418948 | CS-2852 PF-0441848 PF04418948 PF 04418948 PF-04418948 PF 04418948 1-(4-FLUOROBENZOYL)-3-[(6-METHOXYNAPHTHALEN-2-YL)OXYMETHYL]AZETIDINE-3-CARBOXYLIC ACID 1-(4-Fluorobenzoyl)-3-[[(6-methoxy-2-naphthalenyl)oxy]methyl]-3-azetidinecarboxylic acid 3-Azetidinecarboxylic acid, 1-(4-fluorobenzoyl)-3-[[(6-methoxy-2-naphthalenyl)oxy]methyl]- | Inhibitors;Biochemical industry;Small molecule inhibitors |
| 386 | 1086062-66-9 | 2,4-difluoro-N-(2-methoxy-5-(4-(pyridazin-4-yl)quinolin-6-yl)pyridin-3-yl)benzenesulfonamide | CS-55 HYR-582 GSK2126458 GSK-2126458 GSK-2126458 GSK2126458 (GSK458) Omipalisib GSK2126458 BML-275 2HCL,COMPOUND C 2HCL GSK2126458 (HYR-582) 2,4-Difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide 2,4-difluoro-N-(2-methoxy-5-(4-(pyridazin-4-yl)quinolin-6-yl)pyridin-3-yl)benzenesulfonamide | Akt;mTOR;PI3K;Aromatics;Inhibitors;Intermediat;Heterocycles;PI3K/Akt/mTOR;Pharmaceuticals;Cell biology reagents |
| 387 | 1105698-15-4 | Salermide | CS-2458 Salermide N-{3-[(2-Hydroxy-naphthalen-1-ylmethylene)-amino]-phenyl}-2-phenyl-propionamide N-[3-[[(2-Hydroxy-1-naphthalenyl)methylene]amino]phenyl]-α-methylbenzeneacetamide N-[3-[[(2-HYDROXY-1-NAPHTHALENYL)METHYLENE]AMINO]PHENYL]-A-METHYL-BENZENEACETAMIDE Benzeneacetamide, N-[3-[[(2-hydroxy-1-naphthalenyl)methylene]amino]phenyl]-α-methyl- | Cell biology reagent |
| 388 | 112648-68-7 | 1-[6-[[(17B)-3-METHOXYESTRA-1,3,5(10)-TRIEN-17-YL]AMINO]HEXYL]-1H-PYRROLE-2,5-DIONE | U-73122 U-73122 hydrate U-73122 hydrate 1-[6-[[3-Methoxyestra-1,3,5(10)-triene-17β-yl]amino]hexyl]-1H-pyrrole-2,5-dione 1-[6-[((17β)-3-methoxyestra-1,3,5[10]-trien-17-yl)amino]hexyl]-1h-pyrrole-2,5-dione 1-[6-[[(17B)-3-METHOXYESTRA-1,3,5(10)-TRIEN-17-YL]AMINO]HEXYL]-1H-PYRROLE-2,5-DIONE 1-[6-((17BETA-3-METHOXYESTRA-1,3,5(10)-TRIEN-17-YL)AMINO)HEXYL]-1H-PYRROLE-2,5-DIONE (17β)-3-Methoxy-17-[6-[(2,5-dihydro-2,5-dioxo-1H-pyrrol)-1-yl]hexylamino]estra-1,3,5(10)-triene | Inhibitors;Lipid signaling;Small molecule inhibitor |
| 389 | 1204144-28-4 | AZD1208 | CS-794 AZD1208 AZD-1208 AZD 1208 (R,Z)-5-((2-(3-aminopiperidin-1-yl)biphenyl-3-yl)methylene)thiazolidine-2,4-dione (R,Z)-5-((2-(3-aMinopiperidin-1-yl)-[1,1'-biphenyl]-3-yl)Methylene)thiazolidine-2,4-dione (5Z)-5-[[2-[(3R)-3-aMino-1-piperidinyl][1,1'-biphenyl]-3-yl]Methylene]-2,4-thiazolidinedione (5Z)-5-[[2-[(3R)-3-Amino-1-piperidinyl][1,1'-biphenyl]-3-yl]methylene]-2,4-thiazolidinedione AZD1208 | JAK;STAT;JAK/STAT;Inhibitors;Cell biology reagents;Small molecule inhibitors;Pharmaceutical intermediates;Small molecule inhibitors, natural products |
| 390 | 1214265-58-3 | WZ4003 | WZ4003 WZ 4003 CS-1174 N-[3-[5-chloro-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]oxyphenyl]propanamide N-[3-[[5-Chloro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]oxy]phenyl]propanamide N-(3-((5-chloro-2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)oxy)phenyl)propionamide Propanamide, N-[3-[[5-chloro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]oxy]phenyl]- | Inhibitors;Cell biology reagents;Pharmaceutical intermediates;Small molecule inhibitors, natural products |
| 391 | 1222800-79-4 | ML324 | ML243 ML234 ML324 ML 324 ML-324 CS-2198 NCGC00183808-01 ML324(CID-44143209) N-[3-(Dimethylamino)propyl]-4-(8-hydroxy-6-quinolinyl)benzamide | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 392 | 1227158-85-1 | BAY 87-2243 | CS-1786 BAY87-2243 BAY87 2243 BAY 87 2243 BAY 87-2243 1-cyclopropyl-4-{4-[(5-methyl-3-{3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl}-1H-pyrazol-1-yl)methyl]pyridin-2-yl}piperazine 1-cyclopropyl-4-[4-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1H-pyrazol-1-yl]methyl]-2-pyridinyl]-piperazine Piperazine, 1-cyclopropyl-4-[4-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1H-pyrazol-1-yl]methyl]-2-pyridinyl]- 1-cyclopropyl-4-{4-[(5-methyl-3-{3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl}-1H-pyrazol-1-yl)methyl]pyridin-2-yl}piperazine BAY87-2243 | Inhibitors;Control substance;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 393 | 1229208-44-9 | GS 9973 | GS9973 GS-9973 GS 9973 CS-1602 GS 9973 Entospletinib ENTOSPLETINIB Entospletinib (GS-9973) 6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo[1,2-a]pyrazin-8-amine 6-(1H-Indazol-6-yl)-N-[4-(4-morpholinyl)phenyl]imidazo[1,2-a]pyrazin-8-amine | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 394 | 1234480-50-2 | 2-[[2-ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one | XMD8-92 XMD 8-92 XMD 8-92 trifluoroacetate 2-[[2-Ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4 2-[2-ethoxy-4-(4-hydroxypiperidin-1-yl)anilino]-5,11-dimethylpyrimido[4,5-b][1,4]benzodiazepin-6-one 2-((2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl)amino)-5,11-dimethyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one 2-[[2-ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one 2-[[2-Ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one 2-[[2-Ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one XMD 8-92 XMD 8-92 2-[[2-Ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one | Inhibitors;Cell biology reagents;Small molecule inhibitors;Pharmaceutical intermediates;Small molecule inhibitors, natural products |
| 395 | 1234480-84-2 | LRRK2-IN-1 | CS-642 LRRK2-IN-1 LRRK2-TN-1 LRRK2 inhibitor LRRK2 INHIBITOR 2-((2-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl)phenyl)-amino)-5,11-dimethyl- 5,11-Dihydro-2-[[2-methoxy-4-[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]phenyl]amino]-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one 6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one, 5,11-dihydro-2-[[2-methoxy-4-[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]phenyl]amino]-5,11-dimethyl- | Inhibitors;Protein tyrosine kinase;Small molecule inhibitors;Pharmaceutical intermediates;Small molecule inhibitors, natural products |
| 396 | 1242156-23-5 | RN486 | RN468 RN486 RN 486 CS-689 RN-486 RN 486 6-cyclopropyl-8-fluoro-2-(2-(hydroxyMethyl)-3-(1-Methyl-5-(5-(4-Methylpiperazin-1-yl)pyridin-2-ylaMino)-6-oxo-1,6-dihydropyridin-3-yl)phenyl)isoquinolin-1(2H)-one 6-cyclopropyl-8-fluoro-2-(2-(hydroxyMethyl)-3-(1-Methyl-5-((5-(4-Methylpiperazin-1-yl)pyridin-2-yl)aMiNA)-6-oxo-1,6-dihydropyridin-3-yl)phenyl)isoquiNAlin-1(2H)-one 6-Cyclopropyl-2-[3-[1,6-dihydro-1-methyl-5-[[5-(4-methyl-1-piperazinyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]-2-(hydroxymethyl)phenyl]-8-fluoro-1(2H)-isoquinolinone | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 397 | 1243243-89-1 | Wnt-C59 (C59) | C59 WNT C59 Wnt-C59 WNT-C59 (C59) Wnt-C59 (C59) 4-(2-Methyl-4-pyridinyl)-N-[4-(3-pyridinyl)phenyl]benzeneacetamide 2-(4-(2-Methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetaMide 4-(2-Methyl-4-pyridinyl)-N-[4-(3-pyridinyl)phenyl]benzeneacetamide Wnt-c59 | API;Inhibitors;Cell biology reagents;Small molecule libraries;Small molecule inhibitors;Stem cells and Wnt signaling;Small molecule inhibitors, natural products |
| 398 | 1271738-59-0 | MI-3 | MI3 MI-3 MI 3 4-[4-(4 THIENO[2 5-dihydro-5 5-DIHYDRO-5 3-D]PYRIMIDINE Menin-MLL inhibitor 3 MENIN-MLL INHIBITOR 3 MI-3 (Menin-MLL Inhibitor) MI-3(MENIN-MLL INHIBITOR 3) 5-DIMETHYL-2-THIAZOLYL)-1-PIPERAZINYL]-6-(1-METHYLETHYL) 5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-(1-methylethyl) 4-[4-(4,5-Dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-(1-methylethyl)thieno[2,3-d]pyrimidine Thieno[2,3-d]pyriMidine, 4-[4-(4,5-dihydro-5,5-diMethyl-2-thiazolyl)-1-piperazinyl]-6-(1-Methylethyl)- | Inhibitors;Small molecule inhibitors;Small active molecule library;Small molecule inhibitors, natural products |
| 399 | 1271738-62-5 | MI-2 | MI2 MI 2 MI-2 Menin-MLL Inhibitor MENIN-MLL INHIBITOR 2 Menin-MLL inhibitor 2 MI-2 (Menin-MLL Inhibitor) 4-(4-(5,5-diMethyl-4,5-dihydrothiazol-2-yl)piperazin-1-yl)-6-propylthieno[2,3-d]pyriMidine 4-[4-(4,5-Dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-propylthieno[2,3-d]pyrimidine Thieno[2,3-d]pyriMidine, 4-[4-(4,5-dihydro-5,5-diMethyl-2-thiazolyl)-1-piperazinyl]-6-propyl- 4-[4-(4,5-Dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-propylthieno[2,3-d]pyrimidine MI-2 | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 400 | 1276110-06-5 | HS-173 | HS173 HS 173 HS-173 CS-1007 ethyl 6-(5-(phenylsulfonamido)pyridin-3-yl)imidazo[1,2-a]pyridine-3-carboxylate 6-[5-[(Phenylsulfonyl)amino]-3-pyridinyl]imidazo[1,2-a]pyridine-3-carboxylic acid ethyl ester Imidazo[1,2-a]pyridine-3-carboxylic acid, 6-[5-[(phenylsulfonyl)amino]-3-pyridinyl]-, ethyl ester 6-[5-[(Phenylsulfonyl)amino]-3-pyridinyl]imidazo[1,2-a]pyridine-3-carboxylic acid ethyl ester HS-173 | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 401 | 1285515-21-0 | GSK2578215A | CS-1790 GSK2578125A GSK2578215A LRRK2-kinase inhibitor LRRK2 inhibitor GS2578215A 2-(benzyloxy)-5-(2-fluoropyridin-4-yl)-N-(pyridin-3-yl)benzaMide 5-(2-fluoro-4-pyridinyl)-2-[(phenylmethyl)oxy]-N-3-pyridinylbenzamide 5-(2-Fluoro-4-pyridinyl)-2-(phenylmethoxy)-N-3-pyridinylbenzamide GSK2578215A | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 402 | 1285702-20-6 | ML167 | ML167 CID44968231 CID 44968231 NCGC00188654 5-[4-[[(5-Methyl-2-furanyl)methyl]amino]-6-quinazolinyl]-2-furanmethanol (5-(4-(((5-Methylfuran-2-yl)methyl)amino)quinazolin-6-yl)furan-2-yl)methanol 5-[4-[[(5-Methyl-2-furanyl)methyl]amino]-6-quinazolinyl]-2-furanmethanol ML167 | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 403 | 1300031-52-0 | GSK1324726A | CS-1736 I-BET726 I-BET 726 GSK1324726A GSK1324726A (I-BET726) 4-(cis-1-Acetyl-4-((4-chlorophenyl)amino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoic acid 4-((2S,4R)-1-acetyl-4-(4-chlorophenylamino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoic acid 4-[(2S,4R)-1-Acetyl-4-[(4-chlorophenyl)amino]-2-methyl-1,2,3,4-tetrahydro-6-quinolinyl]benzoic acid 4-[(2S,4R)-1-Acetyl-4-[(4-chlorophenyl)amino]-1,2,3,4-tetrahydro-2-methyl-6-quinolinyl]benzoic acid | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 404 | 1314241-44-5 | (5-Bromopyridin-3-yl)(4-(pyrrolidin-1-yl)piperidin-1-yl)methanone | UNC699 UNC669 CS-1146 UNC 669 UNC-669 (5-Bromo-3-pyridinyl)[4-(1-pyrrolidinyl)-1-piperidinyl]methanone (5-Bromopyridin-3-yl)(4-(pyrrolidin-1-yl)piperidin-1-yl)methanone (5-Bromo-3-pyridinyl)[4-(1-pyrrolidinyl)-1-piperidinyl]methanone UNC669 | API;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 405 | 1346704-33-3 | GSK343 | GSK343 GSK 343 GSK-343 N-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[2-(4-methyl-1-piperazinyl)-4-py 1-(1-Methylethyl)-N-[(6-Methyl-2-oxo-4-propyl-1,2-dihydro-3-pyridinyl)Methyl]-6-[2-(4-Methyl-1-piperazinyl)-4-pyridinyl]-1H-indazole-4-carboxaMide 1H-Indazole-4-carboxamide, N-[(1,2-dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]- 1-(1-Methylethyl)-N-[(6-methyl-2-oxo-4-propyl-1,2-dihydro-3-pyridinyl)methyl]-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1H-indazole-4-carboxamide GSK343 | API;Inhibitors;Cell cycle;Cell biology reagents;Pharmaceutical raw materials;Small molecule inhibitors, natural products |
| 406 | 1374601-40-7 | BRD4770 | BRD4770 CS-1814 BRD-4770 BRD 4770 Methyl 2-benzamido-1-(3-phenylpropyl)benzimidazole-5-carboxylate methyl 2-benzamido-1-(3-phenylpropyl)-1H-benzo[d]imidazole-5-carboxylate Methyl-2-(benzoylamino)-1-(3-phenylpropyl)-1H-benzimidazole-5-carboxylate 2-(Benzoylamino)-1-(3-phenylpropyl)-1H-benzimidazole-5-carboxylic acid methyl ester methyl 2-benzamido-1-(3-phenylpropyl)-1H-benzo[d]imidazole-5-carboxylate BRD4770 | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 407 | 1374828-69-9 | GNE-0877 | CS-1275 GNE-0877 GNE 0877 GNE0877. 2-Methyl-2-(3-methyl-4-((4-(methylamino)-5-(trifluoromethyl)-pyrimidin-2-yl)amino)-1H-pyrazol- 2-methyl-2-(3-methyl-4-(4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-1H-pyrazol-1-yl)propanenitrile alpha,alpha,3-Trimethyl-4-[[4-(methylamino)-5-(trifluoromethyl)-2-pyrimidinyl]amino]-1H-pyrazole-1-acetonitrile alpha,alpha,3-Trimethyl-4-[[4-(methylamino)-5-(trifluoromethyl)-2-pyrimidinyl]amino]-1H-pyrazole-1-acetonitrile GNE-0877 | API;Inhibitors;Small molecule inhibitors, natural products |
| 408 | 1380432-32-5 | EHop-016 | EHOP016 EHOP 016 EHop-016 EHOP016 EHOP-016 EHOP-016 EHOP 016 EHOP 016. N4-(9-Ethyl-9H-carbazol-3-yl)-N2-[3-(4-morpholinyl)propyl]-2,4-pyrimidinediamine N4-(9-ETHYL-9H-CARBAZOL-3-YL)-N2-(3-MORPHOLIN-4-YL-PROPYL)-PYRIMIDINE-2,4-DIAMINE N4-(9-Ethyl-9H-carbazol-3-yl)-N2-(3-Morpholin-4-yl-propyl)-pyriMidine-2,4-diaMine EHOP-016 N4-(9-ETHYL-9H-CARBAZOL-3-YL)-N2-(3-MORPHOLIN-4-YL-PROPYL)-PYRIMIDINE-2,4-DIAMINE N4-(9-Ethyl-9H-carbazol-3-yl)-N2-[3-(4-morpholinyl)propyl]-2,4-pyrimidinediamine Ehop-016 | Inhibitors;Cell cycle;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 409 | 1392136-43-4 | Verdinexor (KPT-335) | CS-1798 KPT-335 Verdinexor Verdinexor(KPT-335) Verdinexor (KPT-335) Z)-3-(3-(3,5-bis(trifluoroMethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyridin- (KPT335)(Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyridin-2-yl)acrylohydrazide (2Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]- 2-propenoic acid-2-(2-pyridinyl)hydrazide (2Z)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N -(pyridin-2-yl)prop-2-enehydrazide Verdinexor(KPT-335) | API;Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 410 | 1393477-72-9 | Selinexor (KPT-330) | KPT-330 Aloradine Selinexor KPT330,Selinexor KPT-330,Selinexor Selinexor (KPT-330) (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyrazin-2-yl)acrylohydrazide (2Z)-3-[3-[3,5-Bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-2-propenoic acid 2-(2-pyrazinyl)hydrazide 2-Propenoic acid, 3-[3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-, 2-(2-pyrazinyl)hydrazide, (2Z)- | API;Inhibitors;Small molecule inhibitors;Pharmaceutical raw materials |
| 411 | 1394076-92-6 | GNE-317 | GNE317 GNE 317 CS-1716 GNE-317 5-(6-(3-Methoxyoxetan-3-yl)-4-Morpholinothieno[3,2-d]pyriMidin-2-yl)pyriMidin-2-aMine 5-(6-(3-methoxyoxetan-3-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-2-yl)pyrimidin-2-amine 5-[6-(3-METHOXYOXETAN-3-YL)-7-METHYL-4-MORPHOLIN-4-YLTHIENO[3,2-D]PYRIMIDIN-2-YL]PYRIMIDIN-2-AMINE 2-Pyrimidinamine, 5-[6-(3-methoxy-3-oxetanyl)-7-methyl-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-2-yl]- | inhibitors;Cell biology reagents |
| 412 | 1395084-25-9 | MS436 | MS436 MS-436 CS-1882 MS 436 (E)-4-[2-(2-Amino-4-hydroxy-5-methylphenyl)diazenyl]-N-2-pyridinylbenzenesulfonamide (E)-4-((2-AMINO-4-HYDROXY-5-METHYLPHENYL)DIAZENYL)-N-(PYRIDIN-2-YL)BENZENESULFONAMIDE 4-[(1E)-2-(2-Amino-4-hydroxy-5-methylphenyl)diazenyl]-N-2-pyridinylbenzenesulfonamide 4-[(2Z)-2-(2-amino-5-methyl-4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]-N-pyridin-2-ylbenzenesulfonamide 4-[(1E)-2-(2-Amino-4-hydroxy-5-methylphenyl)diazenyl]-N-2-pyridinylbenzenesulfonamide MS436 MS436 4-[(1E)-2-(2-Amino-4-hydroxy-5-methylphenyl)diazenyl]-N-2-pyridinylbenzenesulfonamide | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small active molecule library;Small molecule inhibitors, natural products |
| 413 | 1404456-53-6 | GSK 2830371 | GSK 2830371 (S)-5-((5-chloro-2-methylpyridin-3-ylamino)methyl)-N-(3-cyclopentyl-1-(cyclopropylamino)-1-oxopropan-2-yl)thiophene-2-carboxamide 5-[[(5-Chloro-2-methyl-3-pyridinyl)amino]methyl]-N-[(1S)-1-(cyclopentylmethyl)-2-(cycloprpylamino)-2-oxoethyl]-2-thiophenecarboxamide 5-[[(5-Chloro-2-methyl-3-pyridinyl)amino]methyl]-N-[(1S)-1-(cyclopentylmethyl)-2-(cyclopropylamino)-2-oxoethyl]-2-thiophenecarboxamide 2-Thiophenecarboxamide, 5-[[(5-chloro-2-methyl-3-pyridinyl)amino]methyl]-N-[(1S)-1-(cyclopentylmethyl)-2-(cyclopropylamino)-2-oxoethyl]- GSK 2830371 (S)-5-(((5-chloro-2-methylpyridin-3-yl)amino)methyl)-N-(3-cyclopentyl-1-(cyclopropylamino) -1-oxopropan-2-yl)thiophene-2-carboxamide | Inhibitors;Small molecule inhibitors, natural products |
| 414 | 1417329-24-8 | MM-102 | MM102 MM-102 MM 102 CS-2007 MM-102 TFA Salt HMTase Inhibitor IX HMTASE INHIBITOR IX 1-[[(2S)-5-[(Aminoiminomethyl)amino]-2-[[2-ethyl-2-[(2-methyl-1-oxopropyl)amino]-1-oxobutyl]amino]-1-oxopentyl]amino]-N-[bis(4-fluorophenyl)methyl]cyclopentanecarboxamide] Cyclopentanecarboxamide, 1-[[(2S)-5-[(aminoiminomethyl)amino]-2-[[2-ethyl-2-[(2-methyl-1-oxopropyl)amino]-1-oxobutyl]amino]-1-oxopentyl]amino]-N-[bis(4-fluorophenyl)methyl]- | Inhibitors;Bioactive molecules;Scientific research reagents;Small molecule inhibitors, natural products |
| 415 | 1421919-75-6 | KPT-276 | KPT276 KPT-276 CS-1100 KPT 276 (Z)-3-(3-(3,5-bis(trifluoroMethyl)phenyl)-1H-1,2,4-triazol-1-yl)-1-(3,3- (Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-1-(3,3-difluoroazetidin-1-yl)prop-2-en-1-one 2-Propen-1-one, 3-[3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-1-(3,3-difluoro-1-azetidinyl)-, (2Z)- (KPT276)(Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-1-(3,3-difluoroazetidin-1-yl)prop-2-en-1-one | API;Inhibitors;Ion channels;Membrane transport;Membrane transport/ion channels;Small molecule inhibitors, natural products |
| 416 | 1431612-23-5 | UNC1999 | CS-999 UNC1999 UNC-1999 UNC 1999 UNC 1999 N-[(1,2-Dihydro-6-Methyl-2-oxo-4-propyl-3-pyridinyl)Methyl]-1-(1-Methylethyl)-6-[6-[4-(1-Methylethyl)-1-piperazinyl]-3-pyridinyl]-1H-indazole-4-carboxaMide 1H-Indazole-4-carboxamide, N-[(1,2-dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[6-[4-(1-methylethyl)-1-piperazinyl]-3-pyridinyl]- N-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[6-[4-(1-methylethyl)-1-piperazinyl]-3-pyridinyl]-1H-indazole-4-carboxamide UNC1999 | API;Inhibitors;Cell cycle;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 417 | 1446144-04-2 | CPI-203 | CPI-203 CPI203 (CPI-203) CPI203(TEN010,JQ2,RG-6146) (S)-2-(4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin- (6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide (6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic amide 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-2,3,9-trimethyl-, (6S)- (6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide CPI 203 CPI 203 (6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide | Inhibitors;Small molecule inhibitors, natural products |
| 418 | 1469337-95-8 | K-Ras(G12C) inhibitor 12 | 105456 CS-1676 K-Ras G12C-IN-12 G12C INHIBITOR 12 K RAS INHIBITOR 12 G12C INHIBITOR 12 K-RAS(G12C) INHIBITOR 12 K-Ras(G12C) inhibitor 12 1-(4-(2-((4-chloro-2-hydroxy-5-iodophenyl)aMino)acetyl)piperazin-1-yl)prop-2-en-1-one 2-Propen-1-one, 1-[4-[2-[(4-chloro-2-hydroxy-5-iodophenyl)aMino]acetyl]-1-piperazinyl]- | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 419 | 1477949-42-0 | Santacruzamate A | CAY1083 CAY10683 Santacruzamate A SantacruzaMate A Santacruzamate A (CAY10683) CAY10683 (SantacruzaMate A) ETHYL 4-OXO-4-(PHENETHYLAMINO)BUTYLCARBAMATE N-[4-oxo-4-[(2-phenylethyl)amino]butyl]-carbamic acid ethyl ester Carbamic acid, N-[4-oxo-4-[(2-phenylethyl)amino]butyl]-, ethyl ester | Standards;Inhibitors;Custom-made;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 420 | 148741-30-4 | Tyrphostin AG 879 | AG-879 AG 879 TYRPHOSTIN 879 Tyrphostin AG 879 TYRPHOSTIN AG 879 ALPHA-CYANO-(3,5-DI-T-BUTYL-4-HYDROXY)THIOCINNAMIDE (3,5-DI-T-BUTYL-4-HYDROXYBENZYLIDENE)THIOCYANOACETAMIDE ALPHA-CYANO-(3,5-DI-TERT-BUTYL-4-HYDROXY)THIOCINNAMAMIDE 2-Propenethioamide, 3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-cyano-, (E)- | Inhibitors;Cell biology reagents;Protein tyrosine kinase;Small molecule inhibitors, natural products |
| 421 | 1536200-31-3 | GNE-9605 | GNE9605 CS-1831 GNE-9605 GNE 9605 Diazepam-d8 (exempt preparation) N2-(5-chloro-1-(3-fluoro-1-(oxetan-3-yl)piperidin-4-yl)-1H-pyrazol-4-yl)-N4-methyl-5-(trifluoromethyl)pyrimidine-2,4-diamine rel-N2-[5-Chloro-1-[(3R,4R)-3-fluoro-1-(3-oxetanyl)-4-piperidinyl]-1H-pyrazol-4-yl]-N4-methyl-5-(trifluoromethyl)-2,4-pyrimidinediamine 2,4-Pyrimidinediamine, N2-[5-chloro-1-[(3R,4R)-3-fluoro-1-(3-oxetanyl)-4-piperidinyl]-1H-pyrazol-4-yl]-N4-methyl-5-(trifluoromethyl)-, rel- | Medicine;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 422 | 155270-99-8 | Istradefylline | CS-285 KW-6002 Itraphylline Istradefylline istradefylline Istradefylline-13C-d3 8-[(E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methyl-purine-2,6 -dione 8-[(1E)-2-(2-(3,4-Dimethoxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-1H-purine-2,6-dione | Inhibitors;Pharmaceutical bulk drugs;Other biochemical reagents;Pharmaceutical raw materia;Raw materials and intermediates;Pharmaceutical customized intermediates;Small molecule inhibitors, natural pr |
| 423 | 1616391-65-1 | EPZ015666 | EPZ015666 GSK3235025 EPZ-015666 EPZ 015666 GSK-3235025 GSK3235025 (EPZ015666) (S)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)-6-(oxetan-3-ylamino)pyrimidine-4-carboxamide N-[(2S)-3-(3,4-Dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl]-6-(3-oxetanylamino)-4-pyrimidinecarboxamide N-[(2S)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-6-(oxetan-3-ylamino)pyrimidine-4-carboxamide | API;Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 424 | 1616632-77-9 | TIC10 | TIC10 ONC201 TIC10 TIC10 ONC201 TIC 10 TIC-10 ONC 201 TIC-10 TIC 10 ONC-201 ONC-201 ONC 201 imipridone NSC350625 IMIPRIDONE NSC-350625 NSC 350625 NSC350625 ONC201,TIC10 NSC 350625 NSC-350625 TIC10(ONC-201) TIC-10 (ON201) TIC 10 active isomer TRAIL INDUCING COMPOUND 10 2,4,6,7,8,9-Hexahydro-4-[(2-methylphenyl)methyl]-7-(phenylmethyl)imidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one | APL;Synthetic material intermediates |
| 425 | 1622921-15-6 | Remodelin (hydrobromide) | CS-1751 REMODELIN Remodelin HBR ReModelin hydrobroMide Remodelin (hydrobromide) 4-[2-(2-cyclopentylidenehydrazinyl)-1,3-thiazol-4-yl]benzonitrile Remodelin 16066 Remodelin (hydrobromide) 4-[2-(2-cyclopentylidenehydrazinyl)-1,3-thiazol-4-yl]benzonitrile | Inhibitors;Cell biology reagents;Small active molecule library;Small molecule inhibitors, natural products |
| 426 | 173529-46-9 | HMN-214 | CS-25 HMN214 IVX214 HMN 214 HMN-214 (E)-4-(2-(N-((4-methoxyphenyl)sulfonyl)acetamido)styryl)pyridine 1-oxide (E)-4-[2-[2-[N-Acetyl-N-[(4-methoxyphenyl)sulfonyl]amino]phenyl]ethenyl]pyridine 1-oxide Acetamide, N-[(4-methoxyphenyl)sulfonyl]-N-[2-[(1E)-2-(1-oxido-4-pyridinyl)ethenyl]phenyl]- (E)-4-[2-[2-[N-Acetyl-N-[(4-methoxyphenyl)sulfonyl]amino]phenyl]ethenyl]pyridine 1-oxide HMN 214 | Inhibitors;Cell cycle;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 427 | 178606-66-1 | U-104 | U104 U 104 U-104 MST-104 CS-1653 MST-104 NSC 213841 NSC-213841 4-[[[(4-Fluorophenyl)amino]carbonyl]amino]benzenesulfonamide | Inhibitor;Inhibitors;Metabolism;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 428 | 199596-05-9 | JIB-04 | JIB-04 NSC 693627 JIB-04 (NSC 693627) (E)-5-CHLORO-2-(2-(PHENYL(PYRIDIN-2-YL)METHYLENE)HYDRAZINYL)PYRIDINE 5-Chloro-2(1H)-pyridinone (2E)-(phenyl-2-pyridinylmethylene)hydrazone 5-Chloro-2-[(E)-2-[phenyl(pyridin-2-yl)methylidene]hydrazin-1-yl]pyridine 5-Chloro-2(1H)-pyridinone (2E)-(phenyl-2-pyridinylmethylene)hydrazone JIB-04(NSC 693627) | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 429 | 210344-95-9 | Z-DEVD-FMK | Z-DEVD-FMK Z-DEVD-FLUOROMETHYLKETONE Z-ASP-GLU-VAL-ASP-FLUOROMETHYLKETONE Z-ASP(OME)-GLU(OME)-VAL-ASP(OME)-FMK Z-ASP(OME)-GLU(OME)-VAL-ASP(OME)-CH2F Z-D(OME)E(OME)VD(OME) FLUOROMETHYLKETONE Z-ASP(OME)-GLU(OME)-VAL-ASP(OME)-FLUOROMETHYLKETONE Z-ASP(OME)-GLU(OME)-VAL-DL-ASP(OME)-FLUOROMETHYLKETONE | API;peptide;peptides;Apoptosis;Pepetides;Inhibitors;Caspases/Apoptosis;biochemical reagent;Caspase/Related Products |
| 430 | 244240-24-2 | LFM-A13 | LFM-A13 LFM-A13(Z) 2-cyano-N-(2,5-dibromophenyl) -3-oxobutanamide (Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide (2Z)-2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide a-Cyano-b-hydroxy-b-methyl-N-(2,5-dibromophenyl)propenamide α-cyano-β-hydroxy-β-methyl-n-(2,5-dibromophenyl)propenamide 2-Butenamide,2-cyano-N-(2,5-dibromophenyl)-3-hydroxy-, (2Z)- (Z)-2-cyano-N-(2,5-dibroMophenyl)-3-hydroxybut-2-enaMide(LFM-A13) | Inhibitors;Small molecule inhibitors, natural products |
| 431 | 273404-37-8 | VX-765 | CS-387 VX-765 VX 765 VX-765 N-(4-Amino-3-chlorobenzoyl)-3-methyl-L-valyl-N-[(2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl]-L-prolinamide L-Prolinamide, N-(4-amino-3-chlorobenzoyl)-3-methyl-L-valyl-N-[(2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl]- (S)-1-((S)-2-(4-amino-3-chlorobenzamido)-3,3-dimethylbutanoyl)-N-((2R,3S)-2-ethoxy-5-oxotetrahydrofuran-3-yl)pyrrolidine-2-carboxamide (2S)-1-[(2S)-2-[(4-amino-3-chlorophenyl)formamido]-3,3-dimethylbutanoyl]-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]pyrrolidine-2-carboxamide | API;Inhibitors;Chemical raw materials;Small molecule inhibitors, natural products |
| 432 | 347174-05-4 | Ferrostatin-1 (Fer-1) | FER1 Fer-1 FERROSTATIN-1 Ferrostatin-1 (Fer-1) Ethyl 3-amino-4-(cyclohexylamino)benzoate 3-Amino-4-cyclohexylaminobenzoic acid ethyl ester Benzoic acid, 3-amino-4-(cyclohexylamino)-, ethyl ester | Small molecule inhibitor |
| 433 | 348622-88-8 | UK 383367 | CS-483 UK 383367 UK-383367 (UK 383367) 3-(Aminocarbonyl)-β-(3-cyclohexylpropyl)-N-hydroxy-1,2,4-oxadiazole-5-propanamide (βR)-3-(Aminocarbonyl)-β-(3-cyclohexylpropyl)-N-hydroxy-1,2,4-oxadiazole-5-propanamide 5-[(1R)-4-Cyclohexyl-1-[2-(hydroxyamino)-2-oxoethyl]butyl]-1,2,4-oxadiazole-3-carboxamide 1,2,4-Oxadiazole-5-propanamide, 3-(aminocarbonyl)-β-(3-cyclohexylpropyl)-N-hydroxy-, (βR)- | Inhibitors;Metabolism;Active small molecule library;Small molecule inhibitors, natural products |
| 434 | 422513-13-1 | Hesperadin | Hesperadin HESPERADIN Hesperadine Hesperadin hydrochloride Hesperadin Hesperadine (Z)-N-(2-oxo-3-(phenyl(4-(piperidin-1-ylmethyl)phenylamino)methylene)indolin-5-yl)ethanesulfonamide N-[(3Z)-2-Oxo-3-[phenyl-[4-(piperidin-1-ylMethyl)anilino]Methylidene]-1H-indol-5-yl]ethanesulfonaMide N-[2,3-Dihydro-2-oxo-3-[(3Z)-phenyl[[4-(1-piperidinylmethyl)phenyl]amino]methylene]-1H-indol-5-yl]ethanesulfonamide Hesperadin | Inhibitor;Inhibitors;Cell cycle;Cell biology reagents;Small molecule inhibitors, natural products |
| 435 | 50892-23-4 | WY-14643 | WY-14643 NSC 310038 wyeth14,643 pirnixicacid 4-chloro-6-(2,3-xylidino)-2-*pyrimidinylthioaceti ((4-chloro-6-(2,3-xylidino)-2-pyrimidinyl)thio)-aceticaci ((4-chloro-6-((2,3-dimethylphenyl)amino)-2-pyrimidinyl)thio)-aceticaci Acetic acid, 2-[[4-chloro-6-[(2,3-dimethylphenyl)amino]-2-pyrimidinyl]thio]- | Inhibitor;Inhibitors;Metabolism;Cell biology reagents;Intracellular receptor;Small molecule inhibitors;Other biochemical reagents;Small molecule inhibitors, natural products |
| 436 | 537049-40-4 | Tubacin | Tubacin BML-GR362 Tubacin (BML-GR362) N1-(4-((2R,4R,6S)-4-(((4,5-Diphenyloxazol-2-yl)thio)methyl)-6-(4-(hydroxymethyl)phenyl)-1,3-di N1-(4-((2R,4R,6S)-4-((4,5-diphenyloxazol-2-ylthio)methyl)-6-(4-(hydroxymethyl)phenyl)-1,3-dioxan-2-yl)phenyl)-N8-hydroxyoctanediamide N1-[4-[(2R,4R,6S)-4-[[(4,5-diphenyl-2-oxazolyl)thio]methyl]-6-[4-(hydroxymethyl)phenyl]-1,3-dioxan-2-yl]phenyl]-N8-hydroxy-octanediamide N1-[4-[(2R,4R,6S)-4-[[(4,5-diphenyl-2-oxazolyl)thio]methyl]-6-[4-(hydroxymethyl)phenyl]-1,3-dioxan-2-yl]phenyl]-N8-hydroxy-octanediamide Tubacin | Standards;Inhibitors;Bulk drugs;Cell biology reagents;Small molecule inhibitors, natural products |
| 437 | 586379-66-0 | PH-797804 | CS-45 PH797804 PH-797804 PH 797804 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide 3-(3-Bromo-4-((2,4-difluorobenzyl)oxy)-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide 3-Bromo-4-[(2,4-difluorobenzyl)oxy]-1-[5-[(methylamino)carbonyl]-2-methylphenyl]-6-methylpyridin-2(1H)-one | MAPK;Inhibitors;Small molecule inhibitors;Other scientific bulk drugs;Small molecule inhibitors, natural products;Signal transduction pathway kinase inhibitor |
| 438 | 587841-73-4 | ZCL278 | ZCL278 ZCL 278 2-(4-Bromo-2-chlorophenoxy)-N-((4-(N-(4,6-dimethylpyrimidin-2-yl)sulfamoyl)phenyl)carbAmothioy 2-(4-broMo-2-chlorophenoxy)-N-(4-(N-(4,6-diMethylpyriMidin-2-yl)sulfaMoyl)phenylcarbaMothioyl)acetaMide 2-(4-Bromo-2-chlorophenoxy)-N-[[[4-[[(4,6-dimethyl-2-pyrimidinyl)amino]sulfonyl]phenyl]amino]thioxomethyl]acetamide 2-(4-Bromo-2-chlorophenoxy)-N-[[[4-[[(4,6-dimethyl-2-pyrimidinyl)amino]sulfonyl]phenyl]amino]thioxomethyl]acetamide ZCL278 ZCL 278 2-(4-Bromo-2-chlorophenoxy)-N-[[[4-[[(4,6-dimethyl-2-pyrimidinyl)amino]sulfonyl]phenyl]amino]thioxomethyl]acetamide | Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 439 | 63208-82-2 | Pifithrin-α | Pifithrin-α Zinc03874684 PFT-α,Pifithrin-α PFTα hydrobroMide Pifithrin-α (PFTα) Pifithrin-alpha . HBr Pifithrin-Hydrobromide 2-(2-imino-4,5,6,7-tetrahydrobenzothiazol-3-yl)-1-p-tolylethanone hydrobromide 1-(4-METHYLPHENYL)-2-(4,5,6,7-TETRAHYDRO-2-IMINO-3(2H)-BENZOTHIAZOLYL)ETHANONE, MONOHYDROBROMIDE Ethanone, 1-(4-Methylphenyl)-2-(4,5,6,7-tetrahydro-2-iMino-3(2H)-benzothiazolyl)-, MonohydrobroMide | Inhibitor;Apoptosis;Inhibitors;Caspases/Apoptosis;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 440 | 71203-35-5 | ML141 | ML141 ML 141 CID-2950007 5-(4-Methoxyphenyl)-1-(4-sulfamoylphenyl)-3-phenyl-2-pyrazoline 4-[3-(4-Methoxyphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide 4-(5-(4-methoxyphenyl)-3-phenyl-4,5-dihydropyrazol-1-yl)benzenesulfonamide 4-[4,5-Dihydro-5-(4-methoxyphenyl)-3-phenyl-1H-pyrazol-1-yl]-benzenesulfonamide 4-[4,5-Dihydro-5-(4-methoxyphenyl)-3-phenyl-1H-pyrazol-1-yl]-benzenesulfonamide ML141 | API;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 441 | 837422-57-8 | WH-4-023 | KIN112 WH-4-023 KIN001-112 2,6-DIMETHYLPHENYL 2,4-DIMETHOXYPHENYL(2-(4-(4-METHYLPIPERAZIN-1-YL)PHENYLAMINO)PYRIMIDIN-4-YL)CARBAMATE 2,6-dimethylphenyl (2,4-dimethoxyphenyl)(2-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)carbamate WH-4-023 Carbamic acid, N-(2,4-dimethoxyphenyl)-N-[2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]-, 2,6-dimethylphenyl ester WH-4-023 2,6-DIMETHYLPHENYL 2,4-DIMETHOXYPHENYL(2-(4-(4-METHYLPIPERAZIN-1-YL)PHENYLAMINO)PYRIMIDIN-4-YL)CARBAMATE | API;Standards;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 442 | 857064-38-1 | WP1066 | WP1066 wp1066(STAT Inhibitor III) Stat3 Inhibitor III, WP1066 (S,E)-3-(6-Bromopyridin-2-yl)-2-cyano-N-(1-phenylethyl)acrylamide (2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylethyl]-2-propenamide (2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylethyl]-2-propenamide WP 1066 | JAK;API;STAT;Inhibitor;Standards;Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 443 | 865362-74-9 | FR 180204 | FR180204 FR 180204 LM-3319 FR 180204 ERK Inhibitor II, FR180204 5-(2-Phenylpyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-amine 1H-Pyrazolo[3,4-c]pyridazin-3-amine, 5-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)- 5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine 5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine FR 180204 | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 444 | 872573-93-8 | Ro-3306 | RO3306 Ro-3306 RO 3306 Ro 3306 TRPV4 ANTAGONIST I 5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone (5Z)-5-Quinolin-6-ylmethylene-2-[(thiophen-2-ylmethyl)-amino]-thiazol-4-one (Z)-5-(quinolin-6-ylmethylene)-2-(thiophen-2-ylmethylamino)thiazol-4(5H)-one 4(5H)-Thiazolone, 5-(6-quinolinylmethylene)-2-[(2-thienylmethyl)amino]-, (5Z)- (5Z)-5-(quinolin-6-ylmethylidene)-2-(thiophen-2-ylmethylamino)-1,3-thiazol-4-one 2-[[(Thiophen-2-yl)methyl]amino]-5-[1-(quinolin-6-yl)meth-(Z)-ylidene]thiazol-4-one | Inhibitors;Reference substance;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 445 | 873436-91-0 | PU-H71 | PU-H71 NSC 750424 PU-H71 Trifluoroacetic Acid 8-[(6-iodo-1,3-benzodioxol-5-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine 8-((6-iodobenzo[d][1,3]dioxol-5-yl)thio)-9-(3-(isopropylaMino)propyl)-9H-purin-6-aMine 6-Amino-8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-N-(1-methylethyl)-9H-purine-9-propanamine 9H-Purine-9-propanamine, 6-amino-8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-N-(1-methylethyl)- 6-Amino-8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-N-(1-methylethyl)-9H-purine-9-propanamine PU-H71 Trifluoroacetic Acid | API;Inhibitors;Cell cycle;Bioactive molecules;Cell biology reagents;Small molecule inhibitors, natural products |
| 446 | 882257-11-6 | Oxytocin-d5 | P5091 CS-726 P-5091 P-5091 P005091 P 5091 P-005091 P 005091 Oxytocin-d5 P005091(P5091) 1-[5-(2,3-dichlorophenyl)sulfanyl-4-nitro-2-thienyl]ethanone Ethanone, 1-[5-[(2,3-dichlorophenyl)thio]-4-nitro-2-thienyl]- 1-[5-(2,3-Dichloro-phenylsulfanyl)-4-nitro-thiophen-2-yl]-ethanone 1-[5-[(2,3-Dichlorophenyl)thio]-4-nitro-2-thienyl]-ethanone P005091 | Inhibitors;Cell biology reagents;Small molecule inhibitors, natural products |
| 447 | 91396-88-2 | PluriSIn #1 (NSC 14613) | NSC14613 NSC 14613 NSC-14613 plurisln 1 PluriSln 1 1,4-Pyridinecarboxylicacid 4-Pyridinecarboxylicacid, 2-phenylhydrazide | Inhibitors;Metabolism;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 448 | 946518-60-1 | LY2409881 (trihydrochloride) | CS-1620 LY2409881 LY2409881 3HCl LY-2409881 HC'l LY2409881 triHCl LY2409881 trihydrochloride LY2409881 (trihydrochloride) 2-(5-chloro-2-(3-(4-methylpiperazin-1-yl)propylamino)pyrimidin-4-yl)-N-cyclopropylbenzo[b]thiophene-4-carboxamide trihydrochloride 2-[5-Chloro-2-[[3-(4-methyl-1-piperazinyl)propyl]amino]-4-pyrimidinyl]-N-cyclopropylbenzo[b]thiophene-4-carboxamide trihydrochloride | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 449 | 1042224-63-4 | IRAK inhibitor 1 | 6-imidazo[1 IRAK inhibitor IRAK inhibitor 1 Cyclopamine inhibitor 1 2-a]pyridin-3-yl-N-4-piperidinyl- 6-Imidazo[1,2-a]pyridin-3-yl-N-4-piperidinyl-2-pyridinamine 2-PyridinaMine, 6-iMidazo[1,2-a]pyridin-3-yl-N-4-piperidinyl- | |
| 450 | 1186206-79-0 | ALW-II-41-27 | CS-2709 ALW-II-41-27 Eph receptor tyrosine kinase inhibitor N-(5-((4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)carbamoyl)-2-methylphenyl)-5-(thiophen-2-yl)nicotinamide BenzaMide, N-[4-[(4-ethyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)phenyl]-4-Methyl-3-[[[5-(2-thienyl)-3-pyridinyl]carbonyl]aMino]- | Cell biology reagent;Protein tyrosine kinase |
| 451 | 1202402-40-1 | Triazolo-pyramidine derivative | CPI444 CS-2828 CPD1110 CPI 444 CPI-444 Ciforadenant Triazolo-pyramidine derivative (S)-7-(5-Methyl-furan-2-yl)-3-[6-(tetrahydro-furan-3-yloxyMethyl)-pyridin-2-ylMethyl]-3H-[1,2,3]triazolo[4,5-d]pyriMidin-5-ylaMine (S)-7-(5-Methylfuran-2-yl)-3-((6-(((tetrahydrofuran-3-yl)oxy)methyl)pyridin-2-yl)methyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine 7-(5-Methyl-2-furanyl)-3-[[6-[[[(3S)-tetrahydro-3-furanyl]oxy]methyl]-2-pyridinyl]methyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-amine | APIs;Inhibitors;Cell biology reagents;Pharmaceutical raw materials |
| 452 | 1334714-66-7 | Eravacycline dihydrochloride | TP-434-046 TP-434 2HCl Eravacyline Eravacycline HCl ERAVACYCLINE 2HCL Eravacycline dihydrochloride Eravacycline (dihydrochloride) | Inhibitors |
| 453 | 1360457-46-0 | Vaborbactam | RPX7009 CS-2636 Vaborbactam {(3R,6S)-2-Hydroxy-3-[(2-thienylacetyl)amino]-1,2-oxaborinan-6-yl}acetic acid 1,2-Oxaborinane-6-acetic acid, 2-hydroxy-3-[[2-(2-thienyl)acetyl]amino]-, (3R,6S)- 2-((3R,6S)-2-HYDROXY-3-(2-(THIOPHEN-2-YL)ACETAMIDO)-1,2 OXABORINAN-6-YL)ACETIC ACID | β-lactamase inhibitor |
| 454 | 129830-38-2 | Y-27632 dihydrochloride | Y-27632 CS-1919 Y27632 Y 27632 ROCK INHIBITOR Y27632 (HYDROCHLORIDE) Y27632 DIHYDROCHLORIDE Y27632 (hydrochloride) Y-27632 DIHYDROCHLORIDE Y-27632 dihydrochloride Y 27632 DIHYDROCHLORIDE RHO-KINASE INHIBITOR Y-27632 (R)-4-(1-aminoethyl)-N-(pyridin-4-yl)cyclohexanecarboxamide dihydrochloride trans-4-[(R)-1-Aminoethyl]-N-(4-pyridyl)cyclohexanecarboxamide dihydrochloride trans-4-[(R)-1-Aminoethyl]-N-(4-pyridyl)cyclohexanecarboxamide dihydrochloride Y 27632 dihydrochloride | APIs;Inhibitors;biochemical reagent |
| 455 | 162520-00-5 | Salirasib | FTS CS-1744 Salirasib Unii-mzh0om550m FARNESYLTHIOSALICYLIC ACID Salirasib(S-Farnesylthiosalicylic aci) (3,7,11-TRIMETHYLDODECA-2,6,10-TRIENYL)-2-THIOBENZOIC ACID 2-(((2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trien-1-yl)thio)benzoicacid 2-[[(2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl]thio]benzoic acid | API;Aromatics;Inhibitor;Inhibitors;Intermediat;Pharmaceuticals;Cell biology reagent;Sulfur & Selenium Compounds;Intermediates & Fine Chemicals;G protein coupled receptor & G protein |
| 456 | 211555-05-4 | WHI-P97 | WHI-P97 WHI P97 WHI-P-97 JAK3 Inhibitor I 2,6-dibromo-4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol Phenol, 2,6-dibromo-4-[(6,7-dimethoxy-4-quinazolinyl)amino]- WHI-P 974-(3',5'-DibroMo-4-hydroxyphenyl)aMino-6,7-diMethoxyquinazoline | Standard;Protein tyrosine kinase |
| 457 | 262352-17-0 | Torcetrapib | cp529 CS-156 CP 529414 Torcetropib Torcetrapib TORCETRAPIB-D3 Torcetrapib (CP-529414) (2R,4S)-ethyl 2-ethyl-4-(methoxycarbonyl)-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H)-carboxylate (2R)-ethyl 4-((3,5-bis(trifluoroMethyl)benzyl)(Methoxycarbonyl)aMino)-2-ethyl-6-(trifluoroMethyl)-3,4-dihydroquinoline-1(2H)-carboxylate | Inhibitor;Aromatics;Inhibitors;Metabolism;Pfizer comp;Chiral Reagents;Pharmaceuticals;Pfizer compounds;Small molecule inhibitors;Pharmaceutical bulk drugs |
| 458 | 431979-47-4 | SJ-172550 | CS-1226 SJ-172550 SJ 172550 MDMX Antagonist, SJ-172550 Methyl 2-(2-chloro-6-ethoxy-4-((3-methyl-5-oxo-1-phenyl-1H-pyrazol-4(5H)-ylidene)methyl)phenoxy)acetate 2-[2-Chloro-4-[(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)methyl]-6-ethoxyphenoxy]aceticacidmethylester Acetic acid, 2-[2-chloro-4-[(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)methyl]-6-ethoxyphenoxy]-, methyl ester | Cell biology reagent |
| 459 | 511296-88-1 | Cyclic Pifithrin-α Hydrobromide | PFT-Β CS-1771 PIFITHRIN B PIFITHRIN-Β Pifithrin B CYCLIC PFT-Α Cyclic PFT-α PIFITHRIN-Β PFT-Β HYDROBROMIDE Cyclic Pifithrin-α HBr CYCLIC PFT-Α HYDROBROMIDE Pifithrin- beta hydrobromide Cyclic Pifithrin-α Hydrobromide CYCLIC PIFITHRIN-Α HYDROBROMIDE 5,6,7,8-Tetrahydro-2-(4-methylphenyl)-imidazo[2,1-b]benzothiazolehydrobromide | Thiazole;Inhibitor |
| 460 | 55778-02-4 | WZ811 | WZ811 WZ 811 N,N'-Di-2-pyridinyl-1,4-benzenedimethanamine N1,N4-Di-2-pyridinyl-1,4-benzenedimethanamine 1,4-Benzenedimethanamine, N1,N4-di-2-pyridinyl- N,N'-(1,4-PHENYLENEBIS(METHYLENE))DIPYRIDIN-2-AMINE N,N'-(1,4-phenylenebis(methylene))bis(pyridin-2-amine) N1,N4-di-2-pyridinyl-1,4-benzenedimethanamine WZ811 WZ 811 N,N'-Di-2-pyridinyl-1,4-benzenedimethanamine | Medicine;Standards;Inhibitors;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 461 | 761439-42-3 | TAE684 (NVP-TAE684) | NVP-TAE684 NVP-TAE 684 TAE684 (NVP-TAE684) NVP-TAE684 - TAE 684 5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine 5-Chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-2,4-pyrimidinediamine 2,4-Pyrimidinediamine, 5-chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]- NVP-TAE684 5-Chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-2,4-pyrimidinediamine 5-Chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-2,4-pyrimidinediamine TAE684 (NVP-TAE684) | API;Inhibitors;Drug reagents;Small molecule i;Protein tyrosine kinase;Small molecule inhibitors;Pharmaceutical intermediates;Antitumor drugs and immunosuppressants;Signal transduction pathway kinase i |
| 462 | 778270-11-4 | GNF-2 | GNF-2 Bcr-abl Inhibitor 3-(6-(4-(TRIFLUOROMETHOXY)PHENYLAMINO)PYRIMIDIN-4-YL)BENZAMIDE 3-[6-[[4-(Trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]benzamide Benzamide, 3-[6-[[4-(trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]- 3-[6-[[4-(Trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]benzamide GNF-2 GNF-2 3-[6-[[4-(Trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]benzamide | Standards;Inhibitors;Angiogenesis;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 463 | 848141-11-7 | Alvelestat | AZD9668 AZD 9668 AZD-9668 Avelestat Alvelestat ALVELESTAT Avelestat (AZD9668) Alvelestat (AZD9668) 6-Methyl-5-(1-methyl-1H-pyrazol-5-yl)-N-[[5-(methylsulfonyl)pyridin-2-yl]methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide | Inhibitors;Metabolism;Active small molecule library;Small molecule inhibitors, natural products |
| 464 | 960374-59-8 | (S)-3-(4-methoxyphenyl)-N-((S)-1-((R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)propanamido)propanamide | PR957 PR 957 PR-957 PR957 PR-957 PR 957 ONX0914 ONX-0914 ONX 0914 ONX0914 ONX-0914 PR 957(ONX 0914) ONX-0914 (PR-957) N-[2-(4-Morpholinyl)acetyl]-L-alanyl-O-methyl-N-[(1S)-2-[(2R)-2-methyl-2-oxiranyl]-2-oxo-1-(phenylmethyl)ethyl]-L-tyrosinamide (S)-3-(4-methoxyphenyl)-N-((S)-1-((R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)propanamido)propanamide | Protease;Inhibitors;Small molecule inhibitors, natural products |
| 465 | 72882-78-1 | PF-9366 | CS-2703 PF9366 PF-9366 PF 9366 72882-78-1 PF 9366 NEW [1,2,4]Triazolo[4,3-a]quinoline-1-ethanamine, 7-chloro-N,N-dimethyl-5-phenyl- | API;Pharmaceutical active molecules |
| 466 | 1644342-14-2 | ML792 | ML792 ML-792 ML 792 1644342-14-2 (1R,2S,4R)-4-[[5-[1-[(3-bromophenyl)methyl]pyrazole-3-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Sulfamic acid, [(1R,2S,4R)-4-[[5-[[1-[(3-bromophenyl)methyl]-1H-pyrazol-3-yl]carbonyl]-4-pyrimidinyl]amino]-2-hydroxycyclopentyl]methyl ester | |
| 467 | 1392399-03-9 | BIX 01294 Trihydrochloride | BIX 01294 BIX 01204 BIX01294 hydrochloride BIX01294 3hydrochloride Trihydrochloride Hydrate BIX 01294 Trihydrochloride BIX 01294 Trihydrochloride Hydrate N-(1-benzylpiperidin-4-yl)-6,7-dimethoxy-2-(4-methyl-1,4-diazepan-1-yl)quinazolin-4-amine 2-(Hexahydro-4-Methyl-1H-1,4-Diazepin-1-yl)-6,7-Dimethoxy-[1-(Phenylmethyl)-4-Piperidynyl]-4-Quinazolinamine Trihydrochloride BIX01294 hydrochloride | Inhibitors;Pyrimidine;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 468 | 1445251-22-8 | ME0328 | ME0328 ME 0328 ME-0328 4-Dihydro-4-oxo-3 4-Dihydro-4-oxo-N-[(1S)-1-phenylethyl]-2-quinazolinepropanamide (S)-3,4-Dihydro-4-oxo-N-(1-phenylethyl)-2-quinazolinepropanamide 2-Quinazolinepropanamide, 3,4-dihydro-4-oxo-N-[(1S)-1-phenylethyl]- 3,4-Dihydro-4-oxo-3,4-Dihydro-4-oxo-N-[(1S)-1-phenylethyl]-2-quinazolinepropanamide | Inhibitors;Small molecule inhibitors, natural products |
| 469 | 1627676-59-8 | PFI-2 | PFI-2 CS-1808 PFI-2 HCl R-PFI-2 HCl 8-fluoro-1,2,3,4-tetrahydro-N-[(1R)-2-oxo-2-(1-pyrrolidinyl)-1-[[3-(trifluoromethyl)phenyl]methyl]ethyl]-6-isoquinolinesulfonamide 6-Isoquinolinesulfonamide, 8-fluoro-1,2,3,4-tetrahydro-N-[(1R)-2-oxo-2-(1-pyrrolidinyl)-1-[[3-(trifluoromethyl)phenyl]methyl]ethyl]- (R)-8-fluoro-N-(1-oxo-1-(pyrrolidin-1-yl)-3-(3-(trifluoromethyl)phenyl)propan-2-yl)-1,2,3,4-tetrahydroisoquinoline-6-sulfonamide (R)-PFI 2 hydrochloride | Inhibitors;Reference substance;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 470 | 300801-52-9 | (1Z)-1-(3-Ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)propan-2-one | TG003 CS-955 TG-003 CS-1704 Cdc2-Like Kinase Inhibitor, TG003 1-(3-Ethyl-5-methoxy-2(3H)-benzothiazolylidene)-2-propanone 2-Propanone,1-(3-ethyl-5-Methoxy-2(3H)-benzothiazolylidene)- (1Z)-1-(3-Ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)propan-2-one (Z)-1-(3-ethyl-5-methoxybenzo[d]thiazol-2(3H)-ylidene)propan-2-one | Inhibitors;Small molecule inhibitors;Other biochemical reagents;Small molecule inhibitors, natural products |
| 471 | 676596-65-9 | 1-AZAKENPAULLONE | azakenpaullone 1-AZAKENPAULLONE InSolution? 1-Azakenpaullone | Inhibitors;All Inhibitors;Protein Kinase Inhibitors and Activators;Small molecule inhibitors, natural products |
| 472 | 76684-89-4 | E-64c | E-64c E-64C NSC 694279 E-64c, EP 475 Loxistatin Acid (E-64C) (2S,3S)-TRANS-EPOXYSUCCINYL-L-LEUCYLAMIDO-3-METHYLBUTANE (2S,3S)-L-TRANS-EPOXYSUCCINYL-L-LEUCYLAMIDO-3-METHYLBUTANE (1S,2S)-2-(((S)-1-(Isopentylamino)-4-methyl-1-oxopentan-2-yl)carbamoyl)cyclopropanecarboxylic (2S,3S)-3-(((S)-1-(isopentylaMino)-4-Methyl-1-oxopentan-2-yl)carbaMoyl)oxirane-2-carboxylic acid 2-Oxiranecarboxylicacid,3-[[[(1S)-3-methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-,(2S,3S)- | peptides;Pepetides;Inhibitors;Cell signaling and neurobiology;Small molecule inhibitors, natural products |
| 473 | 849214-04-6 | c-GpAp | cGAMP c-GpAp C-GPAP di-GAMP di-cGAMP 3'3'-cGAMP cGAMP (Cyclic GMP-AMP 3''-Guanylic acid, adenylyl-(3''?5'')-, cyclic nucleotide 3',3'-Cyclic guanosine monophosphate-adenosine monophosphate | Bioactive molecule-API;Nucleotides, Bases & Related Reagents, Derivatives |
| 474 | 909089-13-0 | SKL-2001 | 2001 CS-2771 SKL2001 SKL-2001 SKL 2001 SKL2001 free base N-(3-(1H-imidazol-1-yl)propyl)-5-(furan-2-yl)isoxazole-3-carboxamide 5-(furan-2-yl)-N-[3-(1H-imidazol-1-yl)propyl]-1,2-oxazole-3-carboxamide | |
| 475 | 913822-46-5 | SC75741 | 75741 V 1810 CS-2697 SC75741 N-(6-Benzoyl-1H-benzimidazol-2-yl)-2-(1-thieno[3,2-d]pyrimidin-4-yl-4-piperidinyl)-4-thiazolecarboxamide 4-ThiazolecarboxaMide, N-(6-benzoyl-1H-benziMidazol-2-yl)-2-(1-thieno[3,2-d]pyriMidin-4-yl-4-piperidinyl)- | Inhibitors;Small molecule inhibitors, natural products |
| 476 | 925701-49-1 | KU-60019 | CS-444 KU60019 KU 60019 KU-60019 KU-60019, 925701-49-1 2-((2S,6R)-2,6-dimethylmorpholino)-N-(5-(6-morpholino-4-oxo-4H-pyran-2-yl)-9H-thioxanthen-2-yl)acetamide 2-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-N-[5-(6-morpholin-4-yl-4-oxopyran-2-yl)-9H-thioxanthen-2-yl]acetamide (2R,6S)-2,6-Dimethyl-N-[5-[6-(4-morpholinyl)-4-oxo-4H-pyran-2-yl]-9H-thioxanthen-2-yl]-4-morpholineacetamide KU-60019 (2R,6S)-2,6-Dimethyl-N-[5-[6-(4-morpholinyl)-4-oxo-4H-pyran-2-yl]-9H-thioxanthen-2-yl]-4-morpholineacetamide | Inhibitors;DNA damage;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 477 | 1338247-30-5 | N-(5-(1-(2,6-dichlorophenyl)-3-(difluoroMethyl)-1H-pyrazol-5-yl)thiazol-2-yl)cyclopropanecarboxaMide | BMS3 BMS 3 BMS-3 CS-2191 N-(5-(1-(2,6-dichlorophenyl)-3-(difluoroMethyl)-1H-pyrazol-5-yl)thiazol-2-yl)cyclopropanecarboxaMide N-[5-[1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]-cyclopropanecarboxamide N-[5-[2-(2,6-dichlorophenyl)-5-(difluoromethyl)pyrazol-3-yl]-1,3-thiazol-2-yl]cyclopropanecarboxamide Cyclopropanecarboxamide, N-[5-[1-(2,6-dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]- | Inhibitor |
| 478 | 1467057-23-3 | PF-06409577 | CS-2760 EOS-61684 PF 6409577 PF06409577 PF-06409577 PF 06409577 6-chloro-5-(4-(1-hydroxycyclobutyl)phenyl)-1H-indole-3-carboxylicacid 1H-Indole-3-carboxylic acid, 6-chloro-5-[4-(1-hydroxycyclobutyl)phenyl]- | |
| 479 | 1698055-85-4 | ARS-1620 | CPD1588 ARS1620 ARS 1620 ARS-1620 (S)-1-(4-(6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)quinazolin-4-yl)piperazin-1-yl)prop-2-en-1-one (S)-1-[4-[6-Chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)-4-quinazolinyl]-1-piperazinyl]-2-propen-1-one 2-Propen-1-one, 1-[4-[(7S)-6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)-4-quinazolinyl]-1-piperazinyl]- 1-?[4-?[(7S)?-?6-?Chloro-?8-?fluoro-?7-?(2-?fluoro-?6-?hydroxyphenyl)?-?4-?quinazolinyl]?-?1-?piperazinyl]?-?2-?propen-?1-?one | API;APIs;Inhibitors |
| 480 | 1997387-43-5 | 1-((S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl)-3-((S)-1-(thiophen-3-yl)propan-2-yl)urea | PZM 21 PZM-21 PZM-21 1-((S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl)-3-((S)-1-(thiophen-3-yl)propan-2-yl)urea 1-[(2S)-2-(Dimethylamino)-3-(4-hydroxyphenyl)propyl]-3-[(2S)-1-(thiophen-3-yl)propan-2-yl]urea Urea, N-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl]-N'-[(1S)-1-methyl-2-(3-thienyl)ethyl]- | |
| 481 | 2141955-96-4 | BLU-782 | BLU782 BLU-782 BLU 782 ALK2-IN-1 (R)-tetrahydrofuran-3-yl 4-(6-(5-(4-ethoxy-1-isopropylpiperidin-4-yl)pyridin-2-yl)pyrrolo[1,2-b]pyridazin-4-yl)piperazine-1-carboxylate 1-Piperazinecarboxylic acid, 4-[6-[5-[4-ethoxy-1-(1-methylethyl)-4-piperidinyl]-2-pyridinyl]pyrrolo[1,2-b]pyridazin-4-yl]-, (3R)-tetrahydro-3-furanyl ester | Organic chemistry;reference substance |
| 482 | 2158197-70-5 | HS1371 | HS1371 HS1371 HS-1371 CS-2831 HS 1371 2158197-70-5 Quinoline, 4-(4-methylphenoxy)-7-[1-(4-piperidinyl)-1H-pyrazol-4-yl]- | API |
| 483 | 2165322-94-9 | USP25/28 inhibitor AZ1； AZ1 | AZ1 AZ-1 AZ 1 USP25 and 28 inhibitor AZ-1 2-((5-bromo-2-((4-fluoro-3-(trifluoromethyl)benzyl)oxy)benzyl)amino)ethanol Ethanol, 2-[[[5-bromo-2-[[4-fluoro-3-(trifluoromethyl)phenyl]methoxy]phenyl]methyl]amino]- | Organic chemistry;Traditional Chinese medicine reference substance |
| 484 | 314054-00-7 | N-(4-iodophenyl)-5-nitrofuran-2-carboxamide | C-176 STING inhibitor 1 C-176 STING inhibitor N-(4-iodophenyl)-5-nitro-2-furamide N-(4-iodophenyl)-5-nitrofuran-2-carboxamide 2-Furancarboxamide, N-(4-iodophenyl)-5-nitro- | |
| 485 | 1819363-80-8 | PFI-3 | PFI3 PFI-3 PFI 3 CS-1803 (2E)-1-(2-Hydroxyphenyl)-3-[(1R,4R)-5-(2-pyridinyl)-2,5-diazabicyclo[2.2.1]hept-2-yl]-2-propen-1-one (E)-1-(2-Hydroxyphenyl)-3-((1R,4R)-5-(pyridin-2-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)prop-2-en-1-one (2E)-1-(2-Hydroxyphenyl)-3-[(1R,4R)-5-(pyridin-2-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]prop-2-en-1-one 2-Propen-1-one, 1-(2-hydroxyphenyl)-3-[(1R,4R)-5-(2-pyridinyl)-2,5-diazabicyclo[2.2.1]hept-2-yl]-, (2E)- | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 486 | 1262414-04-9 | Abediterol | CS-2487 CENERIMOD Abediterol ACT-334441 CENERIMOD ACT334441 ACT 334441 (S)-3-(4-(5-(2-CYCLOPENTYL-6-METHOXYPYRIDIN-4-YL)-1,2,4-OXADIAZOL-3-YL)-2-ETHYL-6-METHYLPHENOXY)PROPANE-1,2-DIOL 1,2-Propanediol, 3-[4-[5-(2-cyclopentyl-6-methoxy-4-pyridinyl)-1,2,4-oxadiazol-3-yl]-2-ethyl-6-methylphenoxy]-, (2S)- | APIS;Pharmaceutical bulk drug |
| 487 | 1342278-01-6 | RKI-1447 | CS-855 RKI1447 RKI-1447 RKI1447 RKI 1447 1-(3-HYDROXYBENZYL)-3-(4-(PYRIDIN-4-YL)THIAZOL-2-YL)UREA Urea, N-[(3-hydroxyphenyl)methyl]-N'-[4-(4-pyridinyl)-2-thiazolyl]- 1-(3-Hydroxybenzyl)-3-[4-(pyridin-4-yl)thiazol-2-yl]urea RKI 1447 | Inhibitors;Cell cycle;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 488 | 2323027-38-7 | N-(1-(2,4-Bis(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-5-(furan-2-yl)isoxazole-3-carboxamide | Ceapin-A7 N-(1-(2,4-Bis(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-5-(furan-2-yl)isoxazole-3-carboxamide 3-Isoxazolecarboxamide, N-[1-[[2,4-bis(trifluoromethyl)phenyl]methyl]-1H-pyrazol-4-yl]-5-(2-furanyl)- | Inhibitor |
| 489 | 831234-13-0 | 1-Benzyl-N-(2-furylmethyl)-1H-benzimidazol-2-amine | AC1903 1-benzyl-N-(furan-2-ylmethyl)benzimidazol-2-amine 1-Benzyl-N-(2-furylmethyl)-1H-benzimidazol-2-amine 1-benzyl-N-(furan-2-ylmethyl)-1H-benzo[d]imidazol-2-amine 1H-Benzimidazol-2-amine, N-(2-furanylmethyl)-1-(phenylmethyl)- | Inhibitor |
| 490 | 2314467-60-0 | 4(3H)-Quinazolinone, 8-fluoro-3-[4-(4-fluorophenoxy)phenyl]-2-(4-methyl-1-piperazinyl)-, hydrochloride (1:1) | OUN67600 TRPV4 agonist RPV4 agonist-1 TRPV4 agonist-1 OUN67600(TRPV4 agonist-1) | |
| 491 | 384859-58-9 | 2-((3-(ethoxycarbonyl)-6-(trifluoromethoxy)quinolin-4-yl)amino)benzoic acid | BCH001 2-((3-(ethoxycarbonyl)-6-(trifluoromethoxy)quinolin-4-yl)amino)benzoic acid 3-Quinolinecarboxylic acid, 4-[(2-carboxyphenyl)amino]-6-(trifluoromethoxy)-, 3-ethyl ester | Standard |
| 492 | 423145-35-1 | N-[1,3-Benzodioxol-5-yl(5-chloro-8-hydroxy-7-quinolinyl)methyl]butanamide | YUM70 N-[1,3-Benzodioxol-5-yl(5-chloro-8-hydroxy-7-quinolinyl)methyl]butanamide Butanamide, N-[1,3-benzodioxol-5-yl(5-chloro-8-hydroxy-7-quinolinyl)methyl]- | Preparation-inhibitor |
| 493 | 1801344-12-6 | SIN44126 | SIN44126 4-Oxazolecarboxamide, N-[5-[(3S)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- | Inhibitor |
| 494 | 2138882-71-8 | KEA1-97 | KEA1-97 1,3,5-Triazin-2-amine, 4,6-dichloro-N-(4'-fluoro[1,1'-biphenyl]-4-yl)- | Inhibitor |
| 495 | 1627138-52-6 | ML380 | ML380 ML380 ML-380 ML 380 N-ethyl-1-(1H-indazol-5-ylsulfonyl)-N-[[2-(trifluoromethyl)phenyl]methyl]piperidine-4-carboxamide | |
| 496 | 2088410-46-0 | 1-Benzyl-N5-cyclopropyl-N3-methyl-2-oxo-1,2-dihydropyridine-3,5-dicarboxamide | GSK620 1-Benzyl-N5-cyclopropyl-N3-methyl-2-oxo-1,2-dihydropyridine-3,5-dicarboxamide 1-benzyl-N5-cyclopropyl-N3-methyl-2-oxo-1,2-dihydropyridine-3,5-dicarboxamide | API;Active molecule |
| 497 | 2170834-63-4 | Benzo[e]cycloprop[c][1,2]oxaborin-4-carboxylic acid, 5-fluoro-1,1a,2,7b-tetrahydro-2-hydroxy-, (1aR,7bS)- | QPX7728 Xeruborbactam Benzo[e]cycloprop[c][1,2]oxaborin-4-carboxylic acid, 5-fluoro-1,1a,2,7b-tetrahydro-2-hydroxy-, (1aR,7bS)- | |
| 498 | 1358715-18-0 | 4-(4-fluoro-3-(2-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyrazine-7-carbonyl)benzyl)phthalazin-1(2H)-one | HS10160 Fuzuopali Fluzoparib Fuzuloparib 4-(4-fluoro-3-(2-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyrazine-7-carbonyl)benzyl)phthalazin-1(2H)-one 1(2H)-Phthalazinone, 4-[[3-[[5,6-dihydro-2-(trifluoromethyl)[1,2,4]triazolo[1,5-a]pyrazin-7(8H)-yl]carbonyl]-4-fluorophenyl]methyl]- | Reference substance |
| 499 | 1800046-95-0 | 6-(6-aminopyrazin-2-yl)-N-{4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl}imidazo[1,2-a]pyrazin-8-amine | GS9876 GS-9876 GS 9876 Lanraplenib LANRAPLENIB Lanraplenib,GS-9876 GS-9876 (lanraplenib) 6-(6-aminopyrazin-2-yl)-N-{4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl}imidazo[1,2-a]pyrazin-8-amine Imidazo[1,2-a]pyrazin-8-amine, 6-(6-amino-2-pyrazinyl)-N-[4-[4-(3-oxetanyl)-1-piperazinyl]phenyl]- | Pharmaceutical raw materials |
| 500 | 1021868-92-7 | ZM 39923 HCl | ZM 39923 HCl 3-(Benzyl(isopropyl) -1-(naphthalen-2-yl) propan-1-one hydrochloride N-benzyl-N-isopropyl-3-(2-naphthyl)but-3-en-1-amine,hydrochloride 3-[(1-Methylethyl)(phenylmethyl)amino]-1-(2-naphthalenyl)-1-propanone hydrochloride | JAK;STAT;JAK/STAT;Inhibitor;Standards;Inhibitors;Small molecule inhibitors, natural products |
| 501 | 1320288-19-4 | UNC 0631 | CS-793 UNC 0631 N-[1-(Cyclohexylmethyl)-4-piperidinyl]-2-(4-isopropyl-1,4-diazepa n-1-yl)-6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinamine N-(1-(cyclohexylmethyl)piperidin-4- yl)-2-(4-isopropyl-1,4-diazepan-1-yl)- 6-methoxy-7-(3-(piperidin-1- yl)propoxy)quinazolin-4-amine N-[1-(CyclohexylMethyl)-4-piperidinyl]-2-[hexahydro-4-(1-Methylethyl)-1H-1,4-diazepin-1-yl]-6-Methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinaMine N-[1-(Cyclohexylmethyl)-4-piperidinyl]-2-[hexahydro-4-(1-methylethyl)-1H-1,4-diazepin-1-yl]-6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinamine UNC0631 | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products;Amines, Aromatics, Heterocycles, Inhibitors, Pharmaceuticals, Intermediates & Fine Chemicals |
| 502 | 1620401-82-2 | 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine | UNC03 UNC0379 UNC 0379 UNC-0379 UNC0379, UNC-0379, UNC 0379 6,7-Dimethoxy-2-(1-pyrrolidinyl)-N-[5-(1-pyrrolidinyl)pentyl]-4-quinazolinamine 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine UNC0379 | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 503 | 136194-77-9 | Go6976 | Go6976 GO 6976 PD406976 InSolution? G? 6976 5,6,7,13-Tetrahydro-13-methyl-5-oxo-12H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-12-propanenitrile 12-2(2-CYANOETHYL)-6,7,12,13-TETRAHYDRO-13-METHYL-5-OXO-5H-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE 12-(2-CYANOETHYL)-6,7,12,13-TETRAHYDRO-13-METHYL-5-OXO-5H-INDOLO(2,3-A)PYRROLO(3,4-C)-CARBAZOLE Go6976,5,6,7,13-Tetrahydro-13-Methyl-5-oxo-12H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-12-propanenitrile | Inhibitor;Inhibitors;Small molecule inhibitors, natural products |
| 504 | 1357302-64-7 | OGL002 | OGL002 CS-830 OGL-002 OG-L002 OG L002 4'-((1R,2S)-2-Aminocyclopropyl)biphenyl-3-ol 4'-((1R,2S)-2-Aminocyclopropyl)-[1,1'-biphenyl]-3-ol [1,1'-Biphenyl]-3-ol, 4'-[(1R,2S)-2-aminocyclopropyl]-4'-((1R,2S)-2-Aminocyclopropyl)biphenyl-3-o OG-L002 4'-((1S,2R)-2-aminocyclopropyl)-[1,1'-biphenyl]-3-ol 3-[4-[(1R,2S)-2-aminocyclopropyl]phenyl]phenol OG-L002 [1,1'-Biphenyl]-3-ol, 4'-[(1R,2S)-2-aminocyclopropyl]- | Inhibitors;Small molecule inhibitors, natural products |
| 505 | 1353859-00-3 | CX-6258 | CX6285 CX-6258 CX-6258HCL CX6258(HCL) CX-6258 Hydrochloride Pim-Kinase Inhibitor X CX6258(HCL) 2H-Indol-2-one, 5-chloro-3-[[5-[3-[(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)carbonyl]phenyl]-2-furanyl]methylene]-1,3-dihydro-, hydro | Inhibitors;Reference substance;Small molecule inhibitors, natural products |
| 506 | 1903008-80-9 | N-{5-[(4-{4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl}pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl}prop-2-enamide | YH25448 GNS1480 CS-2767 YH-25448 YH 25448 GNS-1480 YH25448 YH-25448 GNS-1480 GNS1480. YH 25448 GNS 1480 LAZERTINIB Lazertinib Lazertinib(YH25448,GNS-1480) N-{5-[(4-{4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl}pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl}prop-2-enamide | API;APIs;Customization |
| 507 | 1219739-36-2 | ex229 (compound 991) | EX229 EX-229 EX 229 ex229 (compound 991) AMPK Activator 991 (Compound 991) 5-[[6-Chloranyl-5-(1-Methylindol-5-Yl)-1h-Benzimidazol-2-Yl]oxy]-2-Methyl-Benzoic Acid 5-{[6-chloro-5-(1-methyl-1H-indol-5-yl)-1H-benzimidazol-2-yl]oxy}-2-methylbenzoic acid Benzoic acid, 5-[[6-chloro-5-(1-methyl-1H-indol-5-yl)-1H-benzimidazol-2-yl]oxy]-2-methyl- | API;Inhibitor |
| 508 | 150417-90-6 | GC7 Sulfate | GC7 Sulfate | Standard substance;Reference substance;Cell biology reagent |
| 509 | 1469338-01-9 | 6H05 | 6H05 CS-1817 K-Ras inhibitor 6H05 trifluoroacetate 6H05 trifluoroacetate 1469338-01-9(free base) 1-[2-[(4-Chlorophenyl)thio]acetyl]-N-[2-[[2-(dimethylamino)ethyl]dithio]ethyl]-4-piperidinecarboxamide | Inhibitors;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 510 | 1899921-05-1 | HS-10296 | HS10296 HS 10296 HS-10296 1899921-05-1 Almonertinib Almonertinib (HS-10296) N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(meth)amino)-4-methoxyphenyl)acrylamide N-(5-((4-(1-Cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide 2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]- | Chemical reagent |
| 511 | 2060530-16-5 | K-Ras(G12C) inhibitor 6 | MDK30165 K-Ras(G12C) inhibitor 6 N-[1-[2-(2,4-dichlorophenoxy)acetyl]piperidin-4-yl]-4-sulfanylbutanamide Butanamide, N-[1-[2-(2,4-dichlorophenoxy)acetyl]-4-piperidinyl]-4-mercapto- | Small molecule inhibitors |
| 512 | 1379545-95-5 | M2698 | M2698 M-2698 M 2698 MSC2363318A MSC-2363318A MSC 2363318A M2698 (MSC-2363318A) (S)-4-(2-(azetidin-1-yl)-1-(4-chloro-3-(trifluoromethyl)phenyl)ethylamino)quinazoline-8-carboxamide 8-Quinazolinecarboxamide, 4-[[(1S)-2-(1-azetidinyl)-1-[4-chloro-3-(trifluoromethyl)phenyl]ethyl]amino]- 4-[(S)-2-azetidin-1-yl-1-(4-chloro-3-trifluoromethylphenyl)ethylamino]quinazoline-8-carboxylic acid amide | Custom-made;Control substance |
| 513 | 1566-81-0 | NS1652 | NS1652 2-(3-(3-(Trifluoromethyl)phenyl)ureido)benzoic acid Benzoic acid, 2-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]- | |
| 514 | 1263373-43-8 | 4-((5'-chloro-2'-((1R,4r)-4-((R)-1-methoxypropan-2-ylamino)cyclohexylamino)-2,4'-bipyridin-6-ylamino)methyl)tetrahydro-2H-pyran-4-carbonitrile | NVP-2 4-((5'-chloro-2'-((1R,4r)-4-((R)-1-methoxypropan-2-ylamino)cyclohexylamino)-2,4'-bipyridin-6-ylamino)methyl)tetrahydro-2H-pyran- 4-((5'-chloro-2'-((1R,4r)-4-((R)-1-methoxypropan-2-ylamino)cyclohexylamino)-2,4'-bipyridin-6-ylamino)methyl)tetrahydro-2H-pyran-4-carbonitrile 4-[[[5'-Chloro-2'-[[trans-4-[[(1R)-2-methoxy-1-methylethyl]amino]cyclohexyl]amino][2,4'-bipyridin]-6-yl]amino]methyl]tetrahydro-2H-pyran-4-carbonitrile 2H-Pyran-4-carbonitrile, 4-[[[5'-chloro-2'-[[trans-4-[[(1R)-2-methoxy-1-methylethyl]amino]cyclohexyl]amino][2,4'-bipyridin]-6-yl]amino]methyl]tetrahydro- | Inhibitor |
| 515 | 11052-72-5 | OLIGOMYCIN C | Oligmycin C OLIGOMYCIN C 12-Deoxyoligomycin A Oligomycin A, 12-deoxy- OLIGOMYCIN C, STREPTOMYCES DIASTATOCHROMOGENES Spiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-[2H]pyran]-3,9,13-trione, 22-ethyl-3',4',5',6'-tetrahydro-7,11,15-trihydroxy-6'-[(2R)-2-hydroxypropyl]-5',6,8,10,12,14,16,28,29-nonamethyl-, (1R,2'R,4E,5'S,6S,6'S,7R,8S,10R,11S,12S,14S,15S,16R,18E,20E,22R,25S,28S,29R)- | Antibiotics;Chemical Str;Antibiotics A to;Antibiotics A to;Chemical Structure;AntifungalAntibiotics;Microbial metabolites;Antibiotics by Application;Antibiotics N-SAntibiotics;Antibiotics N-SAntib |
| 516 | 1446261-44-4 | (R)-2-fluoro-10a-methyl-7,8,9,10,10a,11-hexahydro-5,6,7a,11-tetraazacyclohepta[def]cyclopenta[a]fluoren-4(5H)-one | bgb-290 BGB 290 BGB290. BGB-290 EOS-61090 PAMIPARIB Pamiparib Pamiparib(BGB290) BGB-290,Pamiparib (R)-2-fluoro-10a-methyl-7,8,9,10,10a,11-hexahydro-5,6,7a,11-tetraazacyclohepta[def]cyclopenta[a]fluoren-4(5H)-one (R)-2-fluoro-10a-methyl-5,8,9,10,10a,11-hexahydro-5,6,7a,11-tetraazacyclohepta[def]cyclopenta[a]fluoren-4(7H)-one | APIS;Reference substance;Active small fraction library |
| 517 | 497259-23-1 | α-Amyloid Precursor Protein Modulator | TPPB α-Amyloid Precursor Protein Modulator alpha-AMyloid Precursor Protein Modulator (2E,4E)-N-((2S,5S)-5-(hydroxymethyl)-2-isopropyl-1-methyl-3-oxo-1,2,3,4,5,6-hexahydrobenzo[e][1,4]diazocin-8-yl)-5-(4-(trifluoromethyl)phenyl)penta-2,4-dienamide (2E,4E)-N-[(2S,5S)-1,2,3,4,5,6-Hexahydro-5-(hydroxymethyl)-1-methyl-2-(1-methylethyl)-3-oxo-1,4-benzodiazocin-8-yl]-5-[4-(trifluoromethyl)phenyl]-2,4-pentadienamide | Small molecule inhibitors |
| 518 | 205678-31-5 | SB273005 | SB273005 [8-[2-(6-Methylamino-pyridin-2-yl)-ethoxy]-3-oxo-2-(2,2,2-trifluoro-ethyl)-2,3,4,5-tetrahydro-1H-benzo[c]azepin-4-yl]-acetic acid 1H-2-Benzazepine-4-acetic acid, 2,3,4,5-tetrahydro-8-[2-[6-(methylamino)-2-pyridinyl]ethoxy]-3-oxo-2-(2,2,2-trifluoroethyl)-, (4S)- (S)-2-(8-(2-(6-(methylamino)pyridin-2-yl)ethoxy)-3-oxo-2-(2,2,2-trifluoroethyl)-2,3,4,5-tetrahydro-1H-benzo[c]azepin-4-yl)acetic acid | Inhibitors;Small molecule inhibitors, natural products |
| 519 | 222035-13-4 | CDK2 inhibitor II | SC 221409 COMPOUND 3 CDK2 inhibitor II CDK2 INHIBITOR II | Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals |
| 520 | 917562-33-5 | JT010 | JT010 2-Chloro-N-[4-(4-methoxyphenyl)-2-thiazolyl]-N-(3-methoxypropyl)acetamide 2-chloro-N-(4-(4-methoxyphenyl)thiazol-2-yl)-N-(3-methoxypropyl)acetamide Acetamide, 2-chloro-N-[4-(4-methoxyphenyl)-2-thiazolyl]-N-(3-methoxypropyl)- | |
| 521 | 870964-67-3 | Evocalcet | KHK7580 Evocalcet Benzeneacetic acid, 4-[(3S)-3-[[(1R)-1-(1-naphthalenyl)ethyl]amino]-1-pyrrolidinyl]- 2-{4-[(3S)-3-{[(1R)-1-(Naphthalen-1-yl)ethyl]amino}pyrrolidin-1-yl]phenyl}acetic acid | API |
| 522 | 146670-40-8 | SR 11237 | BMS649 SR 11237 BMS 188649 4-[2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1,3-dioxolan-2-yl]-benzoicacid 4-(2-(5,5,8,8-tetraMethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3-dioxolan-2-yl)benzoic acid Benzoic acid, 4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1,3-dioxolan-2-yl]- | |
| 523 | 895542-09-3 | Trifarotene | Trifarotene Trifarotene (CD5789) 4-[3-(3-tert-butyl-4-pyrrolidin-1-ylphenyl)-4-(2-hydroxyethoxy)phenyl]benzoic acid | API;Inhibitors;Dominant products;Customized products;Original drug intermediates;Pharmaceutical raw materials |
| 524 | 1062159-35-6 | WAY-600 | WAY-600 WAY 600 6-(1H-indol-5-yl)-4-morpholino-1-(1-(pyridin-3-ylmethyl)piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidine 4-[6-(1H-indol-5-yl)-1-[1-(pyridin-3-ylmethyl)piperidin-4-yl]pyrazolo[3,4-d]pyrimidin-4-yl]morpholine 6-(1H-Indol-5-yl)-4-(4-morpholinyl)-1-[1-(3-pyridinylmethyl)-4-piperidinyl]-1H-pyrazolo[3,4-d]pyrimidine 1H-Pyrazolo[3,4-d]pyrimidine, 6-(1H-indol-5-yl)-4-(4-morpholinyl)-1-[1-(3-pyridinylmethyl)-4-piperidinyl]- | Akt;mTOR;PI3K;Inhibitors;PI3K/Akt/mTOR;Cell biology reagents;Small molecule inhibitors, natural products |
| 525 | 1062161-90-3 | WYE-687 | WYE687 CS-540 WYE 687 WYE-687 methyl 4-(4-morpholino-1-(1-(pyridin-3-ylmethyl)piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenylcarbamate methyl N-[4-[4-morpholin-4-yl-1-[1-(pyridin-3-ylmethyl)piperidin-4-yl]pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]carbamate N-[4-[4-(4-Morpholinyl)-1-[1-(3-pyridinylmethyl)-4-piperidinyl]-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]carbamic acid methyl ester Carbamic acid, N-[4-[4-(4-morpholinyl)-1-[1-(3-pyridinylmethyl)-4-piperidinyl]-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-, methyl ester N-[4-[4-(4-Morpholinyl)-1-[1-(3-pyridinylmethyl)-4-piperidinyl]-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-carbamic acid methyl ester hydrochloride | Akt;mTOR;PI3K;Standards;Inhibitors;PI3K/Akt/mTOR;Small molecule inhibitors, natural products |
| 526 | 1092679-51-0 | WAY-100635 Maleate | CS-998 PectDrill WAY100635 Superthiol sirup WAY-100635 Maleate WAY-100635 (maleate) N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl-cyclohexanecarboxamide, 2Z-butenedioate | Inhibitors;Neural signals;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 527 | 1139889-93-2 | Golgicide A | GOLGICIDEA Golgicide A 6,8-Difluoro-4-pyridin-3-yl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline rel-(3aR,9bS)-6,8-Difluoro-4-(pyridin-3-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline 3H-Cyclopenta[c]quinoline, 6,8-difluoro-3a,4,5,9b-tetrahydro-4-(3-pyridinyl)-, (3aR,9bS)-rel- | Inhibitors;Heterocycles;Ion channels;Chiral Reagents;Pharmaceuticals;Membrane transport;Intermediates & Fine Chemicals;Membrane transport/ion channels;Small molecule inhibitors, natural products |
| 528 | 1149705-71-4 | XL888 | XL888 CS-831 CS-2629 XL-888 XL 888 5-((R)-sec-butylaMino)-N1-((1R,3r,5S)-8-(5-(cyclopropanecarbonyl)pyridin-2-yl)-8-azabicyclo[3.2.1]octan-3-yl)-2-MethylterephthalaMide N1-[(3-endo)-8-[5-(Cyclopropylcarbonyl)-2-pyridinyl]-8-azabicyclo[3.2.1]oct-3-yl]-2-methyl-5-[[(1R)-1-methylpropyl]amino]-1,4-benzenedicarboxamide 1,4-Benzenedicarboxamide, N1-[(3-endo)-8-[5-(cyclopropylcarbonyl)-2-pyridinyl]-8-azabicyclo[3.2.1]oct-3-yl]-2-methyl-5-[[(1R)-1-methylpropyl]amino]- | Inhibitors;Cytoskeleton signal;Small molecule inhibitors, natural products |
| 529 | 1292799-56-4 | PF-2545920 | CS-114 PF-2545920 Mardepodect Mardepodect (PF-2545920) 2-[[4-(1-methyl-4-pyridin-4-ylpyrazol-3-yl)phenoxy]methyl]quinoline 2-[[4-[1-(Methyl-11C)-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]methyl]quinoline | Inhibitor;Inhibitors;Metabolism;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 530 | 1390637-82-7 | PF-4981517 | CYP3cide PF-4981517 PF-04981517 1-methyl-3-[1-methyl-5-(4-methylphenyl)pyrazol-4-yl]-4-[(3S)-3-piperidin-1-ylpyrrolidin-1-yl]pyrazolo[3,4-d]pyrimidine 1-Methyl-3-[1-methyl-5-(4-methylphenyl)-1H-pyrazol-4-yl]-4-[(3S)-3-piperidin-1-ylpyrrolidin-1-yl]-1H-pyrazolo[3,4-d]pyrimidine 1H-Pyrazolo[3,4-d]pyrimidine, 1-methyl-3-[1-methyl-5-(4-methylphenyl)-1H-pyrazol-4-yl]-4-[(3S)-3-(1-piperidinyl)-1-pyrrolidinyl]- | Inhibitor;Inhibitors;Metabolism;Heterocycles;Pharmaceuticals;Pfizer Compounds;Intermediates & Fine Chemicals;Small molecule inhibitors, natural products;Heterocycles, Inhibitors, Pfizer Compounds, P;H |
| 531 | 193000-39-4 | ZM 323881 HCl | ZM 323881 HCl ZM 323881 hydrochloride | Inhibitors;Protein tyrosine kinase;Small molecule inhibitor;Small molecule inhibitor, natural product |
| 532 | 58131-57-0 | NSC 207895 | NSC-207895 NSC 207895 NSC 179940 NSC-207895 (XI-006) 4-(4-Methyl-1-piperazinyl)-7-nitrobenzofurazan 3-oxide 4-(4-Methyl-1-piperazinyl)-7-nitrobenzofurazane 3-oxide 7-(4-Methyl-1-piperazinyl)-4-nitrobenzofurazane 1-oxide 4-(4-Methyl-1-piperazinyl)-7-nitro-2,1,3-benzoxadiazole 3-oxide | Inhibitor;Apoptosis;Inhibitors;Small molecule inhibitors, natural products |
| 533 | 819812-04-9 | KW-2478 | CS-287 KW2478 KW-2478 KW-2478 KW 2478. 2-(2-Ethyl-3,5-dihydroxy-6-(3-methoxy-4-(2-morpholinoethoxy)benzoyl)phenyl)-N,N-bis(2-methoxye 2-(2-ethyl-3,5-dihydroxy-6-(3-methoxy-4-(2-morpholinoethoxy)benzoyl)phenyl)-N,N-bis(2-methoxyethyl)acetamide 2-Ethyl-3,5-dihydroxy-N,N-bis(2-methoxyethyl)-6-[3-methoxy-4-[2-(4-morpholinyl)ethoxy]benzoyl]benzeneacetamide 2-[2-ethyl-3,5-dihydroxy-6-[3-methoxy-4-(2-morpholin-4-ylethoxy)benzoyl]phenyl]-N,N-bis(2-methoxyethyl)acetamide 2-Ethyl-3,5-dihydroxy-N,N-bis(2-methoxyethyl)-6-[3-methoxy-4-[2-(4-morpholinyl)ethoxy]benzoyl]benzeneacetamide KW2478 | APIs;Inhibitor;Cytoskeleton signal |
| 534 | 1374598-80-7 | TAK-875 | TAK875 TAK-875 CS-1926 TAK-875(0.5H2O) TAK875 hemihydrate TAK-875 hymihydrate [(3S)-6-({2',6'-dimethyl-4'-[3-(methylsulfonyl)propoxy]biphe-nyl-3-yl}meth-oxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid hemi-hydrate TAK875 (3S)-6-[[2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]methoxy]-2,3-dihydro-3-benzofuranacetic acid | API;Inhibitors;Endocrine and hormones;Bioactive molecules-API;Small molecule inhibitors, natural products |
| 535 | 1254035-84-1 | AZD1979 | AZD1979 AZD-1979 (AZD1979 Methanone, [5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl][3-[4-(2-oxa-6-azaspiro[3.3]hept-6-ylmethyl)phenoxy]-1-azetidinyl]- [5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]-[3-[4-(2-oxa-6-azaspiro[3.3]heptan-6-ylmethyl)-phenoxy]azetidin-1-yl]methanone | |
| 536 | 5897-18-7 | Cyclizine 2HCl | Cyclizine 2HCl Marzine hydrochloride Cyclizine 2hydrochloride Cyclizine dihydrochloride Piperazine, 1-benzhydryl-4-methyl-, dihydrochloride 1-Diphenylmethyl-4-methylpiperazine dihydrochloride Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride | |
| 537 | 2307249-33-6 | BAY-885 | BAY-885 [2-amino-4-(trifluoromethoxy)phenyl]-{4-[7-(4-methylpiperazin-1-yl)pyrido[3,2-d]pyrimidin-4-yl]piperidin-1-yl}methanone Methanone, [2-amino-4-(trifluoromethoxy)phenyl][4-[7-(4-methyl-1-piperazinyl)pyrido[3,2-d]pyrimidin-4-yl]-1-piperidinyl]- | Inhibitor |
| 538 | 117591-20-5 | CALPEPTIN | CALPEPTIN Z-LEU-NLE-CHO Z-LEU-NORLEUCINAL N-CBZ-L-LEUCYL-NORLEUCINAL BENZYLOXYCARBONYLLEUCYL-NORLEUCINAL BENZYLOXYCARBONYLDIPEPTIDYL ALDEHYDE N-BENZYLOXYCARBONYL-L-LEUCYLNORLEUCINAL N-BENZYLOXYCARBONYL-L-LEUCYL-NORLEUCINAL | Standards;Inhibitors;Calcium signaling;Small molecule inhibitors, natural products |
| 539 | 58944-73-3 | SINEFUNGIN | SF rp32232 SINEFUNGIN compound57926 6,7,8,9-hexadeoxy-yl)-5 5'-DEOXY-5'-(1,4-DIAMINO-4-CARBOXYBUTYL)ADENOSINE 6,9-diamino-1-(6-amino-9h-purin-9-d-glycero-alpha-l-talo-decofuranuronicaci 6,9-diamino-1-(6-amino-9h-purin-9-yl)-1,5,6,7,8,9-hexadeoxydecofuranuronica | Microbial metabolites;Chemical raw materials;Pharmaceutical raw materials |
| 540 | 197855-65-5 | Z-PHE-DL-ALA-FLUOROMETHYLKETONE | CS-1504 Z-Phe-DL-Ala-FMK Z-PHE-DL-ALA-FLUOROMETHYLKETONE Nalpha-[(Benzyloxy)Carbonyl]-N-(4-Fluoro-3-Oxo-2-Butanyl)Phenylalaninamide Nalpha-[(Benzyloxy)Carbonyl]-N-(4-Fluoro-3-Oxo-2-Butanyl)Phenylalaninamide z-fa-fmk Carbamic acid,N-[(1S)-2-[(3-fluoro-1-methyl-2-oxopropyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-,phenylmethyl ester | API;Inhibitors;Small molecule inhibitors, natural products |
| 541 | 188968-51-6 | Cilengitide | CS-1500 CS-2674 EMD121974 EMD 121974 EMD-121974 cilengitide Cilengitide C(RGDf-Me-V) Cilengitide(EMD121974,NSC-707544) Cyclo(L-arginylglycyl-L-aspartyl-D-phenylalanyl-N-methyl-L-valyl) 2-[(2S,5R,8S,11S)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid | Spot;Inhibitors;Drug peptides;Peptide inhibitors;Polypeptide products;Cell biology reagents;Small molecule inhibitors;Small molecule inhibitors, natural products |
| 542 | 1346546-69-7 | GSK'872 | GSK872 GSK'872 CS-2489 GSK-872 GSK 872 GSK2399872A N-5-benzothiazolyl-6-[(1-methylethyl)sulfonyl]-4-Quinolinamine N-(6-propan-2-ylsulfonylquinolin-4-yl)-1,3-benzothiazol-5-amine N-(6-(Isopropylsulfonyl)quinolin-4-yl)benzo[d]thiazol-5-amine HCl salt | Small molecule inhibitor |
| 543 | 130663-39-7 | PD-123319 | CS-953 PD 123319 PD-123319 PD 123,319 PD 123319 ditrifluoroacetate PD 123,319 DITRIFLUOROACETATE PD 123,319 DITRIFLUOROACETATE POTENT AND SELECTIVE 1-((4-(Dimethylamino)-3-methylphenyl)methyl)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4.5-c]pyridine-6-carboxyli (3S)-9-[(4-DIMETHYLAMINO-3-METHYL-PHENYL)METHYL]-4-(2,2-DIPHENYLACETYL)-4,7,9-TRIAZABICYCLO[4.3.0]NONA-7,10-DIENE-3-CARBOXYLIC ACID 1-[[4-(DIMETHYLAMINO)-3-METHYLPHENYL]METHYL]-5-(DIPHENYLACETYL)-4,5,6,7-TETRAHYDRO-1H-IMIDAZO[4,5-C]PYRIDINE-6-CARBOXYLIC ACID DITRIFLUOROACETATE S(+)-1-[[4-(DIMETHYLAMINO)-3-METHYLPHENYL]METHYL]-5-(DIPHENYLACETYL)-4,5,6,7-TETRAHYDRO-1H-IMIDAZOL[4,5-C]PYRIDINE-6-CARBOXYLIC ACID DITRIFLUOROACETATE | Inhibitors;Angiotensin;Endocrine and hormones;Small molecule inhibitors, natural products |
| 544 | 91037-75-1 | GRGDSP | GRGDSP glycyl-arginyl-glycyl-aspartyl-seryl-proline Glycyl-L-arginylglycyl-L-α-aspartyl-L-seryl-L-proline L-Proline, glycyl-L-arginylglycyl-L-α-aspartyl-L-seryl- | Standard;List of polypeptides |
| 545 | 54863-37-5 | Dapansutrile | OLT1177 OLT-1177 OLT 1177 DAPANSUTRILE Dapansutrile Dapansutrile (OLT1177) PIMASERTIB HYDROCHLORIDE Pimasertib Hydrochloride 3-Methanesulfonylpropanenitrile Propanenitrile, 3-(methylsulfonyl)- | Inhibitors;bulk products |
| 546 | 344458-19-1 | PJ34 | PJ34 PJ-34 PJ34(free base) N,N-Dimethyl-2-(6-oxo-5,6-dihydrophenanthridin-2-yl)acetamide N-(6-OXO-5,6-DIHYDRO-PHENANTHRIDIN-2-YL)-N,N-DIMETHYLACETAMIDE HCL Acetamide, N-(5,6-dihydro-6-oxo-2-phenanthridinyl)-2-(dimethylamino)- N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)-2-(N,N-dimethylamino)acetamide N-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)-N,N-DIMETHYLACETAMIDE HYDROCHLORIDE N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)-2-(N,N-dimethylamino)acetamide PJ 34 | Inhibitors;DNA damage;Small molecule inhibitors, natural products |
| 547 | 2183470-12-2 | GCN2iB | GCN2IB GCN2iB GCN2iB HCl salt N-[3-[2-(2-Amino-5-pyrimidinyl)ethynyl]-2,4-difluorophenyl]-5-chloro-2-methoxy-3-pyridinesulfonamide 3-Pyridinesulfonamide, N-[3-[2-(2-amino-5-pyrimidinyl)ethynyl]-2,4-difluorophenyl]-5-chloro-2-methoxy- | Small molecule inhibitor |
| 548 | 154566-12-8 | SB 204990 | SB 204990 SB-204990(racemic) YTRNLFYTHYWDAU-KDOFPFPSSA-N (3R,5S)-rel-5-[6-(2,4-Dichlorophenyl)hexyl]tetrahydro-3-hydroxy-2-oxo-3-furanacetic acid 2-((3R,5S)-5-(6-(2,4-dichlorophenyl)hexyl)-3-hydroxy-2-oxotetrahydrofuran-3-yl)acetic acid 3-Furanacetic acid, 5-[6-(2,4-dichlorophenyl)hexyl]tetrahydro-3-hydroxy-2-oxo-, (3R,5S)-rel- | Chemical reagent |
| 549 | 1374040-24-0 | Furimazine | 185252 PBI 3939 Furimazine Furimazine (PBI 3939) 8-benzyl-2-(furan-2-ylmethyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one 8-benzyl-2-[(furan-2-yl)methyl]-6-phenyl-3H,7H-imi dazo[1,2-a]pyrazin-3-one 8-benzyl-2-(furan-2-ylmethyl)-6-phenyl-3,7-dihydroimidazo[1,2-a]pyrazin-3-one Imidazo[1,2-a]pyrazin-3(7H)-one, 2-(2-furanylmethyl)-6-phenyl-8-(phenylmethyl)- | Compound;Biochemical Industry |
| 550 | 1256565-36-2 | PTC299 | PTC299 Emvododstat Emvododstat (PTC299) 9-tetrahydropyrido[3 4-b]indole-2-carboxylate (4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1 (4-chlorophenyl) 6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate (4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate 2H-Pyrido[3,4-b]indole-2-carboxylic acid, 6-chloro-1,3,4,9-tetrahydro-1-(4-methoxyphenyl)-, 4-chlorophenyl ester, (1S)- | Chemical reagents |
| 551 | 1186649-91-1 | ML-109 | ML-109 ML-109 (CID-25246343) N-[4-[[2-Methoxy-5-[1,2,3,4-tetrahydro-5-hydroxy-4-oxo-3-(phenylmethyl)-2-quinazolinyl]phenyl]methoxy]phenyl]acetamide Acetamide, N-[4-[[2-methoxy-5-[1,2,3,4-tetrahydro-5-hydroxy-4-oxo-3-(phenylmethyl)-2-quinazolinyl]phenyl]methoxy]phenyl]- | API;Inhibitor |
| 552 | 1660114-31-7 | NIK SMI1 | NIK SMI1 NIK inhibitor 4f(NIK SMI1) (R)-6-(3-((3-Hydroxy-1-methyl-2-oxopyrrolidin-3-yl)ethynyl)phenyl)-4-methoxypicolinamide 2-Pyridinecarboxamide, 6-[3-[2-[(3R)-3-hydroxy-1-methyl-2-oxo-3-pyrrolidinyl]ethynyl]phenyl]-4-methoxy- | inhibitors;Small molecule inhibitors |
| 553 | 2237942-08-2 | MC180295 | MC180295 MC 180295 MC-180295 (rel)-MC180295 MC180295 ((REL)-MC180295) Methanone, [4-amino-2-[(1R,2R,4S)-bicyclo[2.2.1]hept-2-ylamino]-5-thiazolyl](2-nitrophenyl)-, rel- | Inhibitor;reference substance |
| 554 | 1352610-25-3 | EW-7197 Hydrochloride | EW-7197 EW-7197 Hydrochloride TEW-7197 Hydrochloride Vactosertib Hydrochloride VACTOSERTIB HYDROCHLORIDE Vactosertib (EW-7197) Hydrochloride | |
| 555 | 77465-10-2 | Adrenocorticotropic Hormone (ACTH) (1-39), rat | SF-39 ACTH 1-39 CORTICOTROPIN A ACTH (1-39) (RAT) ACTH (1-39) (MOUSE, RAT) ADRENOCORTICOTROPIC HORMONE RAT ADRENOCORTICOTROPIC HORMONE (1-39) (RAT) Adrenocorticotropic Hormone (ACTH) (1-39), rat SER-TYR-SER-MET-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL-GLY-LYS-LYS-ARG-ARG-PRO-VAL-LYS-VAL-TYR-PRO-ASN-VAL-ALA-GLU-ASN-GLU-SER-ALA-GLU-ALA-PHE-PRO-LEU-GLU-PHE H-SER-TYR-SER-MET-GLU-HIS-PHE-ARG-TRP-GLY-LYS-PRO-VAL-GLY-LYS-LYS-ARG-ARG-PRO-VAL-LYS-VAL-TYR-PRO-ASN-VAL-ALA-GLU-ASN-GLU-SER-ALA-GLU-ALA-PHE-PRO-LEU-GLU-PHE-OH | Peptide;Polypeptides;Directory polypeptide |
| 556 | 2095719-92-7 | ASTX-029 | ASTX-029 (R)-2-(6-(5-chloro-2-((tetrahydro-2H-pyran-4-yl)amino)pyrimidin-4-yl)-1-oxoisoindolin-2-yl)-N-((S)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl)propanamide 2H-Isoindole-2-acetamide, 6-[5-chloro-2-[(tetrahydro-2H-pyran-4-yl)amino]-4-pyrimidinyl]-N-[(1S)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]-1,3-dihydro-α-methyl-1-oxo-, (αR)- | Spot supply |
| 557 | 2221948-93-0 | Bis-PEG17-NHS ester | Bis-PEG17-NHS ester Bis-dPEG17-NHS ester 4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52-Heptadecaoxapentapentacontanedioic acid, 1,55-bis(2,5-dioxo-1-pyrrolidinyl) ester | PEG Products-Activated molecular |
| 558 | 2221948-98-5 | Bis-PEG21-NHS ester | Bis-PEG21-NHS ester Bis-dPEG21-NHS ester | PEG Products-Activated molecular |
| 559 | 2221948-96-3 | Bis-PEG25-NHS ester | Bis-PEG25-NHS ester Bis-peg25-nhs ester Bis-dPEG25-NHS ester | PEG Products-Activated molecular |
| 560 | 146478-72-0 | FR901464 | WB 2663B FR901464 PJKVJJDQXZARCA-QHYZBLTGSA-N 2-Pentenamide, 4-(acetyloxy)-N-[(2R,3R,5S,6S)-6-[(2E,4E)-5-[(3R,4R,5R,7S)-4,7-dihydroxy-7-methyl-1,6-dioxaspiro[2.5]oct-5-yl]-3-methyl-2,4-pentadien-1-yl]tetrahydro-2,5-dimethyl-2H-pyran-3-yl]-, (2Z,4S)- | Chemical reagent |
| 561 | 2226733-37-3 | Mal-PEG24-NHS ester | Mal-PEG24-NHS ester Maleimide-PEG24-NHS Ester | PEG Products-Activated molecular |
| 562 | 2358775-70-7 | PROTAC CRBN Degrader-1 | CRBNPROTAC?14A CRBN PROTAC?14a PROTAC CRBN Degrader-1 | Small molecule drug |
| 563 | 1527475-61-1 | PF-06685360 | PFE-360 PF-06685360 PFE-06685360 1H-Pyrrole-2-carbonitrile, 1-methyl-4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]- | Reference substance |
| 564 | 104615-00-1 | CGS 15696 | CGS 15696 9-chloro-2-(furan-2-yl)-3H-[1,2,4]triazolo[1,5-c]quinazolin-5-one 1,2,4]Triazolo[1,5-c]quinazolin-6(5H)-one,9-chloro-2-(2-furanyl)- (9CI) | Nitrogen Heterocycle |
| 565 | 151928-32-4 | WIN 66306 | WIN 66306 | Formulation-antagonist |
| 566 | 127481-29-2 | L 674573 | 573 L674 L-674 L 674 L 674573 2-[[4-phenyl-1-[4-(2-quinolinylmethoxy)phenyl]butyl]thio]Acetic acid | Customized |
| 567 | 841290-81-1 | R406 | R406 CS-735 Tamatinib R406 tosilate R406(benzenesulfonate) 6-[[5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-2H-pyrido[3,2 6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one benzenesulfonate 6-[[5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one benzenesulfonate | APIs-APIs;Inhibitors;Small molecule Inhibitors, natural products |
| 568 | 1421783-64-3 | GZD824 | GZD824 CS-1086 GZD824DIMESYLATE GZD824 GZD824DIMESYLATE GSK-3 INHIBITOR IX, 6-BROMOINDIRUBIN-3-OXIME, 6-BROMOINDIRUBIN-3'-OXIME, MLS 2052 Benzamide, 4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-(1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]-, methanesulfonate GZD824 GZD824DIMESYLATE Benzamide, 4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-(1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]-, meth | Inhibitors;Angiogenesis;Small molecule Inhibitors;Small molecule Inhibitors, natural products |
| 569 | 1802928-88-6 | Cy3.5 Carboxylic acids | Cy3.5 Carboxylic acids | Fluorescent Dye |
| 570 | 1144044-02-9 | CWP232228 | CWP232228 CWP232228?sodium CWP232228 disodium | Standard |
| 571 | 1421854-16-1 | AC 186 | AC 186 4-[4,4-Difluoro-1-(2-fluorophenyl)cyclohexyl]phenol Phenol, 4-[4,4-difluoro-1-(2-fluorophenyl)cyclohexyl]- | Formulation-agonist |
| 572 | 908305-13-5 | S-22611,Epertinib | S222611) Epertinib S-22611,Epertinib Epertinib (S-222611 (S,Z)-1-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)but-2-yn-1-one O-morpholin-3-ylmethyl oxime 2-Butyn-1-one, 1-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-, O-[(3R)-3-morpholinylmethyl]oxime, (1Z)- | Inhibitors |
| 573 | 875356-43-7 | Secukinumab | Secukinuma Secukinumab | Mab 19;Drug Substance;Chemical reagent |
| 574 | 207732-11-4 | BB-78485 | BB-78485 | Formulation-inhibitor |
| 575 | 1688703-26-5 | Stafib-1 | Stafib-1 | |
| 576 | 1394011-91-6 | UC2288 | UC2288 1394011-91-6 | |
| 577 | 2380001-43-2 | Reverse transcriptase-IN-1 | Reverse transcriptase-IN-1 | |
| 578 | 2160546-07-4 | 4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl- | IACS13909 IACS-13909 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl- | Inventory;Pharmaceutical raw materials |
| 579 | 2170848-99-2 | QPX7728-OH disodium | QPX7728-OH disodium | |
| 580 | 2179128-11-9 | J52-2F/J91 | P9178 J91, J52-4F | Research materials intermediates;Organic optoelectronic materials-OPV Donors |
| 581 | 870153-29-0 | 1H-Indole-2-carboxamide, N-[(1S)-1-[[[(1S)-3-hydroxy-2-oxo-1-[[(3S)-2-oxo-3-pyrrolidinyl]methyl]propyl]amino]carbonyl]-3-methylbutyl]-4-methoxy- (9CI) | PF-00835231 PF-00835231 (PF-835231) 1H-Indole-2-carboxamide, N-[(1S)-1-[[[(1S)-3-hydroxy-2-oxo-1-[[(3S)-2-oxo-3-pyrrolidinyl]methyl]propyl]amino]carbonyl]-3-methylbutyl]-4-methoxy- (9CI) | |
| 582 | 2253733-11-6 | NADA-green | NADA-GREEN NADA-green | Small molecule drugs |
| 583 | 2331255-53-7 | 4H-1,4-Benzoxazine-4-carboxylic acid, 2,3-dihydro-, 7-[(4-chlorophenyl)methyl]hexahydro-1,3-dioxoimidazo[1,5-a]pyrazin-2-yl ester | ABC99 4H-1,4-Benzoxazine-4-carboxylic acid, 2,3-dihydro-, 7-[(4-chlorophenyl)methyl]hexahydro-1,3-dioxoimidazo[1,5-a]pyrazin-2-yl ester | Formulation-inhibitor |
| 584 | 896684-04-1 | 4H-1,2,4-Benzothiadiazine-3-propanamide, 6-methyl-N-[3-(tricyclo[3.3.1.13,7]dec-1-yloxy)propyl]-, 1,1-dioxide | BTD-TRPC5 activator 4H-1,2,4-Benzothiadiazine-3-propanamide, 6-methyl-N-[3-(tricyclo[3.3.1.13,7]dec-1-yloxy)propyl]-, 1,1-dioxide | Bioactive Small Molecule |
| 585 | 1952247-05-0 | 1H-Benzimidazole-5-sulfonamide, 1-[(2,4-dimethyl-5-thiazolyl)methyl]-2,3-dihydro-N-(1-methylcyclopropyl)-2-oxo-3-(1,2,4-thiadiazol-5-yl)- | PDD 00017238 1H-Benzimidazole-5-sulfonamide, 1-[(2,4-dimethyl-5-thiazolyl)methyl]-2,3-dihydro-N-(1-methylcyclopropyl)-2-oxo-3-(1,2,4-thiadiazol-5-yl)- | Formulation-inhibitor |
| 586 | 1542132-88-6 | ZED-1227 | ZED-1227 2-Heptenoic acid, 7-[[1-[2-[(2-ethylbutyl)amino]-2-oxoethyl]-1,2-dihydro-2-oxo-3-pyridinyl]amino]-6-[[(1-methyl-1H-imidazol-5-yl)carbonyl]amino]-7-oxo-, methyl ester, (2E,6S)- | Pharmaceutical raw materials |
| 587 | 2381037-82-5 | (S)-5-((1-(3-oxo-3-(4-(5-(trifluoromethyl)pyrimidin-2-yl)piperazin-1-yl)propoxy)propan-2-yl)amino)-4-(trifluoromethyl)pyridazin-3(2H)-one | Cpd 561 RBN-2397 CPD 561 Atamparib Atamparib (RBN-2397) (S)-5-((1-(3-oxo-3-(4-(5-(trifluoromethyl)pyrimidin-2-yl)piperazin-1-yl)propoxy)propan-2-yl)amino)-4-(trifluoromethyl)pyridazin-3(2H)-one 4-[[(2S)-1-[3-oxo-3-[4-[5-(trifluoromethyl)pyrimidin-2-yl]piperazin-1-yl]propoxy]propan-2-yl]amino]-5-(trifluoromethyl)-1H-pyridazin-6-one 3(2H)-Pyridazinone, 5-[[(1S)-1-methyl-2-[3-oxo-3-[4-[5-(trifluoromethyl)-2-pyrimidinyl]-1-piperazinyl]propoxy]ethyl]amino]-4-(trifluoromethyl)- | Inventory;Inhibitors;Active small molecule library |
| 588 | 219861-53-7 | (R)-Citalopram Oxalate | (R)-Citalopram oxalate (R)-Citalopram Oxalate Citalopram Impurity 1((R)-Isomer) Escitalopram EP Impurity K Oxalate ((R)-Citalopram Oxalate) R-(-)-1-[3-(diMethylaMino)propyl]-1-(p-fluorophenyl)-5-phthalancarbonitrile oxalate (1R)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile,oxalic acid 1-(3-Dimethylamino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran-5-carbonitrile Oxalate (-)-(R)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile oxalate R-Citalopram Oxalate (10 mg) (R-(-)-1-[3-(dimethylamino)propyl]-1-(p-fluorophenyl)-5-phthalancarbonitrile oxalate) | Neurochemicals;Pharmaceuticals;229-escitalopram;Heterocyclic Compounds;Escitalopram impurity X;Mediates & Fine Chemicals;Intermediates & Fine Chemicals |
| 589 | 149838-21-1 | PD-85639 | PD-85639 | Formulation-inhibitor |
| 590 | 96206-92-7 | MPEP | MPEP CS-715 MPEP,HCl MPEP HYDROCHLORIDE 2-methyl-6-(2-phenylethynyl)pyridine 6-METHYL-2-(PHENYLETHYNYL)-PYRIDINE HCL 2-METHYL-6-(PHENYLETHYNYL)PYRIDINE HYDROCHLORIDE | Glutamate;Inhibitors;Glutamates;All Inhibitors;Neurochemicals;Pyridines, Pyr;Neural signaling;Glutamate receptor;Glutamates receptors;Small molecule Inhibitors, natural products |
| 591 | 1234365-97-9 | Tenapanor HCl | AZD1722 RDX5791 AZD-1722 IBSRELA. AZD 1722 RDX-5791 RDX 5791 TENAPANOR Tenapanor HCl Tenapanor hydrochloride TENAPANOR HYDROCHLORIDE Tenapanor dihydrochloride TENAPANOR DIHYDROCHLORIDE | |
| 592 | 935283-04-8 | Linzagolix | OBE2109 OBE-2109 OBE 2109 KLH2109 OBE2109 KLH-2109 OBE-2109 OBE 2109 KLH 2109 Linzagolix LINZAGOLIX Thieno[3,4-d]pyrimidine-5-carboxylic acid, 3-[5-[(2,3-difluoro-6-methoxyphenyl)methoxy]-2-fluoro-4-methoxyphenyl]-1,2,3,4-tetrahydro-2,4-dioxo- | |
| 593 | 2056261-42-6 | BRD5648 | BRD5648 (R)-BRD0705 | Formulation-inhibitor |
| 594 | 2307628-67-5 | 4,6-Quinazolinediamine, N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]- | 4,6-Quinazolinediamine, N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]- | Superior Supply |
| 595 | 1704492-14-7 | 5-Pyrimidinemethanamine, α-(4-fluorophenyl)-α-methyl-2-(1-piperazinyl)-, (αS)- | 5-Pyrimidinemethanamine, α-(4-fluorophenyl)-α-methyl-2-(1-piperazinyl)-, (αS)- | |
| 596 | 2222094-18-8 | 2-Propanol, 1-[bis(phenylmethyl)amino]-3-[4-(trifluoromethyl)phenoxy]- | BC-1618 2-Propanol, 1-[bis(phenylmethyl)amino]-3-[4-(trifluoromethyl)phenoxy]- | |
| 597 | 1305116-69-1 | PF-04671536 | PF-04671536 | Formulation-inhibitor |
| 598 | 1599440-20-6 | Glycinamide, glycylglycyl-L-phenylalanyl-N-[(carboxymethoxy)methyl]- | Glycinamide, glycylglycyl-L-phenylalanyl-N-[(carboxymethoxy)methyl]- (S)-16-amino-10-benzyl-6,9,12,15-tetraoxo-3-oxa-5,8,11,14-tetraazahexadecanoic acid | ADC;ADC Linker;Biological reagent |
| 599 | 2479378-45-3 | PRGL493 | PRGL493 | Formulation-inhibitor |
| 600 | 2564467-25-8 | VH 032 amide-alkylC3-amine | VH 032 amide-alkylC3-amine VH 032 AMIDE-ALKYLC3-AMINE (S,R,S)-AHPC-C3-NH2(dihydrochloride) | Small molecule drugs |
| 601 | 2006345-40-8 | BDP 650/665 alkyne | Tool molecule-dye | |
| 602 | 2102681-49-0 | SHMT-IN-2 | SHIN2 SHMT-IN-2 Pyrano[2,3-c]pyrazole-5-carbonitrile, 6-amino-2,4-dihydro-3-methyl-4-(1-methylethyl)-4-[3-(1-pyrrolidinyl)-5-(trifluoromethyl)phenyl]- | APIS;Preparations-inhibitors |
| 603 | 2060573-82-0 | MT1 BET inhibitor | MT1 BET inhibitor MT1 BET INHIBITOR 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, N,N'-3,6,9,12,15,18,21-heptaoxatricosane-1,23-diylbis[4-(4-chlorophenyl)-2,3,9-trimethyl-, (6S,6'S)- | Formulation-inhibitor |
| 604 | 780771-24-6 | BbGL-2 | BBGL-2 BbGL-2 α-D-Galactopyranoside, (2S)-2-[(1-oxohexadecyl)oxy]-3-[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]propyl | Small molecule drugs |
| 605 | 202284-84-2 | Phosphoramidous acid, bis(1-methylethyl)-, 2-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-(methylamino)-2-[(methylamino)carbonyl]-3-oxopropyl 2-cyanoethyl ester (9CI) | PHOSPHORYLATION AMIDITE Phosphorylation amidite Chemical phosphorylation amidite Solid Chemical phosphorylation reagent II 3-(4,4'-Dimethoxytrityloxy)-2,2-dicarboxymethylamido]propyl-(2-cyanoethyl)-(N,N-diisopropyl)-phosphoramidite Phosphoramidous acid, bis(1-methylethyl)-, 2-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-(methylamino)-2-[(methylamino)carbonyl]-3-oxopropyl 2-cyanoethyl ester (9CI) | New reagents |
| 606 | 883944-52-3 | 5-Isoxazolecarboxamide, N-[[4-(4-methyl-1-piperazinyl)phenyl]methyl]- | SSAA09E2 5-Isoxazolecarboxamide, N-[[4-(4-methyl-1-piperazinyl)phenyl]methyl]- | Formulation-inhibitor |
| 607 | 854402-59-8 | SNJ-1945 | SNJ-1945 Carbamic acid, N-[(1S)-1-[[[(1S)-3-(cyclopropylamino)-2,3-dioxo-1-(phenylmethyl)propyl]amino]carbonyl]-3-methylbutyl]-, 2-(2-methoxyethoxy)ethyl ester | Formulation-inhibitor |
| 608 | 2229711-08-2 | ARV-471 | ARV-471 (S)-3-(5-(4-((4-(4-((1R,2S)-6-hydroxy-2 -phenyl-1,2,3,4-tetrahydronaphthalen-1- yl)phenyl)cyclohexyl)methyl)piperazin- 1-yl)-1-oxoisoindolin-2-yl)piperidine-2, 6-dione | Inhibitor;Drug Substance |
| 609 | 2245880-46-8 | PF-07338233 | AV-006 ARX-1796 PF-07338233 ethyl 3-(((((2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl)oxy)sulfonyl)oxy)-2,2-dimethylpropanoate | |
| 610 | 2171019-55-7 | BMS-986256 | BMS-986256 AFIMETORAN 1-Piperidineacetamide, 4-[2-(7,8-dimethyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-(1-methylethyl)-1H-indol-5-yl]- | |
| 611 | 1436862-38-2 | (2S,5R)-7-oxo-2-(2-((S)-pyrrolidine-3-carbonyl)hydrazine-1-carbonyl)-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | WCK-5153 WCK 5153 (S) (2S,5R)-7-oxo-2-(2-((S)-pyrrolidine-3-carbonyl)hydrazine-1-carbonyl)-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | Beta-lactamase inhibitors |
| 612 | 929046-33-3 | N-{6-[(7S,9aS)-7-(hydroxymethyl)-octahydropyrazino[2,1-c][1,4]oxazin-8-yl]-4-(4-fluoro-2-methylphenyl)pyridin-3-yl}-2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethylpropanamide | NT814 NT-814 NT 814 NT814 NT-814 NT 814 GSK1144814A Elinzanetant GSK 1144814A ELINZANETANT GSK1144814A GSK-1144814A N-{6-[(7S,9aS)-7-(hydroxymethyl)-octahydropyrazino[2,1-c][1,4]oxazin-8-yl]-4-(4-fluoro-2-methylphenyl)pyridin-3-yl}-2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethylpropanamide Benzeneacetamide, N-[4-(4-fluoro-2-methylphenyl)-6-[(7S,9aS)-hexahydro-7-(hydroxymethyl)pyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-3-pyridinyl]-N,α,α-trimethyl-3,5-bis(trifluoromethyl)- | Small molecule inhibitors;Pharmaceutical raw materials |
| 613 | 2417089-74-6 | 3-Acridinecarboxamide, 9-chloro-5,6,7,8-tetrahydro-N-[(4S)-5-[4-hydroxy-4-[[7-[[3-(4-methyl-1-piperazinyl)-1-oxopropyl]amino]-4-oxo-3(4H)-quinazolinyl]methyl]-1-piperidinyl]-5-oxo-4-(phenylmethyl)pentyl]- | XL177A 3-Acridinecarboxamide, 9-chloro-5,6,7,8-tetrahydro-N-[(4S)-5-[4-hydroxy-4-[[7-[[3-(4-methyl-1-piperazinyl)-1-oxopropyl]amino]-4-oxo-3(4H)-quinazolinyl]methyl]-1-piperidinyl]-5-oxo-4-(phenylmethyl)pentyl]- | Inhibitors |
| 614 | 2201056-66-6 | Pyrazolo[1,5-a]pyrimidin-7(4H)-one, 3-(1-cyclohexen-1-yl)-6-(4-methoxyphenyl)-2-phenyl-5-(2-pyridinylamino)- | AG-270 (AG270) 3-(1-Cyclohexenyl)-6-(4-methoxyphenyl)-2-phenyl-5-(2-pyridylamino)pyrazolo[1,5-a]pyrimidin-7(4H)-one Pyrazolo[1,5-a]pyrimidin-7(4H)-one, 3-(1-cyclohexen-1-yl)-6-(4-methoxyphenyl)-2-phenyl-5-(2-pyridinylamino)- | Inhibitors;Customized;Pharmaceutical and chemical intermediates |
| 615 | 1570231-89-8 | APG-1387 | SM1387 SM-1387 SM 1387 APG-1387 APG 1387l Pyrrolo[1,2-a][1,5]diazocine-8-carboxamide, 3,3'-[1,3-phenylenebis(sulfonyl)]bis[N-(diphenylmethyl)decahydro-5-[[(2S)-2-(methylamino)-1-oxopropyl]amino]-6-oxo-, (5S,5'S,8S,8'S,10aR,10'aR)- (5S,8S,10aR)-N-benzhydryl-3-((3-(((5R,8S,10aS)-8-(benzhydrylcarbamoyl)-5-((S)-2-(methylamino)propanamido)-6-oxooctahydropyrrolo[1,2-a][1,5]diazocin-3(4H)-yl)sulfonyl)phenyl)sulfonyl)-5-((S)-2-(methylamino)propanamido)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide | Pharmaceutical raw materials |
| 616 | 2451862-42-1 | GSK778 | GSK778 FREEBASE iBET-BD1 iBET-BD1 dihydrochloride 1H-Imidazo[4,5-c]quinoline, 7-(3,5-dimethyl-4-isoxazolyl)-2-(methoxymethyl)-1-[(1R)-1-phenylethyl]-8-[(3S)-3-pyrrolidinylmethoxy]- | |
| 617 | 2648641-36-3 | TPX-0131 | TPX-0131 | API;Organic;Inhibitors;Main products;Small molecule inhibitors;Pharmaceutical raw materials;Active small molecule library |
| 618 | 2569009-58-9 | Benzenesulfonamide, 2,6-dimethoxy-N-[4-methoxy-6-(1H-pyrazol-1-ylmethyl)-1,2-benzisoxazol-3-yl]- | PF-9363 CTX-3648 2,6-dimethoxy-N-[4-methoxy-6-(1H-pyrazol-1 -ylmethyl)-1,2-benzoxazol-3-yl]benzenesulfonamide Benzenesulfonamide, 2,6-dimethoxy-N-[4-methoxy-6-(1H-pyrazol-1-ylmethyl)-1,2-benzisoxazol-3-yl]- | Inventory |
| 619 | 1436862-02-0 | (2S,5R)-7-oxo-2-(2-((R)-pyrrolidine-3-carbonyl)hydrazine-1-carbonyl)-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | WCK 5153 (R) (2S,5R)-7-oxo-2-(2-((R)-pyrrolidine-3-carbonyl)hydrazine-1-carbonyl)-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | Beta-lactamase inhibitors |
| 620 | 1801503-93-4 | BET-IN-4 | ODM-207 BET-IN-4 2(1H)-Quinolinone, 6-(3,5-dimethyl-4-isoxazolyl)-7-methoxy-3-methyl-1-(2-pyridinylmethyl)- | Control |
| 621 | 2364554-48-1 | 1H-Pyrazole-4-carboxamide, N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]-1-methyl- | CK-274 Aficamten AFICAMTEN Aficamten (CK-3773274 1H-Pyrazole-4-carboxamide, N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]-1-methyl- | Inventory |
| 622 | 1675970-12-3 | 2,8-Diazaspiro[4.5]decane-2,3,8-tricarboxylic acid, 8-(1,1-dimethylethyl) 3-ethyl 2-(phenylmethyl) ester, (3S)- | 2,8-Diazaspiro[4.5]decane-2,3,8-tricarboxylic acid, 8-(1,1-dimethylethyl) 3-ethyl 2-(phenylmethyl) ester, (3S)- | |
| 623 | 1358751-06-0 | Pyrazino[2,1-c][1,2,4]thiadiazine, 9-[4-(cyclohexyloxy)phenyl]-3,4-dihydro-7-methyl-, 2,2-dioxide | TAK-653 Pyrazino[2,1-c][1,2,4]thiadiazine, 9-[4-(cyclohexyloxy)phenyl]-3,4-dihydro-7-methyl-, 2,2-dioxide | |
| 624 | 1817773-66-2 | 8-((S)-1-Cyclopropyl-ethyl)-2-(4-cyclopropyl-6-methyl-pyrimidin-5-yl)-6-[(5-methanesulfonyl-pyridin-2-ylmethyl)-amino]-8H-pteridin-7-one | Bevurogant 8-((S)-1-Cyclopropyl-ethyl)-2-(4-cyclopropyl-6-methyl-pyrimidin-5-yl)-6-[(5-methanesulfonyl-pyridin-2-ylmethyl)-amino]-8H-pteridin-7-one | |
| 625 | 2225940-48-5 | Pentanoic acid, 5-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]- | JUN 40485 Pomalidomide-C4-COOH 5-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)pentanoic acid Pentanoic acid, 5-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]- | Small molecule drugs |
| 626 | 1436861-92-5 | (2S,5R)-2-(2-(L-prolyl)hydrazine-1-carbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | (2S,5R)-2-(2-(L-PROLYL)HYDRAZINE-1-CARBONYL)-7-OXO-1,6-DIAZABICYCLO[3.2.1]OCTAN-6-YL HYDROGEN SULFAT (2S,5R)-2-(2-(L-prolyl)hydrazine-1-carbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | Beta-lactamase inhibitors |
| 627 | 1452458-86-4 | OP-0595 | OP-0595 OP 0595 RG 6080 OP0595 free acid Sulfuric acid, mono[(1R,2S,5R)-2-[[(2-aminoethoxy)amino]carbonyl]-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl] ester | Beta-lactamase inhibitors |
| 628 | 14680-51-4 | METONITAZENE | Metonitazen METONITAZENE Metonitazene (4-methoxyphenyl)methyl | Pharm;Chemical raw materials |